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Abstract  
 
Background: Sarcopenic obesity is the condition where obesity and sarcopenia (age-related low 
muscle mass and strength) occur together, which may predispose older individuals to more adverse 
health effects than either of the two conditions alone. Thus, improvements in body composition 
and function are of vital importance. 
 
Aim: The aims of this study were to A) systematically search the databases for nutritional and/or 
exercise interventions in sarcopenic obesity and assess their effectiveness in augmenting body 
composition and function. B) Screen Scottish older community-dwellers for sarcopenia and 
obesity. C) Implement a nutritional and exercise programme for individuals with sarcopenic 
obesity.  
 
Methods: A) Four databases were systematically searched for trials with sarcopenic obese older 
adults. B) Scottish community dwellers (≥ 65 years) were screened for body fat (using bioelectrical 
impedance analysis; BIA), body mass index (BMI), muscle mass, and grip strength. C) Those with 
a high % body fat (≥ 28 % in men; ≥ 40 % in women) and low skeletal muscle mass index (≤ 10.75 
kg·m-2 in men; ≤ 6.75 kg·m-2 in women) were randomly allocated to a 16-week intervention with 
exercise (EX) or exercise plus dietary modifications (EXD). The EX group followed a mixed-
exercise training programme, whereas the EXD followed the same exercise protocol alongside an 
energy-deficit (500 kcal daily deficit) and high protein diet (1.2 – 1.5 g kg bodyweight-1).  
 
Results: A) Two studies were identified from the literature with sarcopenic obese participants (one 
diet and one resistance-exercise trial) but neither noted a significant change in body composition. 
However, resistance exercise training significantly improved physical function. B) In total, 108 
(men, n=29; women, n=79) adults (median (IQR) age, 70 (67, 75) yr) took part in the screening 
test. Prevalence of sarcopenia was 14.8%, of obesity 27.8 % (using BMI) vs 63.0 % (using BIA), 
and sarcopenic obesity 4.6 % (using BMI) vs 12.0 % (using BIA). C) After 16 weeks of the 
intervention, the median (IQR) changes in EXD vs EX in bodyweight, fat mass and muscle mass 
were: -5.0 (-5.0, -6.8) kg vs. +0.5 (0.0, 1.0) kg, -4.7 (-4.8, -4.2) kg vs 0.0 (-0.4, 0.7) kg, and +0.1 
(-0.4, 0.7) kg vs +0.5 (0.3, 0.7) kg, respectively. Improvements that may be of clinical significance 
were noted in both groups for strength and physical function. 
 
Conclusion: More intervention trials are needed with sarcopenic obese older adults. Prevalence of 
high adiposity in Scottish older adults may be higher than what has been previously documented. 
High adiposity and the use of BMI may mask sarcopenia and sarcopenic obesity. A high-protein 
energy-restriction diet with exercise training can potentially improve body compostion, and 
augment physical function in older adults with low muscle and high fat mass.  
 
 
 
 
 
Keywords: sarcopenia, obesity, sarcopenic obesity, body composition, older age, weight loss, 
high protein diet, exercise training, physical function 
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‘The most famous doctors cure by changing the diet and lifestyle of their patient and, by using 
other substances. Such capable doctors have the knowledge and ability to use the therapeutic 
properties of most natural or man-made products’  
The Art 2.6 
 
‘Those who are constitutionally very fat are more apt to die quickly than those who are thin’  
Aphorisms 2.44   
Hippocrates  
 
(Jones 1923; Tsiompanou and Marketos 2013) 
 
 
 ‘The doctor of the future will give no medicine, but will instruct his patient in the care of the 
human frame, in diet and in the cause and prevention of disease’  
 
Thomas Edison  
 
(Anda et al. 1987) 
1 
 
Introduction 
 
Although the previous quotes are separated by approximately 2,000 years, they acknowledge both 
the importance of healthy body composition and how the doctors should embrace lifestyle changes 
as preventative therapy, without however, denying new medical knowledge or the advancements 
that may come with it. Although the medical advancements over the past decades have been 
ground-breaking, one could argue that the essence of the words by Hippocrates and Edison, has 
not been fully materialized. A criticism of contemporary medicine is that it perhaps focuses more 
on alleviating symptoms, mostly by the use of pharmaceutical and surgical interventions, rather 
than embracing a person-centred approach focusing on lifestyle factors, such as diet and physical 
activity (Tsiompanou and Marketos 2013). 
 
Medical advancements have led to a global increase in life expectancy and consequently in the 
number of older adults (Nikolich-Žugich et al. 2016). However, this demographic shift is not 
always translated into more healthy years, since it is accompanied by an increase in rates of 
disabling and often fatal chronic conditions (Group Advisory Council on Ageing Society 2012). 
Approximately 14% of adults aged 65-75 years and 45% of the over 85s require help for activities 
of daily living (Dreyer and Volpi 2005), while falls are the leading cause of accidental-injury 
deaths in older adults in the UK (including Scotland) and the US (CDC 2011; ONS 2015; NRS 
2015). In addition, 70% of hospital admissions and 70% of NHS costs can be accounted for by 
older patients with a long-term condition such as osteoporosis (NOS 2011). Hip fractures amongst 
older adults in the UK account for 85,000 hospital admissions, which equates to £1.9 billion in 
financial costs for the NHS per year (NOS 2011). Moreover, cardiovascular disease remains one 
of the biggest mortality risk factors for men and women aged 65-79 years old (ONS 2015). 
2 
 
Similarly in the US, patients older than 65 years account for 50% of healthcare costs, with the 
leading cause of admissions being cardiovascular disease (Spector et al. 2012). It is therefore 
apparent that the aim of geriatricians and public health systems is not only to cease the rising 
prevalence of disability, morbidity and mortality at a population level but also to extend the years 
of healthy life at an individual level (Nikolich-Žugich et al. 2016).  
 
Sarcopenic obesity is the progressive loss of muscle mass and function with a concomitant 
increase in body fat that comes with advancing age (Baumgartner 2000). It is also one of the key 
metabolic and physiological processes increasing the risk of frailty, bone fractures and disability, 
as well as non-communicable diseases such as cardiovascular disease (CVD), metabolic syndrome 
and type II diabetes (Gusmao-Sena et al. 2016; Molino et al. 2016). In addition, there is evidence 
suggesting that sarcopenic obesity can make older individuals more susceptible to physical 
disability compared to sarcopenia or obesity alone (Baumgartner 2000).  
 
Two of the most fundamental and modifiable lifestyle parameters that can attenuate the deleterious 
effects of ageing on body composition, and augment muscle mass and function as well as 
mobilization of adipose tissue, even in advancing age, are diet and exercise (Witard et al. 2016a). 
The scientific community has placed emphasis on caloric restriction (Picca et al. 2017) with a 
particular focus on optimal protein intakes, and exercise training usually with a combination of 
resistance and aerobic exercises (Churchward-Venne et al. 2014; Witard et al. 2016a).  
 
3 
 
In the following chapter, the definition, aetiology, prevalence, and health consequences of 
sarcopenic obesity will be presented, followed by management strategies based predominantly on 
nutritional and exercise regimes that have shown potential in augmenting body composition and 
function in older age. At the end of Chapter 1, the aims and objectives of this PhD thesis are 
presented.  
 
4 
 
Chapter 1. Literature review: Sarcopenic obesity in ageing  
 
1.1 Overview  
The ageing process can affect the human body in several ways via complex pathways. Considering 
that more than 90% of the older adults (>65 years) suffer from one or more chronic conditions 
(Hung et al. 2011), it is challenging and possibly unrealistic to isolate and study the trajectory of 
single compartments of the body such as the muscle or adipose tissue without investigating whole 
body homeostasis. Moreover, different stressors (genetic or environmental) can potentially modify 
the trajectory of metabolic processes, and affect the quantity as well as the quality of tissues, such 
as the ageing muscle. Therefore, where possible the mechanisms leading to sarcopenic obesity 
will be acknowledged, however greatest emphasis will be placed on the outcomes of muscle 
atrophy and increased adiposity in relation to comorbidities, physical function and health related 
quality of life. Thus, it will be discussed how sarcopenic obesity can potentially lead to functional 
impairments, poor clinical prognosis, increased risk of bone fractures, CVD and metabolic 
syndrome, and consequently loss of independence/ institutionalisation, lower quality of life, and 
increased morbidity and mortality rates. Moreover, it will be discussed how physical inactivity 
and poor dietary habits can affect the onset/progression of sarcopenic obesity.  
 
1.1.1 Definition and operational diagnosis of sarcopenia, obesity and sarcopenic obesity  
One of the most noticeable changes in older age is the loss of muscle, accompanied by a decline 
in strength and physical function. The peak in muscle mass and strength is usually reached 
between 25 and 30 years of age and after that it declines (Lexell et al. 1988). After the third decade 
of life muscle mass declines at a rate of 0.5-2% per year, whereas the loss of strength is more 
precipitous with a decline of 3-4% expected annually (Mitchell et al. 2012). Therefore, by the age 
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of 80 approximately 40% of the muscle mass may be lost (Lexell et al. 1988). The term 
‘sarcopenia’, was initially introduced to define the age-related atrophy of muscle mass (Evans 
1995; Rosenberg 1997). Rosenberg noted that the most significant change that comes with age is 
the loss of lean mass, which is primarily driven by the loss of muscle tissue. The importance of 
this condition was explicitly expressed by Rosenberg: ‘no decline with age is as dramatic as the 
decline in lean body mass’ (Rosenberg 1997).  According to Rosenberg, the loss of lean mass that 
occurs with increasing age can have a deleterious effect on energy intake and nutritional status, 
mobility, breathing and independence. He also suggested that in order for this phenomenon to be 
acknowledged as a serious condition by the scientific community, it should be given a name; 
therefore, he suggested two terms, sarcomalacia and sarcopenia. The latter prevailed in the 
literature in the following years (Rosenberg 1997).  
 
Baumgartner et al. (1998) provided one of the first operational definitions of sarcopenia which, 
similar to osteoporosis, was based on muscle mass two standard deviations (SDs) below the 
appendicular muscle mass (corrected for height) of a young and healthy population cohort. 
Baumgartner reported a prediction equation for appendicular skeletal mass (ASM) based on 
regression analysis derived from Dual-Energy X-ray Absorptiometry (DXA) body composition 
analysis of 301 older men (77.2± 5.8 yr) and women (76.4± 6.7 yr). Values for weight, height, hip 
circumference, grip strength and sex were required for the estimation of ASM. Subsequently, the 
ASM of 808 older white Hispanic and Non-Hispanic men and women was estimated (using the 
prediction formula) and was divided by squared height to produce the appendicular skeletal muscle 
index (ASMI). It was evaluated that adjusting for height2 was the most reliable way of eliminating 
differences in muscle related to greater height, regardless of age, gender and ethnicity. The ASMIs 
derived from the older cohort were then compared against the cut-offs for sarcopenia that were 
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derived from a healthy young cohort (n=229 non-Hispanic men and women, 18-40 yr) who had 
undergone body composition measurements by Dual-Energy X-ray Absorptiometry (DXA).  
 
Although sarcopenia is still frequently regarded as the loss of muscle mass in the literature (Manini 
and Clark 2012; Morley 2012; Maltais et al. 2016), more often than not the term has been used to 
represent the age-related loss of muscle mass that is accompanied by poor strength or poor physical 
function (Cruz- Jentoft et al. 2010). Low strength alone has also been termed ‘dynapenia’ in order 
to distinguish it from low muscle mass (Manini and Clark 2012). To date, several definitions and 
cut-offs for sarcopenia have been proposed, the most popular of which include an index of muscle 
mass, usually two SDs lower than the respective index of a young cohort corrected for height, 
gender and ethnicity, along with a cut off for low physical function (usually low gait speed) and/or 
strength (Cruz- Jentoft et al. 2010; Muscaritoli et al. 2010; Fielding et al. 2011; Morley et al. 
2011). More information about these studies is presented in Table 1.1, alongside their strengths 
and limitations. 
 
In addition to potential overlaps or discrepancies between the cut-offs, the fact that these 
definitions have been introduced in the current decade explains why their validity to predict health 
outcomes (e.g. disability, non-communicable diseases, morbidity and mortality) in the long term 
is yet to be determined. Nevertheless, based on preliminary evidence, the definition proposed by 
the European Working Group in Sarcopenia in Older people (EWGSOP) (Cruz-Jentoft et al. 2010) 
has been reported to have higher validity compared with the others, for predicting the incidence 
of falls (Bischoff-Ferrari et al. 2015). In that study 445 older adults were diagnosed with 
sarcopenia based on all current definitions and were followed-up for three years to allow for the 
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calculation of incidence of falls. Interestingly, the authors also tested the performance of 
definitions based on low muscle mass alone (using the criteria set by Baumgartner et al. (1998), 
which showed consistent validity in predicting the rate of falls. In fact the validity of the criteria 
by Baumgartner and colleagues to predict incidences of falls was similar to the ones that 
incorporated criteria of both muscle and strength/function, such as the one from the EWGSOP) 
(Bischoff-Ferrari et al. 2015).   
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Table 1.1 Definitions of age-related sarcopenia and diagnostic criteria   
Aim/ Group  Definition of 
age-related 
sarcopenia 
Diagnostic Criteria  Population Group Strengths + 
Limitations - 
Consensus 
definition of 
sarcopenia by the 
European 
Working Group on 
Sarcopenia in 
Older People 
(EWGSOP) (Cruz- 
Jentoft et al. 2010) 
Low muscle 
mass combined 
with either a) 
low strength or 
b) low 
performance  
Muscle: 2SDs below the reference 
values for healthy young adults. 
Assessed by: ASM·ht-2 or SMM·ht-2 or 
the residuals method (as explained by 
Newman et al. 2003a) 
 
Low Strength: assessed by HG, knee 
flexion/extension, PEF  
 
Low performance: 
SPPB ≤ 8, low gait speed,  stair climb 
power test, TUG test 
Population data from several 
studies (e.g. Baumgartner et al. 
1998; Newman et al. 2003a, 
Janssen et al. 2002) 
 
 
+ Allows for flexibility in 
operational diagnosis, with 
a variety of option for 
methodologies and 
appropriate cut-offs  
 
-Different cut-offs and 
assessment protocols make 
comparisons between 
studies difficult 
Consensus 
definition of 
sarcopenia by the 
International 
Working Group on 
Sarcopenia 
(IWGS) (Fielding 
et al. 2011) 
Loss of skeletal 
muscle mass and 
function 
Muscle  
< 20 percentile of indices for 
healthy older adults, or <7.23 kg ·m-2 
(men)  
<5.67 kg·m-2 (women). Assessed by 
ALM·ht-2;  
 
Function: GS< 1 m·s-1 (if ambulatory) 
 
Health ABC population; 2,984 
Caucasian and African 
American men and women 70-
79 years old (Newman et al. 
2003a)  
+Fixed values 
 
-Requires specific 
equipment to measure 
ALM; may not be 
applicable to all ethnic 
groups 
Consensus 
definition of 
sarcopenia with 
limited mobility by 
the Society of 
Sarcopenia, 
Cachexia and 
Wasting Disorders  
(Morley et al. 
2011) 
Low muscle 
mass with low 
walking speed  
Muscle: ALM·ht-2 <2 SDs of healthy 
adults (20-30 years old)  
 
Walking speed:  
GS≤ 1 m·s-1 or walk <400m in 6 min.    
NHANES IV population;  
2,402 men and women from 
three US ethnic groups: Non-
Hispanic Whites, Non-Hispanic 
Blacks, and 
Mexican Americans, 20-30 
years old (Kelly et al. 2009)    
+Clear definition; Using a 
young population of the 
same ethnic background 
makes the results more 
valid for the given 
population 
 
-Requires a young and 
healthy population group of 
the same ethnic 
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background;  Requires 
specific equipment to 
measure ALM 
Consensus 
definition of 
sarcopenia by 
Special Interest 
Groups (SIG) 
“cachexia-anorexia 
in chronic wasting 
diseases” and 
“nutrition in 
geriatrics” 
(Muscaritoli et al. 
2010) 
Loss of muscle 
mass and muscle 
strength/function  
Low gait speed, 
e.g. a walking 
speed below 0.8 
m/s in the 4-m 
walking test 
Muscle: SMI: SMM/Body Mass ·100; ≥ 
Class I sarcopenia: SMI within one to 
two 2SDs below the mean SMI of a 
young cohort.  
Class 2 sarcopenia: SMI ≥ 2SD below 
the mean SMI of a young cohort. 
 
Function:  
GS <0.8m·s-1 in the 4-m walk test OR  
by one ‘of the well-established 
functional tests utilized locally’ 
NHANES III population: 3,298 
women and 3,116 men,  non-
Hispanic white, non-Hispanic 
black, and Mexican American 
(Janssen et al. 2002) 
+Body composition 
assessment can be done 
with BIA; accounts for 
body mass 
 
-Does not account for 
stature;  may not be 
applicable to all ethnic 
groups 
 
Notes: ALM, appendicular lean mass; ASM, appendicular skeletal muscle; BIA, Bioelectrical impedance analysis; FFM, fat free mass; GS, gait 
speed; ht, height; PEF, peak expiratory flow; SD, standard deviation; SMM, skeletal muscle mass; SPPB, Short Physical Performance Battery Test, 
TBM, total body mass; TUG, timed up-and-go. 
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In addition to sarcopenia, another important health risk factor in older age is frailty. It is important 
to note that sarcopenia and frailty are two different entities. Frailty is the clinical condition in 
which at least three of the following criteria are present: muscle weakness (low strength), low 
endurance (self-reported exhaustion), slow gait speed, unintentional weight loss and low physical 
activity (Fried et al. 2001). Both sarcopenia and frailty are highly prevalent in the older populations 
and are associated with adverse health events (Baumgartner et al. 1998; Fried et al. 2001); 
however, a clear framework within which these two conditions can be explored and studied is 
currently lacking (Cesari et al. 2014). According to Cesari and colleagues although in theory 
sarcopenia and frailty have fairly distinct theoretical definitions, there is a lack of a unique 
operational definition. The issue may originate in the catabolic nature of these two conditions that 
gives rise to many, and often overlapping manifestations, the most important of which is weakness 
and physical disability. Therefore, the question is often whether frailty is the result of sarcopenia 
or vice versa.  
 
Another condition that is often met in older age is the gradual gain of fat mass that accumulates in 
the body’s adipose stores and especially around the trunk and the visceral depots (Racette et al. 
2006). It has been well documented that fat accumulation around the central region continues 
across the lifespan from middle age to older age, with the waist circumference increasing by 
approximately 0.7 cm·year-1 (Noppa et al. 1980). Furthermore, intermuscular adipose tissue 
accumulation (or infiltration) increases with age (Goodpaster et al. 2001). Due to this gradual 
redistribution of fat, and change in body composition, older adults may have more visceral fat 
compared to their middle-age counterparts even at substantially lower bodyweights (Borkan et al. 
1985). Although at tissue level the accumulation of fat per se does not necessarily elicit a reduced 
capacity for maximal oxygen uptake, it may limit the capacity to exercise due to the increased 
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effort that is required to move the excess mass through space (e.g. when walking, running or 
performing body weight exercises) (Carrick-Ranson et al. 2012).  The fat infiltrating the muscle 
tissue can also change the physiological properties of the muscle, resulting in reduced muscle 
quality (force production per unit of muscle) (Visser et al. 2005).  
 
Therefore, obesity is a condition characterised by an unhealthy excess of adipose tissue (Villareal 
et al. 2005). The most commonly used criterion to classify obesity is total body mass corrected for 
height, also known as body mass index (BMI= total body mass · height-2), with a cut-off for obesity 
at 30 kg m-2 (World Health Organisation 2017). Currently, this cut-off is age and gender- 
independent but ethnicity dependent, with Asians exhibiting overweight and obesity-associated 
risks at BMIs as low as 22-25 kg m-2 (World Health Organisation 2017). Although BMI is perhaps 
the easiest and most practical test to perform, it may not be appropriate for use in older adults as 
it cannot account for body composition changes that come with ageing, thus its usefulness has 
been questioned (Villareal et al. 2005). The age-related body composition changes and the 
appropriateness of using BMI in older adults to identify high body fatness is discussed more 
thoroughly in the next section (1.1.4) in the context of health consequences of obesity and 
especially when it parallels, or more precisely masks, sarcopenia in older age.  
 
The need for a more reliable method for the identification of high adiposity has prompted the use 
of more direct measurements of body fat mass, which is usually expressed as a percentage in 
relation to total body mass, termed percent body fat (%BF) (with cut-off values usually ranging 
27-30% and 35-40% in older men and women, respectively (Donini et al. 2014)). This method 
requires the assessment of body fat by Dual-energy X-ray absorptiometry (DXA), magnetic 
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resonance imaging (MRI), bioelectrical impedance analysis (BIA), computed tomography (CT) or 
air-displacement plethysmography (ADP). Other indices to classify obesity have been increased 
waist circumference (individually or combined with BMI) and more rarely the mid-arm fat area 
and visceral fat area (Donini et al. 2014; Poggiogalle et al. 2014).  
 
Sarcopenic obesity is characterised by the co-occurrence of sarcopenia and obesity, i.e. high fat 
mass and low muscle mass. Heber et al. (1996) first defined the term sarcopenic obesity as low 
lean mass, out of proportion to fat mass. Since there are many diagnostic criteria for sarcopenia 
and obesity but not a single universally accepted definition for each, it is not surprising that many 
different criteria exist for the sarcopenic obese phenotype. Typically a combination of one 
criterion for sarcopenia (e.g. low muscle mass with or without low strength) is used along with an 
obesity criterion (e.g. high %BF or high BMI) to identify sarcopenic obesity (Donini et al. 2014; 
Poggiogalle et al. 2014). In other cases, new diagnostic criteria with sarcopenic obesity-specific 
cut-offs have been developed e.g. ratios of adiposity to muscle, total fat mass to lower-limb muscle 
mass, body weight to fat free mass (FFM), and total fat mass to FFM (Auyeung et al. 2012).  As 
mentioned previously, the ability of the operational definitions to predict future health incidences 
has not been assessed either for sarcopenia or sarcopenic obesity, therefore the scientists usually 
adopt criteria that are compatible with the available resources, the research conditions or questions 
that need to be addressed; usually, MRI or DXA are preferred in clinical settings and/or in studies 
where greater financial resources and trained personnel are available, whereas BIA and 
anthropometry are used primarily in field studies, where the simplicity of measurements and a 
high level of practicality is of primary importance. 
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1.1.2 Aetiology of sarcopenic obesity in older age 
The main cause of ageing is a time-dependent accumulation of damage at a molecular and cellular 
level (López-Otín et al. 2013). The underpinning mechanisms (or ‘hallmarks of ageing’) may 
explain the ageing trajectory (including the sarcopenic obese phenotype), and involve DNA 
damage, loss of proteostasis (failure of autophagy to control damaged proteins), dysregulated 
nutrient sensing (that is, the dysregulation of pathways involved in glucose and amino acid 
metabolism, low energy or high energy states sensing, such as insulin, insulin-like growth factor 
(IGF), mechanistic target of rapamycin (mTOR), adenosine monophosphate-activated protein 
kinase (AMPK) and sirtuins), mitochondrial dysfunction, cellular senescence, stem cell 
exhaustion and deregulated intercellular communication (extensively reviewed by López-Otín et 
al. 2013). Although these ‘hallmarks’ provide the fundamental basis of the age-related changes, 
ultimately, the direction of muscle gain or loss is dictated by the difference in rates of muscle 
protein synthesis (MPS) and muscle protein breakdown (MPB) (Figure 1.1), that is, the net protein 
balance. However, in older age, the sensitivity of pathways that lead to muscle protein synthesis 
(i.e. muscle growth) in response to anabolic stimuli (e.g. food and exercise) is reduced, a 
phenomenon termed ‘anabolic resistance’ (Burd et al. 2013).  
 
The underlying mechanisms for the age-related anabolic resistance may include a decline in 
anabolic signalling, impaired protein digestion and absorption, reduced aminoacidemia due to 
increased splachnic retention, impaired muscle perfusion and lower skeletal muscle uptake of 
amino acids (Burd et al. 2013; McLeod et al. 2016). Moreover, there is a decrease in the number 
of alpha-motorneurons, type II muscle fibres’ number and size, type II satellite cells (muscle stem 
cells), as well as a decline in the capillarisation of muscle fibres (Guccione et al. 2012; Snijders 
and Parise 2017). Further, in older adults the distance between muscle fibres and nearest capillaries 
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is greater than in their younger counterparts, which leads to a diminished delivery of anabolic 
agents and may explain to some extent the blunted muscle satelite cell response (consept termed 
‘capillary impact zone’) (Snijders and Parise 2017). Since muscle fibres are post-mitotic they rely 
on the presence of functional satellite cells for regeneration and long-term hypertrophy (García-
Prat et al. 2016). Satelite cells can maintain a quiescent state through autophagy, which degrades 
and removes misfolded proteins and organells, such as mitochondria (García-Prat et al. 2016). 
However, in older age the autophagic system is impaired, leading to an accumulation of damaged 
proteins and eventually resulting in stem cell exhaustion (senescent state) (García-Prat et al. 2016). 
Thus, it is easily understood that the factors leading to sarcopenia and/or obesity are intrinsically 
complex and multifactorial, and in fact, have not been yet fully elucidated (Molino et al. 2016).  
 
An in-depth discussion of the metabolic pathways involved in molecular, cellular and tissue level 
is not directly involved in the scope of this thesis. Instead, emphasis will be placed on the 
physiological manifestations of these pathways and the aetiology of sarcopenic obesity focusing 
on lifestyle choices and how these can potentially affect the development of the sarcopenic obese 
phenotype. For example, neurodegeneration, inflammation, reduced delivery of amino acids to the 
muscle, as well as the age-related decline in anabolic hormones may be the outcomes of the 
cellular and molecular ‘hallmarks’ mentioned above. However, their manifestations i.e. reduced 
function and neuromuscular coordination, loss of muscle and/or gain of fat, can affect (and equally 
be affected by) the development of sarcopenic obesity as well as by lifestyle choices such as diet 
and physical activity (Morley 2012). In this regard, the most important factors that may affect the 
development/progress of sarcopenia and obesity are malnutrition, physical inactivity, 
neurodegeneration and inflammation, along with age-related declines in anabolic hormones. 
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Therefore, any intervention programme aiming to improve muscle mass and function while 
inhibiting muscle breakdown and accumulation of fat tissue should address most of these factors. 
 
Anorexia of ageing and energy-protein malnutrition 
Although basal, postabsorptive MPS rates between young and older adults are similar (Volpi et 
al. 2001), the feeding-induced MPS response in older adults is blunted compared with young 
adults, and this is even more pronounced in older obese sedentary adults (Phillips 2014; Smeuninx 
et al. 2017). While resistance exercise can elevate MPS even in older age, it is not likely to restore 
a ‘youthful response’ to feeding-induced MPS (Villareal et al. 2011; Phillips et al. 2014). 
However, it has been recently suggested that the old muscle can have a similar MPS potential with 
the young muscle, if older adults consume ~2-fold higher amounts of protein per meal in order to 
overcome the anabolic resistance (Yang et al. 2012; Moore et al. 2015). In these studies graded 
dose-response trials showed that older adults need ~40 g whey protein after exercise to reach a 
plateau of MPS, whereas their younger counterparts reached a maximal plateau after ingestion of 
~20 g protein. In terms of protein intakes in a single meal relative to bodyweight, Moore et al. 
(2015) noted that a maximal MPS rate can be achieved with ~67% higher doses in older vs young 
adults (0.40 g protein kg bw-1 meal-1 vs 0.24 g protein kg bw-1 meal-1, respectively). These studies 
will be further discussed throughout the thesis, but it is important to acknowledge here that 
although the response to anabolic stimuli may be blunted in older age, it is not impossible to 
achieve a ‘youthful response’. 
 
In advancing age, a reduced or sub-optimal MPS is ultimately the main driver of decline in muscle 
tissue accretion, although in cases of inactivity a transient increase in muscle protein breakdown 
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is also possible (Wall and van Loon 2013). Therefore, an adequate provision of energy and 
nutrients (e.g. protein, essential amino acids (EAAs) and particularly leucine) is essential in order 
to stimulate, as well as provide the substrates for the muscle protein synthetic response in older 
age (Witard et al. 2016a). However, the issue in older age becomes more complex considering that 
older adults may limit the amount of food and protein consumed due to anorexia of ageing or 
malnutrition, which may influence muscle growth processes (Morley 2012). Moreover, there are 
age-related changes in appetite and neurosensory capacity that either discourage older individuals 
from eating, or change their food preferences in favour of sugar-rich foods e.g. confectionary 
(Toffanello et al. 2010). Therefore, it is possible that a below-optimal protein intake may co-exist 
with a normal or even high energy intake. Overfeeding and overconsumption of energy dense 
foods can also reflect a state of malnutrition which can lead to obesity and increased inflammation, 
especially when combined with physical inactivity (Roubenoff 2006), but in this instance the term 
malnutrition is used to describe the protein-energy wasting (Biolo et al. 2014).  
Food insecurity, defined as the limited availability, access to or ability to purchase safe food is a 
major concern for older adults, since approximately one out of four Scottish ‘households below 
average income’ is a household with one or more individuals ≥ 65 years old (Douglas et al. 2015). 
In the UK in general, one out of seven pensioners lives in poverty and approximately 1.3 million 
older adults are at risk of, or already suffering from malnutrition, the vast majority of which are 
community-dwellers (Elia and Smith 2009; Age UK 2014). Furthermore, upon admission to a UK 
hospital one out of three older individuals are at risk of malnutrition (Malnutrition Task Force 
2014).  
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Potential cases of malnutrition (poor energy-protein status) can be identified with the use of a 
screening tool (e.g. the Simplified Nutritional Assessment Questionnaire (SNAQ; Wilson et al. 
2005) the Mini Nutritional Assessment tool (MNA; Guigoz et al. 1994) or the Malnutrition 
Universal Screening Tool (MUST; Elia 2003) and following that, diagnosed by involuntary weight 
loss, low BMI and low lean mass index (Sánchez-Rodríguez et al. 2016). In a study with adults 
aged ≥ 70 years admitted to a hospital geriatric ward with a non-disabling disease (and ambulatory 
prior to hospitalisation), the rates of malnutrition and sarcopenia were assessed (Sánchez-
Rodríguez et al. 2016). Approximately 20% of the patients were found to be malnourished and 
almost 83% of them were sarcopenic, whereas in the non-malnourished cohort the prevalence of 
sarcopenia was almost half (45%). This finding is important considering that older patients with 
hip fractures have often been reported to be malnourished (Huang et al. 1996; Hoekstra et al. 2011) 
and further, to consume low amounts of protein pre- and post-operatively (~48 g · day-1), and 
especially of animal origin (Munger et al. 1999; Hoekstra et al. 2011).   
 
Apart from anorexia, food insecurity, poverty and hospitalisation, depression is another important 
factor affecting food intake in older age in both institutionalised and community-dwelling older 
adults (Cabrera et al. 2007; Thakur and Blazer 2008). Also, polypharmacy, dysphagia, 
malabsorption and/or maldigestion can result in reduced energy intakes (Slaughter et al. 2011), 
and potentially in sarcopenia since low energy and protein intakes may lead to muscle losses in 
the physically active (Pasiakos et al. 2010), as well as inactive older adults (Biolo et al. 2007).  
Therefore, regardless of physical activity levels, protein-energy malnutrition can negatively affect 
the responsiveness of skeletal muscle to intervention. On the other hand physical inactivity can 
also result in reduced muscle mass and function regardless of the availability of nutrients/protein 
(Dirks et al. 2017).  
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Physical Inactivity 
Physical inactivity can lead to decreased muscle fibre size due to decreased mechanical stimuli, 
which is an anabolic factor for the muscle fibres (Narici and Mafulli 2010). The muscle disuse 
during periods of intentional or unintentional inactivity (e.g. leg-cast, hospitalisation, bed-rest) can 
significantly reduce MPS rates even in young adults (Glover et al. 2008). In older adults two weeks 
of leg immobilisation can reduce muscle size by 5%, whereas retraining is not likely to restore 
muscle size to its pre-inactivity levels (in contrary to the young muscle which retains this ability) 
(Suetta et al. 2009). Even in the absence of complete immobilisation, a 76% reduction in daily 
step-count can decrease lean mass by 3.9% (p<0.001) in as little as two weeks in healthy older 
adults (n=10, age= 72 ± 1 yr) (Breen et al. 2013). In addition to reduced muscle mass, the step 
reduction significantly lowered post-absorptive insulin sensitivity and MPS, and mediated an 
increased inflammatory response (as indicated by increased levels of Tumoror Nerosis Factor a 
(TNFa) and C-Reactive protein (CRP)), as well as post-prandial insulin resistance. In fact, in cases 
of older adults exposed to complete inactivity (e.g. bed-bound), impaired insulin action and 
dysregulation of glucose metabolism has been observed within five days or even less, possibly 
mediated by an increased inflammatory response and imbalances between energy intake and 
expenditure (Stephens et al. 2010; Kwon et al. 2015a).    
 
This loss of muscle mass can further prevent older adults from participating in physical activities 
due to the increased feeling of tiredness and muscle weakness, and thus continue fuelling the cycle 
of inactivity-inflammation-muscle atrophy (Roubenoff 2006). Another outcome of the inactivity-
induced muscle atrophy is a lower resting metabolic rate. It has been postulated that a 6% reduction 
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in basal metabolic rate (or 30-40 kcal·day-1) is to be expected for every kilogram of lean mass lost 
during bed-rest inactivity (Ritz et al. 1998; Biolo et al. 2014). The lower resting metabolic rate, 
combined with a lower energy expenditure due to inactivity can predispose older adults to positive 
energy balance that can consequently lead to gains in fat mass (Roubenoff 2006). Additionally, 
this effect is even more pronounced in older adults, due to other contributing factors and 
comorbidities (e.g. inflammation, insulin resistance, age-related sarcopenia) (Biolo et al. 2014). 
Therefore, the reduction of muscle size and gain of fat along with the increased perception of effort 
can further exacerbate the perception of fatigue and prevent older adults from participating in 
physical activities, fuelling the vicious cycle of inactivity and impaired muscle mass/function.  
 
Neuromuscular changes  
One of the mechanisms contributing to the loss of muscular strength and function is the loss of 
motor units, a process also known as denervation of muscle fibres (Guccione et al. 2012). A motor 
unit consists of an alpha-motoneuron that innervates and activates all the muscle fibres that are 
connected to it. Advanced ageing has been associated with a 50% loss of available alpha-
motorneurons (Lexell 1995). The denervated muscle fibres then join neighbouring and active 
motor units, which in turn results in bigger motor units (Guccione et al. 2012). The lower efficacy 
of the bigger motor units combined with the fact that the denervation is more likely to happen in 
type II (fast-twitch) muscle fibres than in type I (slow-twitch) accounts to some extent for the 
impaired coordination, tremor, fatigue and loss of speed and power which are often experienced 
by older adults (Lexell 1995; Roubenoff 2000; van Beveren 2012).  
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Alongside the denervation of muscle fibres, there is a concomitant reduction in the number of both 
types (I and II) of muscle fibres with age (Lexel el al. 1988). Although the percentage of type I 
and type II fibres may remain the same with increasing age, the type I fibres occupy more muscle 
area due to the atrophy (reduction in size by 13-31%) of type IIa and IIb fibres (Coggan et al. 
1992). This reduction is more pronounced in type II fibres possibly due to the increased 
degradation of type II myogenic satellite cells and therefore, there is a lower capacity for 
regeneration and growth of the fast-twitch muscle fibres (Verdijk et al. 2006).  
 
As a result, a decline in muscular strength and power with time has been observed. Namely, 
handgrip strength and knee extension strength have been documented to decline at a rate of 1.5-
2.0% p.a., whereas the decline in power can be more precipitous, at rates of 3.2-3.7% p.a. (Skelton 
et al. 1994). This decline in power has been found to correlate strongly with functional tests such 
as the ‘chair rise’ in healthy older adults ≥ 65 years (Skelton et al. 1994), as well as in old 
institutionalised adults with multiple conditions (Bassey et al. 1992). Interestingly, these studies 
have also documented that handgrip strength correlates with leg power (Skelton 1994), and the 
‘chair rise’ test with gait speed (Bassey et al. 1992). In general, both maximal force production 
and explosive force production are important for physical function in older age (Granacher et al. 
2008). For example, in order to maintain postural control after an external disturbance of balance 
a rapid generation of force is necessary in order to counteract these disturbances and regain 
stability (Orr 2010). Older adults who have experienced falls are likely to produce ~ 24% less 
lower body power compared to their ‘non-faller’ counterparts (Skelton et al. 2002). Moreover, 
muscular weakness is also associated with mobility limitations and falling (Skelton et al. 2002), 
as is polypharmacy, lack of physical activity, and reduced capacity for physical movements, e.g. 
inability to bend over (O'Loughlin et al. 1993; Skelton et al. 2002). Consequently, the result of the 
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denervation and atrophy of type II fibres can negatively affect all daily activities that require a 
certain capacity for force generation, such as getting up from a chair, getting on and off public 
transport in a timely manner, climbing stairs, regaining stability after a perturbation of balance etc. 
(Lang et al. 2010).    
 
Inflammation and the endocrine system  
Even though undernutrition and physical inactivity can potentiate the loss of muscle mass, there 
are cases where muscle atrophy can occur even at energy balance due to the catabolic actions of 
inflammatory cytokines. This has been implied in autoimmune disorders such as rheumatoid 
arthritis, where inflammation-induced muscle proteolysis is evident; that is, the increased 
production of inflammatory agents such as the tumour necrosis factor alpha (TNFa) can lead to 
muscle atrophy (Rall et al. 1996). The role of C - reactive protein (CRP), interleukin 1 (IL-1) and 
interleukin 6 (IL-6) in muscle atrophy has since been well established, even in the absence of an 
autoimmune response (Molino et al. 2016). These hormones can be produced by the adipose tissue 
(which in this case acts as an endocrine gland) and can elicit an inflammatory response that can 
negatively affect muscle tissue (Cesari et al. 2005a). Particularly active in producing cytokines 
that can accelerate muscle breakdown are the visceral adipose cells (Schrager et al. 2007). 
Moreover, it has been documented that inflammation is higher in sarcopenic obese older adults 
compared to those with normal body compositions (Schrager et al. 2007). In the same study the 
researchers noted that levels of CRP, IL-1 and IL-6 were significantly associated with indices of 
sarcopenic obesity, such as body mass index (BMI), waist circumference (WC) and muscle 
strength even after adjusting for several factors such as age, gender, history of comorbidities, 
physical activity and smoking. The researchers thus highlighted the catabolic effect that truncal 
obesity can exert on muscle tissue and function through the mediation of an inflammatory 
22 
 
response. Moreover, it has been hypothesised that the cytokines released from the intrahepatic and 
intermuscular fat to local tissues may contribute, at least to a certain degree, to impaired insulin 
action (Molino et al. 2016). It has also been suggested that ageing per se is associated with a state 
of low-grade chronic inflammation, hence the recently introduced term ‘inflammaging’, which is 
regarded as a risk factor for age-associated diseases as well as morbidity and mortality (Franceschi 
and Campisi 2014).  
 
Moreover, there are age-related changes in the physiological effect of anabolic hormones on the 
ageing body. For example, the anti-catabolic properties of insulin have been well documented as 
it has been proven that insulin is involved in the inhibition of muscle proteolysis (Gelfand and 
Barrett 1987). Wilkes et al. (2009) concluded that protein breakdown in the leg muscles in 
response to insulin was not attenuated in older adults to the same extent as in their younger 
counterparts (12% and 47% reduction in proteolysis, respectively). Therefore, this may be a sign 
of a diminished ability of insulin to stop muscle proteolysis with age, which indicates that older 
muscle is likely to experience increased muscle breakdown. Therefore, the blunted anabolic effect 
of insulin on the architecture of older muscle may also potentially lead to muscle atrophy (Guillet 
and Boirie 2005; Lonnie and Jose 2012).  
 
Growth hormone (GH) and the insulin like-growth factor 1 (IGF-1) are anabolic peptides that are 
responsible, amongst others, for the growth of muscle tissue (Adamo and Farrar 2006). Their role 
involves triggering the proliferation and differentiation of satellite stem myocytes, resulting in 
increased muscle protein synthesis rates while they can concomitantly decrease the protein 
degradation rates (Chen et al. 2005; Fryburg 1994). Growth hormone and IGF-1 decline with age 
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and as an outcome older people are often deficient in these hormones (Toogood 2003). Apart from 
the age-related decline in these hormones, there is evidence to suggest that increased 
concentrations of circulating free fatty acids may exert a negative effect on the body’s ability to 
produce these hormones (Van Dam et al. 2000), and perhaps this phenomenon is more pronounced 
in older adults with sarcopenic obesity compared to obesity alone (Waters et al. 2008). 
Testosterone is another anabolic hormone that can significantly increase the rates of muscle 
protein synthesis and strength (Urban et al. 1995), however, its natural production declines with 
age (Zumof et al. 1995; Feldman et al. 2002). Similar to GH and IGF-1, high adiposity can 
interfere with testosterone production in older age (Vermeulen et al. 1999), thus diminishing 
muscle anabolism. Therefore, a clear pattern is evident; it is not only age per se, but also the action 
of adipose tissue and inflammatory cytokines on anabolic hormones, which can have a subsequent 
effect on the trajectory of muscle tissue.  
 
 
Figure 1.1 Aetiology of sarcopenia in older age. Muscle atrophy, hypertrophy and mediators 
(straight arrows), or inhibitors (dashed lines). When muscle protein breakdown exceeds muscle 
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protein synthesis, then muscle atrophy is experienced. MPS; muscle protein synthesis, MPB; 
muscle protein breakdown.   
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1.1.3 Prevalence of sarcopenia, obesity and sarcopenic obesity 
In one of the first studies assessing prevalence rates of sarcopenia using appendicular skeletal 
muscle mass normalised to height2 (two standard deviations below the respective mean of younger 
populations of New Mexico, US), it was found that 24% of women and 15% of men (n=883; 
Hispanics and Non-Hispanics) aged between 65 and 70 years were sarcopenic (Baumgartner et al. 
1998). In the same study, the prevalence of sarcopenia in those aged 80+ was >50% in both sexes. 
In partial agreement with that finding Iannuzzi-Sucich et al. (2002) reported that 23% of Caucasian 
women and 27% of men from New England, US, were sarcopenic, whereas figures increased to 
31% and 53%, respectively, for those aged 80 and over. In Denmark, in a group of 754 women ≥ 
70 years old, sarcopenia was diagnosed in 12% of them (Tanko et al. 2002). Prevalence rates of 
sarcopenia in Taiwan, in 302 men and women ≥ 65 years Chien et al. (2008) were reported to be 
26% in men and 19% in women, while no significant differences were observed between MRI and 
BIA-derived rates. Janssen et al. (2002) in one of the most influential studies in this field (since 
the regression analysis of that data generated the prediction formula for the calculation of total 
skeletal muscle mass from a BIA test), concluded that the prevalence rates of sarcopenia in 
American men and women over the age of 80 years was 50% in men and 72% in women. However, 
it is important to note that none of the aforementioned studies took into account muscle strength 
or function. According to a recent systematic review taking into account muscle strength/function 
as well as mass, the prevalence of sarcopenia has been reported to vary from 1 to 29% in 
community-dwellers and 14-33% in long-term care populations depending on the population 
being studied and the operational criteria (Cruz-Jentoft et al. 2014). 
 
Similar to sarcopenia, obesity is also a growing concern due to its progressively rising prevalence 
rates, including in older adult populations (Porter Star et al. 2014). In 2010, approximately 35% 
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of adults aged 65 years or over in the US were reported to be obese (Fakhouri et al. 2012) while 
the respective figures in Scotland and the UK were 31% and 28%, respectively (Scottish 
Government 2011; Public Health England and Food Standards Agency 2014). However, these 
figures were based on the BMI cut-off of 30 kg m-2 which is likely to underestimate adiposity and 
also mask sarcopenia in older adults (Newman et al. 2003a). Therefore, the true prevalence of 
obesity in older adults is likely to be higher than the reported values, but due to scarcity of studies 
-especially in Scotland- this is yet to be corroborated.  
 
Although sarcopenic obesity has gained significant attention from the scientific community in 
recent years, and there is a plethora of existing definitions and cut-offs for sarcopenia, obesity and 
sarcopenic obesity, there is no universally accepted definition (Cruz-Jentoft et al. 2010, Prado et 
al. 2012; Poggiogalle et al. 2014). As an outcome, depending on the definition criteria and cut-
offs used the prevalence rates of sarcopenic obesity can vary up to 26-fold, which makes detection 
and management of the condition very challenging for healthcare practitioners (Batsis et al. 2013). 
To date, there are no definite figures for the prevalence of sarcopenic obesity and particularly in 
Scotland. In fact there is a substantial lack of studies in Scotland and the UK in general, and 
therefore, it is imperative that more research is conducted with a focus on sarcopenia and obesity 
in Scottish older adults.   
 
1.1.4 Health consequences of sarcopenia, obesity and sarcopenic obesity 
Although the financial implications of sarcopenia can place a vast burden on the public health 
systems (the hospitalisation costs alone for sarcopenic and sarcopenic obese patients may increase 
by 34% and 42%, respectively; Sousa et al. 2016) this thesis will discuss the health-related 
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consequences. Given the existence of a metabolic cross-talk between muscle and bone tissue and 
considering that muscle provides a mechanical-induced growth stimuli for bones (Cianferotti and 
Brandi 2013), it is not surprising that low muscle mass along with the impaired neuromuscular 
coordination and poor balance (the physiological mechanism of which has been discussed 
previously) may lead to reduced bone mineral density and increased risk of falls, osteoporosis and 
bone fractures. In an earlier study, 590 postmenopausal women were grouped based on their 
appendicular muscle mass and grip strength, and were assessed for osteopenia and osteoporosis 
(bone mineral density assessed by DXA) (Sjöblom et al. 2013). It was found that the sarcopenic 
women had a significantly higher odds ratio for osteoporosis (OR: 12.9; p ≤ 0.001) and also, of 
experiencing a bone fracture (OR: 2.1; p ≤ 0.05), compared to their non-sarcopenic counterparts. 
Following a similar pattern, those within the lowest quartiles for strength had significantly higher 
odds for osteoporosis (OR: 11.7, p ≤ 0.001) compared to those within the highest quartiles for 
hand grip strength. Even after adjusting for age, BMI and other parameters such as physical 
activity levels the results remained significant. Similarly Szulc et al. (2005) showed that muscle 
mass was significantly associated with indices of bone mineral density (BMD), and those with the 
lowest muscle mass had low BMD and the highest risk of poor balance and falls.  Moreover, apart 
from the direct action of muscle on bone density, there is substantial evidence supporting that 
chronic inflammation and potentially the metabolic syndrome (both of which may be present in 
sarcopenia, obesity and sarcopenic obesity) may negatively affect bone density and increase the 
risk of osteoporosis (Braun and Schett 2012;  Zhou 2013).    
 
With regard to glucose utilisation, muscle is the primary tissue responsible for glucose uptake via 
muscle-contraction and insulin-dependent pathways (Jessen and Goodyear 2005). Therefore, older 
people with low muscle mass are at an increased risk for type II diabetes due to poor glucose 
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control (Park et al. 2009). In fact, although obesity is a risk factor for insulin resistance, sarcopenia 
alone can exacerbate dysglycaemia regardless of the presence of obesity (Srikanthan et al. 2010). 
This effect can be evident particularly in older adults, given their susceptibility to muscle atrophy, 
which renders this a very serious consequence.   
 
Obesity has been also associated with numerous detrimental health effects (Zamboni et al. 2005). 
For example,  increased BMI (>27 kg m-2) raises the risk of mobility impairment by 2-fold in older 
women (Launer et al. 1994). Increased adiposity and especially abdominal obesity is an 
independent predictor of insulin sensitivity in old age, and according to Racette et al. (2006) it 
may be even more important than physical fitness. This signifies the importance of the assessment 
for abdominal obesity e.g. waist circumference or sagittal abdominal tissue (SAD). Similarly, 
Roubenoff (2006) suggested that increased fat mass, and in particular fatty tissue around the 
abdomen, can increase leptin and TNFa secretion, and may eventually result in insulin resistance. 
Moreover, adipocytes can also elicit a catabolic effect on muscle tissue, either directly through 
infiltration or indirectly via hormonal modulation (Cesari et al. 2005a; Schrager et al. 2007), as 
discussed earlier. It is quite alarming that obesity, and especially excess visceral and intermuscular 
adiposity, can increase the risk of type II diabetes even at normal bodyweights (Goodpaster at al. 
2003).  
 
Although the association between overweight and obesity (defined as high BMI) and higher all-
cause mortality is well established in adults aged 18-65 years, the same relationship has not been 
fully corroborated in people over the age of 65 years (Flegal et al. 2013). According to a 97-study 
meta-analysis by Flegal et al. (2013), there is evidence to suggest that there may be a rightward 
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shift of the ‘normal BMI range’ in older age, with values around ~30 – 34.9 kg m-2 posing no extra 
risk in terms of all-cause mortality compared to BMIs ~25 kg m-2 in older people. Moreover, it 
was suggested that BMIs in the overweight range 25-29.9 kg m-2 may in fact be beneficial by 
exhibiting the lowest mortality risk (Flegal et al. 2013). This phenomenon has been previously 
termed ‘the obesity paradox’ (Oreopoulos et al. 2009). However, the study by Flegal et al. (2013) 
was weakened by the absence of a model that would exclude the first years after the surveys that 
could be potentially affected by ‘reverse causality’. That is, it may not be BMI per se that affects 
mortality, but the presence of comorbidities at the time of the survey that have already affected 
the BMI and may lead to increased mortality rates in the years following the survey.  
 
Stokes (2014), in an attempt to exclude confounders like unintentional weight loss and 
comorbidities at the time of the survey, used the maximum BMI that someone has been at 
throughout their lifespan, to assess the risk between BMI and mortality. For example, if an older 
person has a BMI at the time of the survey of 23 kg m-2 (‘current BMI’) but the maximum BMI 
they have ever been at was 28 kg m-2 (‘maximum BMI’), then the latter was used. This model 
excluded potential confounders related to reverse causality. The analysis indicated that all BMIs 
≥ 25 kg m-2 carried a higher risk for mortality compared to normal BMIs (< 25 kg m-2), when using 
the ‘maximum BMI’ model. In fact, overweight and obesity assessed by using the ‘maximum 
BMI’ accounted for 33% of mortality, compared to only 5% when the ‘current BMI’ model was 
used. It was also suggested that in middle-aged and older adults, normal-BMI cohorts include 
people at low risk (i.e. people who have maintained a healthy BMI throughout their life) as well 
as people at high risk (those who have lost weight unintentionally due to other comorbidities). 
Therefore, the use of BMI at the time of the survey cannot substantiate a reliable indication of 
mortality risk. This is in agreement with other research groups who have disputed the existence of 
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the obesity paradox and suggest that it is probably accounted for by methodological 
inconsistencies (Ferreira and Stehouwer 2012; Strandberg et al. 2013).  
 
Consistent with the previous study, van Uffelen et al. (2010) analysed the data from more than 
11,000 older women (≥ 70 yr) and noted that BMIs 25-27 kg m-2 carried the lowest mortality risk, 
whereas BMIs 22-24 kg m-2 carried the lowest risk of hospital admissions. In the same study, the 
risk of heart disease and type II diabetes increased (almost linearly) with increasing BMIs above 
18.0 kg m-2, whereas risk of hypertension increased above 18.5 kg m-2 but it tended to plateau at 
BMIs > 30.0 kg m-2.  
 
The obesity paradox has been recently disputed with robust methodologies and large scale data 
coming from a meta-analysis by Bowman et al. (2016). That analysis incorporated the Clinical 
Practice Research Datalink (CPRD) data from 995,031 adults ≥ 60 years registered with primary 
care in England (2000-2014). The initial results suggested that higher BMIs (25-35 kg m-2) may 
indeed place no added risk on mortality, however, when the first four years of the follow up were 
excluded from the analysis (that is, only years 4 to 14 were analysed) it was found that the lowest 
mortality risk was for BMIs ~ 23-26.9 kg m-2. In general, BMIs over 25 kg·m-2 increased the hazard 
ratio (95% CI) from 1.03 (0.97 – 1.09) in the 60-64 years group for BMIs ≥ 25 kg m-2 to 1.80 (1.62 
- 2.00) for a BMI ≥ 40 kg m-2 in the 70-74 group. In a sub-analysis for the incidence rates of type 
II diabetes and coronary heart disease (CHD) the risk increased for BMIs ≥ 27 kg m-2, across all 
age groups.  
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The complexity of this issue has been previously highlighted by Romero-Corral et al. (2010) who 
stated that body composition in older age can vary to such a degree that high adiposity can be 
present even at normal bodyweights, which implies that older people can have high body fatness 
and therefore low muscle mass even at normal BMIs. In cases of normal BMIs, it is very 
challenging for a physician to detect high adiposity and/or low muscle mass, and therefore it is 
dubious whether a change in lifestyle would be recommended by health professionals.  
 
Therefore, although the detrimental consequences of sarcopenia on health are well documented, 
and there is a relative agreement on the consequences of overweight and obesity (at least for BMIs 
≥ 27 kg m-2), the effects of sarcopenic obesity have not been fully elucidated. This is mainly due 
to the scarcity of studies with sarcopenic obese populations, a lack of a robust definition and 
diagnostic criteria, as well as the issues implicated with the use of BMI in obesity classification. 
As a result some authors have reported that the combination of sarcopenia with obesity work 
synergistically in creating a health-deteriorating phenotype whereas others have conferred that 
sarcopenic obesity does not carry a higher risk compared to those of obesity or sarcopenia alone.  
 
For example in an 8-year prospective study, Baumgartner et al. (2004) noted that sarcopenic 
obesity predicted more physical impairments (e.g. decline in gait speed, balance) and falls than 
either obesity or sarcopenia alone. An Instrumental Activities of Daily Living (IADL) 
questionnaire was used to assess physical capacity, DXA for body composition and participants 
were included only if they were highly functional at baseline, which allowed the onset of physical 
impairments to be followed up. This finding however does not concur with Davidson et al (2002) 
who suggested that those in the highest quintiles for % body fat as well as those with high BMIs 
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(≥ 30 kg m-2) have a higher risk for physical disabilities, but those with low muscle mass combined 
with obesity (i.e. sarcopenic obese) were not presented with a greater risk for mobility limitations 
compared to obesity alone. That study was, however, a cross-sectional analysis of associations 
between body composition (measured indirectly by anthropometry) and physical capacity assessed 
by a 5-item questionnaire of daily activities and thus could only offer a ‘snapshot image’ of the 
associations at the time of the survey. Apart from methodological differences that may account 
for these discrepancies (e.g. different cut-offs derived by DXA vs anthropometry, different 
questionnaires, and a prospective vs cross-sectional design), it could also be hypothesised that 
there are additional factors, other than absolute muscle mass and fat mass, that may play an 
important role in mobility performance, e.g. distribution of fat, muscle density, strength, power 
and quality (Goodpaster et al. 2001; Fielding et al. 2011). For example, a higher muscle mass does 
not directly translate into higher strength and functional improvements, in fact in some cases gains 
in muscle mass may not even attenuate the decline in strength (Goodpaster et al. 2006). Therefore, 
when examining changes and differences in functional parameters it is important to consider 
factors such as muscle strength and quality, in addition to absolute changes in body tissues.   
 
In terms of cardiovascular risk factors, the relationship between sarcopenic obesity and 
hypertension has also been assessed in a study with 2,099 men and 2,747 women ≥ 60 years (Han 
et al. 2014). After adjusting for factors including age and gender, physical activity, lipid profile, 
smoking status and alcohol consumption, the analysis revealed not only that sarcopenic obese 
presented the highest prevalence of hypertension (approximately 74.7% vs 49.7% in non-obese 
non-sarcopenic, 60.9% in non-obese sarcopenic, and 66.2% in obese non-sarcopenic; p<0.001) 
but also the highest OR. Namely, the non-obese sarcopenic, obese non-sarcopenic and sarcopenic 
obese groups had an OR (95%CI) of 1.5 ( 1.23–1.84), 2.08 (1.68–2.57) and 3.0 ( 2.48–3.63, 
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p<0.001), respectively. Moreover, BMI, %BF, WC and appendicular skeletal mass adjusted for 
weight (ASM/weight) were all significantly associated with blood pressure (all the 
aforementioned factors were positively associated with blood pressure, except ASM/weight which 
showed a negative association). When a separate analysis was conducted based on the presence of 
type II diabetes, the sarcopenic obese group presented again the highest ORs across all groups, 
and in fact the diabetic sarcopenic obese group had the highest OR of all [ 3.95 ( 2.51–6.20)]. 
Consistent with the previous finding, Park et al. (2013) showed that sarcopenia and obesity may 
act synergistically in increasing blood pressure in a study with 6,832 adult participants. The OR 
(95%CI) for obesity, sarcopenia and sarcopenic obesity was 3.15 (2.76–3.59), 2.48 (1.89–6.16) 
and 6.42 (4.85–8.48), respectively. 
 
Chung et al. (2013) assessed the impact of body composition on several cardiometabolic risk 
factors, such as blood pressure, lipid profile, glucose tolerance, metabolic syndrome and Vitamin 
D deficiency. For comparison purposes the researchers divided all participants [2,943 older adults 
(≥ 60 years)] into four groups based on the presence of sarcopenia (ASM/weight regardless of 
strength/function) and obesity (BMI ≥ 25 kg m-2) in a similar pattern to the previous studies. The 
prevalence of metabolic syndrome was significantly higher in the sarcopenic obese group in both 
men and women (60.9 and 71.1%, respectively, p<0.001)) compared with the rest of the groups. 
In men, the sarcopenic obese group was characterised by significantly higher levels of fasting 
insulin and homeostatic model assessment of insulin resistance (HOMA-IR) compared with the 
rest of the groups. Moreover, the sarcopenic obese group had significantly higher systolic and 
diastolic pressure, fasting glucose, triglycerides and HDL cholesterol compared with the healthy 
group. Accordingly in women, the sarcopenic obese group had significantly higher levels of 
fasting glucose compared with the sarcopenic non-obese group and higher fasting insulin, HOMA-
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IR compared with the non-sarcopenic obese group. This highlights that sarcopenia with obesity 
can potentiate insulin resistance and increase the risk for type II diabetes. Further, the sarcopenic 
obese groups exhibited the lowest vitamin D concentrations [25(OH)D: 18.5 ± 7.1 ng mL-1] which 
were significantly lower than those of the non-sarcopenic non-obese (20.5 ± 7.8 ng mL-1) and the 
non-sarcopenic obese (20.9 ± 7.6 ng mL-1) (both p<0.001). Those results, although derived from 
a cross-sectional analysis underline the importance of body composition in cardiometabolic health. 
However, one interesting finding that could account for some of the differences (or confound the 
results), was that adults with sarcopenia were less likely to participate in exercise training 
compared with their non-sarcopenic counterparts, and as such measurements of strength/function 
would offer a more complete understanding of the associations.  
 
The importance of strength in relation to CVD risk was noted by Stephen and Janssen (2009) who 
followed prospectively a cohort of 3,366 older community-dwellers, dividing them into two 
groups for sarcopenic obesity a) high waist circumference with low muscle mass and b) high waist 
circumference with low muscle strength. Participants were followed for eight years in order to 
determine their CVD risk. An interesting finding related to the previous discussion about the 
usefulness of BMI, was that the mean body mass index of the sarcopenic obese group (high WC 
+ low muscle) was 27.1 ± 2.4 kg m-2. That underlined again the possibility of older adults having 
increased central adiposity and sarcopenia even at BMIs < 30 km-2. Moreover, the risk of 
congestive heart failure and CVD increased by 42% and 23%, respectively, in the obese group 
with low strength but not in the obese group with low muscle mass. That finding suggested that 
strength, may account for some of the discrepancies observed in the literature. However, when the 
results were adjusted for age, sex, ethnicity, income, physical activity, alcohol consumption, 
smoking, and cognitive function there was no significance in the CVD risk factors between the 
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groups. In agreement with the previous finding, Atkins et al. (2014) noted that the CVD risk may 
not be significantly higher in sarcopenic obese vs healthy older adults, nevertheless, when 
sarcopenic obesity is defined as abdominal obesity with sarcopenia (derived by low mid-arm 
muscle circumference), then the all-cause mortality risk for the sarcopenic obesity group can be 
significant with an HR (95%CI) of 1.44 (1.10–1.90) (after adjusting for age, physical activity, 
smoking, alcohol, social status and CVD risk factors such as inflammatory markers). 
 
A potentially important parameter that is often overlooked is the dietary profile and especially 
protein intake. Kim et al. (2015) assessed the 10-year CVD risk in 3,320 middle-aged and older 
Koreans after categorising them into four groups based on the presence of sarcopenia (ASMI lower 
than 1SD below the normal values of a healthy 20-40 years group) and obesity (BMI ≥ 25 kg m-
2). In the 10-year follow-up test the crude CVD risk was highest in men and women in the 
sarcopenic obese and the sarcopenic non-obese groups compared with the healthy and non-
sarcopenic obese groups. Protein intakes and sessions of resistance exercise were significantly 
higher in the non-sarcopenic groups regardless of obesity. When the CVD risk was adjusted for 
protein intake, exercise participation, alcohol consumption and income, the risk for the sarcopenic 
obese group remained significant, with the odds ratio (OR) (95%CI) for sarcopenic obese men and 
women being 2.49 (1.53-4.06) and 1.87 (1.02-3.41), respectively.  
 
Apart from CVD risk, sarcopenic obesity may also affect the psychological status of older adults, 
which can be a vital parameter in older age. Ishii et al. (2016) conducted a study assessing the 
prevalence and sarcopenic obesity-associated risk of depression in 1,731 Japanese older adults 
(>65y) using a geriatric depression scale and categorising participants into four groups based on 
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the presence of sarcopenia (low ASMI) and obesity (highest sex-specific quintile for %BF). The 
highest prevalence of depression was reported in the sarcopenic obese group (~26%), whereas it 
ranged between 8.5-11% in the other three groups. In addition, the odds ratio (OR) for depression 
was statistically significant only in the sarcopenic obese group [OR (95%CI) = 3.63 (1.96-6.71), 
p<0.001] whereas this was even more pronounced in the 65-74 years group [OR (95%CI) = 6.05 
(1.89-19.38), p=0.003] even after adjusting for several factors, such as sleep quality, food intake, 
physical activity and comorbidities.   
  
Clinical prognosis 
Sarcopenic obesity may also affect clinical prognosis in chronic disease patients. In a thorough 
review Biolo et al. (2014) provided a wealth of evidence supporting that changes in body 
composition and especially a reduced muscle mass alone or concomitant to fat gains can lead to 
poor prognosis for a wide spectrum of conditions ranging from chronic obstructive pulmonary 
disease (COPD) to several types of cancer, even at normal BMIs. Choudhary et al. (2015) 
concluded that the prevalence of metabolic syndrome in sarcopenic obese patients after liver 
transplantation was significantly higher compared to their non-sarcopenic obese counterparts 
(57% vs 20%, p < 0.05). In cardiac surgery patients, the existence of low muscle with high fat 
mass can increase the risk of adverse health effects, such as post-operative infection by ~28% 
[odds ratio (95%CI): 7.9 (1.2-54.1)] (Visser et al. 2013). This figure is quite alarming considering 
that approximately one out of four surgical procedures in the UK involve patients at or over the 
age of 75 years (Griffiths et al. 2014), and out of ~158,000 deaths due to CVD in the UK in 2015, 
almost 90% of them were accounted for by people ≥ 65 years (BHF 2017a). It is also noteworthy 
that out of the six regions with the highest mortality rates in the UK, four of them are in Scotland 
(BHF 2017b).  
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In a cohort of 328 end-stage renal disease (ESRD) patients with a mean (±SD) age of 52 (±12) yr, 
it was found that both high fat mass index and low lean mass index were associated with high 
inflammation in sarcopenic obese patients (Honda et al. 2007). Furthermore, the patients with 
sarcopenic obesity showed a tendency towards higher prevalence rates of diabetes and CVD. In 
the same study, high fat mass and low muscle were independently associated with a pronounced 
inflammatory response, however, sarcopenia was a stronger predictor of mortality.  
 
In cancer patients, muscle atrophy is a strong predictor of lower/shorter survival (Martin et al. 
2013). It has been repeatedly documented that sarcopenic patients are likely to encounter health 
complications and poor prognosis in various stages of cancers of the lung (Tsukioka et al. 2017), 
liver (Iritani et al. 2015), colon (Lieffers et al. 2012), colorectal (Huang et al. 2015), skin (Sabel 
et al. 2011) and pancreas (Tan et al. 2009). On the other hand obesity alone not only can increase 
the risk for certain types of cancer (e.g. colorectal by >30%; Ma et al. 2013) but also for post-
operation complications (recurrence of cancer and/or mortality; Bardou et al. 2013). Therefore, it 
is not surprising that older cancer patients exhibiting both sarcopenia and obesity upon hospital 
admission are predisposed to suboptimal outcomes and poor clinical prognosis (Gonzalez et al. 
2014; Carneiro et al. 2016).  
 
Fujiwara et al. (2015) demonstrated that low muscle index, intramuscular fat deposition and 
visceral adipose tissue were all independently and significantly associated with mortality, with a 
hazard ratio HR (95% CI) of 1.52 (1.18-1.96), 1.34 (1.05-1.71) and 1.35 (1.09-1.66), respectively. 
Further, Fujiwara and colleagues showed that BMI was only weakly associated with intramuscular 
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fat (r = 0.19 – 0.25) and visceral fat (r = 0.23 – 0.26) and thus, it may not be an appropriate proxy 
for individual body composition assessments. It is not surprising therefore, that sarcopenic obesity 
was an independent predictor of mortality [HR: 4.2 (2.4 – 7.2)] and significantly associated with 
poor functional outcomes in patients with tumors in the gastrointestinal and the respiratory tract 
(Prado et al. 2008). In the last study, it was also suggested that sarcopenic obesity was an 
independent predictor of survival and could also exacerbate chemotherapy-induced toxicity. That 
effect is likely accounted for by the fact that the chemotherapy drugs are usually hydrophilic agents 
primarily metabolised in the lean soft tissue, i.e. the muscle and liver (Carneiro et al. 2016). 
Similarly, a study by Mei et al. (2016) reported an increased risk of infection and lower survival 
after surgery for gastrointestinal cancer in sarcopenic obese patients.  
 
The previous studies provide clear evidence to support the theory that high adiposity accompanied 
by, and often masking, sarcopenia can exacerbate the adverse effects of cancer and/or cancer 
treatments on health (Carneiro et al. 2016). Following up on the previously discussed topic 
regarding the use of BMI and the misleading notion of the obesity paradox, Gonzalez et al. (2014) 
demonstrated that in cancer patients the obesity paradox exists only when obesity is defined as 
high BMI, but not when using body composition proxies such as the fat mass index measured by 
bioelectrical impedance (Gonzalez et al. 2014). Therefore, it was concluded that in the presence 
of low muscle, high adiposity can offer no improvement in survival rates. That finding is in 
agreement with Kalantar et al. (2012) who suggested that direct body composition indices such as 
muscle mass are better predictors of mortality than BMI. 
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In summary, body composition and strength/function in older age are of vital importance. Not 
only does an association exist between body composition and the onset, progression and/or 
prognosis of other conditions such as type II diabetes, CVD, and cancer, but also, the capacity to 
perform physical activities can affect (and be affected by) these conditions, with physical 
inactivity exacerbating the loss of muscle and function, while promoting adiposity. This vicious 
cycle can lead to disability, institutionalization and consequently increased mortality rates. 
Although the importance of this condition has been documented, it is unknown what percentage 
of the older population is affected by sarcopenia and obesity in Scotland, with data existing 
currently only for BMI-derived obesity rates and only very limited information is available about 
sarcopenic obesity. Moreover, in order to reduce the health risks associated with sarcopenic 
obesity and increase the chances of healthier and quality years in older age, interventions should 
be implemented with multi-factorial approaches against both the deterioration of body 
composition as well as the attenuation of physical decline. 
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1.2 Management strategies for sarcopenic obesity in older age  
Decreasing body fat while increasing muscle mass and physical function may not only have 
beneficial effects on body composition and functionality, but also may potentially reduce the risk 
of clinical conditions such as hypertension, dyslipidemia, insulin resistance, metabolic syndrome, 
diabetes and cancer, while also improving quality of life (Garatachea et al. 2015). These health 
benefits will be discussed in this section along with documented lifestyle paradigms focusing on 
nutrition and exercise training.  
  
1.2.1 Exercise & Physical activity 
Physical activity can be defined as any activity that involves muscular contraction and raises 
energy expenditure (American College of Sports Medicine; ACSM 2014). Exercise is a structured 
form of physical activity with specific frequency, intensity, type and duration aiming at increasing 
certain aspects of physical fitness such as strength, power, flexibility and cardiovascular capacity 
(ACSM 2014). Garatachea et al. (2015) in a thorough review presented how exercise can elicit 
beneficial effects on the musculoskeletal, neuromuscular, cardiovascular, respiratory and 
cerebrovascular systems and can attenuate the manifestations of the main ‘hallmarks’ of ageing. 
The physiological adaptations of different types of exercise as well as their metabolic pathways at 
genetic, cellular and molecular level have also been reviewed thoroughly by (Konopka and Harber 
2014; Garatachea et al. 2015; McGlory and Phillips 2015). In this section, focus will be placed 
mainly on the potential for exercise training to induce body composition and functional changes, 
since they may influence the progression of sarcopenic obesity.   
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1.2.1.1 Effects of exercise on body composition and function 
It has been long documented that exercise can improve body composition and strength/function in 
young and older adults. One of the first studies to report changes in muscle mass and strength was 
that by Frontera et al. (1988). Twelve weeks of resistance exercise (three weekly sessions at 80% 
of a maximum repetition-1RM) resulted in significant increases in leg strength (ranged from 107.4 
to 226.7%, p<0.001), total thigh muscle area (11.4%, p<0.01) and fibre type I and II areas (by 
33.5% and 27.6%, respectively, p<0.01 in both) in adults 60-72 years of age.  Similar increases in 
frail older adults (mean age 90±1 yr), after strength training (three times weekly, at 80% 1RM) for 
eight weeks, were documented for strength (average improvement in knee extension was 174± 
31%) and thigh muscle area (by 9.0 ± 4.5%) (Fiatarone 1990). In that trial, a decrease in quadriceps 
strength by 32% was noted within four weeks after the conclusion of the training period (also 
known as detraining effect) (Fiatarone 1990). In a study with 1,644 men and women 21-80 years 
old, the effects of 10-week exercise training based on the guidelines produced by the American 
College of Sports Medicine (ACSM) were assessed (Westcott and Winett 2006; Westcott 2009). 
The gain in lean mass and loss of fat mass were on average 1.4 kg and 1.7 kg, respectively. Sub-
group analyses found that men and women gained on average 2.1 kg and 1.2 kg of lean tissue, 
respectively. 
 
One of the key studies that provided information on body composition and energy expenditure in 
sedentary adults aged 56-80 yr was conducted by Campbell et al. (1994). The exercise protocol 
involved 3x30 min strength training per week for a total of three months. The results indicated a 
significant increase in lean mass (1.4± 0.4 kg, p<0.01) and a concomitant decrease in fat mass 
(1.8± 0.4 kg, p<0.001). Moreover, significant increases in strength (upper and lower body strength 
tests showed increases of 22-94%), resting metabolic rate (~15%) and energy expenditure were 
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reported (~7%). Resting metabolic rate was significantly and positively correlated to lean mass at 
baseline (r= 0.86, p<0.001) and after the exercise training period (r=0.85, p<0.001). Consistent 
with this observation, Pratley et al. (1994) reported similar changes in lean mass, fat mass, strength 
and resting metabolic rates (~7.7%) after a strength training protocol. The same research group 
also noted that resistance exercise may result in significantly increased resting metabolic rates 
even when combined with a weight loss regimen in postmenopausal women (Ryas et al. 1995).   
 
In a 12-month study with post-menopausal women (n=39, 50-70 yr), resistance exercise was found 
to be effective in significantly increasing total muscle mass (by 1.2± 0.4 kg vs -0.5± 0.8 kg) and 
strength (several upper and lower body tests showed a significant increase in the exercise group, 
whilst a decline or no change was observed in the control) as well as dynamic balance measured 
by backward tandem walk (+8.5% in exercise vs -14.3% in control, p=0.005) (Nelson et al. 1994). 
Moreover, the exercise group experienced a significant increase in lumbar spine bone mineral 
density (BMD) (+1.0% vs -1.8% in control, p=0.04) and femoral neck BMD (by +0.9% in exercise 
vs -2.3% in control, p=0.02) (Nelson et al. 1994). Therefore, it was suggested that resistance 
exercise can decrease the risk of bone fractures. Indeed, it has long been documented that poor 
strength, balance and bone mineral density are risk factors for falls and fractures amongst older 
individuals (Tinetti et al. 1988).    
 
The interaction (‘crosstalk’) between muscle and bone tissue is well-established (Maurel et al. 
2017). Thus, it has long been postulated that strong muscles usually complement strong bones 
(Hughes et al. 1995). More recently it has also been shown that a significant association also exists 
between leg power and bone mineral density (BMD) of the hip even after adjusting for weight, 
43 
 
height, smoking, and leisure time (Schwarz et al. 2014). The bone-muscle link is especially evident 
in athletes, who are likely to experience a greater (BMD) and bone mineral content (BMC) in the 
extremities of the dominant side compared to the non-dominant, which is indicative of the anabolic 
effect exerted by the exercising muscles on bone architecture (Haapasalo 1994).   
 
Menkes et al. (1993) showed that a 16-week strength training programme can increase bone 
mineral density in older adults at the femoral neck (by 3.8%, p<0.05) and the lumbar spine (by 
2%, p<0.05). A similar increase in femoral BMD (2.8%) was noted after a 16-week strength 
training programme in men (n=21, age=61±1yr) (Ryan et al. 1994). The positive effect of exercise 
training on BMD of men across all ages > 31 years has also been confirmed by a meta-analysis. 
An increase of ~2.6% in BMD can be expected at the sites loaded during the resistance exercise 
training (Kelley et al. 2000). Endurance training can also prevent the approximate loss of 1% in 
BMD per year in femoral and lumbar sites in pre- and post-menopausal women (Wolff et al. 1999). 
Nonetheless, it is important to note that this effect is likely to be experienced by women who 
consume adequate amounts of calcium; the threshold of which is theorised to be ≥ 1000 mg daily 
(Specker 1996; Wolff et al. 1999). Moreover, based on a meta-analysis of 29 studies, resistance 
exercise has also been found to be beneficial in increasing BMD in femur, lumbar spine and radius 
in post-menopausal women (Kelley et al. 2001).  
 
Aerobic training improves the body’s potential to utilise oxygen more efficiently. The benefits of 
aerobic exercise on the cardiovascular system have been extensively documented (Fleg 2012). 
Similar to resistance training, aerobic exercise can also attenuate the energy restriction-induced 
BMD losses in older women (Pritchard et al. 1996; Ryan et al. 1998). More importantly, an 
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important benefit of aerobic exercise in older people that has been under-reported is its ability to 
enhance muscle hypertrophy and function (in addition to augmenting aerobic capacity). In a 12-
week study with older women (71± 2 yr) exercising at a cycle ergometer (intensity was 
progressively increased from 60 to 80% heart rate reserve), it was shown that quadriceps volume 
and power of the knee extensor increased by 12± 2% (p < 0.05) and 55± 7% (p < 0.05), respectively 
(Harber et al. 2009). The biopsy analysis showed a preferential increase in the size and power of 
type I muscle fibres. Similar results were obtained in a subsequent study with older men (74± 3 
yr) (Harber et al. 2012). Twelve weeks of cycle ergometer training resulted in significantly higher 
quadricep volume by 6± 1% (p<0.05) (which was comparable to increases noted in a group of 
young exercisers). That increase in muscle volume was accounted for by an increase in the cross-
sectional area of type I myofibres. However, contrary to women, the peak power of both type I 
and IIa was increased in older men, indicating that there may be sex-specific differences in 
physiological responses to aerobic-based exercise (Harber et al. 2012).   
 
Power (velocity of force development) is an important determinant of body’s functionality and 
may decline at higher rates than strength in older adults (Skelton et al. 1994; Metter et al. 1997). 
Muscle power may be a better predictor of functional status than absolute strength in older age 
(Foldvari et al. 2000).  Power and speed of muscle contraction is especially important for older 
adults, since it is involved in virtually all functional movements performed in everyday activities, 
from getting up from a chair quickly, to crossing the road swiftly, changing direction to avoid 
obstacles/accidents, getting to the restroom in time etc. (vanBeveren 2012). Power training 
(increasing the speed of performed movements) has therefore been regarded as a beneficial type 
of training. Power training can augment muscle mass (Nogueira et al. 2009) and power as well as 
strength comparably to or even better than traditional strength training (Marsh et al. 2009). 
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Another way of increasing power is by performing plyometric exercises. Plyometric training 
includes movements that initially lengthen the muscle (eccentric contraction) and then swiftly 
shorten it (concentric contraction). They can be used to increase power in lower and upper 
extremities of the body and similar to power training, they can enhance bone formation and 
consequently increase BMD (Stengel et al. 2005).  
 
Furthermore, with advancing age the body adopts a certain posture based on movement patterns 
and positioning. Often this posture results in certain muscles being continuously held in a 
shortened or lengthened status, which can subsequently result in muscular stiffness and poor 
balance (Gajdosik et al. 2004). This is particularly noticed in sedentary older adults who do not 
engage in physical activities and thus do not perform movements at a full range of motion. 
Therefore, stretching is often included in training programmes for older adults, as it can increase 
the range of motion for the targeted joints and alleviate the imbalances in muscle length (Feland 
et al. 2002). Nevertheless, it is important to note, that even in the absence of stretching exercises, 
strength training alone can improve flexibility in older individuals (Barbosa et al. 2009).  
 
Other effective forms of exercise include functional training or task-specific exercise (TSE). 
Functional training refers to movements that require the individual to use multiple joints and move 
through multiple axes of motion challenging his or her balance and proprioception (VanBeveren 
and Avers 2012). This can be done by changing direction or plane of movement, change speed, 
keep the eyes open or closed, by moving the head to different directions while avoiding obstacles 
etc. Task-specific training is a form of functional training that requires the engagement of multiple 
joints and simulates everyday activities, such as getting up from the chair, stair climbing etc. This 
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type of training is considered an effective way of improving strength and balance within a context 
of practicality (Buford et al. 2014). Task specific training has significantly reduced the time 
needed to perform a series of tasks related to bed-rise and chair-rise in congregate housing 
residents (n=161, ≥ 65yr) (Alexander et al. 2001), whereas it has been found equally effective to 
resistance exercise in terms of improving the performance of activities of daily living (ADL) (de 
Vreede et  al. 2004). 
 
Therefore, training paradigms incorporating different modalities (e.g. strength, power, balance, 
daily tasks-simulation exercises, flexibility etc.) would in theory be beneficial for older adults with 
sarcopenic obesity. However, such studies are scarce and the aforementioned ones were performed 
in specific conditions (e.g. in a gym or physiology lab) with specialised equipment and/or at high 
intensities which may have low practicality for community-based interventions targeting at older 
adults with an established deterioration of body composition. Moreover, secondary to functional 
and body composition improvements,  a knowledge gap exists as to whether exercise can elicit 
health-related benefits which are particularly important for the sarcopenic obese, e.g. 
inflammation, abdominal fat deposition, mental status, etc.  
 
1.2.1.2 Health benefits of Exercise  
Exercise training has the potential to elicit a protective effect against CVD and type II diabetes. In 
older adults (66± 8 yr) with diabetes, resistance exercise (twice a week at 60-80%RM for 16 
weeks) has been found effective in improving glycemic control (and reduced the dose of diabetes 
medication) as well as increasing fat free mass (+1.2± 0.2kg) and reducing truncal fat mass (-0.7± 
0.1) and systolic blood pressure (-9.7± 1.6mmHg) (Castaneda et al. 2002). While both aerobic and 
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resistance exercise alone can improve glycemic control, when combined they showed a synergistic 
potential superior to either training type alone in 251 middle aged and older adults (Sigal et al. 
2007). Twenty two weeks of aerobic (60-75% HRmax) plus resistance exercise (2-3 sets at 
maximum weight that can be lifted for 7-9 reps) can reduce glycated haemoglobin (HbA1c) 
significantly more than either of them alone. The aerobic, resistance and combined groups 
experienced a reduction in percentage points in HbA1c concentration by -0.43 (95%CI; -0.70 to -
0.17), -0.30 (-0.56 to 0.05) and -0.90 (1.15 to -0.64), respectively. 
 
Although exercise (especially resistance) can acutely increase blood pressure, it has also positive 
effects on both systolic and diastolic pressure (Baechle and Westcott 2010). In  a study with 1,644 
adults aged 21-80 years, a combination of 20 min aerobic and 20min resistance training performed 
(two or three times weekly) reduced systolic and diastolic blood pressure by ~4 mmHg and ~2 
mmHg, respectively (Westcott 2009). Even in hypertensive patients exercise can produce modest 
reductions in blood pressure, however, the combination of exercise with a weight loss regimen 
and antihypertensive drugs may be the optimal approach for those with moderate to severe 
hypertension according to Ehsani (2001). Indeed, this has been confirmed in randomised control 
trials with older adults who usually experience reductions in blood pressure after exercise training 
alone (2-7 mmHg), and these reductions were significantly associated with body composition 
changes and especially fat losses from the central region (Stewart et al. 2005; Barone et al. 2009).   
 
One other potential benefit of resistance exercise is the anti-depressant effects that it can exert on 
older adults. Singh et al. (2001) conducted a 20-week long RCT employing a resistance exercise 
routine (n=32, 71.3± 1.2 yr). They concluded that depression scores were significantly reduced in 
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the intervention group (weight-lifting) compared with the control group (no exercise). Moreover, 
six weeks after the programme had been finished, 33% of the intervention group was still taking 
part in exercise sessions compared to 0% from the control group. Considering that depression may 
be more prevalent in sarcopenic obese older adults than their healthy counterparts (Ishii et al. 
2016), this anti-depressant effect of exercise can be of vital importance for the mental status of 
this population group.  
 
Albeit this has yet to be confirmed in human studies, exercise has shown a potential in attenuating 
the impairments in autophagy mechanism that are often associated with advancing age and 
sarcopenia (Kim et al. 2013b). Moreover, exercise can decrease the inflammatory response and 
the increase in intermuscular fat depots usually involved in conditions associated with ageing 
(Petersen and Pedersen 2005; Marcus et al. 2010).  
 
1.2.1.3 Physical Activity Guidelines  
According to the World Health Organisation (WHO), most of the health burden in older age can 
be accounted for by risk factors for chronic diseases such as cancer and CVD (WHO 2009). 
Physical inactivity is the fourth overall risk factor for death, affecting all income classes especially 
in middle- and high-income countries. Hypertension, smoking and hyperglycaemia are the first 
three risk factors, whereas overweight and obesity come fifth (WHO 2009). The leading causes of 
death in older people are heart disease and cancer whereas dementia is another leading risk factor 
after the age of 80 (Centres for Disease Control and Prevention 2014; Office for National Statistics 
2015). Lack of physical activity can increase the risk of CVD, breast and colon cancer as well as 
stroke, type II diabetes, depression and obesity (Health and Social Care Information Centre 2013).  
49 
 
 
Regular participation in physical activities (either in the form of structured exercise training or by 
increasing the levels of habitual physical activities) has been associated with higher functional 
status. Physical activity can also reduce the risk of physical disability and may potentially reduce 
the risk of dementia in older adults (Paterson and Warburton 2010) as well as improve cognitive 
function (Tseng et al. 2011). In addition, it can reduce the risk of CVD mortality even among those 
with a high-risk metabolic profile or existing CVD (Hamer and Stamatakis 2009; Hamer and 
Stamatakis 2012).  
 
According to a joint document produced by the four UK Chief Medical Officers (Department of 
Health 2011), there is substantial evidence to suggest that an inverse dose-response relationship 
exists between physical activity and risk of stroke, type II diabetes and cancers of breast and colon 
in older adults. Moreover, regular physical activity can reduce the risk of anxiety, depression and 
dementia and improve strength, balance and bone mineral density while reducing the likelihood 
of falling and bone fractures. The physical activity recommendations for older adults are presented 
in Table 1.2 (adapted from ‘Start Active, Stay Active’; Department of Health, 2011). The 
document suggests that some physical activity is better than none, however, the aim for all older 
adults should be to stay as active as possible and minimise the periods of inactivity. The UK 
physical activity guidelines are in accordance with the respective guidelines published by the 
American College of Sports Medicine (Appendix 1; ACSM 2014). Namely, the ACSM 
recommends a total of 150-300 min of moderate-intensity aerobic activities or 75-100 min of 
vigorous intensities (ACSM 2016).  
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Table 1.2 UK Exercise and Physical activity guidelines for older adults 
 Participation in moderate-intensity activities for at least 150 minutes weekly, which do 
not necessarily need to be continuous but in bouts of 10+ minutes (e.g. five sessions of 
30 minutes each). Example activities: cycling, walking, dancing.  
 
 For those who already exercise at moderate intensities, it is recommended to try activities 
of vigorous intensity lasting 75 minutes spread throughout the week or a combination of 
moderate and high-intensity activities. Example activities: running, tennis 
 
 Activities aiming at improving strength should be undertaken at least twice a week. 
Example activities: Strength exercises for all major muscle groups e.g. legs, hips, back, 
shoulder, arms, abdominals.   
 
 Those at risk of falling should undertake activities aiming to improve balance and 
coordination at least twice a week.  
 
 Avoid long periods of inactivity as it is an independent ill-health risk factor.  
Notes: adapted from the document ‘Start Active, Stay Active’ produced by the UK Chief Medical 
Officers (Department of Health 2011).  
 
1.2.1.4 Current physical activity levels and sedentary behaviours  
The recommendations suggest that older people should perform at least 150 minutes of moderate-
intensity physical activities per week. However, according to data from the ‘Health survey for 
England, 2012’, the ‘Scottish health survey, 2014’, the ‘Welsh health survey, 2015’ and the 
‘Health Survey Northern Ireland 2013/14’ as collated and presented by the British Heart 
Foundation National Centre (BHFNC 2016) report low compliance (Table 1.3). Namely, in 
Scotland only marginally more than half (51%) of the 65-74 age group follow the guidelines, 
whereas the respective figure for the 75+ group falls to 26%. Moreover, 53% of men and 56% of 
women from the 75+ group have reported very low physical activity levels, performing less than 
30 minutes of physical activity per week. In England, only 47% and 20% of the 65-74 and 75+ 
groups, respectively, follow the guidelines. In Wales, although the proportion of the older 
population meeting the guidelines is slightly higher (Table 1.3), 40% of the overall 65+ group 
does less than 30 minutes of physical activities and has therefore been classified ‘inactive’. In 
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Northern Ireland, even more alarming than the low physical activity levels (Table 1.3) is the fact 
that only 1% of the over 75s performs activities at least twice a week in order to improve muscular 
strength. 
 
Along with the declining levels of participation in physical activities is the increasing amount of 
time that older people spend in conditions that require very low energy expenditure (other than 
sleeping), such as sitting or lying, which are known as sedentary behaviours (BHFNC 2012). Such 
behaviours may include sitting and lying while at home or work, while socialising with others or 
while watching TV/reading a book, and commuting (BHFNC 2012). The time spent in sedentary 
behaviours is very important because it has been consistently associated with all cause mortality 
irrespective of physical activity levels (Proper et al. 2011; Thorp et al. 2011). In Scotland, amongst 
all adult age groups (19 years old and over), the 65-74 and 74+ groups are the most sedentary, 
spending an average of 6.5 and 7.5 hours, respectively, on sedentary behaviours during weekdays, 
whereas in weekends the figures are even higher (6.7 and 7.6 hours, respectively) (Scottish 
Government 2013). Similarly, in England the most sedentary among the adults groups are those 
over the age of 65 years, with approximately 6.0, 6.4 and 6.7 of daily sedentary hours for the 65-
74, 75-84 and 85+ groups, respectively (Health and Social Care Information Centre 2013). 
Furthermore, the English older adults with a BMI over 25 kg·m-2 are likely to spend on average 
more sedentary hours than their counterparts of a normal BMI (Health and Social Care Information 
Centre 2013). Additionally, English older adults from deprived areas and low incomes tend to 
spend more time on sedentary behaviours. This finding is in agreement with a study conducted in 
Scotland in 2009 reporting that a lower socioeconomic status is associated with increased periods 
of time spent on sedentary screen-based entertainment (e.g. watching television) (Stamatakis et al. 
2009). Nonetheless, there is limited evidence to provide full understanding of how the 
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environmental and sociocultural factors affect the sedentary behaviours in older adults (BHFNC 
2012a).    
   
Table 1.3 Proportion of the older populations that meet the PA guidelines in the UK. 
Country Age group 
 65-74 75+ 
England Women 42%  
Men 51% 
Women 13%  
Men 30% 
Scotland Women 44% 
Men 59% 
Women 22% 
Men 32% 
Wales Total 56% Total 35% 
Northern Ireland Total 28% Total 12% 
Notes: Data from the British Heart Foundation National Centre (BHFNC 2016)  
  
1.2.1.5 Contraindications to exercise in older adults 
In general, exercise training is safe for most individuals and at any age, however, there are a few 
medical conditions where specific contraindications may exist and can prevent an older person 
from participating in exercise training (Panton and Loney 2011). These conditions may include 
uncontrolled and severe cognitive or psychological problems, terminal illnesses, or conditions that 
can affect the cardiac, lung and/or vascular function such as ischemia, a recent myocardial 
infarction, cardiac dysrhythmias, unstable angina, severe aortic stenosis, uncontrolled heart failure 
or other acute cardiac event, aneurysm, pulmonary embolus or infarction, or other serious acute 
systemic infections (Panton and Loney 2011). 
   
Moreover, avoiding exercises –at least temporarily- may be indicated for conditions that do not 
allow for a proper and safe performance of the exercises such as eye conditions (e.g. retinal 
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bleeding, cataract), hernias or joint injuries. It is important to note that conditions such as 
osteopenia or osteoporosis, arthritis, diabetes, stroke, depression, peripheral vascular disease are 
not by themselves a contraindication to exercise; in fact exercise can offer health benefits and 
improvements that may not be attainable through drug treatment alone (ACSM 2009).   
 
In addition, even though exercise carries an inherent risk of transient musculoskeletal injuries, in 
the long term it can significantly increase strength, gait speed and endurance, improve the 
metabolic profile and reduce the risk of CVD, as well as reduce the risk of falls and fractures in 
older people, all of which outweigh the potential risks. Moreover, the risk of death for older people 
who do not engage in exercise on a regular basis is higher than their fit counterparts (Kokkinos 
2012). The only exception may be death due to cardiac arrest during exercise training in older 
individuals with existing coronary heart disease. Nevertheless, even within the older population 
groups chances of cardiac arrest due to exercise are relatively low (Kokkinos 2012). It is also 
important to note that older adults do not necessarily need to perform high-intensity workouts to 
obtain the health benefits of exercise. Exercising at moderate intensities has been consistently 
proven beneficial in reducing the risk of obesity, type II diabetes, arthritis, heart disease and some 
forms of cancer, especially of breast and colon (Panton and Loney 2011). Furthermore, becoming 
fit by exercising initially at low intensities followed by gradual increases may reduce the risk of 
cardiac events (Riebe et al. 2015). 
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1.2.2 Nutritional Strategies  
The two most popular nutritional strategies that have been documented to affect body composition 
and function include modification of the macronutrient profile, with a particular emphasis on 
protein and energy intakes. Energy-restriction diets in particular, are regarded as the cornerstone 
of weight-loss regimens (Klein et al. 2001). 
 
1.2.2.1 Energy-restriction diets 
One of the most extensively studied paradigms for the treatment of obesity is intentional weight 
loss via dietary energy restriction. Although the benefits of weight loss in obese older adults with 
regard to reducing mortality rates are still inconclusive (and possibly are accounted for by the 
differences in research protocols and diagnostic criteria as discussed previously), it is evident that 
voluntary weight loss via caloric restriction can reduce several obesity-related risk factors for CVD 
and metabolic syndrome, such as insulin resistance, dyslipidaemia and raised blood pressure 
(Klein et al. 2001; Poirier et al. 2006).    
 
In a study including 35 older women (age: 69 ± 8 yr; BMI: 30.97 ± 6.38 kg m-2), following a 
moderate energy restriction regimen (500 kcal daily deficit) for three months, it was reported that 
central adiposity measured by waist circumference (WC) and sagittal adipose depth (SAD) was 
significantly and positively associated with fasting glucose and insulin levels, HOMA-IR, high 
sensitivity CRP (hs-CRP), subcutaneous adipose tissue and intramuscular fat deposition (assessed 
by CT scan at mid-thigh level) and negatively associated with high density lipoprotein (HDL) 
cholesterol (Mazzali et al. 2006). After the 3-month caloric deficit, body weight (−4.66 ± 2.72 kg), 
BMI (−1.95 ± 1.17 kg.m-2), SAD (−1.62 ± 0.98 cm) total fat mass (−3.2 ± 2.03kg) and 
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intramuscular adipose tissue (−2.15 ± 1.59 cm2) all declined significantly (p<0.001). Insulin and 
HOMA-IR were also significantly reduced (p<0.05), however, hs-CRP did not show a significant 
change, although there was a decrease from baseline to 3-months follow-up [from 2.90 (2.0–3.60) 
mg L-1 to 2.50 (1.90–3.70) mg L-1]. Nevertheless, it appears that the study was powered to detect 
changes in body composition, but underpowered for hs-CRP, since other studies with similar 
weight and fat mass changes, noted significant declines in median hsCRP from ~1.80 to 1.40 mg 
L-1 or even from ~0.7 to 0.6 mg L-1 but in considerably larger cohorts, n> 700 (Nicklas et al. 2013; 
Kitagawa et al. 2017). Moreover, the clinical significance of changes in hsCRP depends also on 
the baseline values, since a concentration of > 2 mg L-1 is believed to be linked to increased risk 
of stroke and CVD in Caucasians (Meschia et al. 2014) whereas in Asians the cut off may be lower 
at ~ 1 mg L-1 (Kitagawa et al. 2017).  
 
Bouchard et al. (2007) examined the relationship between body composition and physical capacity 
in 904 older men and women. Their findings revealed a significant negative association between 
% body fat and balance (1-leg stand), walking speed and overall physical capacity in both men 
and women. Moreover, older adults who are obese may be less responsive to exercise-induced 
functional improvements compared with their non-obese counterparts (Manini et al. 2010). This 
may be accounted for by the increased deposition of adipose cells between/within muscles that 
can affect muscle quality (Hausman et al. 2014) and/or by the increased effort required to move 
the extra mass. For example, as we age there are certain muscles that are particularly susceptible 
to the accretion of intermuscular fat, such as the gastrocnemius, which can impair mobility and 
physical performance (Tuttle et al. 2012). It has been hypothesised therefore, that fat losses can 
enhance physical performance. Energy restriction alone (daily deficit of 500-750kcal for 12 
months) has been effective in augmenting physical function in obese frail older adults. In that 
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study body weight decreased by ~10 kg (~3 kg and ~7 kg were lost from lean deposits and fat 
stores, respectively) (Villareal et al. 2011a). The time needed to complete a walking task was 
reduced by 10%, while the time participants could stand on one leg increased by 40%. 
Additionally, a 14% increase was noted in the ‘physical’ component of the health related quality 
of life questionnaire, SF-36. Despite the loss in lean mass, the improvement in physical function 
can be attributed to the decreased mechanical burden on the joints, the improved lean mass to fat 
ratio and the decreased effort required to move the extra mass. Indeed, it has been estimated that 
for every pound of weight lost there is a 4-fold reduction in the mechanical load applied on the 
knee joint per step (Messier et al. 2005).  
 
Similar reductions in body weight after a moderate caloric restriction (<500 kcal daily deficit) 
have also been confirmed in an older study by Katzel et al. (1995). It was noted that nine months 
of reduced energy intake can reduce body weight by ~9.5 kg, while improving fasting glucose and 
insulin levels by 2% and 18%, respectively. Moreover, glucose and insulin areas under the curve 
(AUC) were reduced by 8% and 26%, respectively, during the oral glucose tolerance test. In 
addition, high-density lipoprotein (HDL) was increased significantly by 13%.  
 
Apart from improving the metabolic profile and functional capacity, diets restricting energy intake 
(from as low as 8% up to 30-40%) are regarded as one of the most effective ‘anti-ageing strategies’ 
since they have the potential to lower the accumulation of senescent cells and reduce the age-
related inflammatory response (Phillips and Leeuwenburgh 2005; Marzetti et al. 2008 Franceschi 
2016). In a cross-over study design a modest caloric restriction (~20% below energy 
requirements), significantly attenuated the inflammatory response over 14-day periods of bed-rest 
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and ambulatory conditions at a eucaloric vs. a hypocaloric state (Bosutti et al.2008). In the control 
phase (participants receiving a eucaloric diet matching energy expenditure) IL-6 and CRP plasma 
levels were significantly higher (p=0.01 and p=0.04, respectively) as was the ratio of Il-6: IL-10 
(p=0.001) compared with the hypocaloric phase. Interleukin-10 is an anti-inflammatory marker 
with a potential health benefit, primarily by inhibiting the production of pro-inflammatory 
hormones including but not limited to: IL-1, IL-6 and TNFa (Petrolani 1999).  As discussed at the 
beginning of this chapter even less than two weeks of inactivity can promote muscle atrophy 
(Breen et al. 2013) and one of the potential factors accounting for that effect may be the increased 
secretion of inflammatory hormones. Although these results reveal a potential for caloric 
restriction to attenuate inflammation, these results are yet to be confirmed in sarcopenic obese 
older adults.  
 
In a study with 41 postmenopausal sedentary and obese women (54± 1 yr, 34.8 ± 1.2 kg.m-2) a 
daily energy intake of ~1,250 kcal over a 12-week period resulted in significant loss in total body 
weight, fat mass and trunk fat mass (p<0.001 for all) (Figueroa et al. 2013). However, more than 
one kg of lean mass was lost (p=0.03) due to the energy restriction regimen. The energy deficit-
induced lean mass loss is a common phenomenon in energy restriction regimens and therefore 
raises questions about their effectiveness in adults with sarcopenia.   
 
Thus, although caloric restriction alone may be a viable weight loss strategy, it is debatable 
whether it is the optimal approach for sarcopenic obese older adults. It has been estimated that the 
energy deficit-induced weight loss in obese individuals can be accounted for by ~75-80% fat losses 
and ~20-25% lean mass losses (Ballor et al. 1988). In a 52-study systematic review of energy 
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restriction with/without exercise in adults (age ≥ 50 yr, BMI ≥ 25 kg m-2), Weinheimer et al. (2010) 
concluded that 81% of the studies adopting a calorie-deficit protocol noted losses in lean mass 
(more than 15% of the losses were from lean mass). Even when energy deficit was combined with 
exercise, the same degree of lean mass losses was apparent in 39% of the studies. Therefore, the 
challenge with management strategies for sarcopenic obesity is to promote reductions in fat mass 
while concomitantly preserving (or increasing if possible) muscle mass and function.  
 
1.2.2.2 Dietary protein  
The beneficial effects of protein may be accounted for by its potential for increased thermogenesis 
which combined with its satiating properties (Latner and Schwartz 1999) makes protein the most 
‘calorie-for-calorie efficient nutrient’ in terms of appetite control (Arentson-Lantz et al. 2015). It 
has been documented that increasing protein intake from 15% to 30% can lead to a decrease in ad-
libitum energy intake, which can result in significant weight and fat losses even after 12 weeks 
(Weigle et al. 2005). The lean mass (including muscle and bones) sparing effect of protein may 
be explained by the protein-induced activation of the mTOR pathway and increased IGF-1 
concentration (a detailed review of this pathway has been presented by McLeod et al. 2016). As 
discussed earlier IGF-1 concentrations decline with age. However, a study employing protein 
supplementation (20 g daily) resulted in increased levels of IGF-1 in older adults with a recent hip 
fracture (Schurch et al. 1998). The authors also suggested that the increase in IGF-1 possibly also 
accounted for the attenuation of bone mineral losses and the shorter hospitalisation period.  
 
In addition, a high-protein meal may result in a lower inflammatory response compared to an 
isocaloric carbohydrate-rich meal (Parvaresh-Rizi et al. 2016). Provision of a meal rich in 
59 
 
carbohydrates exerted a negative effect on immunometabolic responses by increasing the 
inflammatory response, which may indicate a greater risk of CVD. Albeit in younger adults, that 
study also confirmed that the obese and insulin-resistant individuals are more susceptible to these 
carbohydrate-mediated negative effects compared to their lean and insulin-sensitive counterparts. 
That finding could be particularly useful for dietary interventions with older sarcopenic obese 
individuals, since the latter may be more susceptible to insulin resistance.  
 
Protein intake during energy restriction  
Although caloric restriction is likely to result in losses of lean mass, it has been hypothesised that 
increased intakes of dietary protein have the potential to attenuate this loss even during energy 
restriction. In a 12-week study employing an energy restriction protocol (~500 kcal daily deficit), 
a higher protein intake (16% vs 25% of daily energy intake) resulted in significantly lower lean 
mass losses (-1.5± 0.3 vs -0.1± 0.3, p<0.03) in overweight adults aged 20-65 yr (Farnsworth et al. 
2003). Moreover, although the overall weight lost was similar in both groups (~8 kg), the glycemic 
response (glucose area under the curve) and triacylglycerol levels were significantly lower in the 
high protein group. In a study with 100 obese men, a diet providing 2.2 g protein ⋅ kg bw−1 ⋅ day 
−1 was compared against a lower protein diet (1.1 g ⋅ kg bw−1 ⋅ day −1), while both groups were on 
an energy deficit diet plan (500 kcal daily deficit) (Treyzon et al. 2008). Both groups lost the same 
amount of weight, however, the high-protein group lost preferentially more body fat compared to 
the low-protein group (-1.65± 0.63 kg vs -0.64± 0.79 kg; p<0.05).  
 
Indeed, a meta analysis of 24 trials (n=1,063) by Wycherley et al. (2012) confirmed this hypothesis 
stating that during energy deficit periods shifting the protein: carbohydrate ratio towards higher 
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protein intakes (at ~1.25 g ⋅ kg bw−1 ⋅ day −1) can have favourable effects on body composition. 
Namely, this shift can promote weight loss through greater losses of fat (and a higher satiety 
response noted in most of the studies) whilst attenuating the decline in lean tissue and resting 
energy expenditure. Therefore, a higher protein intake may be a valuable modifiable parameter in 
nutritional interventions aiming to decrease fat depots while preserving muscle mass, however, 
the effectiveness of such paradigms has not been evaluated in sarcopenic obesity.    
 
Intriguingly, higher protein intakes achieved through increased consumption of dairy products 
may facilitate greater losses of fat mass during short-term energy-restriction interventions (Chen 
et al. 2012). Although in premenopausal women, a study by Josse et al. (2011) showed that 
increased protein and especially dairy protein (30% of energy intake was from protein and half of 
it was from dairy sources) can augment lean mass while concomitantly lowering body fat, during 
energy-restriction combined with exercise training, in overweight and obese participants. That 
study was also one of the first to show an association between a decline in visceral adipose tissue 
and increased protein and calcium intakes.  
 
Protein-induced augmentation of muscle mass and strength  
Although debatable to date, when protein is combined with exercise training (resistance training 
in particular) it may significantly increase lean mass as well as strength. According to a meta-
analysis 22 of studies with young (n=462, age <50 yr) and middle aged/older adults (n=218, age 
>50 yr) protein supplementation (daily average of 42 ± 30g protein) can increase lean mass 
(95%CI) by 0.69 (0.47, 0.91) kg (p < 0.001) and leg strength by 13.5 (6.4, 20.7) kg (p < 0.005) 
(Cermak et al. 2012). The improvements in muscle and strength in the middle-age/older subgroup 
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during a 3-month training period were calculated to be on average 38% and 33%, respectively. 
Nevertheless, there are key information that are yet to be fully elucidated such the effectiveness 
of high protein diets to ameliorate body composition and function in sarcopenic obese adults.  
 
There is evidence supporting the notion that protein ingestion after exercise training can 
significantly enhance muscle protein synthesis rates in both young and older adults (Pennings et 
al. 2011a). Pennings et al. (2011a) examined the effect of ingestion 20 g protein in 24 older adults 
(74 ± 1 yr) after a single session of resistance and moderate-intensity aerobic training and observed 
that de novo muscle protein synthesis in older adults was significantly increased compared to rest-
states. However, that effect was assessed in an acute setting and therefore long term implications 
were not fully explored. In a continuation of their previous findings, Pennings et al. (2012) 
assessed the impact of various protein intakes taken in a bolus dose on muscle protein synthesis. 
They compared the muscle protein synthetic effect of 10, 20 and 35 g of whey protein in 33 healthy 
older adults (73 ± 2 yr). The results revealed a dose-dependent increase in amino acid absorption 
and muscle accretion with the 35 g promoting a significantly higher anabolic response compared 
to the lower doses (p<0.005). In a similar fashion, Yang et al. (2012) conducted a study comparing 
the effects of 0, 10, 20 and 40 g whey protein ingestion after a single bout of resistance exercise 
(n=37, 71± 4 yr). Only the groups receiving 20 g and 40 g experienced significant responses in 
MPS, with the 40 g group exhibiting significantly higher MPS than the 20 g group (95% increase 
vs 60%, p<0.05). Although protein ingestion was explored in an acute setting, these studies made 
it apparent that protein supplementation after exercise can significantly enhance synthesis of new 
muscle tissue in older age. However, the ceiling effect in terms of muscle accretion in older adults 
is still not well defined.   
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In an attempt to further understand the effect of protein timing on muscle hypertrophy and strength 
Schoenfeld et al. (2013) conducted a systematic review and meta-analysis of trials employing 
protein supplementation protocols. Their findings disputed the importance of protein timing and 
indicated that the only significant driving factor for both muscle hypertrophy and strength was the 
total amount of protein consumed per day. Therefore, they suggested that as long as adequate 
amounts of protein are consumed throughout the day (and exercise training is involved) then 
ingesting protein during or immediately post-workout will exert no additional benefit. Perhaps this 
finding may account for the lack of significant improvements in some protein studies. For 
example, in a 12-week study Candow et al. (2006) assessed the effect of protein timing (0.3g 
protein.kg bw-1 pre-workout vs post-workout) on muscle size and strength in older men. The main 
finding was that training alone accounted for improvements in strength and size, regardless of the 
protein supplementation and timing. However, it was apparent that baseline intakes were already 
high (1.2-1.5 g. kg bw-1.day-1) which may explain the lack of additional benefit. 
 
Regarding the type of protein, Burd et al. (2012) conducted one of the first studies assessing the 
effect of 20 g whey vs 20 g casein on muscle protein synthesis in older men. Whey elicited a 
significantly higher synthetic response both at rest and after exercise compared to casein. That 
finding was possibly accounted for by the significantly higher aminoacidaemia and leucinaemia 
observed after ingestion of whey. That shows an anabolic potential for essential amino acids 
(EAAs) and particularly leucine. Indeed, researchers have shown that the anabolic response to 
acute protein feeding may be blunted in older adults unless the leucine content of the meal is ≥ 2.8 
g or the total EAA content is 10 g to 20 g (Cuthbertson et al. 2005; Katsanos et al. 2006).  In a 
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study including 24 healthy older adults, coingestion of 20 g casein with 2.5 g leucine elicited 
significantly higher MPS rates by 22% (p<0.05) compared to 20 g casein alone (Wall et al. 2013). 
With regard to the role of leucine in muscle anabolism, it has been known that leucine can increase 
MPS rates by activating the mechanistic target of rapamycin – complex 1 (MTOR1) pathway, 
which is responsible for the initiation of the muscle hypertrophy cascade; more key information 
about this mechanism have been presented by Wolfson et al. (2016).  
 
1.2.2.3 Protein requirements, recommendations and current intakes  
Recommendations and Requirements  
The current recommended dietary allowance for protein for all adults and regardless of age is 0.8 
g ·kg bw-1 in the US and Canada (Institute of Medicine of the National Academies 2005; Campbell 
et al. 2008) whereas the UK recommendations advise for 0.75 g protein ·kg bw-1 (British Nutrition 
Foundation 2017). This is in agreement with the joint report of the World Health Organization 
(WHO 2007), which suggested an intake ~0.8g ·kg bw-1 to be safe and adequate to meet the 
requirements for protein of 97.5% of the adult population.  
 
These figures have been principally derived from nitrogen-balance studies assessing the protein 
requirements of the healthy adult population (Rand et al. 2003).  Rand et al. conducted a systematic 
review of 19 N-balance studies with 235 participants (however, only one study included older 
adults) and concluded that the mean daily protein requirements in adults were ~0.65-0.83 g ·kg 
bw-1. However, researchers have questioned the applicability of N-balance in certain sub-groups 
of the population such as the older sarcopenic obese, since these studies do not take into 
consideration several conditions (such as health status, hospitalisation, injury, surgery etc) that 
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can profoundly affect protein requirements (Wolfe et al. 2008; Pedersen and Cederholm 2014). 
Sarcopenia may be a very slow process that can take years to develop and eventually lead into 
impaired function and increased risk of morbidity and mortality (Pedersen and Cederholm 2014). 
Indeed most of the N-balance studies have used short duration protocols (~10-30 days). Moreover, 
they have assessed protein requirements in healthy population groups. Campbell et al. (2008) using 
the N-balance method concluded that the daily protein requirements for older adults are ~0.8 g·kg 
bw-1and do not differ significantly to those of young adults. However, the authors acknowledged 
and discussed thoroughly the limitations of the N-balance protocols and why they should be 
interpreted with caution. In a more recent review Volpi et al. (2013) suggested that N-balance 
studies can provide an indication of the minimum average requirements for protein of the general 
healthy population. However, the figures derived from such studies do not necessarily reflect the 
optimum protein intakes that can maximise function in older adults with sarcopenia or other 
conditions associated with muscle atrophy. Therefore, new and reliable protocols need to be 
developed to define more accurately the so called ‘optimal intakes’.  
 
Recent studies using different techniques such as the indicator amino acid oxidation (IAAO) have 
noted that older men and women may require higher protein intakes than what was previously 
believed (Tang et al. 2014; Rafii et al. 2015; Rafii et al. 2016). Rafii and colleagues have sugegsted 
that the protein recommendations for older adults appear to be underestimated by ~30% and as 
such they should be increased to ~1.25g · kg bw-1 day -1. Nonetheless, long-term intervention 
studies modulating the dietary protein content in sarcopenic obese adults are scarce and the 
majority of data come from observational studies.  
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In a 3-year follow-up cohort study with 2,732 healthy older men and women (aged 70-79 yr), the 
mean protein intake of the cohort was 0.9 g· kg bw-1 ·day-1 (Houston et al. 2008). More 
importantly, at the 3-year follow up those in the lowest quintiles for protein intake (0.7-0.8 g kg 
·bw-1·day-1) experienced ~40% higher losses (p<0.05) of lean mass and appendicular lean mass 
compared to those in the highest quintiles (1.0-1.1 g kg ·bw-1·day-1). This may explain why some 
people experience higher loss of lean mass over the years. In a 10-year longitudinal study Vellas 
et al. (1997) assessed the effect of protein intake on several health indices in 304 healthy older 
participants. One of the most interesting findings was that those consuming protein at 1.2-1.76 g  
kg bw-1· day-1 tended to have fewer health problems during the 10 years follow up period compared 
to those with intakes <0.8 g kg bw-1· day-1. In terms of function, in one of the few randomised 
controlled trials conducted in older frail adults, an increase in protein consumption from 1.0 g kg 
bw-1 day-1 to 1.4g kg bw-1 day-1 significantly improved muscle function (Tieland et al. 2012a).   
 
Consequently, in older individuals it has been recently agreed that protein recommendations 
should be actually higher than those for the general population, and in the range of 1.0 to 1.2 g· 
kg bw-1·day-1 (Bauer et al. 2013). Intakes of ~ 1.5 g· kg bw-1·day-1 or even higher are recommended 
for undernourished or sarcopenic older adults who engage in exercise programs and want to 
optimise protein intakes for the associated health and function benefits (Wolfe et al. 2008; Deutz 
et al. 2014).  
 
Current Intakes in the UK  
According to the national diet and nutrition survey (NDNS; GOV UK 2014) the mean daily energy 
intake in 2012 was 1930 kcal in men and 1482 kcal in women. The absolute daily protein intakes 
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for men and women (>65 yr) were 77.6 g and 63.8 g, respectively, contributing to the total daily 
energy intake by approximately 17% in both. Overall, the most substantial contribution to protein 
intakes can be attributed to meat and meat products (32%), milk and dairy products (17%), fish 
and fish products (11%), cereal products (22%), vegetables and potatoes (8%) and eggs (3%).  
 
It is important to mention that absolute dietary amounts should be interpreted with caution since 
these values are based on self-reported dietary intakes. When the method of doubly labelled water 
(DLW) was used to compare self-reported energy intake with total energy expenditure the former 
was found to be 29% lower than the latter, therefore this needs to be taken into consideration when 
interpreting these results (GOV UK 2017).  
 
Moreover, it should be taken into consideration that body mass trends show a rightward shift 
towards higher body weights, but the relative protein intakes (g·kg bw-1) of older adults have not 
been thoroughly studied. Therefore, the relative protein intakes have not been corroborated neither 
for the general population nor for the sarcopenic obese. Existing data from studies in older obese 
and frail older adults suggest that protein intakes in these groups are likely to be lower than 
‘optimal’.  Tieland et al. (2012b) noted that more than 10% of the healthy community-dwellers 
and 30% of the older frail adults, consumed less than 0.7g kg ·bw-1 per day. 
 
Therefore, it could be hypothesised that sarcopenic and/or sarcopenic obese older adults do not 
consume adequate protein in their diet, which may affect the size as well as the quality of the 
musculature. In theory an increased protein intake alongside an exercise programme could 
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potentially offer benefits to that population group, and particularly to those embarking on weight 
loss programmes. However, it is currently unknown what the intakes of sarcopenic obese adults 
are (and particularly in Scotland), and whether interventions introducing increased protein intakes 
can be beneficial  either in terms of body composition or physical function improvements.  
    
1.2.2.3 Adverse effects of high protein intakes  
The evidence to support that daily intakes of protein up to at least 1.2 to 1.5 g · kg bw-1 are safe 
for older people with no pre-existing kidney conditions has been consistent (Pedersen and 
Cederholm 2014; Witard et al. 2016a). Increasing protein intakes (from 1.0 g to 1.4 g · kg bw-1 
·day-1) alongside a resistance-exercise programme has significantly augmented lean mass and 
function in older adults without affecting renal function or causing any health-related side effects 
in a study by Tieland et al. (2012c). Albeit not statistically significant, an improvement in 
glomerular filtration rate (GFR) was noted when protein supplementation was combined with 
resistance exercise in older adults (Ramel et al. 2013). This is in agreement with Mikusova et al. 
(2016) who noted that increasing daily protein intakes from 1.0 to 1.5g · kg bw-1 combined with 
exercise training over a period of 6 months resulted in a small but significant increase in GFR in 
sarcopenic older adults (+1.0 (IQR: 2.8, 4.2) mL/min/1.73m2, p=0.01) whereas no difference was 
observed in the control group (isocaloric supplement). Furthermore, even those who support the 
hypothesis of a link between high protein intakes and impaired kidney function agree that these 
effects may be proved in intakes > 2-3g · kg bw-1 (Marckmann et al. 2015).  
 
The impact of protein consumption on bone health has been a topic of debates due to the raised 
urinary calcium that follows increased protein intakes; however, at the same time protein can a) 
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provide amino acid precursors which can maintain bone architecture b) aid calcium absorption 
and c) potentially increase IGF-1 and muscle mass, and thus promote bone health (Darling et al. 
2009; Thorpe and Evans 2011). Those who support the notion that chronically elevated protein 
intakes may impair bone health are basing their claim on a theory hypothesising that bone minerals 
are dissolved from the bone site to neutralise the amino acid-induced acidity (Vormann and 
Goedecke 2006). However, this view has been rejected by prospective studies, literature reviews 
and meta-analyses which have substantiated that neither an ‘acid-loading’ diet nor an alkaline one 
can be detrimental or protective on bone health, respectively (Fenton et al. 2010; Fenton et al. 
2011; Bonjour 2013). In addition, one systematic review (Pedersen and Cederholm 2014) and one 
meta-analysis (Darling et al. 2009) have concluded that there is no substantial evidence to support 
causality between protein intake and reduced bone mineral content/density or fracture risk in older 
adults. On the contrary, there is a small but significant protective effect of dietary protein intake 
on bone physiology, by increasing mineral density at the lumbar site (Darling et al. 2009). When 
all factors are taken into consideration, it has been suggested that if calcium intake is adequate, 
then increasing protein intakes is not likely to be harmful for bone health and it can even offer 
modest benefits (WHO 2007; Darling et al. 2009; Thorpe and Evans 2011). This opinion is in 
accordance with a prospective study of 20,035 Norwegian men and 19,752 women, which reported 
no association between hip fractures and non-dairy protein intake. When both protein and calcium 
intake were taken into account, only the group in the highest quartile for non-dairy protein and the 
lowest quartile for calcium intake) exhibited a significantly higher relative risk for fracture (1.9, 
95%CI [1.09-3.56]) (Meyer et al. 1997).  
 
Emerging evidence has raised questions about the existence of a link between protein (and 
particularly whey protein) with an impaired glucose response and insulin resistance. A study by 
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Smith et al. (2015) suggested that ingestion of whey protein (0.6 g·kg fat free mass-1) may induce 
insulin resistance in sedentary post-menopausal women as it can blunt the insulin-induced glucose 
uptake by the muscles (and this effect was not accounted for by a leucine-mediated mTOR 
activation). Although this was a very important finding, it was based on an acute study comparing 
water (control group) against ingestion of whey protein and therefore, for more robust conclusions 
to be drawn, long-term studies are essential, and possibly more types of protein need to be tested 
(e.g. casein, albumin). In response to the aforementioned study, Dioguardi (2015) commented that 
the alanine and arginine amino acids-components of whey protein may be responsible for the 
observed effect, however, it was suggested that long-term supplementation with all EAAs is likely 
to improve insulin sensitivity. In middle-aged overweight and obese adults, 12-week 
supplementation with whey protein significantly improved the metabolic profile (lowered 
triglycerides, total and LDL cholesterol) and decreased HOMA-IR and fasting insulin when 
compared against isocaloric glucose supplements (Pal et al. 2010). In acute trials ingestion of whey 
protein has also been proven effective in improving glucose control in type II diabetic participants 
after a high GI meal (21% blood glucose reduction was noted after whey protein vs pork meat) 
(Frid et al. 2005). This effect was accounted for by a significantly higher insulin secretion after 
ingestion of whey. In a large scale 9-month RCT (n=220) combining consumption of different 
quantities of whey (0,10,20,30 g twice daily) with resistance and aerobic training, it was shown 
that whey protein had no significant effect on HOMA-IR, insulin sensitivity index or glucose area 
under the curve (AUC) (Weinheimer et al. 2012). The only difference was a significantly lower 
AUC for insulin between baseline and post-intervention, noticed in all groups and was 
independent of protein supplementation. Interestingly, although protein intakes increased in some 
cases up to ~150 g day-1 or 1.6 g day-1 no changes in GFR were noted in any of the groups. 
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1.2.3 Vitamin D  
Vitamin D is an important, fat-soluble micronutrient essential for physiological functions 
throughout the lifespan. Vitamin D is either synthesised in the skin via direct exposure of skin to 
UV sunlight or taken via dietary sources in the form of Vitamin D2 or Vitamin D3 and gets 
converted to 25-hydoxyvitamin (25(OH)D). The latter is then hydroxylated into the biologically 
active form of Vitamin D, which is 1,25-dihydroxyvitamin (1,25(OH)2D) (MacLaughlin and 
Holick 1985). Although the biologically active form of vitamin D is 1,25(OH)2D, according to the 
UK Scientific Advisory Committee for Nutrition (SACN) the most reliable assessment of vitamin 
D blood status is performed based on serum 25(OH)D levels as it can better reflect the availability 
of vitamin D from both endogenous and exogenous sources (SACN 2016). This stands true 
because 25(OH)D has a long half-life, it is not tightly regulated by homeostatic mechanisms and 
in addition, because the circulating levels of 25(OH)D are 1000-fold higher than those of 1,25(OH) 
2D (SACN 2016; Wagatsuma and Sakuma 2014).  
 
There are several cut-offs for deficiency, insufficiency and optimal levels of blood Vitamin D. For 
example the Scottish Food Standard Agency and SACN, define deficiency as levels <25 nM (or 
10 ng/L), whereas levels >25nM are considered to be sufficient for normal functioning (Purdon et 
al. 2013; SACN 2016). The Institute of Medicine (IOM) has stated that levels <50 nM (or 20 ng/L) 
may not be sufficient for everyone (Ross et al. 2011), whilst others have suggested that the optimal 
levels of serum 25(OH)D are >75 nM (or 30 ng/L), insufficient between 50 and 75 nM and 
deficiency should be defined as serum levels <50 nM (Hollick 2007). 
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1.2.3.1 Vitamin D in older age 
Vitamin D deficiency, assessed by serum 25(OH)D levels, is prevalent on a global scale, affecting 
approximately 1 billion people (Holick 2007). Older people are more susceptible to low vitamin 
D levels due to low dietary vitamin D intake, reduced skin exposure to sunlight and also due to 
reduced capacity of the aged skin to synthesise vitamin D (MacLaughlin and Holick 1985). 
Vitamin D deficiency in older individuals is associated with decreased bone mineral density, 
muscle atrophy, low muscle strength, increased risk of falls and bone fractures and increased risk 
of mobility limitations and disability (Snijder et al. 2006; Ceglia 2008; Houston et al. 2013; 
Sanders et al. 2014). Given that 90% of the bone fractures occur after a fall, it is not surprising 
that vitamin D supplementation has been regarded as an important element in many areas of 
geriatric therapy (Sanders et al. 2014).  
 
In the UK, according to a report from 2005, 9.6% and 15% of men and women, respectively, over 
the age of 65 years living in private UK households were found to be deficient (Hirani and 
Primatesta 2005). A more recent systematic review assessing the effectiveness of vitamin D 
supplementation without the addition of exercise in people over 60 years, concluded that daily 
oral administration of 800-1000 IU (20-30 mcg) of Vitamin D had beneficial effects on strength 
and balance (Muir and Montero-Ontasso 2011). For sarcopenic obese older adults, it has been 
suggested that, doses higher than 1,000 IU vitamin D/day may be required (Villareal et al. 2011a). 
In fact, doses as high as 50,000 IU per week have been administered to obese subjects suffering 
from Vitamin D insufficiency and protein malnutrition (Baer 2013).  
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A longitudinal study by Okuno et al. (2011) in pre-frail older participants showed that a 3-month 
exercise intervention resulted in significant improvements in timed-up-and-go tests only in those 
with serum levels of 25 (OH) vitamin D ≤ 45 nM, while those with serum value  >47.5 nM did 
not experience any significant improvements. It was also suggested that serum levels ≥ 67.5 nM 
are preferable if the aim is improvements in physical fitness. Consistent with this notion, a meta-
analysis by Stockton et al. (2011) reported a significant effect of vitamin D on strength only in 
those with serum levels <25nM. Kim et al. (2011) indicated that Korean sarcopenic individuals 
exhibit lower levels of serum 25 (OH)D compared to their non-sarcopenic counterparts. 
Additionally, in a similar study, the researchers noted that older sarcopenic obese Koreans had 
lower concentrations of 25 (OH)D and higher HOMA-IR and CRP levels than their non-
sarcopenic obese counterparts (Kim et al. 2013a).  
 
In 2007, 90% of the UK adult population were found to have insufficient serum 25 (OH) vitamin 
D (<75 nM) during winter and spring, whereas this figure fell to 60% for the summer months 
(Hyppönen and Power 2007). In the same study, obese participants had a 2-fold increased risk of 
vitamin D hypovitaminosis than non-obese participants. Similarly, Scottish participants were 
twice as likely to have serum levels ≤ 40nM compared with the rest of the UK. 
 
1.2.3.2 Association of vitamin D hypovitaminosis with sarcopenic obesity  
Vitamin D can affect the bone metabolism by regulating a) the gut calcium and phosphorus 
absorption and b) the activity of osteoblasts and osteoclasts (Christakos et al. 2003). Similarly, it 
can affect muscle function a) in the short term by regulating the intramuscular calcium influx 
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required for muscle contraction and b) in the long term by preventing muscular atrophy (Sanders 
et al. 2014).  
Vitamin D deficiency may play a negative role in the development/progression of sarcopenic 
obesity by promoting adipogenesis, muscle atrophy and an increased inflammatory response 
(Sanders et al. 2014). This is in accordance with Wagatsuma and Sakuma (2014) who based their 
findings on epidemiological and clinical trials, and supported that vitamin D can affect the 
musculoskeletal function and architecture, the inflammatory response and the metabolic profile of 
older adults, all of which can potentially affect the development of sarcopenia and obesity.  
 
Chronic inflammation can contribute to muscle atrophy and increased adiposity. Peake et al. 
(2010) and Girgis et al. (2013) have provided substantial evidence supporting the argument that 
vitamin D status may impact upon signalling pathways responsible for the regulation of 
inflammation in older people. This has also been suggested in clinical trials by Schleithoff et al. 
(2006) and Van den Berghe et al. (2003) who showed that Vitamin D supplementation may 
suppress the production of CRP, TNFa and IL-6 and increase the anti-inflammatory hormone IL-
10.  
 
One other potential mechanism through which Vitamin D can be beneficial for older people is the 
reduction in intra- and intermuscular adipose tissue (IMAT) deposition (Scott et al. 2013). 
Although this has not been fully elucidated, research has shown that IMAT increases with age and 
is one of the most important predictors of muscle quality and performance in older adults (Visser 
et al. 2005). It has been suggested that one possible mechanism involves the differentiation of 
muscle cells to adipose cells (Ryan et al. 2013). In muscle cells lines, low concentrations of 
74 
 
vitamin D (simulating deficient states in humans) have resulted in increased adipogenesis via 
increased transdifferentiation of myocyte precursors into adipocytes (driven possibly by up-
regulation of the peroxisome proliferator-activated receptor gamma2 (PPARɣ2) (Ryan et al. 
2013). In normal and supra-physiological concentrations of Vitamin D this effect was suppressed.    
 
A systematic review and meta-analysis noted that individuals with a high serum 25(OH)D 
concentration may have 43% lower risk of developing type II diabetes, however, the exact 
mechanism was not fully elucidated (Mitri et al. 2011). Wagatsuma and Sakuma (2014) have 
suggested a theory based on which Vitamin D can potentially modulate the expression and 
translocation of the Glucose Transporter type 4 (GLUT-4) through insulin-dependent and insulin-
independent pathways. GLUT4 is responsible for the transport of glucose into muscle cells and 
adipocytes and there is evidence to suggest that expression of GLUT4 is increased in the presence 
of 1,25(OH)2D which can result in increased glucose utilisation (Manna and Jain 2012). Another 
potential mechanism for the modulation of glucose intake involves the regulation of mitochondrial 
metabolism via activity of the NADH oxidase and catalase enzymes (Kukal et al. 2016). In that 
study it was shown that the uptake of glucose depends on the presence of vitamin D, with higher 
conentrations of 25(OH)D resulting in higher activity for the aforementioned enzymes. The notion 
of an improved oxidative function of the mitochondria has also been supported by Sinha et al. 
(2013) who noted that vitamin D resulted in improved oxidative capacity in severely deficient 
(25(OH)D<15nM) adults. In that study 20,000 IU vitamin D were administered on alternate days 
for 10-12 weeks and resulted in reduced recovery times for phosphocreatine and adenosite 
diphosphate (ADP) as well as lower fatigue.   
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Daily administration of 4000IU vitamin D3 for 4 months has been shown to increase muscle fibre 
cross-sectional area and intramyonuclear vitamin D receptor concentration (particularly in type II 
fibres), in a randomised control trial with older women, experiencing insufficient vitamin D levels 
at baseline (25-60 nM) and limited mobility (Ceglia et al. 2013). This finding is in agreement with 
Sato et al. (2005) who supported that even lower doses of vitamin D2 (1000IU day-1) administered 
over a 2-year period to older female stroke survivors can significantly increase the number and 
size of type II muscle fibres as well as muscle strength. These studies highlight a potential link 
that may exist between vitamin D and mechanisms that control muscle hypertrophy.  
 
1.2.3.3 Vitamin D status of older adults in the UK 
A previous study of 99 patients who attended an Edinburgh medical healthcare practice reported 
that only 2% had optimal serum [25(OH)D] (>75nM), whereas 45% had severe deficiency (<25 
nM) (Rhein 2008). In a subsequent report those with severe deficiency complained of pains, aches, 
tiredness and bad mood, but usually reported improvements after receiving Vitamin D 
supplementation (Rhein 2014). In 2013, the Scottish Food Standard Agency collated information 
from the 2010-11 Scottish Health surveys and reported that the older Scottish adults had an 
average serum concentration of 36.9 nM (Purdon et al. 2013). In accordance with Dr Rhein’s 
report, the Scottish Health Survey reported that adults of a lower socioeconomic status (low 
income and/or living in deprived areas) had lower Vitamin D serum concentrations. Additionally 
the same report suggested that people with a normal BMI had higher blood concentrations than 
their overweight and obese counterparts. In 2016 the SACN presented data from the latest health 
surveys for the United Kingdom. In the whole of the UK the average serum concentration of the 
65+ group was 47 nM (40.5 nM in winter and 50.5 nM in the summer) but the values were 
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substantially lower for the institutionalised populations (~30 nM). For Scotland, the SACN 
reported values slightly higher than what was previously reported, at an average of 41.5 nM.  
 
1.2.3.4 Food sources, dietary intakes and recommendations in Scotland  
In 2016 the SACN reported that the minimum protective threshold for Vitamin D serum 
concentration is 25nM (SACN 2016). To achieve such levels, a daily intake of 10μg (400 IUs) 
will suffice for 97.5% of the population, even during winter months. However, according to the 
same report the majority of the Scottish older adults (65+ group) is not likely to achieve such 
dietary intakes.  
 
In Scotland, from food sources alone, the daily average intake of Vitamin D in the 65+ group is 
3.2 μg (men: 3.5 μg, women: 2.9 μg), whereas if the supplements are also taken into account, the 
intake rises slightly to 4.7 μg (men: 4.7 μg women: 4.6 μg), but remains less than half (47%) of 
the recommended goal of 10μg day-1 (SACN 2016). The report confirmed the finding of the 
previous health surveys supporting that obesity, institutionalisation, low income and living in 
deprived areas can affect negatively vitamin D intake and levels in blood across all adult age 
groups.  
 
The richest sources of Vitamin D are fish and especially oily fish (e.g. herring, mackerel, salmon, 
sardines) (5-16μg /100g) and although they are easily accessible in Scotland, they are not the 
biggest contributor of Vitamin D in the diet of older Scottish adults. The main food sources of 
Vitamin D in this population cohort are meat and meat products, which contribute 24% to the daily 
intake. The second important contributor is butter (and spread products) at 19%, whereas fish and 
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fish products contribute to 16%. Eggs (and egg dishes), cereals (and cereal products) and milk 
(and dairy products) contribute to 16%, 16% and 4%, respectively.     
 
In conclusion, although there is a trend towards increased serum Vitamin D levels over the last 
years in older Scottish populations, there is still a great need to educate those at risk (older, obese, 
of low socioeconomic status and institutionalised) towards achieving higher dietary intakes. In 
countries with an abundance of food sources rich in Vitamin D, a dietary shift along with mild 
supplementation protocols should be enough to cover the population needs. Nonetheless, although 
there is information on intakes of vitamin D in the general population, it is not clear what the 
intakes of Vitamin D are in older adults with sarcopenic obesity (a similar lack of data exists for 
protein intakes in the same cohort). The only clear indication so far is that participation in physical 
activities is low across all groups > 65 years in the UK. Therefore, given the unequivocal evidence 
for the benefits of exercise training and in older age, lifestyle interventions should incorporate 
exercise training with higher protein intakes, perhaps alongside vitamin D supplementation, in 
order to comply with the guidelines and eliminate any confounders resulting from vitamin D 
deficiencies. What remains to be determined is whether a high protein intake with a controlled 
caloric intake can be beneficial for those with sarcopenic obesity. The ultimate goals for a lifestyle 
intervention would be to preserve or increase muscle mass, decrease fat mass, and improve 
physical function of older adults.    
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1.3 Aims and objectives 
Changes in body composition and strength/ physical function are of utmost importance for 
older individuals characterised by sarcopenia and obesity. However, a robust method to 
ameliorate body composition and function has not been established in this population group. 
Moreover, the prevalence rates of sarcopenia and sarcopenic obesity in Scotland are unknown. 
The evidence for obesity prevalence is limited to the BMI-derived classifications and not % 
body fat.  
Therefore, the aims of this study intended to address the following research questions:  
1. Are there any published scientific trials implementing nutritional and /or exercise 
protocols to augment body composition and function in older sarcopenic obese older 
adults, and how effective have they been?  
2. How prevalent are sarcopenia, obesity and sarcopenic obesity in Scottish older community 
dwellers and how do these rates compare with the national average and other countries?  
3. Can a weight-loss high-protein diet alongside a complex exercise programme (aerobic, 
resistance, balance and flexibility) improve body composition and function in older adults 
with sarcopenic obesity? 
Therefore, the first aim of this research was was to systematically search, identify and evaluate 
the effectiveness of nutritional regimens alone or combined with exercise programmes that 
have been utilised in trials with older community dwellers characterised by sarcopenic obesity. 
That search sought to find protocols which aimed to augment body composition and/or 
function in sarcopenic obese older adults.  
The second aim was to screen for sarcopenia and obesity in order to assess the prevalence rates 
of sarcopenia and sarcopenic obesity in community-dwellers aged 65 years and older living in 
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Lothian, Scotland. The objective was to measure muscle mass, body fat (using both BMI and 
%BF as obesity criteira) and hand grip strength.  
Finally, a novel lifestyle intervention programme combining nutritional modifications and 
exercise training was designed and delivered to Scottish older adults. The aim of this 
intervention trial was to assess the impact of nutrition and exercise on body composition and 
function in older (≥ 65 years) sarcopenic obese community-dwellers. The hypothesis was that 
an energy-restriction diet with a high protein diet alongside mixed exercise training can 
significantly affect body composition and strength/function. The primary objective of the 
intervention study was to assess absolute changes in sarcopenic obesity parameters, 
particularly changes in 1) skeletal muscle mass 2) body fat and 3) hand-grip strength and 
physical function. Secondary objectives involved the assessment of 4) health-related quality 
of life, and 5) changes in the biochemical profile (serum Vitamin D, IGF-1, creatinine, hsCRP, 
alkaline phosphatase). The final objective was to analyse the dietary habits of those with low 
muscle mass and high body fat in order to extract some preliminary data on protein intakes 
and patterns of protein distribution within main meals. 
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Chapter 2. Effectiveness of nutritional and exercise 
interventions to improve body composition and strength or 
function in sarcopenic obese older adults: A systematic review 
(adapted from the published article) 
 
2.1 Introduction  
Sarcopenia has been associated with poor health outcomes such as functional decline, frailty, 
increased risk of falls, institutionalisation and higher mortality risk (Visser and Schaap 2011). 
Secondary to functional impairments, muscle atrophy may also contribute to insulin resistance 
as muscle tissue plays the main role in glucose uptake and utilisation (Gong and Muzumbdar 
2012; Breen et al. 2013). Obesity is characterised by increased adiposity and is a growing 
concern due to its progressively rising prevalence rates in older adults (Porter Star et al. 2014). 
Similar to sarcopenia, obesity can increase the risk of falls and mobility limitations in older 
age (Houston et al. 2009; Himes et al. 2012), and when used in conjunction with indices of 
body composition and especially low muscle mass, it can be associated with adverse health 
effects in older adults such as CVD, metabolic syndrome, type II diabetes and several types of 
cancer (Oreopoulos et al. 2009). Furthermore, adipose tissue can infiltrate the muscle tissue 
(Visser et al. 2005) and mediate an inflammatory response (Greenberg and Obin 2006), which 
can result in muscle atrophy, mobility losses and lower strength and muscle quality (Visser et 
al. 2002; Visser et al. 2005, Koster et al. 2011). 
 
Sarcopenic obesity is the condition where sarcopenia and obesity occur together (Waters and 
Baumgartner 2011), however the relationship of the two conditions is far more complex 
(Figure 2.1). According to Baumgartner (2000), a serious concern around increased adipose 
tissue is that it can mask muscular atrophy, and therefore, the latter cannot be detected unless 
a specific test on skeletal muscle health is performed. Individuals with sarcopenic obesity are 
exposed to ~2.5-fold higher risk of reporting Instrumental Activities of Daily Living (IADL) 
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disabilities compared with adults without obesity but with sarcopenia, or adults with obesity 
but without sarcopenia (Baumgartner et al. 2004). According to a meta-analysis of 12 
prospective cohort studies with a total number of 35,287 participants, sarcopenic obese adults 
had a 24% higher risk of all-cause mortality compared to their healthy counterparts (Tian and 
Zu 2016).  Therefore, finding ways to stop the deteriorating effects of ageing on body 
composition and function is of utmost importance for the longevity and quality of life of older 
adults. Even though sarcopenic obesity has gained significant attention by the scientific 
community in recent years there is no universally accepted definition, perhaps due to the 
plethora of definitions and cut-offs for sarcopenia and obesity (Cruz-Jentoft et al. 2010, Prado 
et al. 2012; Poggiogalle et al. 2014). As an outcome, detection and management of this 
condition is very challenging for healthcare practitioners.  
 
Despite a growing body of evidence highlighting potentially beneficial nutritional and exercise 
strategies to reverse or at least attenuate the negative effects of ageing on body composition 
and physical function (Phillips 2015; McLeod et al. 2016; Witard et al. 2016a) there is still a 
paucity of studies utilising training and nutritional interventions for older sarcopenic obese 
participants (Goisser et al. 2015; Poggiogalle et al. 2014). The challenge associated with such 
strategies lies in the fact that losing body fat while concomitantly gaining or even preserving 
muscle mass is a very challenging goal. As discussed in Chapter 1, the inherent risk of potential 
lean mass losses with energy-deficit diets (which could be otherwise a plausible strategy for 
the young obese and non-sarcopenic adults (Waters et al. 2013)) may negatively impact the 
musculoskeletal health of older sarcopenic individuals (Weinheimer et al. 2010; Shah et al. 
2011; Armamento-Villareal et al. 2012; Waters et al. 2013). Thus, it appears that most 
intervention trials have aimed to attenuate muscle loss at an early stage rather than try to 
‘reverse’ an established condition related to advanced ageing such as sarcopenia or sarcopenic 
obesity, which would be far more challenging (Phillips 2017). 
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Pharmacological approaches are currently limited to androgens and oestrogen administration 
and whilst they can potentially promote positive changes in body composition and function, 
the benefit to risk ratio may not be favourable for this population group (Calof et al. 2005; 
Horstman et al. 2012). While exercise training may be beneficial for both obesity and 
sarcopenia, the dietary management of obesity may require energy restriction, whilst 
management of sarcopenia requires an increased intake of macronutrients, especially protein 
(Naseeb and Volpe 2017). However, as previous systematic reviews have reported 
(Weinheimer et al. 2010; Stewart et al. 2014), although exercise interventions have the 
potential to attenuate the loss of muscle mass in older age, cases where lean mass and muscle 
mass have decreased after an exercise or physical activity programme are not uncommon. 
Therefore, exercise interventions need to be carefully tailored to sarcopenic obese individuals 
so that the frequency, intensity and volume are adequate enough to produce a meaningful 
change in body composition and physical function, but without compromising musculoskeletal 
health.  
 
To date, there has been no systematic review assessing the effectiveness of nutritional and 
exercise strategies, alone or combined, to improve body composition and strength or function 
in sarcopenic obese older individuals. Therefore, the purpose of this systematic review was to 
assess the effectiveness of diets modulating the nutritional content (especially energy and 
protein or amino acids), exercise training regimens, or diet and exercise training combined, in 
older adults with sarcopenic obesity.   
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Figure 2.1 Relationship between sarcopenia and obesity and associated risks as well as 
management strategies. Notes: Solid arrow: direct and positive association; Dashed line 
management strategy attenuating/reversing the condition:  
 
2.1.1 Aims 
The focus of this systematic review was to determine the effectiveness of protein or energy-
modulating regimens, with or without exercise training on body composition and function in 
adults, 65 years of age and older with sarcopenic obesity. In particular, the primary aims were 
to 1) determine changes in absolute muscle mass, total appendicular skeletal muscle (TASM), 
skeletal muscle index (SMI), fat mass, % body fat, body weight and body mass index (BMI) 
and 2) assess changes in muscle strength and/or physical function (including muscle strength, 
power, gait speed and balance). The secondary aim was to evaluate the effect of these 
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interventions on quality of life, metabolic profile, activities of daily living, adverse effects of 
supplementation or food choices, compliance rates and changes in habitual dietary intake 
during or after the interventions.   
 
2.2 Methods 
This systematic review was performed according to the Preferred Reporting for Systematic 
Reviews and Meta-analyses (PRISMA) guidelines. The protocol was registered with the 
International prospective register of systematic reviews (PROSPERO registration number: 
CRD42015017311).  
 
2.2.1 Search Strategy  
The Cochrane Central Register of Controlled Trials, MEDLINE (via EBSCOhost Research 
Databases), CINAHL and SPORTDiscus were searched up to and including May 2016. The 
last search was conducted on 22 May 2016. No limits were applied for date of publication. 
Combinations of key terms with Medical Subject Headings (MeSH) and Boolean operators 
were used. The main keywords and terms used were: Age*/ Adult*/ Old*/ Elderly/ Senior, 
Sarcopeni*/ Lean/ Frail/ Atrophy/ Weakness, Obes*/ Overweight/ Body Mass Index, 
Exercise/ Training/ Strength/ Muscle/ Mass/ Hypertrophy/ Size/ Body Composition, Diet/ 
Supplements/ Protein/ Amino Acids/ Energy, Life Quality/ Intervention. The search limiters 
were English language and studies with human participants (the complete search strategy is 
presented in Appendix 2). 
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2.2.2 Inclusion Criteria  
Randomised control trials (RCTs), randomised control crossover trials and controlled clinical 
trials were included, using prospective nutritional and/or exercise interventions to attenuate/ 
reverse the loss of muscle mass, reduce adipose tissue and optimise muscle strength or 
function. Given that there is no universally accepted definition for sarcopenia, some authors 
may have used different terms to define the participants, e.g. ‘lean’, ‘weak’ or ‘frail’. Such 
studies were included only if the participants could be characterised as sarcopenic based on 
the definition criteria and cut-off scores as presented by the EWGSOP (Cruz-Jentoft et al. 
2010). Therefore, studies were included only if they presented data for a) body composition 
(data on absolute muscle mass, appendicular muscle mass, Total Appendicular Skeletal 
Muscle (TASM) or Skeletal Muscle Index (SMI) assessed by Dual-energy X-ray 
Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), Computerised Tomography 
(CT) or Magnetic Resonance Imaging (MRI) and b) muscular strength and/ or physical 
function identified by one of the following tests: handgrip strength, knee flexion/extension, 
peak expiratory flow, gait speed, the Short Physical Performance Battery test (SPPB), the 
timed up-and-go test or the stair climb power test. The mean age cut-off for inclusion was ≥ 
65 years based on how ‘old age’ is defined in the joint recommendations from the American 
College of Sports Medicine (ACSM) and the American Heart Association (AHA) (Nelson et 
al. 2007). The inclusion criterion for obesity was defined as body fat percentage (BF%) ≥ 28% 
in men and ≥ 40% in women (Baumgartner et al. 2004) or in the absence of %BF data, a BMI 
≥ 27 kg m-2. For any given BMI, a sarcopenic person will have by definition more body fat 
compared with their non-sarcopenic counterparts, therefore, adults with sarcopenia can present 
high-adiposity at BMIs substantially lower than 30 kg m-2 (Newman et al. 2003a). Moreover, 
it is not uncommon for intervention studies to recruit overweight and obese participants with 
a BMI≥ 27 kg m-2 especially when the focus is on sarcopenic obesity (Prado et al. 2012; Donini 
et al. 2013; Poggiogalle et al. 2014). Studies which presented neither the % body fat nor BMI 
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were included only if these indices could be derived from the weight, height and body fat mass 
values or if the authors of the study when contacted provided the essential information. 
 
 Nutritional interventions aiming to promote muscle hypertrophy by macronutrient profile 
modification or weight loss via energy restriction were of primary interest. Studies providing 
extra macronutrients (especially proteins or amino acids and their metabolites) or 
micronutrients either in the form of whole foods or dietary supplements administered through 
the oral route only, were considered. Exercise regimens including resistance, balance, aerobic 
and mixed exercise protocols influencing lean mass, fat mass, muscle hypertrophy, strength, 
power, speed and/ or physical functional were of primary interest.  
 
2.2.3 Exclusion Criteria  
Studies were excluded if the protocol involved administration of any kind of prescription 
only/pharmaceutical agents or any type of supplementation administered via a route other than 
oral. Studies including participants with cachexia or with serious mental and cognitive 
conditions prohibiting adherence to a structured exercise/ nutrition regime such as Alzheimer’s 
or dementia, were excluded.  
 
2.2.4 Study Selection 
The titles and abstracts were screened for eligibility and the full text copies of potentially 
eligible articles were obtained for further inspection. The full-text articles were independently 
assessed for eligibility by two reviewers. The reference lists of eligible articles and review 
papers as well as journals specialising in geriatrics were hand searched for potential articles. 
Any disagreement between the two reviewers was resolved by a third reviewer.    
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2.2.5 Data Extraction 
Data were extracted from each eligible article using a standardized form by two reviewers. 
Any disagreements between the two reviewers were resolved by discussion until consensus 
was reached. Demographic (age, gender, ethnicity/host country and habitation), 
methodological (study design, sample sizes, duration, nutritional/dietary and/or exercise 
intervention plan, supplement type, dosing/frequency of administration, exercise training 
type/frequency/volume, assessment method, blinding) and outcome data (changes within and 
between groups, significance, drop out rates, compliance, adverse effects) were compiled in a 
standardised Excel spreadsheet.  
 
2.2.6 Quality Assessment 
The quality of the studies was assessed by two independent reviewers using a modified version 
of the Downs and Black rating scale (Downs and Black 1998; Eng et al. 2007). The Downs 
and Black scale is one of the most credible instruments for the quality assessment of 
randomised (Olivo et al. 2008) and non-randomised intervention trials (Saunders et al. 2003). 
Modified scoring for Question 27 was performed as detailed by Eng et al. (2007): the original 
scale had a maximum score of 32 but in this review Question 27 was modified to score either 
0 or 1 point instead of the original 0-5 points. Therefore, the maximum total score for the five 
sections of the scale (reporting, external validity, internal validity/bias, internal 
validity/confounding, power) was 28.  
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2.2.7 Principal Summary Measures  
The primary outcome measures were 1) differences in mean of skeletal muscle mass (either 
absolute, relative or appendicular) and body fat or BMI, and 2) differences in mean of muscle 
strength and physical function/performance. 
 
2.3 Results  
2.3.1 Description of studies 
Our search strategy resulted in 1,440 potential articles. After the exclusion of 1,331 articles 
based on titles and abstracts, 109 full-text articles reporting 109 studies were retrieved and 
assessed for eligibility. The detailed flow chart of the selection process is presented in Figure 
2.2. The authors of two potentially eligible studies (Wouters-Wesseling et al. 2003; Kwon et 
al. 2015b) were contacted for further information but retrieval of all the essential data was not 
possible for reasons unrelated to this review, therefore the articles were excluded.  A total of 
n=2 studies (study A by Aleman-Mateo et al. 2012 and study B by Balachandran et al. 2014) 
including n= 61 participants met the inclusion criteria and were included in the review. Study 
A was a nutritional intervention and study B an exercise training intervention; neither of the 
studies combined exercise with diet. 
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 Figure 2.2 Information flow through the phases of the systematic review according to 
PRISMA guidelines. 
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2.3.2 Quality Assessment  
The two studies were randomised control trials of moderate methodological quality based on 
the modified Downs and Black rating scale (Downs and Black 1998; Eng et al. 2007). The 
total score for each study was 18 out of 28. The summary key information of the two 
methodological strengths and limitations is presented in   
91 
 
Table 2.1. The complete breakdown of the scoring in the different subsections of the scale is 
shown in Table 2.2. Both studies performed power calculations to determine the population 
sample size prior to recruitment but finally study B (Balachandran et al. 2014) was 
underpowered; target was n=21 per group but the final analysis was conducted with n=9 and 
n=8 for the control and intervention group, respectively. In study A only the testers were 
blinded but not the participants. In study B the two groups were exercising at different times, 
therefore participants were partially blinded. Study A reported and tested for a range of 
potential confounders but failed to report essential information regarding the participants’ 
dietary intake at baseline and follow-up. The results in Study A were based on an intention-
to-treat analysis whereas in Study B the analysis conducted was per-protocol.  
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Table 2.1 Summary key points of the included study designs.   
Study  Summary  Strengths  Limitations 
Study A  
(Aleman-
Mateo et al. 
2012) 
Nutritional 
Intervention 
 
-40 participants  
-3 months 
-Habitual diet plus 
210g Ricotta 
cheese ·day-1 
(intervention) vs 
habitual diet 
(control)  
 
-Intention to treat 
analysis 
-Body composition by 
dual-energy xray 
absorptiometry 
-Physically-independent 
participants.  
-Baseline and follow up 
clinical tests for kidney 
and liver function 
-Blinded personnel 
delivering the 
assessment tests.  
-Lack of baseline and 
follow up dietary 
intake and physical 
activity data (unclear 
whether they were not 
assessed or not).  
 
 
Study B  
(Balachandran 
et al. 2014) 
Exercise 
Intervention 
 
-21 participants  
-15 weeks 
-High speed circuit 
resistance (HSC)  
training 
(Intervention) vs 
strength 
hypertrophy (SH) 
resistance training 
(control)   
-Independent living 
community-dwellers.  
-Participants were 
partially blinded to the 
intervention. 
-Testing personnel 
blinded 
-All sessions supervised 
by 2 physiology majors 
-No allocation 
concealment 
-Per-protocol analysis  
- Underpowered 
-Characteristics of 
participants lost to 
follow-up not 
described 
-No description of the 
exercise setting 
 
 
Table 2.2 Assessment of the methodological quality of the included studies with the 
modified Downs and Black Scale.   
 Reporting  
( /11) 
External 
Validity  
( /3) 
Internal 
Validity 
Bias  
( /7) 
Internal 
Validity-
Confounding  
( /6) 
Power   
( /1) 
Total  
( /28) 
Study A 
(Aleman-
Mateo et al. 
2012) 
9 1 4 3 1 18 
       
Study B 
(Balachandran 
et al. 2014) 
8 0 7 2 1 18 
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2.3.3 Participant Characteristics  
Participants in study A (Aleman-Mateo et al. 2012) were physically-independent individuals 
living in Mexico. Their mean ± SD age was 76 ± 5.4 years. The mean percentage body fat of 
men and women in the intervention group was 31.3% and 45.6%, respectively, while in the 
control group the respective values were 32.4% and 45.7%. The mean BMI and TASM were 
26.3 ± 3.8 kg m-2 and 15.5 ± 2.9 kg, respectively. Out of the 40 participants (17 men and 33 
women) 29 completed the protocol. 
 
All participants in study B (Balachandran et al. 2014) were independent-living community 
dwellers from South Miami (USA). The mean ± SD age and BMI of participants was 71.3 ± 
7.8 years and 32.6 ± 4.7 kg m-2, respectively. Their mean SMI was 6.6 ± 1.0 kg m-2.  Of the 21 
initial participants, 17 completed the protocol, 16 of whom were female.  
 
2.3.4 Study Design    
The aim of study A (Aleman-Mateo et al. 2012) was to assess whether the addition of a protein 
rich food to the habitual diet could increase TASM and strength in older sarcopenic 
individuals. The study was a 3-month RCT with a control (habitual diet) and an intervention 
group (habitual diet + 210g ricotta cheese per day; RCH+HD). The cheese provided 15.7g 
extra protein (including 8.6 g of EAAs), 10.4 g of carbohydrate, 18.4 g fat and a total of 267 
kcal per day.  Cheese was divided into three 70 g portions that were pre-packed and delivered 
ready-for-consumption to the participants, who were instructed to consume the cheese portions 
along with their usual breakfast, lunch and dinner. Dual-energy x-ray absorptiometry was used 
to measure TASM and body composition changes.  
  
Study B (Balachandran et al. 2014) was a 15-week single blind RCT which aimed to assess 
the effectiveness of a novel exercise regime based on a high speed circuit (HSC) resistance 
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training programme (intervention) on body composition, neuromuscular performance and 
IADL compared with a conventional strength hypertrophy (SH) regime (control group) in 
sarcopenic obese community-dwellers. Body composition was assessed by single frequency 
BIA. Both groups performed exercises at 11 pneumatic gym machines (five lower and six 
upper-body) twice per week. The SH protocol involved three sets of 10-12 repetitions at 70% 
of the 1RM with a 1-2min recovery break between sets. Participants were instructed to keep a 
similar speed of contraction for the concentric and eccentric phase (2 sec). Resistance 
increased by five percent only when the participant could perform three sets of 12 repetitions. 
The HSC group performed 10-12 repetitions at all 11 exercises in a circuit pattern (i.e. moving 
from one exercise to the other) with no break in between exercises unless one full circuit was 
complete. Then they were allowed a 1-2 min recovery break and were asked to repeat the same 
circuit until they had completed three full circuits. The resistance load was selected based on 
the maximum power output for each machine and ranged from 50 to 80 percent 1RM. The 
concentric phase was performed as fast as possible while the eccentric in 2 sec. Resistance 
load was increased by five percent when a power plateau was reached. A typical HSC and SH 
training session would last 40-45 min and 55-60 min, respectively. No dietary or nutritional 
element was introduced in the study and neither dietary patterns nor intakes were reported.   
 
2.3.5 Outcomes  
Body composition  
No significant changes were seen in body composition in either experimental or control 
groups. In study A (Aleman-Mateo et al. 2012) the addition of ricotta cheese resulted in no 
significant changes in lean mass, TASM or body fat in the intervention group or control group 
(Table 2.3). Secondary analysis by gender showed that although men (n=8) in the intervention 
group experienced an increase in TASM by 490g, this was not significantly different either 
from baseline or when compared against the control group (p=0.42), which gained a non-
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significant 220g of TASM.  Similarly, in study B (Balachandran et al. 2014) no statistically 
significant differences were detected in any of the body composition indices, regardless of the 
exercise regimen (Table 2.3). Skeletal muscle index (SMI) increased non-significantly in both 
groups (from 6.5± 0.66 kg·m-2 to 6.6± 0.59 kg·m-2 in HSC and from 6.7± 0.45 kg·m-2 to 6.8 
±0.42 kg·m-2 in SH).  
 
Strength and/ or function 
In study A (Aleman-Mateo et al. 2012), the group receiving the extra protein had a non-
significant increase in strength (+0.9% relative increase). Although the control group 
experienced a drop in strength (-3.5%), the difference between the two groups did not achieve 
statistical significance (p=0.06).  
 
Study B (Balanchandran et al. 2014) reported significant improvements in several aspects of 
strength and function in both exercise groups (Table 2.3). In particular, the strength-
hypertrophy (SH) control group experienced significant improvements in leg press 1RM by 
22% (p<0.01), chest press 1RM by 16% (p=0.03), leg press peak power by 19% (p=0.03) and 
chest press peak power by 15% (p<0.01) whereas a non-significant increase of 12% was 
detected in hand grip strength (from 17.3± 2.7kg to 19.4± 4.6 kg; p>0.05). The HSC group 
had a significant improvement in chest press 1RM by 21% (p<0.01), leg press peak power by 
41% (p<0.01) chest press peak power by 24% (p<0.01) but hand grip strength did not change 
significantly (increased by 10%, from 17.7± 7.8kg to 19.4± 6.6kg; p>0.5). Between group 
differences were detected only for leg press peak power, with the HSC group performing better 
than the control by 158 W (95% CI (2, 315), p=0.005).    
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The SPPB test improved significantly over time only within the HSC group from 8.0± 1.5 to 
9.6 ±1.2 (p=0.02).  Between group differences favoured the HSC group [mean difference 1.1 
(95%CI (-0.1, 2.4), p=0.08)] although this was not statistically significant.  
 
Secondary Outcomes  
Consumption of ricotta cheese in study A, resulted in significantly lower fasting insulin levels 
in men (p=0.05) but not in women. There were no other significant changes in hepatic markers 
(SGOT, SGPT and Alkaline Phosphatase), kidney function (blood urea, uric acid, creatinine 
and GFR), anabolism (IGF-1) or insulin resistance. No cases of microalbuminuria were present 
in the RCH+HD group after the intervention period. Moreover, 25% of women in the 
intervention group reported early satiation after the consumption of ricotta cheese, however 
dietary intakes were not reported. Eight participants from the intervention group dropped out; 
five were due to personal health issues, two could not eat the entire portion of ricotta cheese 
and one had to relocate. In the control group three people dropped out (two for personal reasons 
and one for modifying the habitual diet). However, all participants were measured pre- and 
post-intervention according to an intention-to-treat analysis.      
 
The exercise intervention in study B resulted in acute joint pain only in the SH group. In 
addition, the HSC group reported significantly lower rates of perceived exertion (RPE) with a 
mean difference of -1.5 (95%CI -2.0,-0.12, p=0.04). Adherence rates were similar in the two 
groups; 81% in HSC and 85% in SH. Regarding the Instrumental Activities of Daily Living 
(IADL) there were significant improvements within both groups (pre vs post); namely, time 
needed for jacket on and off (from 11.5± 3.5s to 10.2± 2.0s; p=0.04), scarf pick-up (5.2± 1.1s 
to 4.7± 0.91s; p<0.01 and pan carry (4.9± 0.61s to 3.9± 0.77s; p<0.01) improved significantly 
within the control group, while the HSC group experienced significant improvements in time 
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for sit-to-stand (from 16.1± 5.7s to 13.4± 3.9s; p=0.02) and pan carry (5.4± 1.3s to 4.5± 1.2s; 
p<0.01). No differences were observed between the two groups in the aforementioned IADLs.     
 
In summary, neither of the studies had a significant effect on body composition in sarcopenic 
obese older adults. The introduction of ricotta cheese in the habitual diet of participants in 
study A aimed to increase their protein intake but it was not reported whether or not this was 
achieved, nor to what extent. In the same study, there was a trend for increase in strength in 
the intervention group but not significantly. The only significant improvement reported was 
the fasting insulin level but only in men in the intervention group. Despite the lack of body 
composition changes, in study B, the high speed circuit resistance training and strength 
hypertrophy resistance training protocols significantly improved strength, power and function 
indices but did not significantly change either muscle mass or body fat in any of the groups.   
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Table 2.3 Summary of the included studies 
Study Setting/ 
Study 
Design/ 
Duration 
Group Participants Mean Age  
(SD)/ characteristics 
Exercise 
Training  
Nutritional 
Intervention 
Sample Size (n) 
Drop-out (DO n)  
Female (F n) 
Adherence (%) 
 
 
Assessment of  
a)body 
composition 
b) strength or 
function 
Outcome 
Measure  
Study A 
(Aleman-
Mateo et al. 
2012)   
Mexico/ 
RCT: two 
arms, one 
control, one 
intervention 
/ 3 months 
Control  76.7 (5.8) / physically-
independent, sarcopenic 
based on low TASM 
and strength, obese 
based on %BF 
No Habitual diet 
(HD) 
Baseline n=20 
Final n= 12 
DO n= 8 
F n=12 
N/A 
a)DXA 
b) HG strength 
TASM →, 
FM →, 
LM →, 
HG →  
Intervention 75.4 (5.0)/ independent 
living sarcopenic based 
on low TASM and 
strength, obese based on 
%BF 
No HD plus 210 
g of ricotta 
cheese/day, 
(providing 
15.7 gr extra 
protein/day) 
Baseline n=20 
Final n=17 
DO n=3 
F n=11 
N/A 
 TASM →,  
FM → , 
LM →, 
HG → 
Study B 
(Balachandran 
et al. 2014) 
USA/ RCT: 
Two arms, 
one control, 
one 
intervention/ 
15 weeks 
Control 71 (8.2)/ independent 
living community 
dwellers from South 
Miami, sarcopenic 
based on SMI and 
strength, obese based on 
%BF and BMI 
strength-
hypertrophy (SH) 
training, 11 
exercises, 3 sets 
of 10-12 reps per 
set at 70% 1RM  
No Baseline n=10 
Final n=9 
DO n= 1  
F n=8 
85% 
a)BIA 
b) HG  strength, 
SPPB, Leg press 
1RM, Chest press 
1RM, Leg press 
power, Chest 
press power,  
SMI→, %BF →, 
SPPB→, Leg 
1RM↑**, Leg 
Power↑*, Chest 
1RM↑*, Chest 
Power↑**, HG→ 
 
Intervention 71.6 (7.8)/ independent 
living community 
dwellers from South 
Miami 
High speed circuit 
(HSC) training, 
11 exercises:  3 
circuits of 10-12 
reps per exercise 
at loads that 
maximised peak 
power output 
No Baseline n=11 
Final n= 8 
DO n= 3  
F n =8 
81% 
 SMI→, %BF →, 
SPPB↓*, Leg 1RM 
→, Leg 
Power↑**ǂ, Chest 
1RM↑**, Chest 
power↑**, HG→ 
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Notes: → no significant change, ↑significant increase, ↓significant decrease, *<0.05, **<0.01, ǂ significantly better than the control group;   
%BF, percent body fat; BMI, body mass index; DXA, dual-energy xray absorptiometry; FM, fat mass; HG, handgrip; LM, lean mass; RCT, randomised control 
Trial; RM, repetition maximum; SPPB, short physical performance battery test; TASM, total appendicular skeletal muscle.   
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2.4 Discussion  
The aim of this review was to assess the effectiveness of nutritional and/or exercise interventions 
on body composition and strength or function in older sarcopenic obese adults. With regard to the 
main outcomes, neither an increase in protein intake by 15 g · day-1 nor a resistance exercise 
protocol produced significant improvements in body composition indices in older sarcopenic 
obese adults. However, the exercise intervention (both the control group following a strength-
hypertrophy resistance exercise protocol and the intervention group utilising a high-speed power-
orientated circuit resistance training) reported significant improvements in both strength and 
function. However, the small number of studies identified clearly highlights the need for more 
research in the area and potentially a consensus for the definition of sarcopenic obesity.   
 
Study A (Aleman-Mateo et al. 2012) attempted to utilize the effectiveness of protein in enhancing 
skeletal muscle mass accretion rates. Although the authors (Aleman-Mateo et al. 2012) 
acknowledged that the suggested recommendations for protein intake in the older sarcopenic 
individuals are 1.2-1.5 g ·kg bw-1 ·day-1 they did not report the daily protein intake which was a 
major limitation. It has been suggested that maximal muscle protein synthesis (MPS) rates in older 
adults can be achieved using ~35 - 40g protein · meal-1 (Pennings et al. 2012; Yang et al. 2012; 
Moore et al. 2015) or 0.4 g protein · kg bw-1 · meal-1 (Moore et al. 2015). A valid question would 
be whether a daily addition of 210 g ricotta cheese (delivering 15.7g protein) to the habitual diet 
could practically augment muscle mass in sarcopenic older adults. It is important to note that the 
cheese servings were not consumed in one meal but were spread over the three main meals, that 
is, 70 g cheese (~5 g of extra protein) consumed across breakfast, lunch and dinner. Protein intakes 
in Study A were not reported but extrapolatation of the data from studies in similar population 
cohorts (Tieland et al. 2012b), suggests that older individuals are not likely to consume an 
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adequate amount of protein during all main meals. Tieland et al. (2012b) reported mean protein 
intakes of ~8g, ~18g and ~29g for breakfast, lunch and dinner, respectively. Therefore, it is 
uncertain whether the addition of 5g protein in the main meals in study A was enough to 
significantly augment MPS. Another confounder may have been the potential impact of the 
addition of cheese on the habitual diet given the fact that 25% of women in Study A experienced 
early satiation. It could be consequently speculated that women’s habitual diet was modified with 
the addition of ricotta, potentially displacing the intake of other foods. However this cannot be 
confirmed as the habitual diet was not reported.  
 
In study A, even though there was a trend towards increased strength, it could be argued that 
higher, and perhaps different distributions of protein intake were needed to enhance muscle 
strength and accretion of skeletal muscle mass. The potential for high protein meals to maintain 
or increase muscle mass and strength in older adults has been recently reported by Loenneke et al. 
(2016) who reported that one or two meals containing 30-45 g protein · day-1 were associated with 
higher lean mass and strength compared with those who did not consume any meals over the 
threshold of 30 g protein. It should be also noted that the power calculation for sample size in 
study A was based on lean mass as a primary outcome, rather than muscle strength. Therefore, it 
is unknown whether a larger sample size was needed to reveal a significant change in handgrip 
strength. 
 
In spite of possible methodological limitations of study B the improvements in strength, power 
and IADL provide evidence to support that exercise can improve several domains of physical 
performance such as strength and power. This is in agreement with previous reviews supporting 
the benefits of resistance exercise training on clinically important outcomes even in the absence 
of increased muscle mass (Cruz-Jentoft et al. 2014; Churchward-Venne et al. 2015; Witard et al. 
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2016a). This may be partly accounted for by the adaptive plasticity in the neuromuscular system 
and skeletal muscle tissue in response to resistance exercise even in advanced older age (Aagaard 
et al. 2010). A significant improvement particularly in power, can be very important for sarcopenic 
obese individuals since muscle power can be a predictor of mobility skills and a more influential 
indicator of physical capacity compared with absolute changes in strength (Bean et al. 2003). 
Another interesting finding from study B was the large effect size observed in peak leg power 
achieved by exercising at 50% 1RM. To a certain extent, that finding may be explained by the 
novel aspect of the study design, that is, the resistance exercise progression protocol. Resistance 
load would increase only when a power plateau was reached (Balachandran et al. 2014). Therefore, 
the protocol was designed in such a way as to favour maximum power output and possibly this 
fact may explain the lack of significant changes in leg strength in the HSC group but significantly 
better improvements in leg power compared with the control group.   
 
With regards to the lack of significant changes in lean mass or muscle mass after exercise training 
in sarcopenic adults, it has been reported elsewhere in the literature (Cruz-Jentoft et al. 2014) and 
may be accounted for by protocol-specific differences such as duration, type, intensity, time-
under-tension, volume and frequency of exercise as well as the quality and availability of adequate 
nutrients (protein/amino acids) to elicit a muscle anabolic response and consequently hypertrophy 
(Borde et al. 2015; Witard et al. 2016a; Witard et al. 2016b). One limitation of study B 
(Balachandran et al. 2014) was the lack of control for dietary intake which could have partly 
explained the lack of effect on body composition. It has been shown that a bout of resistance 
exercise can stimulate muscle protein synthesis (MPS) to a higher degree than protein breakdown, 
however, in the absence of post-workout provision of nutrients (especially protein) it can result in 
negative net muscle protein balance (Philips et al. 1997; Koopman and Van Loon 2009) and is a 
limitation of study designs to date.  
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These data support the potential benefit of a resistance exercise programme within lifestyle 
intervention protocols due to its positive effect on muscle strength, power and function in 
sarcopenic obese older adults. Although no statistically significant body-composition changes 
were reported in the included studies, the significant improvements in strength, power and function 
may be more important for the quality of life of older sarcopenic obese adults than absolute 
changes in body fat or lean mass per se. In the protein study (study A), even though there was a 
trend towards a maintenance of muscle strength, it could be argued that higher protein intakes and 
potentially a more careful timing/distribution of protein were needed to enhance muscle strength 
and accretion of skeletal muscle mass.  
 
More intervention trials should be undertaken to identify effective lifestyle strategies in adults 
with sarcopenic obesity that will inform more robust approaches to combat this condition. Future 
research should also bridge the gap in knowledge with respect to multimodal approaches 
combining resistance exercise training with dietary strategies. More trials combining resistance 
exercise training with protein supplementation, in order to augment muscle mass and strength, and 
potentially alongside an energy-deficit diet to promote fat loss are needed. According to a recent 
study in young adults, after a whole-body resistance exercise the body is able to utilize 40 g protein 
for anabolic purposes (Macnaughton et al. 2016). Therefore, considering that older adults require 
more protein that their younger counterparts to reach the same MPS rates, it should be 
corroborated in future studies whether the optimal protein dose is even higher than 40 g in older 
adults performing whole-body resistance exercise workouts. It is also important to note that 
although the need to augment/preserve muscle mass is paramount, a reduction in fat mass and 
especially fat infiltrating the muscle tissue is equally important, since intermuscular fat can lead 
to mobility limitations (Visser et al. 2005). Exercise training can preferentially reduce 
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intermuscular adipose tissue more effectively than caloric-restriction alone (Murphy et al. 2012). 
However, a combination of exercise with caloric-restriction can lead to greater losses of total fat 
mass, which in turn may result in greater improvements in physical function, sometimes even at 
the expense of lean tissue (Villareal et al. 2011a; Beavers et al. 2014).  
 
2.4.1 Limitations  
The main limitation of this review is the scarcity of studies with older population groups and the 
strict inclusion/exclusion criteria implemented by the Reviewers. Only studies including obese 
older adults having the sarcopenic phenotype as defined by the EWGSOP (Cruz-Jentoft et al. 
2010) using an appropriate methodology to assess body composition, were reviewed. Although in 
2010 the EWGSOP agreed on the definition and assessment of sarcopenia adopting criteria for 
low muscle and low strength or function, it is not uncommon for studies (Mason et al. 2013; 
Maltais et al. 2016) to use only the criterion of low muscle mass to define sarcopenia as it was 
initially proposed (Evans 1995). Such studies were not included in the current review. In addition, 
two studies conducted before 2010 were excluded. In one study, muscle mass was assessed using 
urinary creatinine (Yarasheski et al. 1999), a method not included in the EWGSOP definition, and 
in the second study (Wouters-Wesseling et al. 2003) despite using an acceptable methodology the 
authors could not provide the required information (skeletal muscle mass pre- and post-
intervention) in order to confirm eligibility. Similarly, a recent study (Kwon et al. 2015b) with 
Asian older and possibly sarcopenic individuals was excluded due to lack of essential data on body 
fat and BMI, and after personal communication, retrieval of that information was not possible.  
Although of vital importance, there is an apparent lack of interventions with sarcopenic obese 
older adults. This is in accordance with Finger et al. (2015) who commented that interventions 
may refer to or discuss sarcopenia, however, the number of studies recruiting sarcopenic adults is 
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very limited. Indeed, there is a number of reviews (Weinheimer et al. 2010; Li and Heber 2011; 
Cermak et al. 2012; Malafarina et al. 2012; Poggiogalle et al. 2014; Goisser et al. 2015) presenting 
intervention studies with healthy, overweight, obese or sarcopenic older participants which usually 
extrapolate data in order to propose ways to improve the sarcopenic obesity phenotype in older 
age.  
 
2.4.2 Conclusion  
This review assessed studies investigating the effectiveness of exercise or nutritional interventions 
to improve the body composition and strength/function of older adults with sarcopenia and 
obesity. None of the included studies significantly reduced body fat or increased either skeletal 
muscle mass or lean mass. Although the number of included studies was low, it is evident that an 
exercise intervention can elicit significant improvements in aspects of physical function such as 
muscle strength, power and ability to perform activities of daily living. The addition of 15 g 
protein·day-1 to the habitual diet via cheese consumption revealed a non-statistically significant 
trend towards increased handgrip strength, and resulted in an improved insulin response in men 
but not women. The lack of published data highlights the necessity for new research adopting 
universally accepted cut-offs for sarcopenic obesity with the inclusion of appropriately designed 
exercise programmes and dietary regimens, and with detailed assessments of dietary patterns and 
intakes for the targeted population group. 
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Chapter 3. Protocol development for a lifestyle intervention for 
older sarcopenic obese community-dwellers: Rationale for a high-
protein hypocaloric diet combined with mixed exercise training. 
 
3.1 Overview 
Chapter 1 presented the evidence supporting the beneficial effects of exercise and high-protein 
nutritional regimens, however, the systematic review in Chapter 2 highlighted that such protocols 
have not been employed in sarcopenic obesity. Thus, protocols for sarcopenic obese older 
community-dwellers are currently lacking and in particular, there is a lack of practical and realistic 
interventions that combine exercise with an appropriate nutritional regimen. Therefore, this 
Chapter presents a) the evidence for the proposed lifestyle intervention that has been employed in 
the current study, and b) discusses its practicality and how it can be implemented and monitored. 
Thus, in the first section of this chapter (section 3.1) a justification for the proposed protocol is 
presented along with the operational implications. In the second section (3.2), an overview is 
provided of the different methodologies allowing researchers to assess the effectiveness of the 
intervention.  
 
3.1.1 Exercise  
Before designing an exercise intervention that can be replicated at a community level, it is essential 
for researchers to take into consideration the specific characteristics, abilities and preferences of 
the population group that is being targeted.  When it comes to older adults participating in exercise 
programmes, in order for them to adopt and maintain a regular attendance, the programme must 
be inexpensive, realistic and enjoyable (Jette et al. 1999). It is especially important in adults with 
obesity to select the right exercise equipment in order to ensure adherence to the programme 
(Baechle and Westcott 2010). Moreover, the exercise routine needs to be challenging enough to 
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elicit physiological adaptations but at the same time manageable, realistic and not overly 
complicated to perform, in order to avoid discouraging the trainees and undermine their self-
esteem, which can eventually result in diminished interest (Chen et al. 2013). Therefore, before 
even initiating the design of the exercise-specific principles such as frequency, intensity, type of 
exercise and duration, the aim of the current strategy was to create a programme that will be 
appropriate for a group of older adults with varying levels of physical skills and capacity to 
exercise. Equally vital is the fact that the programme needs to be easily replicated and maintained 
at a community setting without the need for sophisticated or expensive equipment.  
 
It is often reported that obese older adults prefer exercises and machines that can accommodate 
their weight and capacity for physical movements (Baechle and Westcott 2010). When balance is 
a concern the ideal way to initiate an exercise programme is by adopting a stable position (ideally 
seated) as a starting point and observe the trainee’s performance in order to provide feedback and 
support as necessary. Moreover body-weight exercises are a good starting point for someone who 
does not have experience in performing a complex exercise routine (Baechle and Westcott 2010). 
Therefore using chair-based exercises combines all previous principles and additionally, removes 
the burden of having participants adopt unfamiliar positions when using fixed-path machines. 
Additionally, obese or not highly functional trainees feel more comfortable, at least at the initial 
stages of a programme, when performing activities in a supported environment/piece of equipment 
instead of a treadmill or outdoor jogging (Baechle and Westcott 2010). 
 
As presented in section 1.2.1.3, the UK Department of Health (2011) and the ACSM (2014) 
recommend 150-300 mins of a moderate intensity multi-modal exercise training (i.e. a programme 
combining strength, aerobic, balance and stretching exercises) for older adults (ACSM 2014). The 
aim of combining different training modalities is to promote improvements in several aspects of 
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physical fitness such as strength, power, muscular and cardiovascular endurance, flexibility and 
balance. High body functionality is essential considering that neuromuscular coordination, 
proprioception, stability and balance are crucial for older adults and especially for those with 
increased risk for physical disabilities. A regular mixed exercise programme (3 x 90 min weekly 
sessions for three months combining balance, flexibility, aerobic and strength exercises) can help 
older frail and obese adults to augment their strength and appendicular lean mass (Villareal et al. 
2011b). The resistance protocol in this study involved exercising at progressively increasing 
intensities (from 65 to 80% 1RM) on a Hoist machine and a squat rack. Moreover, at the end of 
the 3-month intervention the mixed MPS rates significantly increased by approximately 50%. 
However, there was no interaction between training and protein feeding-induced changes in MPS 
over time, since ΔMPS (post-prandial – basal) rates between pre-intervention and post-
intervention were similar, at ~0.02%/h. This lack of effect in response to feeding after 3-months 
of exercise training may be accounted for by the low protein content of the supplement used (~11 
g mix of milk and soy protein), which was possibly too low to significantly stimulate MPS in older 
adults, and capture any changes in anabolic sensitivity in response to exercise and protein feeding.   
 
Although progressive resistance training using free-weights (e.g. dumbbells, barbells, medicine 
balls etc.) and/or fixed path machines have a well documented positive impact on muscle mass, 
strength, power and function (Liu and Latham 2009; Peterson et al. 2010; Steib et al. 2010; 
Villareal et al. 2011b), their use may be not be ideal for this cohort since they may not be easily 
accessible (Martins et al. 2013). Moreover, it is not ideal for a community-based intervention, 
where the organisers may not be able to afford to provide such equipment due to financial or 
practical limitations (e.g. lack of space, inability to transport). An alternative to machines and free 
weights is the use of elastic bands (EBs) that come in different levels of resistance. The main 
advantage of the EBs is the fact that they can be used anywhere since they are portable, 
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inexpensive and easy to use and maintain (Colado and Triplett 2008). In addition, elastic bands 
can work in multiple planes, unlike free weights which work only against gravity. For example to 
perform a chest press with free weights one will need to adopt the supine position and move the 
weights vertically upwards (against gravity) to engage the chest muscles. Elastic bands on the 
other hand can be used while seated or standing which is more convenient especially for the older 
adults who are in the initial stages of an exercise programme.  
 
The main purported disadvantage of EBs comes from its key mechanical characteristic, that is the 
lack of a fixed resistance; instead, the resistance is initially negligible and increases progressively 
with the elongation of the band. This also makes it difficult to measure changes in strength as well 
as monitor intensity, as they both depend on the degree of elongation. However, a modified 10-
point Borg’s scale has been effectively used in the past to monitor intensity for older adults 
exercising with EBs (Anderson et al. 2010). Moreover, EBs exert the maximum resistance at the 
end of the range of motion (ROM), whereas the greatest mechanical advantage of the muscles is 
around mid-range of ROM, which has led to the suggestion that muscles cannot be fully activated 
with EBs, and therefore may have a limited potential for hypertrophy and strength augmentation 
(Hostler et al. 2001; Aboodarda et al. 2016). Electromyography (EMG) has thus been utilized to 
measure muscle activation with EBs (Anderson et al. 2010; Jacobsen et al 2013). These studies 
have reported that there may be some exercises which produce greater muscle activation with one 
training method over the other, e.g. EBs result in greater activation of the infraspinatus muscle 
during external rotation of the shoulder, whereas free weights activate more the extensor 
digitorum, deltoids and trapezius during wrist extensions and shoulder lateral raise, respectively 
(Anderson et al. 2010). However, these findings were in young adults and secondly, may not be 
directly applicable to older groups since the previous exercises are mostly isolation exercises that 
would usually complement more complex exercises (which are of primary importance for muscle 
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strengthening, balance and proprioception purposes). For example, in one of the few studies that 
was done with young and old participants, no differences were found in leg muscle activation 
using EBs vs dumbbells when performing lunges with similar loads (Jacobsen et al 2013). In fact, 
when an overall analysis was conducted averaging all upper leg muscles, velocities and loads, the 
EMG activity was significantly higher with EBs (37 ± 1.2%) than dumbbells (29 ± 1.2%) 
(p<0.001).  Overall, according to a meta-analysis of trials providing EMG data from EB exercises 
or traditional free weights/ resistance machines (excluding isokinetic) there are no significant 
differences in the level of muscle activation (Aboodarda et al. 2016).  
 
Even with exercises, such as squats, where EBs exert minimal resistance at the lowest part of the 
motion, the use of EBs may be advantageous for older adults. There is phenomenon called ‘the 
sticking point’ which limits the maximum weight that can be lifted due to the body’s lever system. 
For example in squats or bench presses the sticking point is at the bottom of the movement, which 
makes it the most disadvantaged point throughout the range of motion (ROM), thus limiting the 
amount of  weight that can be lifted (Elliott and Wilson 1989). The sticking points also limit the 
force and acceleration produced (Anderson et al. 2008). Therefore, if it was possible to minimise 
the resistance around these points it would allow for exercise trainees to perform the movements 
easier and perhaps with a higher overall load and thus greater tension where the muscle is at a 
greater mechanical advantage (Anderson et al. 2008). For example, when trying to get up from a 
seated position (i.e. in a motion resembling the ‘squat’ exercise), the most challenging part is the 
initial push up from the chair. Therefore, with the use of elastic bands, there is no external 
resistance initially (apart from that of the person’s bodyweight), but it progressively increases until 
it reaches its maximum resistance when the person is fully up.  
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Moreover, EBs also challenge the muscles during the eccentric part of the movement to allow for 
a controlled shortening of the band and thus the muscles remain under tension, but without the 
fear of additional external weight. Time-under-tension is the time period during which the muscles 
stay engaged. It is an important factor that can lead to physiological adaptations since an increased 
time under tension can improve the motor unit recruitment and motor unit firing rate, and 
especially when the eccentric part of the movement is prolonged, it can promote hypertrophy by 
increasing the satellite cell number in type II muscle fibers (Toigo and Boutellier 2006; Cermak 
et al. 2013). Consistent with the previous example of the chair rise (or similarly with the squat 
exercise), it is far safer (but still challenging on the muscles) for an older person to return to the 
seated position in a controlled manner holding an EB than external weight (e.g. dumbbells).  
 
With regards to changes in body composition and strength or function, although EBs have been 
introduced relatively recently compared to more traditional pieces of exercise equipment such as 
the weight-machines and free weights (e.g. dumbbells and barbells), the results have been 
promising. One of the first studies using EBs in older community-dwellers (n= 62 Caucasian 
women, ≥ 65 years from retirement residential communities) reported strength gains of 19.7% 
(p<0.001) in latissimus dorsi, 27% (P<0.001) in quadriceps and 16.5% (p<0.01) in pectoralis in 
as little as eight weeks, whereas the control group (no exercise) did not note any significant 
improvements), however, no information was provided regarding body composition (Damush and 
Damush 1999). When EBs were compared against weight-machines they were found to result in 
similar improvements in body composition and function of middle-aged sedentary but 
independent-living women, as long as the number of repetitions and intensity were similar in both 
protocols (Colado and Triplett 2008). In that study the rate of perceived exertion (RPE) and the 
number of repetitions were monitored to ensure that intensity and volume remained the same in 
both groups (one using the EBs and the other using weight-machines). It was noted that EBs can 
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be as effective as the conventional resistance equipment in increasing lean mass (+0.5 kg vs +1.0 
kg, respectively, p>0.05 between groups), reducing fat mass (-0.5 kg vs -1.1 kg, respectively, 
p>0.05 between groups) and improving function as indicated by the significantly higher number 
of repetitions that participants could perform over time in knee press-ups and 60-sec squats (with 
no differences noted between groups). A systematic review and meta-analysis of clinical trials 
focusing on strength changes in adults ≥ 60 years after resistance training with EBs, noted 
significant improvements in strength in healthy cohorts as well as in groups with some kind of 
mobility limitations and even with pathologies such as type II diabetes and chronic obstructive 
pulmonary disease (Martins et al. 2013). The mean (±sd) duration of the trials, number of weekly 
sessions, number of sets, and average intensity were 17.6 (±8.6) weeks, 2.7 (±0.5) sessions week-
1, 2.5 (±1.0) sets, and 70% (±12.7) of 1RM, respectively, however a dose-response relationship 
could not be established between any of these factors and strength changes.  
 
Training with elastic bands can significantly improve muscle strength and function even at home-
based sessions (Zion et al 2003). Twelve adults ≥ 60 years with orthorstatic hypotension performed 
10 EB exercises every other day for eight weeks at home (after an initial supervised 
demonstration), starting from the lightest available resistance and increasing only after they could 
perform 10-12 reps with proper form at the end of the third and final set. Although participants 
did not have a fixed time schedule to complete the routine, and they could perform it in the comfort 
of their home, the completed sessions were ~78% and there were four dropouts (two for lack of 
motivation and two for other illnesses). In theory supervised classes offer better motivation and 
can result in greater attendance rates in older cohorts (Picorelli et al. 2014). Nevertheless, at the 
end of eight week home-based workout participants experienced a significant improvement in 
chest press, knee extension and leg press strength, with the latter being the most noteworthy 
change from a median 77.1 (IQR: 54.4, 149.7) kg to 197.3 (115.7, 316.2) kg (p = 0.025) (Zion et 
113 
 
al 2003). In addition, function as indicated by a timed-up-and-go (TUG) test, was improved in 
seven out of eight participants, with an average improvement in time of 14% (p=0.018). The 
usefulness of the TUG test is discussed further in the next section (3.2.2).  
 
In another study where EB exercises (knee flexion/extension, squats, hip flexion/extension, ankle 
dorsi/plantarflexion) were compared against balance exercises (using bodyweight-only and 
performing exercises such as tandem walking, side steps, braiding, one-leg stance etc.) in 
community-dwellers ≥ 75 years exercising for eight weeks in a senior center (twice ·week-1) and 
at home (three times ·week-1), both regimens resulted in similar improvements in balance (assessed 
by fall index with the use of a Tetrax balance platform) and strength (assessed by dynamometry) 
(Cho and An 2014). Namely, strength was improved in the hip flexor and extensor, the knee 
extensor, the hip abductor, and ankle dorsiflexor muscles in the balance-trained group, whereas 
the EB trained group improved strength in all the aforementioned muscles in addition to knee 
flexor and ankle plantar flexor muscles. The fall index was significantly improved in both groups 
over time, with no significant between-group differences.  
 
More recently, the EBs have been found effective in increasing muscle power, flexibility, balance 
and cardiovascular capacity in older adults after 3-6 months of 3x40min/week multi-modal 
exercise training programmes (Wessner 2016). The benefits of EBs have also been assessed in 
community-based stations where the use of EBs resulted in improved functional fitness, namely, 
upper limb power and lower limb muscular endurance, flexibility, lung capacity and self-perceived 
physical health status in older adults (Chan et al. 2016). In addition to improving body 
composition, strength, balance, power and function, EBs have been found effective in improving 
joint mobility (Sugimoto and Blanpied 2006) and quality of sleep (Chen et al. 2013) as well as 
reducing knee pain in older adults with osteoarthritis (Topp et al. 2002).   
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In terms of exercise intensity, when exercise equipment and resources are limited or high intensity 
exercise is prohibited due to low physical capacity to exercise, then low-to-moderate intensity 
exercise regimens may be implemented. Exercising at 40% of one repetition maximum (40% 1RM 
three times week-1) produced comparable results in terms of strength with high-intensity resistance 
exercise (80%1RM three times week-1) in healthy older participants who were also consuming a 
carbohydrate (26g) and EAAs (22 g ≈ 50 g intact protein) supplement within 15 minutes post-
workout (Onambélé-Pearson et al. 2010). No change in body fat or body composition was noted 
in either of the groups. Interestingly, the low-moderate intensity group experienced a statistically 
significant improvement in thigh muscle thickness (from 33.6 ± 1.7 mm to 36.1 ± 1.4 mm) and the 
TUG test (from 5.7 ± 0.52 s to 5.1 ± 0.2 s) whereas the high-intensity group did not. Moreover, no 
changes in inflammatory markers was noted, which is consistent with the lack of fat loss in both 
groups. The differences in muscle thickness may lie in the fact that the low-intensity group 
performed more sessions at home (with the use of EBs) complemented by 20 mins of brisk-
walking. Therefore, the two groups were perhaps not matched for exercise volume and 
additionally, the brisk walking sessions may have confounded the results since as discussed in 
Chapter 1 (section 1.2.1) aerobic exercise may also increase muscle size and power. Exercise 
volume is actually an important factor for young and older adults. In young adults, low-intensity 
resistance-exercise (30% 1RM) to failure has the potential to exert the same anabolic effects on 
muscle hypertrophy in young men as a high intensity exercise of 90% RM to failure (Burd et al. 
2010). In young male participants (22.7 ± 3.1 yr), it was found that a resistance-exercise intensity 
as low as 16% RM followed by repeated protein feeding (~6 g protein every hour for 10 hrs post-
workout) has been shown to keep protein synthesis rates significantly higher than resting levels 
(Bechshoeft et al. 2013). When older adults (70 ± 5 yr) perform exercises at similar intensities 
with young adults but at higher total volumes then they can experience comparable rates of muscle 
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hypertrophy (Kumar et al. 2012). For example the mean area under the curve (± SD) of muscle 
protein synthesis within four hours of performing three sets vs six sets of resistance exercise at 
40% 1RM in young was 0.07 (±0.02)% vs 0.06 (± 0.02) % (p>0.05) but in old 0.01 (±0.01) % vs 
0.13 (±0.03)% (p<0.01), respectively (Kumar et al. 2012).  
 
The previous finding indicates that increased exercise volume and a frequency of three sessions 
per week, may potentially reduce the ‘anabolic resistance’ phenomenon. Perhaps this is the reason 
why no muscle mass increase was noted in the study by Balachandran et al. (2014) with sarcopenic 
obese older adults (discussed in detail in Chapter 2). That is, exercising twice a week with three 
sets of 10-12 reps per exercise may not be enough to elicit a hypertrophy response in older adults, 
and especially when protein intake is not taken into consideration. Nevertheless, exercising at 
moderate intensities (~50% 1RM) and trying to perform the concentric part of the exercises 
explosively and the eccentric part slowly, can be effective in improving power in sarcopenic obese 
older adults (Balachandran et al. 2014). An interesting protocol with protein supplementation from 
different sources (2 x 20 g whey or collagen daily for a year) differing volume and intensity 
workouts, that can provide valuable data for all these different factors has been developed by 
Bechshoeft et al. (2016), but the trial findings are yet to be published. All the previous studies 
discussed in this section are particularly important and have informed the current protocol which 
cannot accommodate the use of free weights/machines or high intensities due to low practicality 
and/or discouragement of participants. Therefore, exercising at low-to-moderate intensities but at 
a higher overall volume may be a beneficial strategy for body composition and functional changes 
in older adults.  
 
In terms of frequency and duration, although a few exercise routines have shown the potential to 
increase strength when performed only once or twice a week (Di Francisco-Donoghue et al. 2007; 
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Sousa et al. 2013), such studies refer to protocols using increased volumes (e.g. repetitions to 
volitional fatigue) and/or have been conducted in healthy older adults and not sarcopenic obese. It 
is usually recommended that an exercise protocol is performed at least 3 times·week-1 in order to 
elicit significant improvements in various fitness components and not just absolute strength 
(ACSM 2014). The ACSM also recommends that a mixed exercise programme should be 
performed 3-5 times·week-1 to allow for various physiological adaptations. For example, a 
combination of resistance, aerobic and balance exercises that takes place 3 times·week-1 at 
moderate intensities, has the potential to improve co-ordination, balance and prevent falls (Baker 
et al. 2007). Exercising for > 150 mins week-1, even at low-moderate intensities, can promote 
physical independence and longevity, and increase disability-free life expectance (McPhee et al. 
2016). This is in accordance with a meta-analysis by Steib et al. (2010) and the ACSM reports 
(ACSM 2009; Garber et al. 2011) suggesting that neuromotor exercise training that involves 
power, agility, balance and proprioceptive training needs to performed 2-3 times·week-1 even at 
moderate intensities in order to improve muscle power and reduce the incident of falls in older 
adults. The duration of mixed exercise interventions and those incorporating EBs is usually 30 – 
60 min with a varied proportion of time allocated to different fitness aspects (Baker et al. 2007; 
Martins et al. 2013). In group classes it is usually established that the first 10-15 min are used for 
warming up exercises, the main body of the class lasting from 30-50 min is dedicated to strength, 
aerobic and balance exercises, whereas the final part should be used for activities of low impact 
and effort such as flexibility exercises in order to let the participants cool down appropriately 
(ACSM 2014). Such protocols have been found to have moderate to high attendances from ~62% 
for community-based classes, up to 100% for research centre-based classes when full attendance 
is required for the research purposes (Baker et al. 2007). 
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Regarding practicality and delivery of the exercise programme, the use of chairs and EBs allows 
participants to perform the same exercises all together and thus, gain a better appreciation of the 
exercise techniques by looking at each other as well as immediate feedback from the instructor. 
After an initial training period during which participants can familiarise themselves with the 
different requirements of the training protocol using only chair-based body-weight exercises, the 
introduction of elastic bands can help them maintain and gradually improve their balance, dynamic 
movement and kinesthetic awareness (Baechle and Westcott 2010). An extra advantage of the 
elastic bands is that participants can adjust the resistance quickly and relatively effortlessly either 
by holding the band at a different length or by selecting a band of different thickness. If participants 
were instructed to use free-weights or resistance machines they would have to let the weights down 
and pick up new ones or get in and out of the machine in order to change the intensity. That 
scenario would have a very low practicality during a group session with older adults. 
 
It is important to note that although exercise training may elicit significant improvements in 
physical function, performance and potentially body composition, it has been hypothesized that 
the benefits in older populations may rely more on losses of fat mass than changes in lean mass 
(Santanasto et al. 2010). After comparing exercise training alone with exercise and diet-induced 
weight loss they reported that improvements in physical function, as indicated by a mean SPPB 
score change (±SD) of +0.7± 1.4, were significantly associated with abdominal and intermuscular 
adipose tissue losses but not with changes in lean mass or strength in overweight older community-
dwellers. In fact, appendicular lean mass and strength were significantly lower after six months of 
exercise plus diet by 0.9± 0.8 kg and 16.8± 17.9 N ·m, respectively. Nevertheless, SPPB score 
was significantly improved. Interestingly, the exercise-only group did not notice any significant 
changes in muscle mass, fat mass, strength, or function, which could suggest that the exercise 
programme was not challenging enough to elicit any physiological adaptations. Thus, all 
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improvements in the exercise and diet group could be attributed to fat loss. This could be 
accounted for by the fact that the exercise routine was relying heavily on walking and less on 
resistance and balance exercises (40-min, 10-min, and 10-min respectively), whereas frequency 
(3 sessions·week-1 for the eight first weeks and twice week-1, for the following 16 weeks) and 
volume (2 sets x 10 reps) might have been less than optimal. Therefore, it could be proposed that 
when muscle mass and/or strength cannot be improved then fat loss alone may be beneficial for 
activities that require a movement of bodyweight around space.  
 
Although resistance exercise alone (3 sets x 10 reps at 70% 1RM three times week-1) has been 
effective in reducing intermuscular fat and enhancing function in sedentary overweight/obese 
older adults, those with the highest levels of adiposity at baseline, experienced the smallest 
improvements after a 5-month intervention (Nicklas et al. 2015). Therefore, baseline adiposity 
plays a role and can be a confounder in such interventions. Moreover, it was noted that moderate-
intensity exercise in combination with caloric restriction (600 kcal) resulted in greater 
improvements in some indices of performance  (self-reported disability and 400-m walk time) 
compared to exercise alone, but overall there were similar improvements in both groups (e.g. for 
knee-extension strength, power, 4-m gait speed). In an 18-month trial, a moderate-intensity 
physical activity programme for 288 older overweight and obese men and women, resulted in 
significant improvements in body composition only when physical activity was combined with a 
weight-loss programme (daily energy deficit 300-500 kcal) that promoted significant losses of fat 
mass; on average 4.9 kg fat mass was lost (Beavers et al. 2014). In the same study, although a 
significant amount of lean mass was lost (~2.5kg) that was outweighed by the substantial loss of 
fat mass which resulted in an improved ratio of fat to lean mass as well as in improvements in 
mobility and cardio-metabolic risk factors at the end of the study. Similarly, Wang et al. (2007) 
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reported greater improvements in muscle strength and quality with greater losses of fat mass, even 
at the expense of lean mass, after an exercise and hypocaloric diet programme.  
 
In conclusion, the addition of an exercise training programme to the lifestyle routine of older 
people is very important. Resistance exercise with the use of elastic bands can be an effective 
strategy when free weights or exercise machines are not available or realistic. Exercise training 
can improve older adults’ functional abilities whilst it has the potential to increase their lean mass, 
as long as it is performed three times weekly at low-moderate intensities and adequate volume. It 
seems however, that in overweight and obese older adults, the loss of adipose tissue is equally 
vital not only for cardio-protective reasons but for improved physical functioning as well. 
Therefore, the addition of a nutritional regimen may work in synergy with an exercise routine for 
the optimization of physiological changes in older sarcopenic and obese adults. 
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3.1.2 Nutritional regimen and supplementation  
There are many parameters that need to be considered before designing a nutritional intervention 
for older adults, especially when a food product and/or a supplement are introduced to the diet. 
The most important factors include the quality, quantity and volume of food, type, frequency, 
timing and more practical issues such as palatability, sustainability over a long period of time as 
well as handling, delivery and storage of the foods/supplements. In this study, the main nutrient 
of interest is protein therefore, all the aforementioned parameters were carefully considered when 
designing the most appropriate ‘food vehicle’ that can deliver extra protein without compromising 
the diet’s overall quality, practicality and easiness of use. The rationale for the addition of 
supplementary vitamin D will also be discussed.    
 
To tackle the development and progression of sarcopenic obesity two seemingly contradicting 
conditions need to be met simultaneously; that is, gaining or preserving muscle mass and strength, 
while losing fat mass (Goisser et al. 2015). Weight loss diets via energy restriction (from <500 to 
800 kcal deficit) have been found effective in reducing body weight, however the weight loss is 
accounted for not only by reduced fat stores but also substantial losses of lean mass, as shown in 
a meta-analysis of weight-loss trials in middle-aged and older adults (Weinheimer et al. 2010). 
Even modest reductions of energy intake ~250 kcal can produce such lean mass losses 
(Weinheimer et al. 2010) and therefore, weight loss regimens via reduced energy intake in older 
sarcopenic obese adults remain a topic of controversy (Waters et al. 2013; Goisser et al. 2015). 
Although the addition of exercise to a hypocaloric diet can synergistically enhance the utilization 
of fat (Amati et al. 2008) and minimise the losses of lean mass, it is still likely that some lean mass 
(mainly muscle tissue) will be lost (Weinheimer et al. 2010). This is not surprising considering 
that exercise alone can stimulate muscle protein synthesis but without the availability of substrates 
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for tissue synthesis, the net protein balance may remain negative. Therefore, an adequate protein 
intake alongside a resistance exercise protocol has the potential to attenuate the reduction in 
muscle protein synthesis rates during periods of energy restriction in young and older adults (Areta 
et al. 2014; Murphy et al. 2015). It is generally agreed that when an energy-deficit plan along with 
regular exercise training is undertaken, then an increased protein intake in the range of 1.2-1.5 g · 
kg bw-1 or ~30% of total daily energy intake is mandatory to mitigate reductions in MPS (Leidy 
et al. 2007; Wolfe et al. 2008; Morley et al. 2010; Deutz et al. 2014; Paddon-Jones and Leidy 
2014). Protein intakes providing such ranges have been found more effective in promoting fat loss 
and preserving lean mass during caloric restriction compared to low-to-moderate protein diets, 
e.g. 0.5-0.9 g· kg bw-1  (≈16-21% energy intake) (Wycherley et al. 2012; Goisser et al. 2015). 
Protein intakes around the 1.3 g· kg bw-1 range have the potential to attenuate the fall in MPS rates 
during hypocaloric diets (-750 kcal) in young, middle aged and older overweight/obese adults 
(52± 2 yr, 34.7± 1.1 kg m-2) (Hector et al. 2014). In addition to an increased anabolic response, 
high intakes of dietary protein can elicit favourable effects upon adherence to an energy-restricted 
diet, via increased satiety and perception of the eating-related feeling of pleasure, which can be an 
important factor especially in obese adults (Leidy et al. 2007). 
 
Increased intakes of protein and dairy protein in particular (30% and 15% of total energy intake, 
respectively), may be able to attenuate, or even reverse, the loss of muscle mass in middle aged 
adults especially during periods of reduced energy intake (Josse et al. 2011). Although the 
maximum anabolic response to protein feeding in a single meal has not been fully elucidated in 
older adults, it has been proposed that 40 g of whey protein, or potentially even more if a whole 
body training session has preceded the protein feeding, should be consumed to optimally stimulate 
muscle protein synthesis in older adults (Hamilton et al. 2016). It has also been suggested that 
although both whey and casein are milk proteins, whey has a more pronounced effect on the acute 
122 
 
stimulation of muscle protein synthesis in older adults compared to casein (Dangin et al. 2003; 
Burd et al. 2012). The enhanced anabolic properties of whey protein have been attributed to its 
higher leucine content when compared to casein and milk solids; 1g of whey, casein and milk 
solids contain 108 mg, 82 mg and 77 mg leucine, respectively (Philips et al. 2009). Since whey 
protein has approximately a 30% higher leucine content compared to casein -which is the most 
abundant protein in milk-, the equivalent of 40g whey in terms of leucine content would be ~52 g 
of casein or 56 g skimmed milk powder (≈ 3 pints of semi-skimmed milk).  
 
As discussed in Chapter 1, the timing of protein administration may not be crucial for hypertrophy 
(as long as the total daily protein intake is sufficient ~1.2-1.5 g · kg bw-1), however, there may be 
timings of protein feeding that could potentially offer benefits to older adults. Overnight sleep is 
perhaps the longest post-absoptive period during which net protein balance remains neutral (i.e. 
muscle protein breakdown ≃ muscle protein synthesis) (Groen et al. 2012). Thus, it may provide 
a ‘window of opportunity’ for a protein feeding to elicit higher aminoacidemia and maintain 
elevated MPS rates. Trials measuring the acute response to protein have shown that 40 g casein 
can increase MPS and maintain a positive net protein balance during the night hours, with/out the 
addition of an evening exercise session in young and older adults (Groen et al. 2012; Res et al. 
2012). Therefore, pre-sleep protein feeding may offer a pragmatic approach to increase total 
protein intake, and elevate MPS rates during the night, which may have an additive effect on total 
daily muscle protein synthesis and attenuate muscle loss, however, no studies have employed this 
protocol in sarcopenic obese older adults.  Moreover, casein offers a more sustained and prolonged 
appearance of amino acids in blood compared to whey, whereas the latter produces a higher but 
more transient effect of aminoacidemia and thus MPS over periods of ~six hours (Pennings et al. 
2011b). Therefore it could be hypothesised that milk protein that contains fractions of both 
proteins would be the best approach for pre-sleep feeding in sarcopenic obese older adults.     
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Although requiring further corroboration, dairy products may be also beneficial for fat loss 
purposes (Zemel 2004a; Josse et al. 2011). Previous research has suggested that the fat-loss 
properties of dairy products in obese populations may be accounted for by their high calcium 
content, which may promote increased lipid utilization especially from the trunk combined with 
an energy restriction diet (1100-1300 mg Ca2+ day-1, and 500 kcal daily deficit, respectively) 
(Zemel 2004b; Zemel et al. 2005). In those studies a hypocaloric diet with the addition of extra 
calcium coming from supplements or dairy products while the rest of the macronutrients were 
similar in the control (~500 mg Ca2+ day-1) vs intervention groups (1100-1300 mg Ca2+ day-1)), 
resulted in greater fat losses for the high dairy groups with an extra of ~2kg of fat lost compared 
to control, and ~50% more fat lost from the waist region. Calcium intake has also been inversely 
associated with the metabolic syndrome and sarcopenia in middle-aged and older adults, even after 
adjusting for several factors, such as age, physical activity, smoking and energy intake (Liu et al. 
2005; Seo et al. 2013; Lee et al. 2014) 
 
Another important micronutrient is Vitamin D. As reported in Chapter 1, Vitamin D deficiency in 
older individuals is associated with muscle atrophy, low muscle strength, increased risk of falls 
and bone fractures and increased risk of mobility limitations and disability (Snijder et al. 2006; 
Ceglia 2008; Houston et al. 2013). The UK Department of Health (2012) and SACN (2016) advise 
that people aged 65 years and over should take a daily Vitamin D supplement of 10 μg (equal to 
400 International Units (IU)) since the dietary intakes are not sufficient as discussed in Chapter 1 
section 1.2.3.4. A systematic review assessing the effectiveness of vitamin D supplementation 
without the addition of exercise in people over 60 years, concluded that daily oral administration 
of 800-1000 IU (20-30 mcg) of Vitamin D had beneficial effects on strength and balance (Muir 
and Montero-Ontasso 2011). Furthermore, it has been suggested that for sarcopenic obese older 
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adults, doses higher than 1,000 IU vitamin D day-1 may be required since sarcopenia, obesity and 
sarcopenic obesity are associated with vitamin D deficiency (Villareal et al. 2011a; Kim et al. 
2013a). Therefore, vitamin D status may be a confounding variable for any intervention aiming at 
improvements in strength, muscle mass and functional ability in older sarcopenic obese adults. 
 
In 2010, an expert panel convened by the Society for Sarcopenia, Cachexia and Wasting Disease 
developed a report with nutritional recommendations for the management of sarcopenia (Morley 
et al. 2010). The panel’s guidelines state that adequate protein can slow the progression of muscle 
atrophy, however, the optimal strategy against sarcopenia includes exercise (resistance and 
aerobic) along with a high-protein intake (up to 1.5 g · kg bw-1) which would be ideally 
complemented by adequate vitamin D intakes. Therefore, in order to avoid vitamin D deficiency 
and any confounders that may arise from very low serum 25(OH)D concentrations, it would be 
prudent for studies (especially in countries with a low exposure to sunshine and for vulnerable 
groups such as those aged ≥ 65 years) to supplement their diets with at least the minimum 
recommended amount of Vitamin D (10 μg daily ≈ 70 μg weekly) (UK Chief Medical Officers 
2012; SACN 2016).  
 
An ongoing study proposes that a high-protein supplement containing beta-hydroxy-methyl-
butyrate (HMB; a leucine metabolite) and vitamin D may be beneficial for sarcopenic older 
patients with a hip fracture (Malafarina et al. 2013). Since ~40% of the older adults do not manage 
to recover their functional capacity after a hip fracture (Uriz-Otano et al. 2015) it was hypothesized 
that an oral supplement containing ~ 18.3g milk protein, 500 IU (12.5 μg) vitamin D3 and 1.2g 
HMB administered twice a day would have a significant effect on functional recovery and muscle 
mass of older patients (Malafarina et al. 2013). According to preliminary findings, the oral 
supplement attenuated the loss of muscle mass and weight (which significantly declined in the 
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control group), but there was no impact on fat mass, strength, gait speed, physical function and 
inflammatory markers (Malafarina et al. 2017).  
 
Although nutritional interventions characterised by a high protein intake have shown great 
potential, the actual intake of high protein foods seems to decline with age (Nieuwenhuizen et al. 
2010; Tieland et al. 2012b). There are certain barriers that can account for this decline, such as 
deterioration in appetite, impaired vision, dementia, deterioration in dentition and physical skills, 
medication, changes in gut function, and reduction in chemosensory abilities (Best and Appleton 
2013). For example, the number and efficiency of taste buds may deteriorate with age, resulting 
in impaired perception of taste especially in sweet and salty foods, which may start to taste more 
sour or bitter (Omran and Morley 2000).  
 
 Therefore, palatability, taste and effort required to prepare the meals are often some of the most 
important parameters that can facilitate the consumption of high-protein meals in older adults 
(Best and Appleton 2013). Thus, the most realistic way of increasing an older individual’s protein 
intakes in a sustainable and practical way without probing them to purchase more and/or non-
habitual foods would be through an oral supplement. Oral nutritional supplements have been found 
to be effective in delivering an increased amount of protein to institutionalized and community-
dwelling older adults; always bearing in mind that a variety in sensory attributes is essential in 
order to avoid the phenomenon of ‘taste fatigue’ (i.e. daily consumption of the same exact meal) 
and thus, promote compliance (Nieuwenhuizen et al. 2010). Therefore, the use of a ready-to-drink 
milk-based liquid supplement that comes in a variety of flavours offers advantages that can 
overcome all the aforementioned issues. From a nutritional perspective, the supplement must have 
the desired amount of protein (>40 g) along with a favourable amino acid profile, especially in 
relation to leucine. Therefore, the current protocol includes the use of an affordable commercially 
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available liquid dairy supplement with a protein and leucine content of 50 g and 6 g, respectively. 
These quantities are sufficient to trigger a significant response in muscle protein synthesis rates as 
outlined in this chapter and discussed in more detail in Chapter 1. Moreover, the selected drink 
has a long shelf-life of approximately eight months, a period during which it can be stored at room 
temperature. If opened but not consumed immediately it can be stored in the fridge for three days. 
The four different flavours (vanilla, chocolate, strawberry and banana) ensure that most 
preferences are likely to be accommodated. It is also proposed the use of an affordable and 
commercially available vitamin D supplement containing 25 μg vitamin D3 per tablet. The 
nutritional plan will be supplemented by a simple exercise training routine, using chairs, elastic 
bands and the bodyweight of the trainees as exercise aids with resistance, aerobic, stretching and 
balance elements.      
 
In conclusion, a moderate energy-restriction diet with a high protein intake in the range of 1.2 -
1.5 g · kg-1 day-1 accompanied by exercise training three times weekly for 24 weeks may have the 
potential to improve older adults body composition and physical function (Table 3.1). Apart from 
the total protein intake it is important to administer one meal during the day with a protein content 
high enough to optimally stimulate muscle protein synthesis either after the exercise training or 
before sleep. Pre-sleep ingestion of protein may offer additional benefit by utilizing the overnight 
hours during which net protein balance usually does not benefit muscle tissue accrual. The lifestyle 
intervention can be supplemented with vitamin D to avoid confounders related to low serum 
25(OH)D and ensure adequate calcium absorption. An outline of the strengths and rationale of the 
present protocol is presented in Appendix 3.  
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Table 3.1 Proposed protocol for a dietary and exercise interventions in Scottish older 
adults with sarcopenic obesity.  
 Dietary protocol Exercise protocol 
(common for both groups) 
Intervention  
(exercise + diet: 
EXD)  
 500 kcal caloric deficit 
 ~1.5 g protein · kg bw-1 
 Protein supplementation 
(50g milk protein day-1) 
post-workout or before bed 
on the non-exercise days.  
 ~70 μg Vitamin D3 week-1  
 Three hourly sessions 
weekly 
 Resistance, balance, aerobic 
and flexibility exercises of 
low-to-moderate intensity.  
 Progressive increase in 
resistance, complexity and 
speed of contraction, starting 
with seated bodyweight and 
moving onto increased 
resistance using elastic 
bands. 
 
Control  
(exercise only: 
EX) 
 
 Habitual diet  
 ~70 μg Vitamin D3 week-1 
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3.2 Assessment methods   
Designing lifestyle interventions requires the existence of methods/tools able to detect and 
measure changes in the desired outcomes with sufficient validity and reliability. In the context of 
ageing muscle, the advancements in technology have provided scientists with diverse tools and 
techniques to measure the size/ mass of the different body compartments, and in particular skeletal 
muscle and fat mass. Furthermore, the body’s functionality and capacity to perform physical tasks 
is a crucial aspect affecting the life quality of individuals. Especially in older age where a certain 
degree of decline in physical performance is expected, maintaining high levels of strength and 
functionality is paramount. Therefore, in this section an analysis of the reliability, validity and 
practical differences of the main methodological approaches to measure changes in body 
composition, muscular strength and physical function is provided.      
 
3.2.1 Body composition 
In the past years many initiatives have taken place in order to reach a consensus for the definition 
of sarcopenia and sarcopenic obesity (Baumgartner and Waters 2006; Cruz-Jentoft et al. 2010; 
Donini et al. 2013). Depending on the definition criteria, the methodological approach and the 
tools to assess body composition can change. These tools can offer different methodological 
robustness (reliability and validity) and practical applications. This section will discuss the 
properties of key scientific tools and methodologies to measure body composition changes, 
particularly in muscle and fat mass. Moreover, the feasibility and practicalities of such tools will 
be evaluated especially in the context of measuring body composition changes in community-
dwelling older adults.    
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Although, the use of body mass index (BMI) is used widely to classify obesity, it is not sensitive 
in identifying high adiposity (Okorodudu et al. 2010). Particularly a BMI ≥ 30 kg·m-2 is likely to 
mask sarcopenia in older people (Newman et al. 2003a). A meta-analysis by Okorodudu et al. 
(2010) concluded that BMI failed to detect half of the cases of adults with a high percentage body 
fat (%BF). Not only does body mass index underestimate body fatness, it also fails to provide any 
information about the distribution of fat (Villareal et al. 2005). For any given BMI, women are 
more likely to express higher adiposity than men (Gallagher et al. 1996) and Asians than 
Caucasians (Chung et al. 2013). Similarly, individuals with low muscle mass will have by 
definition a higher percent body fat compared with their healthy counterparts for a given BMI. 
Therefore, since the current study focuses on older adults with low muscle mass, the use of BMI 
as the only obesity criterion would not be suitable. An appreciation of the importance of the 
different physiological characteristics of people with similar BMI but different levels of adiposity 
is presented in figure 3.1. 
 
Two of the ‘gold-standard’ methods to measure body fat and muscle mass are magnetic resonance 
imaging (MRI) and computed tomography (CT) since they have the advantage of calculating 
segmental and total muscle mass, as well as discriminate between visceral and subcutaneous 
adipose tissue (Van der Kooy and Seidell 1993; Sampaio et al. 2006; Malafarina et al. 2012). They 
can also assess the degree of fat infiltration in the muscle tissue, which is a valuable indicator of 
muscle quality, especially in the ageing muscle (Marcus et al. 2013). Although MRI and CT are 
considered valid and reliable for the assessment of body composition they are not used routinely 
to detect sarcopenic obesity firstly due to the high cost and secondly because they require 
specialised software and highly-trained staff. Moreover, they are time-consuming and not easily 
accessible as patients are required to travel to the test centre. Therefore, it is not of high practical 
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value for field studies. In addition to these, another key limitation of CT is the considerable amount 
of exposure to radiation for the patients (Sampaio et al. 2006).     
 
Dual-energy x-ray absorptiometry (DXA) has been routinely used for the assessment of bone 
mineral density and the detection of osteoporosis. In the past years its applications have been 
expanded to a 3-compartment (bone, fat and lean mass) model of body composition assessment. 
It takes only 3 minutes for a whole-body scan and the amount of exposure to radiation is only 
minimal. One of its biggest limitations, that can especially affect obesity interventions, is that the 
thickness of the scanned body part may affect the measurements (Schoeller et al. 2005). This can 
result in systematic differences between obese and lean individuals, or in errors between serial 
measurements in people trying to gain or lose weight. Moreover, the presence of bones and/or 
calcification of soft tissues, e.g. in the aortas of older adults, can negatively affect the results of a 
regional soft tissue analysis (Lee and Nieman 2007). Although it is cheaper than CT and MRI it 
is neither sufficiently affordable nor easily accessible to the general public to be used as a routine 
tool for the detection of sarcopenic obesity. Therefore, it is mainly used for research purposes in 
clinical settings or university labs. 
 
Bioelectrical impedance analysis (BIA) is a popular, non-invasive and quick technique in 
measuring body composition. A BIA device creates an electrical current that passes through the 
body. The device can measure the resistance (created by the non-conducting tissues and mainly 
fat) of the body to the current. The resistance value is used to calculate body-fat and fat-free mass. 
BIA is a reliable instrument to measure total body water (Lee and Nieman 2007), however, its 
ability to estimate fat-mass, fat-free mass and skeletal muscle mass depends heavily on the 
regression equation used (Haapala et al. 2002). Another weakness of BIA is the assumption that 
participants are normally hydrated, however this may not be the case in individuals who, prior to 
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the assessment, have consumed alcohol, have exercised or taken drugs that can affect the water 
and electrolyte balance of the body (such as diuretics). However, if a standardized protocol is used 
along with a regression equation developed for a specific population group, BIA can be a 
convenient and reliable instrument with high concurrent validity  for the assessment of body 
composition in young and older adults (Janssen et al. 2000; Lee and Nieman 2007; Mijnared et al 
2013). One of the most reliable equations for the estimation of skeletal muscle mass by BIA was 
produced by Janssen et al. (2000) who cross-validated the BIA results of 388 men and women 
aged 18-86 years of age against their MRI-derived results and reported an r2 of 0.86 and a SE of 
the estimate (SEE) of 2.7 kg in Caucasians, Hispanics and African-Americans.  
 
Other body-composition assessment techniques that could be performed at a patient’s home or at 
non-clinical environments include calf and mid-upper arm circumference as well as skinfold 
thickness. Although these tools are portable, non-invasive and practical, they have shown a low 
association with DXA and are not highly recommended for older individuals if other more reliable 
equipment is available (Haapala et al. 2002; Rolland et al. 2003). However, anthropometrical tools 
can provide scientists with useful information, such as an estimation of fat distribution. It is well 
documented that abdominal fat (subcutaneous, visceral and intrahepatic) which is a risk factor for 
metabolic diseases and insulin resistance, increases with age (Beaufrere et al. 2000). When a cross-
sectional analysis technique for the measurement of abdominal fat is not available for field studies 
then simple anthropometric methods can be used, such as the sagittal abdominal diameter (SAD). 
The sagittal abdominal diameter test involves a simple anthropometric measurement (in a seated 
or supine position) that has been associated with cardiometabolic risk factors (Pouliot et al. 1994; 
Iribarren et al. 2006; Sampaio et al. 2007; Anunciacao et al. 2014). It has a high validity in 
identifying abnormally high abdominal fat that may pose a health risk when compared against CT 
(r=0.80, p<0.001 in women and r=0.64, p<0.001 in men) and MRI (standing SAD vs MRI: r=0.94, 
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p<0.001, supine SAD vs MRI: r=0.93, p<0.001), and high reliability (intra-class coefficient of 
0.99) (Van der Kooy et al. 1993; Sampaio et al. 2007). Standing SAD is positively associated with 
age, blood cholesterol, hypertension and type II diabetes, and inversely associated with education 
(Iribarren et al. 2006). When adjusted for age and race, a SAD of ~26 cm can increase the hazard 
ratio HR (95%CI) of coronary heart disease by 1.70  (1.57, 1.83) in men, and 1.79 (1.63 - 1.96) in  
women (Iribarren et al. 2006). This is in agreement with Pouliot et al. (1994) who has proposed 
cut-offs of SAD > 25cm being indicative of an increased risk for atheromatic metabolic disorders, 
and related to increased fasting and insulin concentrations. A cut-off of ~25 cm for standing SAD 
may also indicate an increased age-adjusted risk of sudden death [(RR(95%CI): 4.1 (2.0-8.3), 
p<0.001], as noted in a study with middle aged French men (43 – 52 yr; n>7,000) who were-
followed up for 23 years (age at follow-up assessment 66-75 yr) (Empana et al. 2004). The relative 
risk for sudden death remained significant [2.6 (1.0 to 6.7)] even after further adjustments for 
smoking, blood pressure, trunk subcutaneous fat, type II diabetes and plasma cholesterol 
concentrations. Other studies have suggested that even lower cut-offs of ~ 20 cm may predict 
increased risk of CVD (Sampaio et al. 2007; Riserus et al. 2010), however these studies measured 
SAD in a supine position which is known to depress abdominal fat due to gravity, which may 
explain the lower cut-offs (Sampaio et al. 2007). Finally, SAD has been used to assess changes in 
abdominal adiposity in older women undergoing a weight-loss programme (Mazzali et al. 2006) 
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Figure 3.1 Differences in skeletal muscle mass (light grey) and adipose tissue (subcutaneous 
and intermuscular; black outer tissue) between three men of similar bodyweights. MRI 
images depict skeletal muscle architecture in young (A), old-inactive (B) and old-active (C) males. 
The white tissue in the middle represents the bone. IMAT, intermuscular adipose tissue; LM, lean 
mass; FM, fat mass.  
[Adapted by McLeod et al. (2016) and used under the terms of the Creative Commons Attribution 
4.0 International License found at http://creativecommons.org/licenses/by/4.0 , changes have been 
made to the text, and colours of the cross-sectional images). 
   
3.2.2 Strength/function 
The loss of muscle function has been included in the consensus for the definition of sarcopenia by 
the International Working Group on Sarcopenia (IWGS) and the loss of muscle strength and/ or 
physical performance in that of the European Working Group on Sarcopenia in Older People 
(EWGSOP). Therefore, assessing strength and function/performance is very important in older 
age. There are various methods available to measure strength, including but not limited to: chest 
press, leg press, pull down, handheld dynamometry, isokinetic dynamometry, knee 
flexion/extension and vigorometer, whereas some of the most popular tests for function are gait 
Physically inactive 
kg 
kg 
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speed, functional reach, the Fullerton functional fitness test, the Short Physical Performance 
Battery test (SPPB), sit-to-stand, stair climb and the timed up and go test (Cruz-Jentoft et al. 2010; 
Mijnared et al. 2013).  
 
The timed ‘Up and Go’ (TUG) test is a quick tool for the assessment of functional mobility in 
older adults (Podsiadlo and Richardson 1991). It does not require any special equipment or training 
to perform and is reliable with good intra-rater and inter-rater variability. It is highly associated 
with the Barthel Index of ADL (r=0.78) and can predict the ability of an older individual to go 
outside safely (Podsiadlo and Richardson 1991). The use of TUG test has been recommended by 
the American and British Geriatric societies as a screening tool for falls (Panel on Prevention of 
Falls in Older Persons 2011) and by the National Institute of Clinical Evidence (NICE) for the 
assessment of balance in the falls prevention guidelines for older adults (NICE 2013). 
Interestingly, TUG is not just a simple functional mobility test but it is also associated with slow 
cognitive processing speed and executive function (Donoghue et al. 2012), as well as cognitive 
impairments and poor motor control due to asymptomatic brain atrophy or cerebrovascular 
damage (Kose et al. 2016).  
 
The SPPB test includes three simple tests, 1) gait speed, 2) static balance and 3) five repeated chair 
stands (RCS), the results of which can reliably predict institutionalisation and mortality rates 
(Guralnik et al. 1994; Cooper et al. 2010). Older individuals with low SPPB scores (≤ 10) at 
baseline had a higher risk of mobility limitations, and in particular loss of the ability to walk a 
distance of 400m after a 3-year follow up (Vasunilashorn et al. 2009). Moreover, poor 
performance in SPPB has been associated with abnormal pulmonary function and therefore, SPPB 
can be potentially used as an early screening tool for the prediction of impairments in pulmonary 
function in older age (Choi et al. 2012). The gait speed test in SPPB has been previously suggested 
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to independently predict risk of falls, decline in function and health, hospitalization and mortality, 
both in well-functioning older adults and in older clinical populations (Cesari et al. 2005b; 
Studenski et al. 2003). Similarly, the RCS test is a quick and reliable test for the assessment of 
lower limb strength with excellent intra-rater, inter-rater and test-retest reliability in healthy older 
community-dwellers and stroke survivors (Bohannon 2007; Mong et al. 2010). It can also predict 
the risk of recurrent falls in community-dwellers ≥65 years (Buatois et al. 2008). When the RCS 
test was compared against other tests such as the 6-meter walk, the half-turn or the pick-up-weight 
test, it was found to be the best in terms of predictive validity and feasibility (Tiedemann et al. 
2008). 
 
Although lower extremity strength may be more important for functional abilities than upper body 
strength (Samuel and Rowe 2012), grip strength is one of the few tests that has consistently shown 
high intra-rater and inter-rater reliability as well as high construct and concurrent validity 
(Mijnared et al. 2013). Additionally, low hand grip strength has been associated with increased 
risk of falls (Sayer et al. 2006), disability (Rantanen et al. 1999), increased length of hospitalization 
(Kerr et al. 2006), low health-related quality of life (Syddall et al. 2005) and increased risk of 
mortality (Laukkanen et al. 1995). Apart form reliability, the main advantage of handgrip 
dynamometry compared to other strength tests is that it is portable and can be performed quickly 
at any setting (clinical or non-clinical) without the need for large equipment or specialized 
computer software.  
 
One other important aspect of function is balance (static and dynamic). Whereas the tandem 
balance test in SPPB provides an indication of static balance capacity, the 1-arm functional reach 
is a screening tool for dynamic balance, which is equally important in older adults (Cech and 
Martin 2012). The functional reach test can detect impairments in balance or changes in balance 
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performance and is a reliable, precise, quick and portable screening tool for the margin of stability 
in older adults (Duncan et al. 1990).  
 
In summary, although the assessment of concurrent validity is disadvantaged by the lack of gold 
standards when assessing muscle strength and performance, it has been suggested that handgrip 
strength and SPPB are two valid and reliable tools for the assessment of strength and physical 
performance in older community-dwellers. Finally both TUG and the functional reach test are 
quick and reliable functional-balance and mobility tests that have been used consistently as 
screening tools for the prediction of falls and mobility performance in older populations. 
 
3.2.3 Quality of life   
One of the main aims of researchers is to promote physiological adaptations that can be eventually 
translated into a better sense of well-being. Therefore, the goal of many intervention studies is to 
help people improve their health-related quality of life (HRQoL). For example, the benefit of 
increasing the size of the knee extensor and flexor muscles for an older individual is of minor 
practical significance if it is not accompanied by an increment in some or all of the fitness 
components such as strength, power, agility, muscular endurance, cardiovascular endurance, 
which may eventually translate into better balance, co-ordination, physical function and ability to 
perform everyday activities. These aspects will affect the individual’s perception of his/her life 
quality.  
 
One of the most valid and reliable tools to measure HRQoL is RAND 36/ SF-36. It has been 
translated, modified and adopted by researchers and clinicians in 45 countries (Hays and Morales 
2001). The test has good construct validity and internal consistency (Lyons et al. 1994). It takes 
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only 7-10 minutes to complete, and has been used in studies assessing quality of life in older 
individuals with a wide range of conditions, from independent-living community-dwellers to 
hospitalised patients (Hays and Morales 2001). It takes into account eight health-related concepts: 
physical functioning, limitations related to physical health issues or emotional problems, social 
functioning, energy and fatigue, emotional well-being, health perceptions, pain and a single item 
on changes in perceived health over the last year.  
 
3.3 Summary 
In summary, findings from published studies favour the use of a dairy product with a high-protein 
content alongside a moderately hypocaloric energy intake in order to promote fat loss while 
accruing skeletal muscle tissue. Vitamin D is a micronutrient of vital importance for calcium 
absorption, bone health and potentially physical function of older adults, especially in countries 
with low levels of exposure to sunshine. Exercise training has been consistently found to be 
beneficial for many aspects of physical function and should be included in every lifestyle. 
Therefore, the current protocol proposed the use of a commercially available liquid dairy 
supplement with a high content of milk protein (~50 g) to ensure at least one meal per day has 
adequate protein to achieve ‘optimal’ muscle protein synthesis. That meal could be consumed after 
the exercise session, or before bed on the non-exercise days. The high-protein milk could also aid 
in increasing the total daily intake of protein to 1.2 – 1.5 g protein · kg bodyweight-1 during a 
hypocaloric diet (~500 kcal deficit). A realistic exercise programme employing affordable 
equipment (elastic bands) and exercises (bodyweight, resistance, flexibility and balance) that can 
be easily replicated in a community setting, was also employed. The assessment protocol has been 
designed for field studies, without however, compromising validity. Biolectrical impedance 
analysis can measure changes in muscle and fat mass, while practical tests requiring a minimum 
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amount of equipment can measure changes in physical function (hand-grip dynamometry for 
strength, timed up-and-go for functional mobility, SPPB for overall physical function, 1-arm reach 
for dynamic balance), and the SF-36 questionnaire can measure quality of life. The detailed 
methodology is presented in the following chapter. 
 
 
139 
 
Chapter 4. Methods: A cross-sectional assessment of body 
composition and a 16-week intervention programme combining a 
high-protein hypocaloric diet with a mixed exercise regimen for 
Scottish older adults with low muscle mass and high fat mass.  
 
In this chapter the detailed methodology of the research study is presented. The first stage of the 
study included a screening test (one-off assessment) of community dwellers aged 65 years and 
older. The main purpose of the test (denoted as Screening (Test 1) in Figure 4.1) was to assess 
body composition and strength. Bioelectrical impedance analysis and handgrip dynamometry 
were the main tools used to measure fat/muscle mass and strength, respectively. The data collected 
from the screening test were used to determine the presence of sarcopenia, obesity and sarcopenic 
obesity. Furthermore, the screening sessions allowed the researcher to identify eligible participants 
for the intervention study. A brief outline of the intervention follows in the next two paragraphs, 
with more details presented in section 4.5.2 and 4.5.3.  
 
Those participants who met the inclusion and exclusion criteria for a high percentage of body fat 
and a low amount of muscle mass during Test 1, were allocated to an exercise-only group (EX; 
control) or an exercise and diet group (EXD; intervention). The duration of the intervention 
programme was 16 weeks and involved group exercise classes of low to moderate intensity (three 
classes weekly) combining different exercise modalities, which were the same for both groups. 
The diet in EXD provided a daily energy deficit (≤500 kcal) and a high protein intake relative to 
participants’ bodyweight (1.2 – 1.5 g protein · kg bw-1 · day-1). A commercially available milk-
based oral supplement rich in protein content (50 g milk protein per 500 mL serving) was 
administered once daily to assist the EXD group achieve the desired protein intakes.  All 
participants received supplemental Vitamin D3 (25 μg three times weekly) regardless of their 
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group allocation. The primary outcomes (body composition, strength and function) were assessed 
at baseline, week 10 and end of week 16, whereas secondary outcomes such as dietary intakes and 
health related quality of life were assessed at baseline and at the end of week 16.      
 
It is important to note here that the initial plan included the delivery of a 20-week intervention 
study with measurements taken at baseline, week 10 and week 20. However, due to 
methodological challenges (slow recruitment phase and hesitation of participants to commit to a  
20-week programme), this was amended to a 16-week programme. When that decision was taken, 
two participants had already successfully completed 10 weeks of the programme and therefore 
had already undergone all measurements as per initial plan (at baseline and week 10). As a result, 
it was decided to keep the same time-plan for the first 10 weeks, with all measurements taken at 
baseline, week 10 and week 16 to ensure that all participants received the same treatment and were 
assessed at the same time points. Moreover, the inclusion criterion for sarcopenia was initially low 
skeletal muscle index combined with low strength, however, this criterion was amended to low 
muscle mass only, in order to improve recruitment rates for the intervention. This amendment 
occurred at the same time point as the change in total study duration (i.e. from 20 weeks to 16). 
The challenges related to the methodological design and implications will be discussed in detail 
in Chapter 8.  
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Figure 4.1 Study timeline and testing protocol. BIA: Bioelectrical Impedance Analysis, BMI: 
Body Mass Index, BP: Blood Pressure, HR: Heart Rate, MoCA: Montreal Cognitive 
Assessment, SAD: Sagittal Adipose Diameter, SPPB: Short Physical Performance Battery test. 
Week-1 assessments were conducted on any day of the two weeks preceding the initiation of the 
16-week programme, whereas week 0 was a day of the week preceding week-1.  
 
4.1 Population Characteristics - Inclusion and Exclusion criteria  
Independent-living community dwelling adults from Lothian, Scotland, aged 65 years or older, 
and without a pacemaker, were eligible to participate in the screening visit. The exclusion of 
pacemaker-users was communicated to potential participants via email/phone enquiries and in the 
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study’s information sheet, so that potential participants with pacemakers were informed before 
visiting the research premises. Eligible participants for the intervention study needed to have the 
physical, psychological and cognitive capacity to follow simple dietary plans/ advice and 
participate in regular and structured group exercise classes. The specific inclusion cut-offs for the 
intervention study were i) age ≥ 65 years, ii) percent body fat (%BF) ≥ 28% in men and ≥ 40% in 
women (Baumgartner et al. 2004), (iii) skeletal muscle index (SMI) ≤ 10.75 kg m-2 in men and ≤ 
6.75 kg m-2 in women, and (iv) score ≥ 26 out of 30 in the cognitive assessment test (see section 
4.5.1.5 Cognitive Assessment Test). The SMI cut-offs were based on the cut-offs published by the 
European Working Group on Sarcopenia in Older People (EWGSOP; the cut off scores are 
presented in more detail in the following section 4.5.1.1 Assessment of sarcopenic obesity) (Cruz-
Jentoft et al. 2010). Initially, a low handgrip strength score was also used as an inclusion criterion 
(< 20 kg in women, and < 30 kg in men; Laurentani et al. 2003) however, this was later amended 
to allow for a greater number of participants in the study due to slow recruitment rates (discussed 
further in Chapter 8).  
 
Exclusion criteria for the intervention study included self reported lactose intolerance, Parkinson’s 
disease, uncontrolled pain, severe osteoporosis or arthritis, use of corticosteroids, history of  
pulmonary embolus or myocardial infarction within the previous two years, heart disease, chronic 
obstructive pulmonary disease, chronic kidney disease, hypertension (resting systolic pressure 
>200mmHg or resting diastolic >100mmHg), acute systemic illnesses or any other uncontrolled 
physical, psychological, mental or cognitive impairment that would either prohibit adherence to 
the study protocol or would significantly increase health risks for participants.  
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4.2 Recruitment 
Printed material was distributed to potential participants and community groups in the greater area 
of Lothian and in particular, Edinburgh, Musselburgh, Haddington, Dunbar and North Berwick. 
Posters, leaflets and information sheets providing details about the study were distributed at places 
commonly visited by older individuals. Public libraries, community settings, local markets, social 
events and exhibitions for older people were mainly targeted for recruitment. The researcher 
booked an exhibitor’s stall at three separate events for older people in order to advertise the project 
and attract further public attention. Namely, the ‘Spring Fling 2015’, ‘Mix & Mingle 2015’ and 
‘Live Well in Later Life 2015’ fairs were attended. Moreover, announcements were placed in local 
newspapers, community newsletters, social media and internet websites in the form of a press 
release, adhering to QMU research recruitment guidelines. Additional contact was made with the 
following organisations for recruitment purposes: the ‘Ageing Well’ association in East Lothian 
and Edinburgh, the ‘University of 3rd Age’, ‘Age Scotland’, ‘Generations Working Together’, 
‘Community connect’, ‘Changes’, ‘Edinburgh Health Forum’, ‘East Lothian Community Care 
Forum’, ‘Living it up’, the ‘Hollies’ Day Centre in Musselburgh and the Rotary clubs in 
Musselburgh and Haddington. 
 
4.3 Study Design 
The first part of the study included a cross-sectional assessment of body composition and strength 
in older Scottish adults (Screening / Test 1; Figure 4.1). Older adults aged 65 years or older were 
invited to visit the research labs via recruitment strategies, as explained in more detail in section 
4.2. That screening test involved a single session for each participant and took place at Queen 
Margaret University. The tests conducted during the screening visit were used to assess prevalence 
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of low strength (dynapenia), low strength combined with low muscle mass (sarcopenia), obesity 
(high %BF) and sarcopenic obesity, and to identify participants for the intervention study.  
The intervention study was a randomised control trial (RCT) that took place at Queen Margaret 
University, (QMU) Edinburgh. Eligibility of the study participants was based on the results 
obtained during the screening test (Figure 4.1). If eligibility was confirmed, participants were 
allocated into either an exercise only group (EX), acting as a control, or an exercise and diet (EXD) 
group (intervention group). The two groups were stratified for sex and age (<75y and ≥75y). 
Stratification was achieved by the method of minimisation (Altman and Bland 2005), using a 
Microsoft Excel spreadsheet and an allocation algorithm designed by a statistician independent of 
the study. For minimisation purposes, a 75% element of chance was implemented. That is, every 
new participant had a 75% chance of being allocated into that group that would minimise the 
imbalances in group sizes and characteristics (in order to stratify for age and sex). When the total 
number of participants in the groups was the same (e.g. when the very first participant enrolled 
and all group sizes were equal to zero), the allocation was done based on a 50% chance of being 
allocated to either of the groups.  
 
4.4 Ethical approval 
This study was conducted in accordance with the Declaration of Helsinki ‘Ethical Principles for 
Medical Research Involving Human Subjects’ (World Medical Association 2013) and ethical 
approval was granted by the local (QMU) Research Ethics Committee (REC). Information sheets 
detailing the necessary information about the nature of the study were handed out to participants 
at least 24 hours prior to obtaining written consent. Written consent was then obtained by all 
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participants, however, participants were free to withdraw from the study at any time without the 
need to provide justification.  
 
All data were anonymised and kept in a secure location, according to the Data Protection Act 
(1998) and the local QMU policy. The contact details of individuals were separated from the rest 
of the data and were securely stored in a separate locked cabinet to ensure that none of the sensitive 
data related to this study could be identifiable and traceable. All collected data were also duplicated 
in an electronic form (with no traceable contact details) and were stored in a password-protected 
computer. The data collection commenced in October 2014 and was completed in May 2016. 
 
4.5 Outcome Measures 
4.5.1 Screening (Test 1, observational data)  
4.5.1.1 Assessment of sarcopenic obesity  
The criteria proposed by the EWGSOP were used for the classification of participants with low 
muscle mass based on low skeletal mass index (SMI; skeletal muscle mass over squared height). 
Obesity was not identified based on body mass index (BMI) but by percent body fat (%BF).  The 
cut-offs were sex-dependent. Namely, the cut-off for obesity in men was ≥ 28%, whereas in 
women ≥ 40% (Baumgartner et al. 2004). The %BF values were derived directly from the BIA 
device.   
Nevertheless, the BMI of participants was measured and is presented in Chapter 6. The BMI cut-
offs are underweight: BMI <18.5;  normal: 18.5 ≤ BMI ≤ 24.99; overweight: 25.0 ≤ BMI ≤ 29.99; 
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Class I obesity: 30.0 ≤ BMI ≤ 34.99; Class II obesity 35.0 ≤ BMI ≤ 39.99; Class III obesity: BMI 
≥ 40 kg m-2. 
 
Height was measured using a portable stadiometer (Seca 217 Stable Stadiometer, Seca, 
Birmingham, UK) after a maximum inhalation to the nearest 0.1 cm, and weight by a calibrated 
digital weighing scale (Seca 875 Class III, Seca, Birmingham, UK) to the nearest 0.1 kg, after 
shoes and heavy clothing were removed (International Society for the Advancement of 
Kinanthropometry 2001). Participants were asked to wear light and comfortable clothing that 
would not restrict movement on the assessment days.  
 
BIA  
Skeletal muscle mass (SMM), SMI and %BF were assessed using a dual-frequency (5 and 50Hz) 
Bioelectrical Impedance Analysis device (BodyStat 1500MDD, Bodystat ltd, Isle of Man, British 
Isles). Participants were asked to remove clothing with metal appurtenances and jewellery as well 
as their right sock (or stockings/tights) and lie in a supine position for five minutes prior to the test 
(Cote et al. 2014). They were asked to refrain from alcohol consumption, use of sauna and rigorous 
exercise 24 h prior to their visit. All BIA tests were performed in the morning, at approximately 
the same time for each participant ~ 9-11 am. The testing procedure for the assessment of body 
composition was performed according to the manufacturer’s guidelines. 
The equation used to calculate skeletal muscle mass (SMM) was that of Janssen et al. (2000);  
SMM (kg) = [(height2/R x 0.401) + (sex * 3.825) + (age x -0.0710)] + 5.102 
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where height is measured in centimetres, R is the resistance in Ohms, age in years and sex: women 
= 0 and men = 1. Skeletal muscle index (SMI) was derived from the formula SMI= SMM · height-
2 (kg·m-2). Sarcopenia was indicated by a SMI ≤ 10.75 kg·m-2 in men and ≤ 6.75 kg·m-2 in women 
(Janssen et al. 2004).  
 
4.5.1.2 Sagittal Abdominal Diameter 
Sagittal abdominal diameter (SAD) was measured to the nearest millimetre using large sliding 
calipers (Rosscraft, Surrey, Canada) with the participant adopting a relaxed standing position with 
a normal breathing pattern and the arms folded across the chest. After following two normal 
breathing circles of the participant, the researcher took the measurement at end-tidal expiration. 
The measurement was taken horizontally at the site of the abdomen with the maximum anterior 
extension, inferior to the umbilicus. If however, the level of umbilicus was lower than the 5th 
lumbar spinal process, then the measurement was taken starting from the base of the lumbar 
spinous process presenting the greatest curvature to the corresponding point of the abdomen (the 
full protocol has been presented previously by Marfell-Jones et al. 2012).  
 
4.5.1.3 Handgrip strength 
A hydraulic handheld dynamometer (Takei 5001, Niigata City, Japan) was used to measure 
maximum hand grip strength to the nearest 0.5 kg. Participants were asked to press the 
dynamometer with the dominant hand and were encouraged to keep pressing it for 3-5 seconds as 
forcefully as possible with the elbow flexed at a 90° angle (Cote et al. 2014). That action was 
performed for a total of three times with a 30-sec rest period between the trials. All values were 
recorded but only the maximum value was used in further analysis. The hand grip strength 
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assessment was based on a standardised protocol recommended by Roberts et al. (2011). Although 
a handgrip score of <20 kg and <30 kg, in women and men, respectively, would denote low 
strength (i.e. dynapenia), handgrip strength was not used as an inclusion criterion for the 
intervention study. 
 
4.5.1.4 Blood pressure and heart rate  
Blood pressure and resting heart rate were measured using an electronic monitor (OMRON MX2, 
Omron Corporation, Kyoto, Japan) on the left arm after a 15 min rest (Tang et al. 2013). A 3-
minute interval was allowed between each successive measurement according to the 
manufacturer’s guidelines (Omron 2004), for a total of 3 measurements.  
 
All anthropometrical tests (height, weight, SAD) as well as blood pressure and heart rate 
measurements were taken in triplicate and the mean values were used for analysis.  All the 
aforementioned variables were measured in the morning and tests took place on a day of week -1 
(figure 4.1), and subsequently for those who took part in the intervention study in week 10, and 
finally upon completion of the 16-week period (figure 4.1).  
 
4.5.1.5 Cognitive Assessment Test 
A cognitive status assessment was conducted only once, as a screening test before the start of the 
intervention trial to identify participants who scored below the cut-offs for normal cognitive 
function (Malafarina et al. 2013). The test used was the Montreal Cognitive Assessment (MoCA© 
Version 7.3) developed by Nasreddine et al. (2005). The test includes 11 questions and takes 
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approximately 10 minutes to complete. It assesses several domains of cognitive function including 
memory, concentration and attention, vigilance, orientation, executive functions and conceptual 
thinking. The maximum score that can be achieved is 30 and the cut-off value for inclusion in the 
present study was ≥ 26, which is indicative of normal cognitive function according to the 
developers of the test (Nasreddine et al. 2005).  
 
4.5.2 Randomised Control Trial: Test 2, 3 and 4. 
The second visit (test 2, Figure 4.1) was attended only by those who met the criteria for 
participation in the RCT study. During test 2 physical function, quality of life, and dietary 
patterns were assessed, and blood samples collected. All tests conducted during test 1 and 2 
were repeated following the same exact methodology in week 10 (test 3) and at the end of 
programme (test 4), with the exception of the cognitive test, the dietary assessment, quality of 
life and blood collections. The cognitive test was performed only at baseline, and the remaining 
three were performed at baseline and at the end of week-16 (Figure 4.1).  
 
4.5.2.1 Short Physical Performance Battery (SPPB)  
Physical performance was assessed using the Short Physical Performance Battery test (SPPB; 
Guralnik et al. 1994). The three components of the SPPB are 1) balance, 2) gait speed and 3) five 
repeated chair stands. The tests were always performed in this order. The maximum score for each 
of the tests was four points, with 12 points being the maximum score for the overall test. If a 
particular test could not be performed then the score achieved for that test was zero.  A full copy 
of the detailed protocol guidelines and operationalisation has been previously published by 
Shumway-Cook and Woollacott (2007). 
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The balance test involved three different variations, the side by side stance, the semi-tandem and 
the full-tandem stance, trying to maintain each position for 10 or more seconds without making 
any steps or losing their balance. The researcher would initially demonstrate each position and if 
needed he would support the participants to adopt the required stance until they were confident 
they could independently maintain the position. The balance test was performed only once.   
 
For the walking speed test, participants were asked to walk at their normal walking pace for a 
straight predesignated course. Two marks were placed on the floor eight ft (2.44 m) apart from 
each other. Participants would start from a standing position behind the first mark and were 
instructed to walk past the second mark. This was done to ensure that participants maintained a 
steady speed throughout the course without slowing down before reaching the second mark. A 
stopwatch was used to record the time. The timing would start upon the participant’s first step and 
would stop when the participant’s foot would land on the floor after the second mark. The 
instructions participants were given were ‘I want you to walk at your normal walking pace, 
imagine that you walk down the road to go to a store’ and ‘when you are ready you will start 
walking from this mark until you have walked past the final mark’ .  They were allowed to use a 
walking aid if needed. They performed the test twice and the faster of the two was used for further 
analysis. Before the actual recording of the test they were instructed to walk up and down the room 
three times at their usual speed.  
 
The third and final task tested ability to rise from a straight-backed chair for five consecutive times 
in the quickest possible time. They were not allowed to use their arms to rise; instead they were 
instructed to fold their arms across the chest. After they had received a demonstration from the 
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researcher, they were asked to perform one repetition with correct form to ensure that they were 
able to get up from the chair unassisted and to familiarise themselves with the task. If they were 
able to perform that, after a 30sec break they were asked to complete five chair stands as fast as 
possible maintaining the same stance with the arms folded across the chest.  
 
4.5.2.2 Dynamic Balance  
The 1-arm functional reach test was developed by Duncan et al. (1990) to assess dynamic balance 
and the full protocol has been described previously (Duncan et al. 1990; Rehabilitation Measures 
Database 2010). Participants were asked to adopt a comfortable upright stance with their right 
shoulder perpendicular to a wall (but without touching it) and their feet shoulder-width apart. A 
tape was then fixed on the wall at the participant’s acromion height and parallel to the floor. 
Participants were instructed to raise their right arm until it is parallel to the tape (with their shoulder 
flexed at 90°), and close their fist so that the assessor could record the position of the 3rd metacarpal 
on the tape. Following this, the assessor instructed them to reach as far forward as comfortably 
possible keeping their right fist closed and next to the wall-affixed tape, without making a step or 
losing their balance. The final position of the 3rd metacarpal was recorded again. The distance 
covered between the initial and end position of the 3rd metacarpal was recorded in cm (Duncan et 
al. 1990; Kage et al. 2009) (Appendix 4.3). This was repeated 3 times, with a 1-min break between 
the trials. The mean value of the three attempts was calculated and used for analysis.    
 
4.5.2.3 Functional Mobility  
A timed get-up-and-go 6-m test was used to measure functional mobility. Participants were seated 
on a chair and on the command ‘go’ they tried to cover as fast as possible a pre-designated straight 
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distance of 3 meters and return back to the chair to adopt their initial seated position. The timing 
started on the command ‘go’ and was terminated when the back of the participant was in contact 
with the chair as described in more detail by Ramsbottom et al. (2004). The task was first 
demonstrated by the assessor and then the participants performed the test three times with one 
minute break in between the trials. The fastest time was recorded.  
 
4.5.2.4 Muscle quality  
Although muscle quality has been defined as muscle strength per unit of muscle mass, a single 
definition and diagnostic criterion has not been established yet (McGregor et al. 2014). In this 
study the definition of muscle quality was based on the operational criterion as presented by 
Barbat-Artigas et al. (2012), which is, handgrip strength measured by hand dynamometry (as 
described in 4.5.1.3) divided by skeletal muscle mass (calculated based on the BIA-derived 
equation by Janssen et al. (2004) as described in section 4.5.1.1). 
 
4.5.2.5 Quality of Life (Rand 36/ SF-36)  
Health related quality of life (HRQoL) was assessed using RAND-36/SF-36 questionnaire (RAND 
2014). Participants were asked to complete the questionnaire on two occasions; the first was before 
the commencement of the intervention and the second upon the completion of the project (Figure 
4.1). The scoring of the questionnaire was done according to the guidelines as detailed in the 
official website of the RAND Corporation (RAND 2014).  
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4.5.2.6 Collection and Storage of Blood Samples 
Blood samples were taken at baseline at week-0 and after the completion of the 16-week period 
(Figure 4.1). The researcher was trained according to the NHS procedures in adult phlebotomy. 
The blood was taken from the superficial veins of the arm, namely the cephalic, basilic or median 
cubital veins. A single-use safety butterfly 21 or 23 gauge needle and a single use VACUETTE© 
collection tube were used for the collection of the blood samples. Immediately after each sampling 
the needle was safely discarded in a sharps bin. Blood was collected into Serum Gel-coated red 
tubes and was left at room temperature for 30-60 minutes in order to coagulate, according to the 
‘Standard Operating Procedures for Serum and Plasma Collection’ published by Tuck et al. 
(2009). The room temperature, as well as the time period from collection to centrifugation, were 
recorded for every blood sample.  The blood samples were centrifuged at 3000 RPM at 4°C for 
10 minutes to separate the serum from the other blood components (clotting factors and cells). 
Serum was extracted using a sterile pipette and was inserted in Eppendorf tubes. The tubes were 
stored in accordance with the standard operational procedures at -80oC in a QMU laboratory 
freezer.  
 
The blood serum was collected by the primary researcher of the current study but analysed for 
high-sensitivity C-Reactive Protein (hsCRP; Immunoturbidimetry), blood urea [Enzymatic 
(urease)], creatinine (Enzymatic), Insulin-like Growth Factor-1 (IGF-1; Chemiluminescent 
immunoassay), alkaline phosphatase [ALP; Enzymatic (para-nitrophenyl phosphate)], thyroid 
stimulating hormone (TSH; Chemiluminescent immunoassay), and 25(OH)D (Liquid 
chromatography tandem mass spectrometry LC-MS/MS) by the NHS Greater Glasgow and Clyde 
(NHSGGC) Specialist Endocrine Laboratory.   
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4.5.2.7 Assessment of dietary intake, analysis, and estimation of energy needs 
Both groups were instructed to record their food intake for two weekdays and one weekend day 
to ensure that habitual intake was accurately recorded for a total of three days (week preceding the 
initiation of the exercise programme, denoted as week 0 in Figure 4.1). The 3-day diet diaries 
have been found to be reliable and valid in older populations free of cognitive impairments 
(Luhrmann et al. 1999). The diet diaries were collected twice. The first one was obtained before 
the initiation of the 16-week programme and the second during the last week (16th) of the 
programme. Written and oral advice were given to all participants about diet recording techniques 
and how to estimate and report the portion sizes of the consumed meals in terms of common 
household measures (Appendix 4.2). When participants had difficulties estimating and reporting 
their food portions, the photographic food atlas was used (Nelson 2002) to quantify the portions 
consumed. The researcher reviewed the recorded diet diaries, and if anything was unclear or 
missing, participants were asked to provide further clarification. Dietary analysis to estimate 
energy and nutrient intakes was done with the use of the commercially available dietary analysis 
software, Nutritics (Nutritics Limited, Dublin, Ireland).  
 
To estimate energy requirements in the EXD group, the basal metabolic rate (BMR) was estimated 
using the age and sex-specific Oxford equations produced by Henry (2005) and was multiplied by 
an individual physical activity level (PAL) factor (self reported by each participant) to calculate 
the estimated energy requirements (EER). Five hundred calories were subtracted from EER to 
produce a daily energy deficit that would allow for weight loss of approximately 0.45 kg (1.0 lbs) 
· week-1. An example of the calculations can be found in Appendix 4.3. It was expected that a 
155 
 
daily deficit of 500 kcal would result in a maximum loss of approximately 7.2 kg (16 lbs) of body 
weight over the 16-week intervention period.  
 
4.5.3 Intervention study protocol 
 
4.5.3.1 Diet and supplementation protocol 
The protein content of the diet (including the supplemental protein) was designed to achieve a 
protein intake of 1.2- 1.5 g · kg bw-1, which translates to approximately 25 - 30% of the daily 
energy intake (Josse 2011; Tang et al. 2013). The post-workout liquid supplement provided 50 g 
of protein, which was consumed outside the main meals and counted towards the targeted energy 
intake and relative protein intake. The contribution of dietary fats to the daily total energy intake 
(TEI) was estimated at 25-30%, and the remaining energy requirements were provided by 
carbohydrates (~40-45% TEI).  
 
Based on the desired relative proportions of energy derived from the different macronutrients and 
on the dietary preferences of the participants a diet plan was designed and given to each participant 
in EXD, using portion sizes/ servings in familiar units, (such as piece, spoonful, cup, or where 
necessary a metric amount was used, e.g. grams). Diet plans were aiming to include at least five 
portions of fruits and vegetables, minimise free sugar intake and consumption of processed foods. 
Vitamin D intakes were aided by the vitamin D supplement. An example diet plan can be found 
in Appendix 4.4. Alternative options with foods containing similar amounts of macronutrients 
were given based on lists of food exchange lists published elsewhere (Thomas and Bishop 2007; 
Josse 2011).  
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 The protein-rich milk supplement was Promilk50 (Myprotein©, The Hut Group Ltd, Northwick, 
UK). The nutritional breakdown is presented in Table 4.1 and the full amino acid profile in 
Appendix 4.5. Participants in the EXD group consumed one 500 mL bottle of milk supplement 
daily. On the exercise days they were instructed to consume one full serving after the workout.  
On non-exercising days they were encouraged to consume the supplement as a pre-sleep meal. A 
vitamin D3 tablet (Vitamin D, Sainsbury’s Ltd, London, UK) of 25 μg was administered three 
times a week for a weekly total of 75 μg. To monitor adherence to the diet/supplementation 
protocol all participants were given a notebook to note their supplement and vitamin intake (those 
in the EX group received only the vitamin D tablets) (example in Appendix 4.6). The supplements 
were given to the participants every other week with sufficient amounts provided to cover the 
subsequent two weeks of the programme. During the delivery of the protein/vitamin supplements, 
the participants had a short discussion with the researcher to address compliance and any potential 
issues with the dietary and/or supplementation protocol. Participants were given oral and written 
guidelines for a healthy diet (Appendix 4.7). If any deviations or concerns were raised from 
participants, adjustments were made to ensure that participants adhered to the protocol. For 
example, if participants found it difficult to comply with the portion sizes, they were advised to 
increase the portion of the salad/vegetables (Appendix 4.7). If participants wanted to consume 
foods that were not in the initial diet plans (e.g. alcoholic beverages) allowances were made 
without compromising the overall diet plan (Appendix 4.7).  
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Table 4.1 Nutritional Information of the milk-based supplement (Promilk 50).  
  Per 100ml Per Bottle (500ml) 
Energy 64 kcal/ 270 kJ 320 kcal /1350 kJ  
Fat 0.2 g 1.0 g 
  of which saturates 0.1 g 0.5 g 
Carbohydrate 5.2 g 26 g 
  of which sugars 5.1 g 26 g 
Protein 10.1 g 50.5 g 
Salt 0.14 g 0.7 g 
Notes: Milk ingredients: Skimmed Milk, Milk Protein, Butter Milk Powder (or Fat-Reduced 
Cocoa Powder in the case of Chocolate flavour), Flavourings, Thickener (E407), Sweetener 
(E955). 
 
4.5.3.2 Exercise  
The exercise classes combined simple existing exercise protocols that have been tailored towards 
older adults and are practical and affordable enough to be used again in the future. The exercise 
sessions included resistance, balance, aerobic and flexibility elements. The resistance element 
aimed to promote strength, function and hypertrophy, the aerobic for its cardiovascular benefits, 
the balance in order to challenge and improve postural stability, and lastly flexibility in order to 
maintain healthy joints engaging at a functional range of movement.  
 
The difficulty and complexity of the exercises was planned to increase progressively over time. 
Participants trained under constant supervision in small groups of up to five people and the classes 
took place three times per week on non-consecutive days (e.g. Monday-Wednesday-Friday). Only 
the absolute necessary pieces of equipment were provided in the classroom, namely, chairs, 
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resistance exercise bands (Theraband®), and in some sessions wall mirrors. The sessions took 
place at Queen Margaret University Sports Centre in studios dedicated to drama, dancing and other 
group sessions and the duration of the exercise sessions was approximately one hour. The exercise 
programme followed a progressive loading and periodization structure but it was also tailored to 
individual abilities and tolerance. The researcher, personal trainer and fitness professional 
(member of the UK Register of Exercise Professionals), qualified in strength training for older 
people as well as in chair-based exercise classes for older adults, delivered and supervised all 
exercise sessions. The researcher was also trained to provide first aid and cardiopulmonary 
resuscitation (CPR) by the Royal Life Saving Society (RLSS) UK. In addition, at any time there 
were another two members of staff in the building able to provide first aid assistance. A semi-
automatic defibrillator was clearly signposted and available for the first aiders.  
 
An individual record sheet was used to register attendance frequency, injuries, adverse clinical 
events that could occur during the workout sessions or any other comments that the participants 
wished to make in regard to intensity, difficulty or the general nature of the programme.  
 
Exercise Days 
The main objective of the exercise programme was to improve muscle strength and/or function of 
the most important muscle groups responsible for maintaining good balance, posture and mobility. 
Therefore, exercises focusing on the back, chest, leg and trunk muscles were of primary interest. 
Particularly exercises that engaged the shoulder adductors/ abductors, hip adductors/ abductors 
and flexors/extensors, knee flexors/extensors and elbow flexors/extensors were performed (Lobo 
2010; Williamson 2011; VanBeveren 2012) (Appendix 4.8).  
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Exercise sessions were performed in the morning, with at least 48 hours between each session. 
The exercise sessions lasted ~1 hour; the first 10 minutes were used for warm up and the last 10 
min for stretching, cool down and recovery. The main body of the session (40 minutes) consisted 
of balance, seated and bodyweight exercises during the first two weeks. This allowed participants 
to familiarise themselves with the exercises and techniques, improve their proprioception, aerobic 
capacity and engage progressively the major muscle groups to minimise delayed onset muscle 
soreness (DOMS), which could potentially discourage participation in the study. The exercise 
instructor would give a detailed demonstration of how the exercises should be performed, placing 
particular emphasis to correct technique and posture as well as breathing patterns. When 
participants were performing the exercises they would receive instant and constructive feedback 
by the instructor, explaining whether the technique was correct and what could be improved, using 
simple terms and prompts.    
 
The progressive resistance exercise training was based on the use of elastic bands (Theraband© 
Hygienic Co., Akron, OH) from week-3 and forward. These elastic bands offer different resistance 
levels depending on their thickness and colour. Namely, in an ascending order of thickness, the 
yellow, red, green, blue, black and silver bands, can produce a force of 1.32, 1.77, 2.27, 3.22, 4.40, 
and 5.99  kg, respectively, when elongated by 100% (Page and Ellenbecker 2011). Before initiating 
the exercise programme participants were asked whether they were allergic to latex, in which case 
latex-free elastic bands of the same resistance were available. 
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All participants started with the lightest band in week-3, i.e. the yellow colour band and were 
instructed to perform initially 8-12 repetitions of each exercise. The exercises were performed in 
a circuit pattern until all exercises had been executed for a total of three times. To avoid early 
fatigue due to the circuit pattern, upper and lower body (or opposing muscle groups) exercises 
were alternated. Between each exercise there was a ~15 sec break during which the instructor 
would demonstrate the next exercise, whereas in-between each circuit there was a 1-2 min break. 
In week-4 the same exercises were performed but the repetitions increased to 10-15. All exercises 
for legs, back and chest in the last circuit (3rd) were performed to volitional fatigue (i.e. to that 
point that participants were unable to perform an additional repetition, or at least were unable to 
perform it with a proper form). If participants were able to perform ≥ 15 repetitions, they were 
then allowed to progress to the next colour of bands the following week. Similarly in week 5, 
participants would start from 8-12 repetitions and would gradually increase to 10-15 until the end 
of the week 6, when they would perform the last sets to volitional fatigue to demonstrate an ability 
to progress to the higher resistance level. Therefore, every two weeks the participants could 
progress to the next level of resistance as presented in table 4.2.  
 
During the first 14 weeks participants were encouraged to perform the exercises with the elastic 
bands in a controlled manner, concentrating more on technique and using the full range of motion, 
rather than speed of movement. Therefore both the concentric and eccentric phase of each 
movement would last ~1-2 secs, with a further 2 sec pause/rest between each phase. During the 
last two weeks (15-16) participants were instructed to increase the velocity of movement to ≤1 
sec, but maintain a slow eccentric phase (≥2 sec). A 10-point Borg scale was used to monitor the 
participants’ rate of perceived exertion during the exercise classes, during the breaks at the end of 
circuits. The instructor aimed to keep the intensity at moderate levels, that is, not surpassing a 6-
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grade rating in the Borg scale (with the exception being the last circuit of the even weeks, where 
exercises were performed to volitional fatigue).  
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Table 4.2 Planned progression of resistance exercise training  
 Weeks 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
 BW X X               
Yellow   X X             
Red     X X           
Green       X X         
Blue         X X       
Black           X X     
Silver             X X X* X* 
Notes: BW, bodyweight. * The concentric part of the movement was increased to ‘as fast as possible’ and of the eccentric decreased to 
~2 sec.  
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4.5.4 Sample Size calculation and statistical analysis  
Sample size was calculated based on the primary outcome, which was change in skeletal muscle 
mass as estimated by dual-frequency BIA. The equation used to calculate sample size has been 
previously presented by Noordzij et al. 2010 (Appendix 4.9). With a statistical significance level 
set at 0.05, a power of 80%, a standard deviation of ± 1.4 kg (Siervo et al. 2012) and a 1.1 kg 
change needed to detect a significant difference between the groups (Borsheim et al. 2008), 18 
participants per group would allow for such calculations. Considering a 25% drop out rate, a final 
sample size of 50 participants (25 per group) was required. 
 
A Shapiro-Wilk test was used to assess the distribution (normality) of data. Non-normally 
distributed data were presented accordingly; that is, the measure of centrality with a median and 
that of dispersion with the interquartile range (IQR 25th, 75th). Similarly, associations between 
non-normally distributed variables were assessed using a Spearman’s correlation test. A 
Spearman’s Rho value between 0.1 and 0.3 indicated a weak association, 0.3 to 0.5 a moderate 
association, and ≥ 0.5 a strong association Cohen (1988).  Statistical differences at baseline were 
assessed by Mann-Whitney U-test. A one-sample Wilcoxon signed-rank test was used to compare 
median (IQR) outcomes from the current cohort to known single values from the Scottish Health 
Survey (Scottish Government 2017) for body mass index, and from the national official statistics 
from the latest National Diet and Nutrition Survey (NDNS) (GOV UK 2018) for dietary intakes. 
A statistical package (SPSS version 19.0) was used for the statistical analysis. 
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4.5.5 Summary 
On the first test day the objective was to assess body composition indices that would allow the 
researcher to evaluate how many adults ≥ 65 years had low strength (dynapenia), low muscle mass, 
low strength and low muscle mass (sarcopenia), obesity (based on BMI and %BF), and sarcopenic 
obesity. The second test day focused on measuring function, quality of life and dietary habits, for 
those who had been screened during the first test day and were found to be eligible for the 
intervention study (i.e. have low muscle and high fat mass). Participants were then allocated to 
either a control group (EX: exercise only) or intervention group (EXD: exercise and diet), and 
took part in a 16-week trial. All participants received a vitamin D supplement and performed the 
same exercise routine. Participants in EXD received an energy deficit diet (500 kcal less than their 
individual estimated energy requirements) on top of the exercise and the Vitamin D tablets, and 
were also supplemented with a milk based protein supplement to achieve the target of 1.2-1.5 g 
protein · kg bw-1 · day-1. The results of all test days (observational data for the whole cohort, and 
the data from the intervention study at baseline, week 10 and week 16) are presented in the 
following chapters.
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Chapter 5. Results: Sarcopenic obesity in Scottish older 
community-dwellers. A cross-sectional study.  
 
The cohort characteristics from the screening session (cross-sectional study) are presented in this 
chapter. Due to a non-normal distribution of the main outcomes results are presented using median 
(IQR: 25th, 75th percentile) and Spearman’s Rho values. Initially, 156 adults ≥ 65 years old 
responded to the advertisement and subsequently, 108 of them consented to take part in the 
screening test. Recruitment flow is presented in Figure 5.1, in agreement with the CONSORT 
guidelines.  
 
Based on the BMI classification criterion, obese adults had a significantly higher skeletal muscle 
mass (SMM) than the non-obese. However, when obesity was defined as high % BF (≥ 28 % in 
men and ≥ 40 % in women), the opposite pattern was observed. That is, the non-obese had 
significantly higher SMM than the obese and additionally, the non-obese exhibited a higher 
handgrip (section 5.1.1). Overall prevalence of sarcopenia was 14.8 % (16/108) (section 5.1.2).  
The use of sex-specific %BF cut-offs identified more cases of obesity and sarcopenic obesity than 
the BMI cut-off of ≥ 30 kg·m-2. Namely, prevalence of obesity based on BMI was 27.8 % (30/108) 
vs 63.0 % (68/108) based on %BF, whereas prevalence of sarcopenic obesity was 4.6 % (5/108) 
based on BMI vs 12.0 % (13/108) based on %BF (section 5.1.2). Muscle quality (handgrip strength 
per unit of skeletal muscle mass) showed a significant and negative association with bodyweight, 
sagittal abdominal diameter (SAD) and absolute fat mass in men and women (section 5.1.3). More 
details are presented in the following sections.  
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Figure 5.1 CONSORT recruitment flow. * cross-sectional data, presented in section 5.1 . ** RCT data are 
presented in Chapter 6. # Exclusion reasons are presented in Section 6.3. DO, drop-out. 
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5.1 Screening for sarcopenia, obesity and sarcopenic obesity in Scottish older 
adults (cross-sectional data) 
 
5.1.1 Participant characteristics  
One hundred and eight adults (men, n=29; women, n=79) took part in the screening visit, which 
involved undertaking the tests described in Chapter 4. Results are presented as median (IQR) 
values (Table 5.1). Overall, the median age of participants was 70 (67, 75) yr. Weight and BMI, 
were 73.8 (63.4, 86.3) kg and 26.9 (24.0, 31.0) kg·m-2, respectively. Fat mass was 28.0 (22.2, 35.9) 
kg and % BF 40.3 (32.2, 45.6) %. Lean mass (LM) was 42.9 (37.3, 52.9) kg, skeletal muscle mass 
(SMM) 19.3 (17.1, 27.7) kg and skeletal muscle index (SMI) 7.44 (6.71, 9.28) kg m-2. Handgrip 
strength and sagittal abdominal depth (SAD) were 25.0 (21.5, 31.5) kg and 27.3 (24.2, 31.0) cm, 
respectively (Table 5.1). Based on the BMI cut-offs 30 participants met the obesity criteria, 
whereas based on high % BF 68 participants were classified as obese (Table 5.2). 
 
Differences between Scottish older men and women  
Men were significantly younger than women, 67 (65, 73) yr vs 71 (68, 75) yr (p=0.003) and had 
a higher bodyweight, 85.6 (74.8, 97.5) kg vs 69.5 (61.4, 80.0) kg (p<0.001) (Table 5.1). Men had 
significantly higher % LM [73.1 (68.3, 75.3) % vs 57.7 (53.0, 60.8) % (p<0.001)], SMI [9.96 
(9.34, 11.11) kg ·m-2 vs 7.08 (6.42, 7.73) kg ·m-2, (p<0.001)] and handgrip strength [42.5 (31.4, 
46.5) kg vs 23.5 (20.5, 26.5) kg, p<0.001]. Women had significantly higher % BF [42.3 (39.2, 
47.0) % vs 26.9 (24.7, 31.8) %, p<0.001] and ratio FM: SMM [1.6 (1.3-2.0) vs 0.7 (0.6-0.9) 
p<0.001] (Table 5.1). The BMI of men (27.1 kg m-2) and women (26.7 kg m-2) of this cohort was 
not significantly different to the national average BMI of Scottish men (29.7 kg m-2) (p=0.088) 
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and women (28.4 kg m-2) (p=0.195) of a similar age group, 65-75 years (Scottish Government 
2017).  
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Table 5.1 Baseline characteristics of men and women who participated in the screening session.   
Overall 
n=108 
 Men  
n=29 
 
Women 
n=79 
 
p (sig.) 
value  
Median IQR Median IQR Median IQR 
 
Age (yr) 70 (67, 75) 67 (65, 73) 71 (68, 75) 0.003 
Weight (kg)  73.8 (63.4, 86.3) 85.6 (74.8, 97.5) 69.5 (61.4, 80.0) <0.001 
Height (m) 1.63 (1.60, 1.69) 1.75 (1.72, 1.80) 1.61 (1.58, 1.64) <0.001 
BMI (kg m-2) 26.9 (24.0, 31.0) 27.1 (24.2, 33.4) 26.7 (23.9, 31.4) 0.579 
%BF 40.3 (32.2, 45.6) 26.9 (24.7, 31.8) 42.3 (39.2, 47.0) <0.001 
FM (kg) 28.0 (22.2, 35.9) 22.4 (18.9, 30.5) 28.6 (23.2, 36.5) 0.001 
% LM 59.8 (54.5, 67.8) 73.1 (68.3, 75.3) 57.7 (53.0, 60.8) <0.001 
LM (kg) 42.9 (37.3, 52.9) 60.6 (56.3, 69.3) 40.6 (36.0, 44.3) <0.001 
SMM (kg) 19.3 (17.1, 27.7) 30.6 (29.2, 33.7) 18.5 (16.4, 20.1) <0.001 
SMI (kg m-2) 7.44 (6.71, 9.28) 9.96 (9.34, 11.11) 7.08 (6.42, 7.73) <0.001 
FM:SMM  1.4 (1.0, 1.9) 0.7 (0.6, 0.9) 1.6 (1.3, 2.0) <0.001 
Handgrip (kg) I  25.0 (21.5, 31.5) 42.5 (31.4, 46.5) 23.5 (20.5, 26.5) <0.001 
Muscle Quality 
(HG:SMM) I  
1.28 (1.06, 1.51) 1.37 (1.03, 1.49) 1.28 (1.08, 1.51) 0.792 
SAD (mm) II  27.3 (24.2, 31.0) 28.3 (24.7, 33.5) 26.8 (23.3, 30.3) 0.048 
SBP (mmHg) III  137 (127, 149) 134 (127, 150) 136 (127, 146) 0.823 
DBP (mmHg) 
III 78 (71, 83) 
75.5 (71, 82) 78 (71, 83) 0.910 
HR III  68 (60, 74) 64 (57, 69) 70 (62, 76) 0.003 
Notes: I n=105 (78f, 27m); II n=101 (74f, 27m); III n=107 (79f, 28m); %BF, percent body fat; BMI, body 
mass index; DBP, diastolic blood pressure; FM, fat mass; HR, heart rate; LM, lean mass; SAD, sagittal 
abdominal diameter; SBP, systolic blood pressure; SMI, skeletal muscle index; SMM, skeletal muscle 
mass. 
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Differences between obese vs non-obese older adults 
Body mass index, % BF and absolute fat mass were significantly higher in the obese groups 
regardless of classification method (Table 5.2). Based on the BMI classification criterion, obese 
adults had a significantly higher skeletal muscle mass (SMM) than the non-obese [21.8 (19.1, 
28.4) kg vs 18.7 (16.4, 26.7) kg] (p=0.008) (Table 5.2). Moreover, adults with obesity based on 
BMI had a significantly higher SMI than their non-obese counterparts [8.4 (7.47, 10.67) kg·m-2 vs 
7.08 (6.42, 9.00) kg·m-2, p<0.001]. When obesity was defined as increased % BF, the opposite 
pattern was observed; the non-obese group had significantly higher SMM than the obese [21.1 
(18.7, 16.4) kg vs 18.9 (16.4, 21.8) kg, p=0.005] and was also stronger [27.5 (24.5, 42.3) kg vs 
24.5 (20.0, 21.8) kg, p=0.001. Regardless of the classification criterion used, muscle quality was 
significantly lower in the obese vs the non-obese (Table 5.2).   
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Table 5.2 A comparison of body composition and strength indices between obese and non-obese Scottish older adults, based on 
two different classification methods, BMI and % body fat. 
 
 
 
 
 BMI   %BF  
 
Non-Obese 
n=78 
Obese 
n=30 
  Non-Obese 
n=40 
Obese 
n=68 
 
 Median (IQR) Median (IQR) p (sig.)  Median (IQR) Median (IQR) p (sig.) 
Age (yr) 69 (66, 74) 71 (68, 76) 0.142  68 (66, 71) 73 (68, 77) <0.001 
BMI (kg m-2) 25.5 (23.3, 27.1) 34.7 (32.7, 36.8) <0.001  23.9 (22.6, 26.6) 29.4 (25.9, 34.5) <0.001 
%BF 38.4 (28.8, 42.3) 47.3 (40.0, 50.3) <0.001  33.9 (26.1, 37.9) 43.7 (40.8, 48.8) <0.001 
FM (kg) 24.0 (20.9, 28.3) 40.0 (35.7, 47.3) <0.001  21.4 (19.1, 22.8) 32.5 (28.0, 39.6) <0.001 
% LM  61.6 (57.5, 71.4) 52.0 (49.6, 60.2) <0.001  66.4 (62.0, 74.1) 56.1 (51.2, 59.3) <0.001 
SMM (kg) 18.7 (16.4, 26.7) 21.8 (19.1, 28.4) 0.008  21.1 (18.7, 16.4) 18.9 (16.4, 21.8) 0.005 
SMI (kg m-2)  7.08 (6.42, 9.00) 8.4 (7.47, 10.67) <0.001  7.84 (7.02, 9.52) 7.16 (6.53, 8.61) 0.060 
Strength (kg) 25.0 (21.5, 31.8) 25.5 (21.5, 30.5) 0.681  27.5 (24.5, 42.3) 24.5 (20.0,28.0) 0.001 
Muscle 
Quality (ratio) 
1.35 (1.16, 1.58) 1.11 (0.90, 1.31) <0.001  1.39 (1.24, 1.55) 1.21 (1.02, 1.46) 0.036 
Notes: %BF, percent body fat; %LM, percent lean mass; BMI, body mass index; FM, fat mass; HR, heart rate; Muscle Quality 
(handgrip: skeletal muscle mass); SMI, skeletal muscle index; SMM, skeletal muscle mass.  
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Outliers  
Regarding outliers, one person produced consistently higher values than the rest of the cohort for 
BMI, body fat mass, SMM, and SMI and was detected as an outlier by the SPSS-derived boxplots 
(Appendix 5; participant no.44). This participant was a 69 years old woman who had the highest 
bodyweight of 127.6 kg, highest BMI (44.8 kg m-2) and highest amount of absolute fat mass (FM: 
67.5 kg) amongst the whole cohort, regardless of sex. Interestingly, the same participant exhibited 
the highest amounts of absolute lean mass (LM=60.1 kg) and muscle mass (SMM=28.4 kg), as 
well as one of the three highest SMIs (SMI=10.58 kg m-2) amongst women. That person met the 
eligibility criteria for screening and there were no numerical errors or incorrect procedures during 
the assessment tests; moreover, in a larger sample size it is likely that this participant would not 
appear as an outlier. Therefore, all data from this participant were included in the analysis and 
presentation of the results.    
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5.1.2 Prevalence rates of low strength (dynapenia), low muscle mass, sarcopenia, 
underweight, overweight, obesity and sarcopenic obesity.  
Low hand grip (dynapenia) characterised five men (17.2% of all men), 17 women (21.5% of all 
women) and 22 out of 108 (20.3%) participants in total (Table 5.3). A total of 18 out of 29 men 
(62.1%) were characterised by low skeletal muscle mass (SMM), whereas in women the respective 
figure was 39% (29 out of 79). In total, low SMM was present in 43.5% (47 out of 108) of 
participants. Prevalence of sarcopenia (i.e. those with low SMM combined with low handgrip 
strength) was 14.8% (16 out of 108) overall, with rates in men and women being 13.8% and 15.2%, 
respectively (Table 5.3).   
 
Based on BMI classification, one person (n=1) was identified as underweight, 32 participants had 
a BMI within the normal range, and 45 participants were classed as overweight (Table 5.4). Thirty 
out of 108 (27.8%) were classified as obese based on BMI ≥ 30 kg  m-2. Out of those 30 participants 
with obesity, 17 were characterised by class I obesity, 11 by class II obesity and two by class III 
obesity (the full BMI classifications and cut-offs are presented in Table 5.4). Based on the gender-
specific %BF cut-offs, 63.0% of all participants (68 out of 108) were classified as obese. Finally, 
when sarcopenia was combined with a high BMI, 4.6% (five out of 108) presented the sarcopenic 
obesity phenotype, compared with 12.0% (13 out of 108) who were characterised by sarcopenic 
obesity based on sarcopenia and high %BF. Table 5.5 presents the different BMI categories 
(normal, overweight, obesity) corresponding to %BF values, in men and women. Overweight men 
and women had a median (IQR) % BF of 26.9 (24.7, 28.5) % and 42.1 (40.6, 45.8) %, respectively. 
Obese men and women had a median (IQR) % BF of 32.6 (31.7, 35.6) % and 49.4 (45.7, 52.4) %, 
respectively.   
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Table 5.3 Prevalence of low strength (dynapenia), low muscle mass, sarcopenia, obesity 
and sarcopenic obesity (based on high BMI and high %BF) in a cohort of 108 older (≥65 
yr) Scottish dwellers. 
 Men 1 
(%) 
 Women 2 
(%) 
 All 3 
(% total) 
Dynapenia  5 (17.2)  17 (21.5)  22 (20.3) 
Low SMM 18 (62.1)  29 (36.7)  47 (43.5) 
Sarcopeniaa 4 (13.8)  12 (15.2)  16 (14.8) 
Obesity by BMI 7 (24.1)  23 (29.1)  30 (27.8) 
Obesity by %BF 12 (41.4)  56 (70.9)  68 (63.0) 
Sarcopenic Obesity 
by BMI 
0 (0)  5 (6.3)  5 (4.6) 
Sarcopenic Obesity 
by %BF 
2 (6.9)  11 (13.9)  13 (12.0) 
1n=29; 2n=79; 3n=108; a sarcopenia regardless of obesity; BMI, Body Mass Index; %BF, 
% body fat 
 
 
 
Table 5.4 Overall and gender-specific BMI classifications of the whole cohort based on the 
WHO guidelines 
Classification  BMI (kg m-2) 
category range 
Men1 
 (%) 
Women2 
(%)  
All3 
(% total) 
Underweight BMI <18.5 0 (0) 1 (1.3) 1 (0.9) 
Normal  18.5 ≤ BMI ≤ 
24.99 
8 (27.6) 24 (30.4) 32 (29.6) 
Overweight 25.0 ≤ BMI ≤ 
29.99 
14 (48.3) 31 (39.2) 45 (41.7) 
Class I 30.0 ≤ BMI ≤ 
34.99 
4 (13.8) 13 (16.5) 17 (15.7) 
Class II 35.0 ≤ BMI ≤ 
39.99  
2 (6.9) 9 () 11 (10.2) 
Class III BMI ≥ 40  1 (3.4) 1 2 (1.9) 
1n=29; 2n=79; 3n=108 
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Table 5.5 Percent body fat in the different BMI categories in men (n=29) and women 
(n=79).  
BMI (kg m-2)  
 
Median %BF (IQR) 
(men n1: women n2) Men  Women  
≤ 18.49 (0: 1) - * 
18.5-24.99 (8: 24) 24.7% (23.0, 26.4) 37.8% (34.2, 40.3) 
25-29.99 (14: 31) 26.9% (24.7, 28.5) 42.1% (40.6, 45.8) 
≥ 30 (7: 23) 32.6 % (31.7, 35.6) 49.4% (45.7, 52.4) 
1n=29; 2n=79; * One woman (n=1) had BMI < 18.5 kg m-2,  at a %BF of 41.5%   
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5.1.3 Relationship between age, body composition, and strength/function.  
All associations are presented as Spearman’s Rho (rank correlation coefficient) values. A 
moderate positive and significant association was observed between age and %BF (Rho=.45, 
p<0.001; Figure 5.2). A strong, significant and negative association was reported between age 
and handgrip strength (Rho=-0.63, p<0.0001; Figure 5.2). Handgrip strength was also strongly, 
significantly and positively associated with SMM (Rho=0.63, p<0.001; Figure 5.2), whereas it 
was significantly and negatively associated with %BF (Rho=-0.60, p<0.001; Figure 5.3) and FM: 
SMM ratio (Rho=-0.58, p<0.001; Figure 5.3).  
 
Although a weight bearing exercise was not performed for the assessment of muscle quality 
(handgrip strength per unit of skeletal muscle mass), the latter showed a significant and negative 
association with bodyweight (Rho=-0.33, p=0.001), SAD (Rho=-0.40, p<0.001) (Figure 5.4) and 
absolute fat mass (Rho=-0.35, p<0.001) (Figure 5.5). All reported associations remained 
significant after a separate subgroup analysis for men and women (Figure 5.5 presents the 
association between muscle quality and fat mass in men and women).  
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Figure 5.2 Association between %BF, %LM, and Handgrip with age. Top left: Association between % body fat and age (yr). Top right: 
Association between % lean mass and age (yr). Bottom left: Association between handgrip strength (kg) and age (yr).  
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Figure 5.3 Association between handgrip with SMM, %BF and FM:SMM. Top left: Association between handgrip (kg) and skeletal muscle 
mass (kg). Top right: Association between handgrip (kg) and % body fat. Bottom left: Association between handgrip and ratio of fat mass: skeletal 
muscle mass. 
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Figure 5.4 Association between muscle quality with SAD, and body weight. Left: association between muscle quality and sagittal abdominal 
diameter (cm).  Right: Association between muscle quality and bodyweight (kg). A cut off is placed at the 25th percentile for muscle quality 
(1.06). 
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Figure 5.5 Association between muscle quality and fat mass. Left: a cut off is placed at the 25th percentile for muscle quality (1.06). The line of 
best fit applies to the overall cohort. Participant no.44 who was characterized by the highest fat mass and highest lean mass is highlighted in 
orange.  Right: Correlation between muscle quality and FM in men (n=29, Rho=-0.49, p=0.01) and women (n=78, Rho=-0.315, p=0.005).
No.44 
N=100 
Rho= -.35 
p<0.001 
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Chapter 6. Results: A complex exercise and high-protein 
intervention to augment body composition and function in older 
age. A randomised controlled trial. 
 
Due to a small number of individuals who took part in the RCT, the requirements for a parametric 
analysis were not met, therefore a non-parametric/ descriptive approach was followed. Results are 
thus presented using medians (IQR: 25th, 75th percentile) and boxplots. Statistical comparisons for 
the RCT were performed at baseline before the drop-outs (n=18 participants, n=9 in each group). 
Namely, statistical comparisons were performed a) at baseline between EX vs EXD, b) between 
those who completed the study (completers) vs their counterparts who dropped-out before 
completing the study (non-completers), and c) between baseline dietary intakes of the female 
participants of the current study vs the national UK averages for women of the 65+ age group 
(section 6.2).  
 
In total, 18 participants (women, n=16; men, n=2) were allocated to two groups, control (EX: 
exercise only) and intervention (EXD: Exercise and Diet) after application of the exclusion criteria 
(section 6.1) (recruitement flow was presented in Figure 5.1). All participants were Caucasian 
Scottish community-dwellers. Nine participants were allocated to each group (EX: n=9; EXD: 
n=9). Seven dropped out (EX, n=3; EXD, n=4) after being allocated to a group. Two participants 
dropped out before commencing with the programme, one (n=1) from EX and one (n=1) from 
EXD. Details for drop-outs are presented in section 6.3 Drop outs. Finally, n=6 participants from 
the EX group and n=5 participants from the EXD group, completed the study.  
 
At the end of week16 the median (IQR) change in bodyweight was 0.5 (0.0, 1.0) kg in EX and -
5.0 (-6.8, -5.0) kg in EXD. Skeletal muscle mass (SMM) increased by 0.5 (0.3, 0.7) kg in EX and 
by 0.1 (-0.4, 0.7) kg in EXD. Change in body fat was 0.0 (-0.4, 0.7) kg in EX and -4.7 (-4.8, -4.2) 
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kg in EXD. All body composition changes are presented in section 6.4. Median (IQR) changes in 
strength and function were: handgrip [EX: 1.5 (0.5, 1.5) kg; EXD: 1.0 (0.5, 2.0) kg], gait speed 
[EX: 0.4 (0.1, 0.5) m s-1; EXD: 0.1 (-0.1, 0.3) m s-1], timed up-and-go test [EX: -1.6 (-3.2, -1.0) s; 
EXD: -1.2 (-1.8, -1.0) s], SPPB [EX: 0.1 (0.0, 2.0); EXD: 1.0 (1.0, 1.0)], repeated chair stands 
[EX: -4.3 (-6.3, -2.3) s; EXD: -2.4 (-2.7, -2.2) s], 1-arm forward reach [EX: 7.6 (0.1, 9.1) cm; 
EXD: 1.3 (-5.1, 6.4) cm] (section 6.5). The most noticeable change in quality of life was in 
perceived overall health compared to previous year, where the median (IQR) score increased in 
both groups by 25 (0, 25) (section 6.6). Serum 25(OH)D concentrations increased numerically in 
both groups, in EX by 15 (-1, 31) nmol L-1 and in EXD by 19 (9, 27) nmol L-1 (section 6.9). Overall 
median (IQR) attendance to the exercise classes for those who completed the 16-week programme 
was 73 (67, 81) % (section 6.10). Adherence to diet and protein drink for the EXD group was 80 
(70, 87) % and 92 (79, 95) %, respectively (section 6.10). Overall, changes in body composition 
were more pronounced in the EXD group, particularly in body weight and body fat, whereas both 
groups experienced positive changes in physical function and serum 25(OH)D concentrations at 
the end of 16-week research trial.  
 
 
6.1 Exclusions  
In total, 30 individuals met the inclusion criteria for body composition (Figure 5.1), but three 
(n=3) volunteers decided not to participate, due to difficulties in commuting or because they would 
only take part as a group with their friends/ spouses (Table 6.1). Of the remaining 27, seven (n=7) 
were excluded for health reasons (Table 6.1). One female participant was underweight (n=1), and 
although her %BF (41.5%) and SMI (5.02 kg m-2) were within the cut-off limits, she was excluded 
in order to prevent potential weight loss, especially if allocated in the diet group. Finally, one 
individual was excluded based on the cognitive assessment test.  
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Table 6.1 Exclusions from intervention study with reasons 
 
Reasons  Details 
 
Decided not to participate (n=3) 
 
 Not residing close to university premises and 
unable to commute (n=1) 
 Friends/spouses not eligible to participate, thus 
the eligible participants decided not to participate 
on their own (n=2)  
 
Health issues (n=7)    Receiving corticosteroids, arthritis in several 
joints, gout, glaucoma and occasionally 
uncontrollable pain (n=1) 
 Receiving corticosteroids, abnormal blood tests 
indicating high inflammation (n=1) 
 Heart problems (n=2)  
 Severe osteoporosis (with recent fragility 
fractures) (n=1)  
 Double hernia, scheduled for operation within 
two months (n=1)  
 Recent health incident, suspected mini-stroke but 
still under investigation (n=1) 
 
Other (n=2)  Failed cognitive test (n=1) 
 Underweight, BMI=17.9 kg m-2 (n=1) 
 
 
6.2 Baseline characteristics of all participants in the RCT 
Baseline characteristics are presented in Table 6.2. In EX, six out of the nine participants reported 
suffering from health conditions (hypertension: n=4; arthritis: n=3; fasting hyperglycemia: n=2, 
osteopenia: n=1, irritable bowel syndrome (IBS): n=1, depression: n=1, Barrett’s esophagus: n=1), 
whereas three participants reported none. In EXD one out of nine participants did not report any 
conditions. Arthritis was reported by n=3, hypertension by n=3, high cholesterol by n=1, fasting 
hyperglycemia n=1, osteopenia n=1, uncontrolled coughing n=1, stroke survivor n=1). Apart from 
sarcopenic obesity, out of the 18 participants in total, seven reported to suffer from more than one 
condition.  
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No significant differences were observed at baseline for any of the body composition or physical 
function parameters, serum 25(OH)D concentrations (Table 6.2), or quality of life (Table 6.3). 
Median (IQR) age was 74 (71, 77) yr and 73 (68, 76) yr in EX and EXD, respectively. At baseline, 
both groups scored 70 or higher in all subsections of the quality of life questionnaire, with the 
exceptions being ‘Energy & Fatigue’, EX: 45 (38, 65), ‘change in health since previous year’, 
EX: 50 (50, 56); EXD: 50 (50, 75) and ‘general health’ EXD: 65 (55, 88), but no significant 
differences were detected at baseline between groups (Table 6.3).   
 
Baseline dietary intakes before the drop-outs (n=18) are presented in Table 6.4. The EX group 
reported a daily energy intake (EI) of 1554 (1489, 1745) kcal, and the EXD group an EI of 1627 
(1469, 1749) kcal. Daily protein intakes relative to bodyweight in EX vs EXD at baseline were 
0.9 (0.8, 1.1) g kg bw-1 vs 0.8 (0.7, 1.2) g kg bw-1, respectively. Protein distribution in the three 
main meals (breakfast, lunch, dinner) for the overall group (n=18) was 10 (7, 16) g, 19 (13, 23) g 
and 30 (21, 34) g. The respective values for EX vs EXD at baseline were 10 (9, 15) g vs 10 (6, 12) 
g, 22 (16, 23) g vs 16 (14, 21) g and 28 (17, 35) g vs 30 (23, 32) g for breakfast, lunch and dinner 
(Figure 6.1). No significant differences were detected between the two groups at baseline. The 
current cohort of women at baseline (n=16) reported significantly higher energy intakes than the 
national average, 1605 (1526, 1695) kcal vs 1483 kcal, respectively (p=0.039), but significantly 
lower % contribution protein to energy intake, 15.1 (13.8, 16.7) % vs 17.5% (p=0.008). No other 
differences were noted in the remaining dietary intake values. 
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Figure 6.1 Boxplots with protein intakes in the main meals at baseline. Between groups 
differences at baseline for protein intake in breakfast (p=0.286), lunch (p=0.452) and dinner 
(p=0.791) were non significant. EX: n=9, EXD: n=9. 
 
 
 
EX (control) 
EXD  (intervention) 
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Table 6.2 Baseline body composition, function and Vitamin D 25(OH) measurements, overall and between group comparisons.  
  
Overall  
(n=18) 
EX  
(n=9)¹ 
EXD  
(n=9)¹ 
 
 
Median (IQR) Median (IQR) Median (IQR) p (sig.) value 
Age 74 (69, 76) 74 (71, 77) 73 (68, 76) 0.450 
Weight (kg) 68.3 (57.4, 76.1) 66.2 (56.4, 75.0) 70.4 (58.4, 82.4) 0.453 
Height (kg)  160.9 (152.9, 164.8) 157.4 (152.8, 164.0) 162.5 (153.0, 166.5) 0.453 
BMI (kg m-2) 26.8 (24.0, 28.9) 26.9 (23.3, 28.7) 26.7 (25.0, 29.0) 0.566 
%BF 44.6 (40.5, 47.2) 44.7 (40.3, 48.7) 44.5 (41.8, 47.8) 0.895 
FM (kg) 28.7 (25.4, 33.8) 26.7 (23.6, 35.1) 29.5 (26.5, 34.4) 0.354 
SMM (kg) 15.4 (14.4, 17.7) 15.3 (14.3, 16.7) 16.3 (14.2, 18.7) 0.691 
SMI (km m-2) 6.31 (5.95, 6.65) 6.20 (5.92, 6.58) 6.42 (5.95, 6.76) 0.724 
SAD (cm)  27.0 (24.0, 31.4) 27.9 (22.3, 31.9) 25.7 (24.15, 31.8) 0.691 
Handgrip (kg) 22.8 (18.3, 27.3) 23.0 (17.3, 27.8) 22.5 (19.5, 27.5) 0.627 
Muscle Quality  1.36 (1.07, 1.67) 1.20 (1.04, 1.71) 1.48 (1.09, 1.64) 0.965 
SBP (mmHg) 138 (127, 147) 134 (124, 140) 146 (130, 153) 0.200 
DBP (mmHg) 69 (75, 82) 74 (73, 83) 76 (66, 82) 0.507 
HR (bpm) 64 (69, 77) 70 (65, 77) 68 (62, 78) 0.689 
SPPB 11 (10, 12) 11 (11, 12) 11 (8, 12) 0.463 
GS (m s-1) 1.1 (1.0, 1.2) 1.0 (0.9, 1.2) 1.1 (1.0, 1.2) 0.289 
RCS (s)  12.1 (9.3, 14.8) 12.0 (8.5, 13.5) 12.3 (9.5, 16.8) 0.402 
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1-Arm Reach 
(cm) 
27.6 (23.2, 32.4) 25.7 (22.9, 32.6) 28.1 (25.1, 33.6) 0.566 
TUG (s) 6.7 (5.5, 7.2) 6.7 (5.5, 7.3) 6.7 (5.4, 7.6) 1.000 
 
25(OH)D (nmol 
L-1) 57 (48, 67) 49 (43, 61) 60 (49, 83) 
 
 
0.223 
           
%BF, percent body fat; ¹ men: n=1, women: n=8;  BMI, body mass index; DBP, diastolic blood pressure; GS, gait speed; FM, fat mass; 
HR, heart rate; LM, lean mass; Muscle Quality= Handgrip (kg): SMM (kg); RCS, repeated chair stands; SAD, sagittal abdominal 
diameter; SBP, systolic blood pressure; SMI, skeletal muscle index; SMM, skeletal muscle mass; SPPB, short physical performance 
battery test; TUG, timed up and go 
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Table 6.3 Health Related Quality of Life (HRQoL) at baseline, overall, and between group comparisons. 
  overall  
(n=18) 
EX  
(n=9)1 
EXD  
(n=9)1 
  
  median IQR Median IQR Median IQR p (sig.) 
value 
Physical Functioning 78 (69, 86) 70 (60, 85) 80 (70, 90) 0.265 
Role limitations due to physical health 88 (44, 100) 75 (38, 88) 100 (50, 100) 0.118 
Role limitations due to emotional 
problems 
100 (92, 100) 100 (33, 100) 100 (100
, 
100) 0.249 
Energy & fatigue 55 (44, 81) 45 (38, 65) 80 (55, 85) 0.074 
Emotional well-being 78 (67, 92) 76 (62, 80) 88 (74, 94) 0.051 
Social Functioning 88 (63, 100) 75 (50, 100) 100 (75, 100) 0.164 
Pain 79 (64, 90) 78 (50, 95) 90 (68, 90) 0.419 
General health 68 (54, 86) 70 (48, 85) 65 (55, 88) 0.894 
Change in health from previous year 50 (50, 56) 50 (50, 50) 50 (50, 75) 0.370 
Scores can range from 0 to 100, with higher scores indicating a higher quality of life. ¹ men: n=1, women: n=8 
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Table 6.4 Overall baseline dietary intakes and differences between groups before the drop-
outs.  
  
Overall  
(n=18) 
 
EX 
(n=9)1 
 EXD 
(n=9)1 
  
 
Median IQR Median IQR Median IQR p (sig. 
value) 
 
 
Daily Energy Intake (kcal) 1617 (1483, 
1729) 
1554 (1489, 
1745) 
1627 (1469, 
1749) 
.825 
Daily Energy intake relative 
to bodyweight (kcal ·kg bw-
1) 
24.6 (21.1, 26.2) 24.1 (21.4, 27.2) 24.1 (21.9, 26.8) .757 
Daily Protein Intake (g) 61 (53, 70) 58 (51, 71) 66 (55, 70) 0.453 
Contribution protein to EI 
(%) 
15 (14, 17) 15 (14, 18) 15 (13, 18) 0.825 
Daily Protein Intake 
Relative to bodyweight (g 
·kg bw-1) 
0.9 (0.8, 1.1) 0.9 (0.8, 1.1) 0.8 (0.7, 1.2) 0.691 
Daily CHO Intake (g)  184 (124, 210) 181 (163, 201) 198 (130, 217) 0.691 
Contribution CHO to EI (%) 45 (42, 48) 45 (43, 48) 47 (34, 51) 0.895 
Daily Fat Intake (g) 65 (54, 78) 66 (56, 78) 63 (48, 80) 0.627 
Contribution Fat to EI (%) 36 (32, 41) 37 (34, 43) 34 (28, 39) 0.145 
Daily Sat. Fat Intake (g) 23 (18, 30) 24 (19, 31) 21 (16, 28) 0.423 
Contribution Sat. Fat to EI 
(%) 
14 (11, 16) 14 (11, 17) 14 (12, 16) 0.200 
Free sugar Intake (g) 28 (17, 50) 28 (20, 49) 30 (15, 51) 0.743 
Contribution free sugar to 
EI (%) 
8 (4, 12) 8 (6, 12) 8 (4, 12) 0.541 
Dietary Fibre (g) 17 (15, 20) 17 (14, 20) 17 (15, 20) 0.730 
Vitamin D intake (μg) 2.3 (1.1, 4.3) 2.9 (1.4, 3.9) 2.3 (1.5, 4.4) 0.888 
Calcium intake (mg)  746 (665, 836) 723 (665, 795) 752 (674, 907) 0.541 
¹ men: n=1, women: n=8; Bw, bodyweight; CHO, carbohydrates; EI, energy intake.  
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6.3 Drop outs  
Seven people (n=7) dropped out from the programme after they had been allocated to a group. 
The comparison at baseline between the participants who completed the study (n=11) against those 
who were lost to follow-up (‘non-completers’), revealed that the non-completers had significantly 
higher SMM than the completers, namely 16.3 (15.4, 28.5) kg vs 14.5 (14.0, 17.1) kg (p=0.042) 
(Table 6.5). The only two men who were allocated to a study group were both non-completers, as 
they dropped out. Although non-completers had a significantly greater muscle mass, they had a 
significantly lower gait speed [1.0 (0.8, 1.1) m s-1] than their counterparts who completed the study 
[1.1 (1.0, 1.3) m s-1] (p=0 .020). No other differences were found in any of the anthropometry and 
function indices (weight, height, BMI, %BF, FM, handgrip, muscle quality, SPPB, repeated chair 
stands, single-arm forward reach and timed up-and-go test) (Table 6.5). No significant differences 
were noted in quality of life domains, and dietary intakes between the two groups, with the 
exception of free sugar intake [non-completers: 48 (36, 55) g vs completers: 21 (15, 28) g in 
(p=0.019)] and free sugar relative contribution to energy intake [non-completers: 9 (8, 14) % vs 
completers: 6 (4, 8) % (p=0.014)]. 
 
In EX, three participants were lost to follow-up. One person dropped out after completing all the 
assessment tests and being allocated to a group but before commencing with the exercise classes 
due to lack of time. Two participants dropped out after commencing the exercise programme. One 
woman dropped out at week-7; however, she last attended the exercise classes in week-4 and then 
went on a two-week holiday. Upon her return she informed the researcher about a discomfort at 
the neck area, which was reported to be a trapped nerve (according to the general practitioner (GP) 
who performed an examination) and thus, after a discussion with the researcher of the current 
study it was decided that she should stop the exercise classes until full recovery.  The second 
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participant was informed in week-4 that they were suffering from heart disease after receiving a 
medical health check and had to undergo further medical examinations.  
 
    
Table 6.5 Differences in body composition and physical function at baseline between the 
participants who completed the study (completers) and those who dropped out before 
completing the study (non-completers).    
completers  
(n=11) 
non-completers  
(n=7)1 
 
 
median IQR median IQR p (sig.) 
value 
Age 73 (68, 74) 76 (73, 83) 0.075 
Weight (kg) 66.2 (56.4, 76) 70.4 (62.8, 87.6) 0.441 
Height (cm) 157.4 (152.9, 164.4) 162.4 (152.7, 174.6) 0.390 
BMI(kg m-2) 25.2 (23.8, 29.9) 26.9 (25.6, 27.5) 0.526 
%BF 44.7 (40.6, 51.1) 43.7 (33.6, 45.8) 0.342 
FM (kg)  26.7 (24.2, 37.9) 29.1 (26.6, 30.8) 0.751 
SMM (kg) 14.5 (14.0, 17.1) 16.3 (15.4, 28.5) 0.042 
SMI (kg m-2) 6.05 (5.84, 6.54) 6.61 (6.20, 9.17) 0.051 
Handgrip (kg) 23.0 (17.0, 26.5) 22.0 (18.5, 29.5) 0.683 
Muscle Quality 1.63 (1.17, 1.73) 1.15 (1.03, 1.48) 0.135 
SPPB 11 (10, 12) 11 (9, 12) 0.814 
GS (m s-1) 1.1 (1.0, 1.3) 1.0 (0.8, 1.1) 0.020 
RCS (s) 12.1 (9, 14.3) 12 (9.4, 17.3) 0.930 
1-Arm Reach 
(cm) 
30.7 (23.04, 35.8) 27 (22.6, 28.2) 0.135 
TUG (s)  6.7 (5.6, 7.5) 6.7 (5.4, 7.1) 0.964 
¹ men: n=2, women: n=5; 8%BF, percent body fat; BMI, body mass index; GS, gait speed; 
FM, fat mass; LM, lean mass; RCS, repeated chair stands; SMI, skeletal muscle index; SMM, 
skeletal muscle mass; SPPB, short physical performance battery test; TUG, timed up and go 
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Four participants dropped out from the EXD group. One was admitted to hospital with a chest 
infection prior to commencing the exercise and diet regimen and decided to drop out before 
starting with the programme. Another participant had been suffering from flare-ups of coughing 
due to unknown cause before commencing with the programme, and decided to drop-out for the 
same reason on the first day of the programme. The third participant decided to drop out at week-
3 after being home-bound for one week with symptoms of the seasonal flu. She reported that her 
peers and family members discouraged her from continuing with the programme as she was told 
that it is not something appropriate for her age. The fourth participant suffered a mini stroke at 
week-9 and dropped out.   
 
The exercise programme was generally well tolerated and no injuries were noted. There was one 
incident of a fall which was due to inappropriate footwear rather than weakness or poor balance. 
Although the participant who experienced the fall was happy to continue with the exercises, they 
were asked by the researcher to refrain from exercises for the rest of the day, and were present at 
the subsequent class, with no evidence of injury or discomfort.  
 
All results presented in the following sections refer to those participants who completed the 
programme, that is, 11 participants in total, six in the control (EX) and five in the intervention 
group (EXD). It was not possible to collect blood samples from one participant (EX group) at both 
time points (baseline and week-16), and from one participant at baseline from the EXD group. 
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6.4 Body composition  
Body composition changes in all participants who completed the study (EX: n=6; EXD: n=5) are 
presented in Table 6.6Table 6.6. From baseline to week16, participants in EX experienced a 
median (IQR) gain in bodyweight of 0.5 (0.0, 1.0) kg, whereas the EXD group lost 5.0 (5.0, 6.8) 
kg of bodyweight (Figure 6.2). It is important to note that the difference of the medians for any 
given variable does not necessarily coincide with the median differences for the same time points. 
For example, median bodyweight at baseline and week16 in EXD was 72.6 kg and 69.1 kg, 
respectively (Table 6.6), but the median change in bodyweight in EXD for the same period was 
5.0 kg (as presented in more detail in Table 6.7). 
  
Changes in body weight were mainly accounted for by changes in fat mass and skeletal muscle 
mass. In terms of absolute fat mass, the median fat mass change in EXD group was -4.7 (-4.8, -
4.2) kg, whereas EX group experienced a change of 0.0 (-0.4, 0.7) kg (Figure 6.2). The median 
change of SMM was positive in both groups [EX: 0.5 (0.3, 0.7) kg; EXD: 0.1 (-0.4, 0.7) kg] 
(Figure 6.2). The median change in the ratio of fat mass to skeletal muscle mass (FM: SMM) in 
week16 was -0.05 (-0.13, 0.00) in EX and -0.35 (-0.37, -0.25) in EXD.  
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Figure 6.2 Boxplots with changes in bodyweight (kg), fat mass (kg) and skeletal muscle 
mass (kg) from baseline to week16 for the EX and EXD groups. EX: n=6; EXD: n=5.  
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Table 6.6 Body composition changes over the course of 16 weeks for the two groups of participants who completed the study. 
    
Baseline Week 10 Week 16 Median (IQR) change 
baseline-week16   
median IQR median IQR median IQR  
EX  Weight (kg) 61.3 (55.1, 74.2) 62.4 (53.8, 73.9) 62.2 (54.7, 75.5) 0.5 (0.0, 1.0) 
n=6 BMI (kg m-2) 23.9 (22.6, 30.6) 23.9 (22.8, 30.6) 24.1 (22.9, 31.4) 0.3 (0.1, 0.4)  
%BF 43.8 (40.3, 51.4) 43.7 (39.1, 51.6) 43.7 (39.1, 51.8) -0.2 (-1.4, 0.5)  
FM (kg) 25.5 (22.9, 38.2) 25.0 (22.9, 38.1) 25.3 (23.1, 39.1) -0.1 (-0.4, 0.7)  
SMM (kg) 14.9 (14.1, 15.8) 15.4 (13.8, 16.2) 15.7 (14.3, 16.4) 0.5 (0.3, 0.7)  
SMI (kg m-2) 6.09 (5.82, 6.50) 6.20 (5.94, 6.60) 6.31 (6.16, 6.50) 0.22 (0.18, 0.29)  
SAD (cm)  22.7 (21.1, 27.0) 22.0 (20.2, 25.6) 22.4 (20.9, 25.1) -1.3 (-1.7, -0.3)  
FM:SMM 1.66 (1.54, 2.63) 1.65 (1.41, 2.65) 1.64 (1.47, 2.59) -0.05 (-0.13, 0.00)            
 
EXD Weight (kg) 72.6 (57.2, 90.3) 70.6 (51.8, 86.6) 69.1 (50.4, 85.3) -5.0 (-6.8, -5.0) 
n=5 BMI (kg m-2) 26.9 (24.6, 32.8) 26.2 (22.4, 31.5) 25.7 (21.8, 31.0) -1.9 (-2.7, -1.8)  
%BF 45.7 (42.6, 51.8) 44.0 (42.2, 49.7) 43.5 (41.4, 49.0) -2.4 (-3.3, -2.2)  
FM (kg)  29.5 (25.8, 47.1) 29.8 (22.4, 43.3) 28.7 (21.4, 42.1) -4.7 (-4.8, -4.2)  
SMM (kg) 14.5 (13.8, 18.7) 14.8 (13.7, 19.0) 15.2 (13.7, 18.6) 0.1 (-0.4, 0.7)  
SMI (kg m-2) 6.05 (5.67, 6.76) 5.95 (5.71, 6.87) 5.94 (5.83, 6.73) 0.05 (-0.11, 0.26)  
SAD (cm) 25.7 (23.9, 33.2) 26.0 (22.2, 32.5) 24.4 (20.7, 31.3) -2.0 (-3.1, -1.8)  
FM:SMM 1.90 (1.72, 2.77) 1.72 (1.63, 2.44) 1.66 (1.57, 2.37) -0.35 (-0.37, -0.25) 
            
%BF, percent body fat; BMI, body mass index; FM, fat mass; FM:SMM, fat mass to skeletal muscle mass ratio; LM, lean mass; 
SAD, sagittal abdominal diameter; SMI, skeletal muscle index; SMM, skeletal muscle; mass. 
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Table 6.7 Median bodyweight at baseline, week16 and median bodyweight change between 
the two time points. 
Group 
Participant 
No.  
Bodyweight (kg) 
baseline 
Bodyweight 
(kg) week16 Weight change (kg) 
EX 2 56.4 57.4 1.0 
 43 66.2 67.0 0.8 
 53 73.5 75.2 1.7 
 91 76.4 76.4 0.0 
 102 56.4 55.8 -0.6 
 105 51.2 51.4 0.2 
 Median 61.3 62.2 0.5 
     
EXD 5 104.6 99.6 -5.0 
 20 57.6 50.8 -6.8 
 49 56.8 50.0 -6.8 
 62 76.0 71.0 -5.0 
 107 72.6 69.1 -3.5 
 median 72.6 69.1 -5.0 
6.5 Strength & Physical performance 
All median (IQR) scores from the physical assessment tests performed at baseline, week10 and 
week16 along with median changes from baseline to week16 are presented in Table 6.8. A 
numerical improvement was noted in both groups from baseline to follow-up at week16 in all tests 
(handgrip, SPPB, gait speed, repeated chair stands (RCS), 1-arm reach, and timed up-and-go 
(TUG)), and muscle quality. The most noticeable change was that in time to complete five RCSs 
in both groups [EX: -4.3 (6.3,-2.3) s; EXD: -2.4 (-2.7,-2.2) s], TUG [EX: -1.6 (-3.2,-1.0) s; EXD: 
-1.2 (-1.8,-1.0) s] (Figure 6.3), and 1-Arm reach distance in EX: 7.6 (0.1, 9.1) cm.  
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Table 6.8 Physical function changes over the course of 16 weeks for the two groups of participants who completed the study.   
Baseline Week 10 Week 16 Median (IQR) 
change baseline-
week16   
median IQR median IQR median IQR  
EX  HG (kg) 24.5 (20.0, 30.8) 24.0 (21.3, 31.8) 26.0 (20.8, 31.8) 1.5 (0.5, 1.5) 
(n=6) Muscle Quality 1.67 (1.01, 1.82) 1.73 (1.48, 1.88) 1.66 (1.43, 1.94) 0.10 (-0.04, 0.05)  
SPPB 12 (10, 12) 12 (12, 12) 12 (12, 12) 0 (0, 2) 
 
GS (m s-1) 1.1 (1.0, 1.3) 1.4 (1.3, 1.6) 1.4 (1.4, 1.7) 0.4 (0.1, 0.5) 
 
RCS (s) 10.57 (7.87, 15.40) 7.56 (6.18, 8.08) 6.84 (5.57, 8.07) -4.3 (-6.3,-2.3) 
 
1-Arm Reach 
(cm) 
28.3 (23.3, 33.1) 32.9 (29.9, 35.9) 34.1 (32.3, 35.8) 7.6 (0.1,9.1) 
 
TUG (s) 6.23 (5.30, 7.85) 4.85 (4.42, 5.17) 4.36 (4.08, 4.73) -1.6 (-3.2,-1.0) 
           
 
EXD  HG (kg) 22.5 (18.0, 27.3) 23.5 (20.5, 28.8) 24.5 (19.0, 28.0) 1.0 (0.5, 2.0) 
(n=5) Muscle Quality 1.53 (1.11, 1.73) 1.66 (1.25, 1.80) 1.68 (1.27, 1.76) 0.06 (0.04, 0.14)  
SPPB  11 (9, 12) 12 (11, 12) 12 (12, 12) 1 (1,1) 
 
GS (m s-1) 1.1 (1.1, 1.3) 1.2 (1.0, 1.4) 1.3 (1.1, 1.6) 0.1 (-0.1, 0.3) 
 
RCS (s) 12.27 (10.80, 15.10) 9.76 (8.02, 15.48) 9.80 (7.42, 11.40) -2.4 (-2.7,-2.2) 
 
1-Arm Reach 
(cm) 
30.7 (25.2, 37.8) 32.7 (28.5, 34.2) 31.9 (28.1, 35.6) 1.3 (-5.1,6.4) 
 
TUG (s) 6.73 (5.61, 7.64) 5.67 (4.31, 6.98) 4.91 (4.56, 6.80) -1.2 (-1.8,-1.0) 
GS, gait speed; RCS, repeated chair stands; SPPB, short physical performance battery test; TUG, timed up and go 
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Figure 6.3 Boxplots with time to complete Repeated Chair Stands and a Timed Up and Go test, at baseline, week10 and week16. 
Left: Boxplots with time (s) to complete 5 repeated chair stands (RCS); Right: Boxplots with time (s) to complete a timed get up-and-go 
(TUG) test; n=6 in EX and n=5 in EXD. 
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6.6 Health Related Quality of Life (HRQoL)  
Median (IQR) baseline and week16 values, as well as the median changes (IQR) in domains of 
health related quality of life are presented in detail in Table 6.9.  Higher values for each domain 
indicate better quality of life. In EX, the median change from baseline to week16, was positive for 
all domains with the exception of perceived ‘Pain’ [median (IQR) change : 0 (-13, 13)]. A median 
change of 0 (0, 33) was also noted for the domain ‘Role limitations due to emotional problems’, 
however, that domain had scored the maximum points at baseline (100), hence the zero median 
change. Similarly, in EXD three domains (‘Role limitations due to physical health’, ‘Role 
limitations due to emotional problems’ and ‘Social Functioning’) scored a median of 100 points 
at baseline, and thus the median change from baseline to week16 was zero. In EXD, three negative 
changes were noted in ‘Energy/ fatigue’ [-5 (-5, 5)], ‘Emotional well-being’ [-8 (-12, 0)], and 
‘Pain’ [-10 (-13, 0)]. The median increase in perceived ‘Change in health in comparison to one 
year ago’ was the same in both groups 25 (0, 25). 
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Table 6.9 Changes in Perceived Health Related Quality of Life (HRQoL) in the EX and EXD groups from baseline to week16.  
EX (n=6) EXD (n=5) 
 
 
 
Baseline Week 16 Median (IQR) 
change 
baseline-
week16 
Baseline Week 16 Median 
(IQR) change 
baseline-
week16  
median IQR median IQR 
 
median IQR median IQR  
               
Physical 
Functioning 
 
70 (63, 90) 85 (74, 91) 10 (5, 15) 80 (70, 88) 80 (75, 98) 5 (0, 10) 
Role limitations 
due to physical 
health 
 
63 (44, 81) 100 (38, 100) 13 (0, 25) 100 (50, 100) 100 (88, 100) 0 (0, 0) 
Role limitations 
due to emotional 
problems 
 
100 (50, 100) 100 (58, 100) 0 (0, 33) 100 (67, 100) 100 (83, 100) 0 (0, 0) 
Energy/ fatigue 
 
48 (35, 63) 65 (46, 76) 15 (0, 20) 80 (40, 83) 75 (60, 85) -5 (-5, 5) 
Emotional well-
being 
 
74 (52, 86) 84 (70, 88) 4 (4, 24) 88 (74, 94) 76 (74, 86) -8 (-12, 0) 
Social 
Functioning 
 
81 (47, 100) 100 (66, 100) 6 (0, 25) 100 (75, 100) 100 (100, 100) 0 (0, 13) 
Pain 
 
78 (53, 93) 73 (59, 93) 0 (-13, 13) 80 (68, 95) 68 (63, 90) -10 (-13, 0) 
General health 
 
68 (44, 76) 73 (59, 93) 8 (5, 25) 65 (55, 88) 75 (68, 93) 10 (5, 20) 
Change from 
previous year 
50 (44, 50) 63 (50, 81) 25 (0, 25) 50 (38, 75) 75 (63, 100) 25 (0, 25) 
Scores for each domain can range from 0 to 100, with higher scores indicating better quality of life.   
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6.7 Dietary intakes 
Median (IQR) energy intake at baseline and week-16 in EX (n=6) was 1546 (1502, 1704) kcal and 
1531 (1343, 1601) kcal, respectively. In EXD (n=5) baseline energy intake was 1627 (1527, 1749) 
kcal, final was 1294 (1156, 1410) kcal, and the median change between the two time periods was 
-473 (-492, -333) kcal (Table 6.10). Absolute protein intake in EX was 57 (54, 60) g at baseline 
and 57 (51, 64) g at week16, whereas in EXD, 66 (61, 69) g at baseline and 97 (84, 102) at week16 
(Figure 6.4). The median increase in absolute protein intakes in EXD was 35 (27, 36) g. The 
median protein intake relative to bodyweight remained the same from baseline to week16 in EX 
[0.9 (0.8, 1.1) g kg bw-1]. In EXD it increased by 0.4 (0.4, 0.6) g kg bw-1 to reach 1.4 (1.1-1.7 g) 
at week-16.  In general, dietary intakes remained relatively stable in EX. In EXD carbohydrate 
(including free sugars), fat and saturated fat intakes, and their % contribution to total energy intake 
were numerically reduced. Vitamin D intakes (including supplementation) increased in both 
groups, in EX by 10.3 (2.9, 10.6) μg and in EXD by 9.0 (7.1, 10.0) μg. Calcium intakes changed 
by -40 (-97, 113) mg in EX and by 265 (133, 456) mg in EXD. All dietary intake median values 
from baseline and week16 (and median changes for the same period) are presented in Table 6.10. 
 
Figure 6.4 Boxplots with median (IQR) daily protein intake (g) at baseline and week-16 in EX 
(control; n=6) and EXD (intervention; n=5) groups. 
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Table 6.10 Baseline and follow-up dietary intakes in EX (control) and EXD (intervention) for those who completed the study.  
EX  
(n=6) 
EXD 
 (n=5) 
 
Baseline Week16 Median 
change 
(IQR) 
baseline to 
week16 
Baseline Week16 Median 
change 
(IQR) 
baseline 
to 
Week16 
 
Median  IQR Median  IQR  Median  IQR Median  IQR  
Daily Energy 
Intake (kcal) 
1546 (1502, 1704) 1531 (1343, 1601) -7 (-199, 
27) 
1627 (1527, 1749) 1294 (1156, 1410) -473 (-
492, -333) 
Daily Energy 
Intake relative to 
bodyweight (kcal· 
kg bw-1) 
26.4 (21.7, 28.1) 24.1 (19.5, 28.4) -0.2 (-4.5, 
0.6) 
22.4 (19.1, 27.6) 18.7 (14.4, 26.9) -3.9 (-5.4, 
-3.7) 
Daily Protein 
Intake (g) 
57 (54, 60) 57 (51, 64) 5 (-10, 8) 66 (61, 69) 97 (84, 102) 35 (27, 
36) 
Contribution 
Protein to EI (%) 
14 (13, 16) 17 (13, 19) 2 (-3, 5) 15 (13, 18) 29 (26, 34) 14 (12, 
18) 
Daily Protein 
Intake Relative to 
bodyweight (g· kg 
bw-1) 
0.9 (0.8, 1.1) 0.9 (0.8, 1.1) 0.1 (-0.2, 
0.1) 
0.8 (0.6, 1.2) 1.4 (1.1, 1.7) 0.4 (0.4, 
0.6) 
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Daily CHO Intake 
(g)  
173 (163, 197) 175 (144, 190) 9 (-51, 13) 170 (130, 210) 131 (120, 172) -25 (-46, -
2) 
Contribution CHO 
to EI (%) 
46 (42, 48) 46 (43, 48) 1 (-4, 3) 45 (39, 53) 45 (32, 490 -4 (-7, -2) 
Daily Fat Intake 
(g) 
65 (59, 81) 61 (54, 72) -3 (-9, 3) 55 (46, 80) 36 (20, 42) -27 (-34, -
19) 
Contribution Fat to 
EI (%) 
38 (32, 46) 37 (35, 40) 2 (-5, 4) 32 (25, 44) 25 (15, 27) -10 (-13, -
8) 
Daily Sat. Fat 
Intake (g) 
25 (21, 32) 21 (20, 36) -1 (-5, 6) 17 (15, 22) 14 (10, 16) -5 (-6, -4) 
Contribution 
Sat.Fat to EI (%) 
15 (11, 18) 14 (12, 21) 1 (-2, 5) 10 (8, 13) 9 (7, 11) -1 (-2, 1) 
Daily Free Sugar 
Intake (g) 
26 (17, 46) 20 (19, 50) 2 (-5, 15) 15 (13, 25) 6 (4, 22) -8 (-16, 3) 
Contribution Free 
Sugar to EI (%) 
7 (4, 11) 6 (5, 12) 1 (-1, 4) 4 (3, 6) 2 (1, 7) -2 (-4, 2) 
Daily Dietary 
Fibre Intake (g) 
18 (15, 20) 16 (8, 18) -2 (-6, 0) 18 (13, 20) 16 (13, 18) -2 (-4, -1) 
Vitamin D intake 
(μg) 
2.2 (0.7, 4.8) 10.9 (10.5, 14.5) 10.3 (2.9, 
10.6) 
4.4 (2.6, 7.5) 13.1 (11.9, 14.8) 9.0 (7.1, 
10.0) 
Calcium intake 
(mg) 
708 (584, 795) 721 (683 784) -40 (-97, 
13) 
723 672 876 1053 988 1149 265 (133, 
456) 
Abbreviations: CHO, Carbohydrates; EI, Energy Intake; Sat Fat, Saturated fat 
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6.8 Protein distribution 
At baseline, the protein intake in the three main meals, i.e., breakfast, lunch and dinner, in EX 
(control; n=6) was 11 (9, 15) g, 20 (10, 24) g and 28 (16, 35) g, respectively. The respective 
values for EXD (intervention; n=5), were 10 (7, 12) g, 15 (14, 16) g and 32 (30, 33) g (Figure 
6.5). At week16 the protein distribution in the three main meals in EX vs EXD was 9 (8, 11) g vs 
10 (6, 13) g in breakfast, 18 (13, 23) g vs 16 (12, 19) g in lunch, and 31 (17, 36) g vs 22 (17, 26) 
g in dinner, whereas the protein milk was consumed outside these meals and contained 50 g 
(Figure 6.6). Total protein intake was increased by 35 (27, 36) g in EXD.    
 
Figure 6.5 Boxplots with baseline protein distribution in main meals for those who 
completed the study. EX n=6, EXD n=5. 
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Figure 6.6 Boxplots with protein distribution in the main meals at week16. Notes: The milk 
supplement (first from the right) had a protein content of 50g and was consumed outside the 
main meals (either post-workout or pre-sleep) only by the EXD group. EX n=6, EXD n=5. 
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6.9 Blood markers 
Changes from baseline to follow-up for serum 25(OH)D, Insulin-like growth factor 1 (IGF-1), 
thyroid stimulating hormone (TSH), urea, creatinine and alkaline phosphatase, along with the 
reference values (as provided by the microbiology laboratory which conducted the analysis) are 
presented in Table 6.11. At baseline, six out of nine participants exhibited serum (25OH)D 
concentrations within the reference range (>50 nmol L-1), except participants no.20 (49 nmol L-1; 
EXD), no.53 (48 nmol L-1; EX) and no.102 (38 nmol L-1; EX) (Figure 6.7). After 16 weeks of 
supplementation with vitamin D, serum (25OH)D concentrations increased from 57 (43, 72) nmol 
L-1 to 79 (54, 88) nmol L-1 in EX and from 67 (53, 108) nmol L-1 to 87 (76, 117) nmol L-1 in EXD. 
In terms of individual changes, serum vitamin D (25OH) values increased in nine participants and 
decreased in two. Participant no.43 (EX) and participant no. 102 (EX) experienced a decline from 
83 nmol L-1 to 82 nmol L-1 and from 38 nmol L-1 to 31 nmol L-1, respectively (Figure 6.7). After 
16 weeks only participant no.102 exhibited levels below the reference cut-off. As reported in more 
detail in section 6.11 participant no. 102 discontinued the use of vitamin D tablets half way through 
the programme (week 8).    
 
All creatinine concentrations at baseline and week16 were within the reference range (Figure 6.8). 
Median (IQR) changes in creatinine were -3 (-4, 0) μmol L-1 in EX and -5 (-10, 1) μmol L-1 in 
EXD (Table 6.11). Individual serum creatinine levels declined, with two exceptions being 
participant no.43 (EX group) (increased from 67 μmol L-1 to 76 μmol L-1) and that of participant 
no.107 (EXD) which increased from 62 μmol L-1 to 64 μmol L-1 (Figure 6.8).  
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Table 6.11 Changes in blood markers from baseline to week-16 for EX (control) and EXD (intervention) groups. 
  
 
Baseline Week 16 
 
Reference 
value/range 
Median change 
(IQR) from 
baseline to 
week16 
% Median change 
(IQR) Baseline to 
week16 
  
 
median IQR median IQR 
 
   
EX  25(OH)D (nmol L-1) 57 (43, 72) 79 (54, 88) >50 15 (-1, 31) 24.6 (-1.2, 64.6) 
 n=5* IGF-1 (ng mL-1) 74 (54, 85) 75 (64, 84) 35-168 0 (0, 14) 0.0 (0.0, 18.9) 
  TSH  (mU L-1) 1.3 (0.4, 1.7) 1.1 (0.4, 1.8) 0.35-5.0 -0.1 (-0.1,0.4) -5.3 (-12.5, 28.6) 
  Urea (mmol L-1) 4.7 (4.1, 6.2) 5.2 (4.1, 6.1) 2.5-7.8 0.1 (-0.2, 0.4) 2.2 (-5.5, 7.5) 
  Creatinine (μmol L-1)  67 (59, 68) 64 (55, 73) 40-130 -3 (-4, 0) -4.4 (-6.6, 0.0) 
  ALP (U L-1) 74 (73, 100) 78 (71, 101) 30-130 3 (-3, 5) 4.2 (-3.3, 5.6) 
  hsCRP (mg L-1) 2.0 (0.5, 5.5) 2.0 (0.5, 4.0) <10 0.0 (-2.0, 0.0) 0.0 (-42.9, 0.0) 
  
      
     
EXD  25(OH)D  (nmol L-1) 67 (53, 108) 87 (76, 117) >50 19 (9, 27) 31.5 (11.4, 47.7) 
 n=5** IGF-1 (ng mL-1) 90 (83, 101) 104 (89, 123) 35-168 11 (-1, 29) 10.1 (-1.1, 32.3) 
  TSH  (mU L-1) 1.4 (0.3, 4.4) 1.5 (0.7, 2.1) 0.35-5.0 -0.1 (-1.8, 0.2) -12.5 (-38.3, 11.9) 
  Urea (mmol L-1) 5.2 (3.0, 6.9) 5.6 (4.0, 8.1) 2.5-7.8 1.2 (0.4, 1.4) 19.4 (3.4, 41.2) 
  Creatinine (μmol L-1)  67 (61, 73) 63 (60, 64) 40-130 -5 (-10, 1) -6.2 (-13.9, 1.6) 
  ALP (U L-1) 67 (56, 77) 65 (54, 78) 30-130 -4 (-11, 5) -4.7 (-18.4, 8.0) 
 hsCRP (mg L-1)  1.3 (0.5, 4.3) 0.5 (0.5, 1.6) <10 -0.8 (-2.3, 0.0) -30.0 (-67.5, 0.0) 
Notes: * it was not possible to collect blood samples from participant no.91 either at baseline or at follow up, therefore, n=5 for blood samples in 
EX. ** one blood sample was collected only at follow up but not at baseline for participant no.5, therefore, in EXD, n=4 at baseline and n=5 at 
week-16, respectively. ALP, alkaline phosphatase; hsCRP, high sensitivity C-Reactive protein; TSH, thyroid stimulating hormone  
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Unlike creatinine, median serum urea increased numerically in both groups, in EX by 0.1 (-0.2, 
0.4) mmol L-1, and in EXD by 1.2 (0.4, 1.4) mmol L-1 (Table 6.11). At baseline one participant 
had a serum urea concentration below the reference range, and at the end of the programme, one 
participant had serum urea above the reference range. In particular, serum urea for participant no. 
20 (EXD) increased from 7.4 mmol L-1 to 8.5 mmol L-1 over the course of 16 weeks (Figure 6.9).     
 
The median value for insulin-like growth factor-1 (IGF-1) changed from baseline to week-16, 
from 74 (54, 85) ng mL-1 to 75 (64, 84) ng mL-1 in EX and from 90 (83, 101) ng mL-1 to 104 (89, 
123) ng mL-1 in EXD (Table 6.11). All individual IGF-1 serum concentrations were within the 
reference range. Both groups experienced a similar change in thyroid stimulating hormone (TSH) 
(EX: -0.1 (-0.1, 0.4) mU L-1; EXD: -0.1 (-1.8, 0.2) mU L-1). Median change in alkaline phosphatase 
(ALP), was 3 (-3, 5) U L-1 in EX and -4 (-11, 5) U L-1 in EXD (Table 6.11). Serum high-sensitivity 
C - reactive protein (hsCRP) remained relatively unchanged in EX [median (IQR) change 0.0 (-
2.0, 0.0) mg L-1] and numerically declined in EXD [median (IQR) change: -0.8 (-2.3, 0.0) mg L-
1]. Individual serum hsCRP concentrations either remained constant or declined with one 
exception. Namely, participant no.2 (EX) experienced an increase in hsCRP levels from 2 to 4 mg 
L-1. All hs-CRP values at baseline and follow-up were within the reference range. 
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Figure 6.7 Individual changes in serum 25(OH)D concentrations from baseline to week16. 
The reference cut-off has been placed at 50 nmol L-1. 
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Figure 6.8 Individual changes in serum Creatinine concentrations from baseline to week16. 
The reference range is 40 – 130 μmol L-1.  
  
 
 
Figure 6.9 individual changes in serum Urea concentrations from baseline to week16. The 
reference range is 2.5-7.8 mmol L-1.  
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6.10 Attendance rates and compliance to diet 
The total number of exercise classes in the 16 week period was 48. Median (IQR) attendance rate 
to exercise was 73 (67, 81) %. All individual and group data are presented in Table 6.12. The 
attendance rates to the exercise classes for the two groups were 71 (60, 81) % in EX and 79 (54, 
85) % in EXD. Compliance to a) diet and b) consumption of the protein milk supplement in EXD 
was 80 (70, 87) % and 92 (79, 95) %, respectively.  
 
In general, compliance to diet and milk consumption was good. The main reasons for not adhering 
to the diet were periods of holidays and social get-togethers, whereas the majority of non-
attendances to exercise classes was accounted for by Christmas and Easter holidays (sports 
facilities were closed for 14 days and four days, respectively, and no classes took place during 
these periods), social commitments and periods of sickness.  
 
Two participants (no.91 in EX and no.107 in EXD) presented the lowest attendance rates to the 
exercise classes (Table 6.12). For participant no. 91, reaching QMU premises was a challenging 
task, because commuting via public transport took on average two hours (single direction). 
Participant no. 107 from EXD was still in part-time employment which allowed her to attend 
classes usually once or twice a week. Moreover, the same participant reported that adherence to 
the dietary protocol was not optimal because often her partner was responsible for 
cooking/preparing meals and additionally, because she liked to attend social events during 
weekends and/or after work.    
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Table 6.12 Individual and group attendance rates in exercise classes (%) and adherence to 
the diet and milk supplement for EXD (intervention group).  
 
Group Participant 
# 
Age (yr) Weight 
(kg) 
Adherence to 
diet (%) 
Adherence to 
milk 
consumption 
(%) 
Exercise 
class - 
Attendance 
rate (%) 
Control  2 74 56.4 
  
68.8 
(EX) 43 69 66.2 
  
66.7 
n=6 53 73 73.5 
  
79.2  
91 73 59.2 
  
39.6 
 
102 74 56.4 
  
72.9  
105 75 51.2 
  
87.5 
Median 
(IQR) 
 
    
71 (60, 81) 
       
       
Intervention 5 73 104.6 71.4 92.0 66.7 
(EXD) 20 67 57.6 91.1 96.4 87.5 
N=5 49 68 56.8 79.5 89.3 83.3  
62 77 76.4 83.0 92.9 79.2  
107 65 72.6 68.8 67.9 41.7 
Median 
(IQR) 
 
  
80 (70, 87) 92 (89, 95) 79 (54, 85) 
 
Notes: All participants are women 
 
 
6.11 Feedback from participants  
With regard to vitamin D supplementation only one participant reported side effects. After eight 
weeks participant no.102 from EX group expressed concerns that the Vitamin D supplement had 
triggered a flare-up of gastrointestinal pain that she had been experiencing chronically (due to 
IBS), therefore, she was advised by the researcher to discontinue the consumption of Vitamin D 
tablets. The same participant experienced a drop in serum 25 (OH) levels, and remained under the 
cut-off reference value for 25(OH)D, as presented in section 6.9.  
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One participant from the EXD group commented that consuming one bottle of protein milk every 
day became an ‘uncomfortable necessity’ towards the end of the programme but the fact that she 
was experiencing positive body composition changes was a strong motivational factor that helped 
her adhere to the regimen. At the end of week 16 she stated that she was feeling very well and 
being able to improve her body composition was an invaluable life achievement for her.  
 
At baseline, one participant from EX group reported symptoms of depression and was also 
concerned that certain family problems would prevent her from taking part in the programme. 
However, at the end she reported that the programme helped her feel better and she had one of the 
highest attendance rates (87.5 %).  At the start of the study, another participant from the EX group 
reported that she found great difficulty in performing a simple movement, i.e. to bend down to 
pick up an item from the floor. At the end of the 16 weeks she was able to fully adopt a correct 
squatting position without any support and reach the floor with her hands. A participant from the 
EX group stated that at the end of the trial she was able to take the stairs instead of using a lift 
without feeling exhausted, which was frequently the case before the trial commenced. She reported 
that her stamina improved substantially and she was also able to join her friends for outdoor walks, 
which was something that she was not able to perform prior to the trial, at least without feeling 
worn out; a feeling that was reported to be very demoralizing. Moreover, she mentioned that she 
experienced more regular bowel movements, which was a positive change.  
 
Participant no.5 (EXD) reported that before engaging with the programme she was told by her GP 
that she suffered from impaired fasting blood glucose and she was advised to start exercising. 
After taking part in the research study she reported that her fasting blood glucose had substantially 
improved, but no further information was given. In terms of physical function she reported that 
she was feeling stronger and able to do more everyday activities with less effort. She expressed 
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how disheartening it was for her to not be able to get up from a soft-cushioning sofa without 
assistance before the programme. By the end of the study she stated that she was able to rise from 
any sofas or chairs without any assistance. Additionally, when driving she was unable to turn her 
head to the side at a 90 degree angle, which was something that she could effortlessly perform at 
the end of the study, an ability that made her feel more confident in driving.   
 
Participant no.91, who was suffering from osteoarthritis in both hands, reported that the body 
weight exercises and the elastic bands gave her confidence in performing physical activities better, 
more effortlessly and with better co-ordination. For her, being able to maintain independence and 
body functionality was very important since she was also responsible for caring for her husband.  
Performing daily activities using her hands was challenging and resulted in a progressive decline 
in engaging with physical activities prior to the study. Although, she did not attend as many 
exercise sessions as she wanted to, the positive results that she experienced from this programme 
encouraged her to join an NHS led exercise programme taking place within her local community.    
 
With regard to diet, two participants no.5 and 107 reported that there were periods during this 
study which they were not feeling satiated during the day and wanted to snack more or increase 
their portion sizes. Moreover, participant no.107 reported that since her partner was often 
responsible for cooking and food preparation, it was difficult for her to adhere strictly to the 
regimen. Participants no.62 and 107 asked for some alcohol to be regularly allowed in their diet 
so that they can socialize with peers and family. They were advised that they could have a small 
glass of wine or small bottle of beer (330 mL) three times a week, but it should be complementing 
it with regular sips of still or sparkling water. Participants no.20, 49 and 62 expressed positive 
comments about the diet and did not find it a challenging task to adhere to it. Apart from participant 
49, the rest of EXD group found that switching between the different flavours of the protein milk 
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supplement encouraged them stick to the protocol. After this research study was concluded, 
participants who were keen to continue with an exercise programme were advised to visit 
appropriate settings at close proximity to their home. In addition, some participants wanted to keep 
exercising at QMU premises, therefore an exercise class for the over 60s was created at QMU 
sports centre for older adults who want to exercise on a regular basis, and it is now also open to 
the general public. At the end of the trial, there was a presentation delivered to all participants, in 
the form of an educational session, so that they could all receive information about healthy eating. 
Emphasis was placed on consuming at least five portions of fruits and vegetables every day, have 
balanced meals with adequate protein and healthy unsaturated fats, and how to limit the 
consumption of free sugars.  
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6.12 Summary 
In summary, after 16 weeks the high-protein hypocaloric diet resulted in weight loss in EXD 
[median (IQR) change: -5.0 (-5.0, -6.8) kg)], which was driven mainly by loss of fat mass [-4.7 (-
4.8, -4.2) kg]. A numerical increase in skeletal muscle mass was noted in EX [0.5 (0.3, 0.7) kg], 
and a maintenance in EXD [0.1 (-0.4, 0.7) kg]. Both groups improved their strength and physical 
function. Mixed results were obtained for quality of life, with the most noticeable numerical 
change being an increase in both groups in perceived health compared to previous year by 25 (0, 
25) points. Serum 25(OH)D increased in nine participants, and decreased in two, one of which 
had stopped taking the vitamin D supplement half-way through the programme. The higher protein 
intake in EXD (intervention) group did not appear to negatively affect serum creatinine.  
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Chapter 7. Discussion: Sarcopenic obesity in Scottish older 
community-dwellers. A cross-sectional study. 
 
7.1 Sarcopenia and sarcopenic obesity in Scotland: a comparison with the rest of 
the UK and world.  
This is one of the first studies to assess sarcopenia and sarcopenic obesity rates in Scottish older 
independent-living community-dwellers. In the present study the overall prevalence of sarcopenia 
was 14.8%, and of sarcopenic obesity 4.6% based on a BMI ≥ 30 kg m-2 or alternately, 12.0% 
based on increased body fat (≥ 28% in men and ≥ 40% in women). As discussed in this chapter 
these results are in agreement with the published literature (Cruz-Jentoft et al. 2014), however the 
scarcity of studies in this area (particularly in Scotland and the UK), combined with the lack of 
standardized operational protocols, as well as the plethora of definition criteria, render a direct 
comparison of prevalence rates across studies quite challenging. Nevertheless, the findings of the 
present study are discussed and compared with the most relevant data from studies on sarcopenia 
and sarcopenic obesity rates.  
 
7.1.1 Sarcopenia 
In the present study only one method for the detection of sarcopenia was used, in agreement with 
EWGSOP, however a plethora of different cut-offs exists (Cruz-Jentoft et al. 2010). In a recent 
study of 965 German men (≥ 70 years) in Germany, the rates of sarcopenia prevalence (defined 
using a local reference group of n=1189 young men) were 4.9% based on the EWGSOP criteria 
and 3.8% based on the IWGS criteria (Kemmler et al. 2017a). In addition to these two, another 
recently introduced diagnostic method was applied, developed by the Foundation National 
Institution of Health (FNIH; Studenski et al. 2014). The FNIH uses fixed cut-off scores for 
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handgrip strength (<26 kg in men and <16 kg in women) combined with an index of low lean mass 
normalized for BMI (low appendicular lean mass · BMI-1 <0.789 in men and <0.512 in women) 
(Studenski et al. 2014). Based on the FNIH criteria, the prevalence of sarcopenia in the same 
cohort of German older adults was 3.7%. Although there were not large differences in the 
prevalence rates derived from the three methods (4.9%, 3.8% and 3.7%), the actual overlap of 
these definitions was moderate at best (36%-47% overlap). That is, people who were classified as 
sarcopenic based on one method had less than a 50% chance of being diagnosed with sarcopenia 
based on another. The findings of that study agree with those of a previous trial that included 1,325 
women (Kemmler et al. 2016). That study reported that sarcopenia prevalence ranged from 3.3% 
(IWGS) to 4.5% (EWGSOP) but the overlap between the two was again moderate, with only 20 
women being defined as sarcopenic by both methods (~33-45% overlap).  The authors suggested 
that this discrepancy is likely to be accounted for by the different muscle mass cut-offs and the 
diagnostic tests employed in each methodology (e.g. gait speed vs handgrip).  
 
In the current study, the rates of sarcopenia (13.8% in men and 15.2% in women) were higher than 
those of Kemmler et al. (2016) and Kemmler et al. (2017a), whereas prevalence of low muscle 
mass alone, was alarmingly high at 62.1% in men and 36.7% in women. However, the reference 
cut-offs used in the current study, were fixed and derived from a US rather than a young adult 
Scottish population cohort, whereas those of Kemmler and colleagues were derived from local 
young adult healthy groups. Additionally, the sample size was relatively small, and as such, it 
cannot be corroborated whether it reflects the true sarcopenia rates for the whole population of 
Scottish community dwellers over the age of 65 years. It is however, surprising that approximately 
three out of five men and two of five women had a muscle mass below the reference values, even 
though many of them were ‘young old’, that is 65-74 years old (Zicca et al. 2009) and not 
physically weak as discussed later.  
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In a UK study, Patel et al. (2013) examined the prevalence of sarcopenia in English older adults 
from the Hertfordshire Sarcopenia Study (HSS) and the Hertfordshire Cohort Study (HCS). The 
reported rates in men were again lower that those of the current study, 6.8%-7.8% in HSS, and 
5.0% in HCS. In a cohort of older English women (n=1,022, mean age 67.1 years from the HCS 
cohort; Patel et al. (2013).), sarcopenia rates were ~8%, still lower than the rates noted in Scottish 
women in the current study. Similar to the present study, Patel et al. (2013) used the EWGSOP 
criteria for sarcopenia, however, muscle mass was measured by anthropometry (skinfolds), which 
may account for some of the differences noted in the two studies. A trial including the HCS cohort 
of English older adults compared the rates of sarcopenia using DXA for body composition 
analysis, and three different diagnostic criteria; the EWGSOP, IWGS and FNIH, and noted 
prevalence rates of 3.3%, 8.3% and 2.0%, respectively (Clynes et al. 2015). Therefore, even in the 
same population cohort, different criteria can potentially affect the outcome. However, it should 
be noted that although the studies by Patel et al. (2013) and Clynes et al. (2015) are not in absolute 
agreement, on average they report prevalence rates lower than the ones from the current study. 
Another trial from the UK in hospitalised older patients reported prevalence rates of sarcopenia of 
~10 % (Gariballa and Alessa 2013), whereas in COPD patients the rates have been reported to be 
be somewhat higher (15%) (Jones et al. 2015a), and similar to the current ones. Only Dodds et al. 
(2017) have reported higher prevalence rates in the UK than the present ones, with 21% of 
participants (149 out of 719) diagnosed with sarcopenia. However the mean age of participants in 
that study was 86 years, which is substantially higher than the median age of participants in the 
current study [70 (67, 75) yr].   
 
Based on these findings it could be hypothesised that the prevalence of sarcopenia is higher in 
Scottish community dwellers compared to the rest of the UK or other parts or Europe. Since 
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sarcopenia diagnosis was based on low muscle mass and low strength, for such hypothesis to be 
corroborated it would require a) the Scottish older adults to have lower muscle mass and strength 
than their counterparts, and/or b) BIA to systematically underestimate the amount of muscle mass, 
resulting in consistently lower muscle mass and higher prevalence of sarcopenia. In the current 
cohort the median value of hand grip in men was 42.5 kg, which is in good agreement with the 
national average for the same age group (39-43 kg; Dodds et al. 2014), but lower than the one 
from the HCS cohort (43.9 kg; Patel et al. 2013) and higher than that by Kemmler et al. (2017a) 
(36.2 kg). Similarly, women’s strength in the current study (23.5 kg) was in good agreement with 
the mean value from the study with German women (23.4 kg) (Kemmler et al. 2016), and with the 
national average (24-25 kg) (Dodds et al. 2014). Regarding BIA validity, it has been previously 
discussed that BIA is in relatively good agreement with DXA for assessing body composition 
(Ling et al. 2011), and therefore, is not likely to account for the high rates of low muscle noted in 
the current study. In fact some studies have shown that, if anything, BIA may overestimate the 
amount of skeletal muscle mass when compared against DXA (Beaudart et al. 2015; Buckinx et 
al. 2015), which may theoretically result in consistently lower prevalence rates of sarcopenia and 
not higher. In terms of skeletal muscle mass per se, there is currently a scarcity of data, since most 
studies have used lean mass (appendicular or total) as a surrogate for muscle mass (Patel et al. 
2013; Clynes et al. 2015) or mid-arm muscle circumference (Gariballa and Alessa 2013). Only 
Jones et al. (2015a) and Dodds et al. (2017) used a BIA-derived skeletal muscle mass value to 
assess sarcopenia, and the indices obtained from 85+ years old adults (SMI: 9.90 kg m-2 in men 
and 7.70 kg m-2 in women) and COPD patients (SMI: 9.61 kg m-2 in men and 6.93 kg m-2 in 
women) are very similar to the ones noted in the current study (section 5.1.1). This finding 
suggests that the current cohort was actually characterised by low muscle mass. Whether the latter 
hypothesis can be generalized for the whole older population of Scotland will need to be confirmed 
in future studies. However, as discussed in more detail in section 7.1.3, it is proposed that this may 
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be part of a wider health problem in Scotland that has been long identified, and has been linked to 
higher mortality rates (Leon et al. 2003).  
 
In other European studies, the rates of sarcopenia prevalence have been reported to be similar or 
even higher than these of the current study; for instance in Belgium, albeit in oldest old adults 
(mean age 85 years), the average rate of sarcopenia diagnosis in both sexes (n=103 men and n=185 
women) was 12.5% (Legrand et al. 2013). In the Netherlands sarcopenia was present in 17.4% of 
a cohort of older Dutch men (n=450) and women (n=434) (Bastiaanse et al. 2012). In a cohort of 
older Spanish community-dwellers (mean age 75 years) prevalence rates were 10% in men and 
33% in women (Masanes et al. 2012).  One of the highest rates of sarcopenia has been reported 
by researchers in Italy, with 67.7% of men and 20.8% of women, being defined as sarcopenic 
(Landi et al. 2012). The latter study was however conducted in a cohort of older adults residing in 
nursing homes (n=121, ≥ 70 years). In general, according to a systematic review by Cruz-Jentoft 
et al. (2014) prevalence of sarcopenia may range from 1-30% in community dwellers, and is 
expected to be somewhat higher in long-term institutionalized adults, ranging from 14% to 33%. 
According to Kemmler et al. (2017a), socio-economic and lifestyle differences between 
population cohorts may generate a strong confounder not only when comparing prevalence of 
sarcopenia in neighboring countries, but even within the same country. Such factors may include 
but are not limited to, income, education, deprivation index, access to healthcare, unemployment 
rates, and neighborhood/district (Mello et al. 2014; Kemmler et al. 2017a). However, this kind of 
information was not collected in the current study.   
 
With regard to gender differences the present study noted that although low muscle mass was 
observed in the majority of men (62.1% vs 36.7% in women), when handgrip was also taken into 
account, sarcopenia rates were reversed with more women being diagnosed as sarcopenic than 
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men (13.8% in men vs 15.2% in women). The fact that the two genders were not represented in 
equal numbers and men were mostly ‘young old’ (compared with women whose age was more 
evenly distributed across the cohort) may account to some degree for these differences. Studies 
have reported that sarcopenia may affect men more than women (Landi et al. 2012; Clynes et al. 
2015), however the study by Patel et al. (2013) argued for the opposite. According to the 
systematic review by Cruz-Jentoft et al. (2014), a consistent pattern in differences between genders 
is not evident and depends on the population cohort. In general, the topic of gender differences in 
predisposition to sarcopenia is not very easy to approach. In fact, one study reported that men ≥ 
65 years may be affected more from sarcopenia than women of the same age, but the pattern seems 
to reverse in those over > 85 years, with women experiencing higher rates of sarcopenia (Yamada 
et al. 2013). Thus, it is apparent that generalisations may not be prudent, as this is a very complex 
issue. An anecdotal observation from the current study was that the majority of men who attended 
the screening phase considered themselves physically ‘fit’ and were either seeking for more 
information about their body composition and strength status, or were encouraged to join the study 
by their partners. Therefore, it could be speculated that even if the muscle of men had atrophied 
over the years, they had maintained their physical function and strength through participation in 
physical activities, which would also explain the fact their handgrip was not lower than the 
national average. 
 
Besides obvious sources of discrepancy such as different diagnostic criteria and cut-offs, gender, 
age and ethnicity, a very recent study also highlighted the fact that the measurement tools can 
account for large differences between studies (Beaudart 2015). The authors stated that there may 
be up to a 2-fold difference between sarcopenia prevalence rates obtained using a pneumatic 
handgrip dynamometer vs a hydraulic one, even after calibration. Namely, the prevalence rates 
were 22.4% with a pneumatic dynamometer, as opposed to 11.4% with a hydraulic, which were 
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used to measure the strength of the same individuals, using the same criteria, methodologies and 
cut-offs. Another important factor to consider is that it was not until recently that studies included 
assessment of the performance of the different sarcopenia definitions in predicting physical 
disability and adverse health outcomes in older adults (Bischoff-Ferrari et al. 2015; Clynes et al. 
2015; Schaap et al. 2015), and their findings are so far conflicting. Therefore, it has not been 
corroborated which definition of sarcopenia is the most valid at predicting changes in health status, 
and as such, the main criteria for selection of a methodology are availability of resources, 
affordability and types of studies (e.g. field vs clinical/ lab based). Based on all the above facts the 
utility of sarcopenia prevalence (and consequently sarcopenic obesity) is currently questionable. 
This emphasizes more the need for universally adopted diagnostic criteria and simplification of 
the operationalisation process.    
 
7.1.2 Obesity  
According to the latest Scottish Health Survey, mean BMI has increased across all adult age-
groups since 2003 from 27.1 kg m-2 to 27.7 kg m-2, and obesity alone (BMI≥ 30 kg m-2) affects 
approximately 36% of the overall Scottish population aged 65-75 years (41% in men and 32% in 
women) (Scottish Government 2016a). These figures report obesity rates based on the BMI 
classification, however, no large-scale data have been reported in Scotland based on body 
composition indices, such as % body fat. In the current study, the obesity rates based on BMI were 
24.1% in men and 29.1% in women, which are lower compared to the Scottish average. This can 
be mainly attributed to the fact that participants were young old free-living community dwellers.  
In addition, participants of the current study were resident in areas of Scotland with a diverse 
deprivation index (Scottish Government 2016b). Obesity rates have been associated with the index 
of deprivation, with a ~10-20% difference in BMI-assessed obesity rates observed between 
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Scottish cohorts of different SIMD quintiles (Scottish Government 2016a). However, some rather 
conflicting results have also been presented, with those from the second highest deprived areas 
reporting higher obesity rates than their counterparts from the highest deprived areas (Scottish 
Government 2017), which suggests that factors other than deprivation may play an important 
factor.   
 
According to % BF classification, obesity rates in the current study were approximately 2-fold to 
2.5-fold higher than the BMI-derived prevalence rates. Namely, 41.4% of men (vs 24.1% by BMI) 
and 70.9% of women (vs 29.1% by BMI) were diagnosed with obesity based on the body fat cut-
offs. This finding agrees with published data showing that obesity rates may be substantially 
higher if body composition is used as a proxy for obesity instead of BMI (Kemmler et al. 2016; 
Kemmler et al. 2017a). In the study with older women prevalence of obesity based on BMI> 30 
kg m-2 vs prevalence based on % body fat (> 35%) was 19.8% vs 63.6%, respectively (Kemmler 
et al. 2016). Obesity prevalence rates in men were 63.3 % (for a %BF> 28%) vs 19.9 % (for BMI> 
30kg m-2) (Kemmler et al. 2017a). Although the magnitude of the differences in prevalence 
between BMI and BIA values cannot be reliably applied to the national averages, if it is 
hypothesised that there is at least a 2-fold difference between BMI-derived and % body fat-derived 
rates, then the real prevalence of obesity in Scottish older adults may be even greater than 70%. 
The implications of the discrepancies between obesity rates is discussed in detail in section 7.1.4. 
 
7.1.3 Sarcopenic Obesity 
Interpreting findings on sarcopenic obesity is even more complex compared with the two 
conditions alone. In the current study, an approximate 3-fold difference was demonstrated between 
the prevalence rates of sarcopenic obesity obtained by two different methods (Chapter 5 Results, 
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section 5.1.1). If more diagnostic criteria were used also for sarcopenia perhaps the difference 
would be further amplified. Batsis et al. (2013) has shown how variable the prevalence rates of 
sarcopenic obesity can be depending on the definition criteria and the assessment methods. In fact, 
they suggested that prevalence rates may differ by 19-fold in men and 26-fold in women, ranging 
from as low as 3% to as high as 96% depending on the definition criteria, and assessment methods 
used, as well as due to real differences related to population characteristics (e.g. age, gender and 
ethnicity). Similar to the present study, the two studies by Kemmler and colleagues (Kemmler et 
al. 2016; Kemmler et al. 2017a) aimed to examine these discrepancies and obtained similar results; 
that is, a ~2.5-fold difference between the sarcopenic obesity rates was detected when obesity was 
defined as high BMI vs high body fat. 
 
The heterogeneity in the diagnosis of sarcopenia, obesity and sarcopenic obesity (apart from real 
differences between different population cohorts) can be accounted for by various reasons. Firstly, 
there are different adiposity and muscle mass indices (BMI, %FM, WC, Fat mass index, SMI, 
ASMI, SMM · FM-1, ALM · BMI-1). Secondly, the determination of cut-offs has been based on 
quartiles, quintiles, fixed cut-offs based on regression analysis data and T-scores (2SDs below the 
average of a young/healthy population). Thirdly, there are different body composition assessment 
protocols (DXA, BIA, MRI, CT, ADP, skinfolds), and finally, even when similar protocols are 
employed the use of  different assessment tools (e.g. pneumatic vs hydraulic dynamometer) may 
account for the discrepancies (Prado et al. 2012; Siervo et al. 2014; Beaudart 2015). Given the 
complexity of the assessment methods, it is not surprising that studies show that the prevalence of 
sarcopenic obesity may vary from 0% to 100%, even in the same population cohort when different 
diagnostic criteria/protocols are used (Johnson-Stoklossa et al. 2017). This highlights the necessity 
for a single universally adopted operational definition, which should become the first priority since 
sarcopenia and obesity are particularly important for our swiftly-ageing societies.       
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In a preliminary study in a smaller cohort of Scottish older men and women (n=59, ≥ 65 years, 
independent living community dwellers and sheltered-housing residents in Lothian), 27 out of the 
59 screened (46%) were diagnosed with sarcopenia, and 21 of them were sarcopenic obese (36%) 
(Jones et al. 2015b). Although the rates of sarcopenia and sarcopenic obesity were higher than in 
the current study (perhaps because participants in Jones et al. (2015b) were older with a mean± sd 
age of 81.1± 7.2 years, and not all of them were independent-living dwellers), that study provides 
a relatively good comparison with the current one since the diagnostic criteria and assessment 
protocols were similar. However, some small differences were noted, e.g. Jamar dynamometer in 
Jones et al. (2015b) vs Takei in the current. The differences in prevalence rates underlines that 
even in cohorts from the same population source (in this case older adults from Lothian, Scotland) 
substantial differences can be observed. Although the study suffered from the same limitation as 
the current study, that is, the small sample size, it agrees with the previous hypothesis, and perhaps 
stresses it to a higher degree, that Scottish older adults may have lower muscle mass compared to 
their counterparts from the rest of the UK, and possibly other countries of the Western Europe.  
 
The characteristics of the current cohort were similar to Scottish national averages, that is, BMI 
was not significantly different than the Scottish average, and the proportion of participants with a 
normal, overweight and obese BMI was comparable to the national averages (15%, 44%, and 35% 
, respectively) (Scottish Government 2017). It could therefore be assumed that even though the 
current cohort size was small, it offers a relatively good representation of the Scottish older 
community-dwellers. Although the current study only provides a ‘snapshot’ of the current body 
composition status of Scottish adults, other published findings show that in the past years fat mass 
and particularly abdominal fat has been increasing disproportionally to muscle mass in Scottish 
older adults, and especially in women (Lean et al. 2013). It is also known that Scottish older adults 
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have higher average BMI, body weight, and waist circumference compared to their English 
counterparts (NHS National Archives 2016; Scottish Government 2017). Moreover, inflammatory 
responses increase with age in Scottish adults, and average blood hs-CRP concentrations in 
Scotland appear to be higher than England (Scottish Government 2012; Zheng and Xie 2017). 
Therefore, it is hypothesised that the low muscle mass findings of the current study may be part 
of a bigger issue that has been long identified, and has been termed ‘the Scottish effect’, which 
refers to Scotland as the ‘sick man of Europe’ (Leon et al. 2003; Minton et al 2017). Scotland has 
higher cancer, CVD, CHD, stroke, alcohol, drug-related mortality, and overall mortality rates than 
the rest of the UK but also the rest of Western Europe, and the gap continues to widen (McCartney 
et al. 2015; Bhatnagar et al. 2016; Minton et al. 2017). Perhaps it is the result of a chronic 
accumulation of stress and inflammation due to several reasons (e.g. unemployment, deprivation, 
alcohol misuse, low fruit and vegetable consumption, smoking) that may account for this 
phenomenon, at least to a certain extent (Leon et al. 2003; Hughes et al. 2015), which may also 
explain this shift towards higher body fat and lower muscle phenotypes. However, differences in 
deprivation and socioeconomic factors only explain some of the variability in mortality rates. In 
fact, even when adjusting for socioeconomic factors, Scotland still has higher CVD, cancer, and 
overall mortality rates than the rest of the UK and Western Europe (Bhatnagar et al. 2016). 
Recently, it has also been shown that muscle atrophy in older adults can increase mortality risk 
(Santanasto et al. 2017). This finding combined with the suspected low muscle mass of Scottish 
older adults, would indeed provide an additional factor that could explain some of the variability 
in the higher mortality rates in Scotland. The question is whether low muscle mass is actually 
prevalent in Scotland and this combined with increased adiposity per se leads to increased 
mortality; or perhaps it is the general lifestyle and other factors (e.g. age, sex, ethnicity, genetic/ 
biological factors, psycho-cognitive status), that may promote deterioration of body composition 
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and increased mortality rates. In either case, it underlines the necessity for immediate actions in 
Scotland and more studies to explain this phenomenon.  
 
7.1.4 Importance of body composition in older age and implications of different 
classification criteria 
In Scotland, long-term conditions are responsible for 80% of GP consultations and for over 60% 
of all cause-mortality (Scottish Government 2009). The prevalence of such conditions can range 
from 21% in young adults to 60% in those older than 75 years, with the steepest increase in health 
conditions occurring between the 65-74 years group and the 75+ group (from 45% to 60%, 
respectively) (Scottish Government 2016a).  
 
Despite the fact that obesity can promote adverse health events, its definition and operational 
diagnosis in older adults has not been robustly established, which can have a subsequent effect on 
the diagnosis of sarcopenia and sarcopenic obesity. Although BMI can predict the risk of disorders 
such as CVD and type II diabetes, its sensitivity especially in older age is only modest, 
predominantly due to its inherent inability to distinguish between the two main body components, 
that is, fat mass and lean mass (Ashwell et al. 2012; Siervo et al. 2014). In the current study, it 
was evident, especially in women, that high fatness can be present even at normal or overweight 
BMIs. This is in agreement with Koster et al. (2011) and Sahillary et al. (2016) who reported that 
a mean BMI of ~27 kg m-2 in older adults corresponds to a mean % body fat of ~28% in men and 
~42% in women. Moreover, making assumptions on health risks based on BMI may affect the 
interpretation of data, since within any given BMI category there may be older adults with 
increased body fatness (also supported by Stokes 2014), which would directly imply lower lean 
mass. In fact, the only participant in the current study with a BMI below 18.5 kg.m-2 had a % body 
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fat > 40%, which was, unsurprisingly, accompanied by a very low muscle mass. However, most 
studies to date have been observational and therefore, cause and effect cannot be determined. This 
highlights the importance of measuring not only body composition but also the ability of certain 
cut-offs to predict changes in function and morbidity/mortality rather than simply reaching 
conclusions based purely on body size from observational studies (Berrigan et al. 2016).  
  
The present study showed a 2-fold difference in the prevalence of high adiposity based on BMI vs 
%BF. This is in agreement with Okorududu et al. (2010) who noted that a BMI of 30 kg.m-2 can 
misidentify high body fatness in > 50% of the cases in older adults, which then profoundly 
underestimates the true prevalence of obesity. Therefore, the use of BMI as an obesity surrogate 
in older age can lead to a serious underestimation of obesity and subsequently sarcopenic obesity 
diagnosis (Newman et al 2003a; Kemmler et al. 2016). In fact, it has been suggested that the ideal 
BMI cut-off in older adults is 25 kg m-2, since a BMI of 30 kg m-2 carries a very low diagnostic 
accuracy and sensitivity, and the majority of older adults are likely to exhibit high adiposity if 
body fatness is assessed based on %BF (Batsis et al. 2016).  
 
Newman et al. (2003a) suggested that BMI is associated with fat mass, lean mass and lean mass 
adjusted for stature (LM · height-2). In fact, absolute lean mass is likely to be higher in an obese 
individual than their lean counterpart since weight gain leads to an increase in both lean and fat 
mass (Newman et al. 2003a; Muller et al. 2016). Newman et al. (2003a) reported that using lean 
mass adjusted for stature as a surrogate for sarcopenia leads to low likelihood of overweight and 
obese individuals be diagnosed with sarcopenia. That is, in high BMIs even if muscle is ‘normal’ 
either in absolute amounts or relative to stature, it may be low in relation to fat mass. For these 
reasons, some scientists have gone as far as characterising the use of BMI in older age as ‘absurd’, 
especially when focusing on conditions such as sarcopenia and sarcopenic obesity (Kemmler et 
231 
 
al. 2017a). Considering that BMI is perhaps the most frequent tool used in primary health settings, 
this questions the need to re-evaluate the importance of body composition changes in older age 
and how these can be diagnosed in practice.  
 
The present study has shown that the use of BMI and % body fat may result in different phenotypes 
in terms of muscle mass and strength between those who are obese vs non-obese counterparts. 
Namely, muscle mass in the obese group was higher than the non-obese based on BMI, however, 
when  %BF was used to define obesity, the opposite pattern was observed, with the non-obese 
having higher muscle mass, as well as strength compared to the obese group. This has also been 
implied by Newman et al. (2003a), who reported that the use of BMI can mask sarcopenia since 
individuals with higher BMIs are likely to have higher absolute (or adjusted for stature) muscle 
mass due to their high overall mass. For example, a person weighing 100 kg out of which 30 kg 
are muscle mass, will have a higher muscle mass or muscle index (muscle mass · height-2) than a 
counterpart of similar age and height, with a 50 kg bodyweight and 25 kg muscle mass. Recently, 
a study with 674 women >65 years old assessed differences in muscle mass index between 
participants with obesity (based on BMI) and their normal-weight counterparts (Muscariello et al. 
2016). Their findings are in agreement with the current study, demonstrating that the obese group 
had a significantly higher muscle index compared with the non-obese (9.3 kg m-2 vs 8.1 kg m-2). 
However, the same comparison was not conducted based on % body fat classifications, nor were 
strength data presented, which would offer a direct comparison with the present study. 
Nevertheless, muscle mass index was assessed via bioelectrical impedance analysis in the study 
by Muscariello et al. (2016), in addition to using also the same prediction equation as in the present 
study.  
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The impact of the use of BMI on muscle mass phenotypes has been also observed by Graf et al. 
(2016), who assessed the prevalence of low muscle mass in 3,122 older German individuals. It 
was reported that those with higher BMIs (>25 kg m-2) were less likely to be identified with low 
muscle mass compared with their eutrophic counterparts (Graf et al. 2016). This may have wider 
repercussions, for instance, limiting the pool of potential participants with sarcopenic obesity, 
conflicting interpretation of research findings (e.g. the ‘obesity paradox’), or incapacity to 
compare the effectiveness of intervention strategies. Similarly, Beaudart et al. (2015) suggested 
that if the clinical characteristics and phenotypes in older adults are different depending on the 
tools or methodologies used, then the long term health consequences of body composition-related 
conditions may differ, and as an outcome will be challenging to evaluate the effectiveness of 
therapeutic strategies.   
 
In the current study, the associations between muscle quality and body weight, absolute fat mass, 
and sagittal abdominal depth (SAD), were all significant (section 5.1.3). In terms of SAD, there 
are no other studies showing a direct relationship between muscle quality and SAD per se, and 
this finding could be further examined mechanistically in larger cohorts. It can be hypothesised 
that this relationship could be partly an indication of increased myosteatosis (Reinders et al. 2016) 
and/or mediated by pro-inflammatory agents (Beasley et al. 2009; Zoico et al. 2010). Reinders and 
colleagues reported that intermuscular and intramuscular fat deposition can be deleterious for 
muscle quality, and more importantly, for every SD-increment in myosteatosis the mortality risk 
can increase by 13-23%. 
 
The assessment of muscle quality in the current study was based on handgrip strength and not on 
a weight-bearing strength exercise, therefore, in theory fat mass should not be a confounder. 
However, fifteen individuals exhibited poor muscle quality (lower than the 25% percentile) even 
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though they had an adequate amount of muscle mass and were not sarcopenic. The most 
characteristic example was participant no. 44 who had a high amount of absolute muscle mass but 
low muscle quality. Therefore, it is suggested that fat tissue can account for some of the variance 
in muscle quality. In the current study, this appeared to be relevant especially in men since it 
accounted for 24% of the variance in muscle quality. This could be partly accounted for by gender 
differences, such as visceral adiposity, which appear to be more pronounced in older men than 
women of similar age and body composition (Beasley et al. 2009). As reported in Chapter 1, 
visceral adiposity is particularly associated with cytokines production that may negatively affect 
indices of sarcopenic obesity, such as muscle mass and strength.  
 
The relationship between fat mass and muscle quality has also been examined in other studies. 
Vilaca et al. (2014) used a %BF >38% as a surrogate for obesity in 75 Brazilian older women (65-
80 years old) and found that the obese women had significantly lower muscle quality compared 
with their eutrophic counterparts. Muscle quality, however, was measured as strength standardised 
for lean mass in the respective limb (e.g. handgrip strength over arm lean mass or knee extension 
over leg lean mass). Such measurements were not feasible in the present study due to technical 
limitations. Koster et al. (2011) examined data from 1,178 women and 1,129 men from the Health, 
Ageing and Body Composition study (ABC study) cohort. At baseline, one standard deviation of 
fat mass was associated with 1.3 kg and 1.5 kg more lean mass in men and women, respectively. 
However, when lean mass was normalised (i.e. adjusted) for body weight (lean mass · body 
weight-1), a higher fat mass was associated with a lower lean mass (normalized), in both sexes. 
Moreover, those with higher fat mass at baseline experienced the steepest losses in lean mass after 
three years follow up (approximately 0.2 kg of leg lean mass was lost per year).  
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Using data from the same cohort of older adults (the ABC health cohort), Newman et al. (2003b) 
conducted further analysis aiming to determine the % body fat characteristics of older men and 
women for optimal muscle quality. Their findings indicated an inverted U-shape relationship 
between muscle quality and body fatness, with very low or very high levels of % body fat 
exhibiting the lowest muscle quality, whereas at body fat ranges of ~ 16% - 22% in men and 26% 
- 34% in women, muscle quality was optimal. However, despite the significant association 
between muscle quality and body fat, which is consistent with the current study, Newman et al 
(2003b) proposed that other factors, such as the proportion of muscle fibre types, increased 
connective tissue with advancing age, and altered muscle metabolism may also account for some 
of the variation in muscle quality.  
 
Therefore, it can be proposed that it is not only the absolute amount of muscle or fat mass, but also 
factors, such as the relative contributions of the different tissues, that can play an important role 
in older age. Indeed, the ratio of visceral fat to thigh muscle area assessed by computed 
tomography (CT) has been shown to be associated with an increased risk of metabolic syndrome 
in the Korean Sarcopenic Obesity Study (KSOS; Lim et al. 2010). On a similar note, a higher ratio 
of lean mass to fat mass has shown association with a lower likelihood of functional impairments 
and a higher gait speed, in 1,655 older adults (Sternfeld et al. 2002). The ratio of lean mass to fat 
mass can also predict a 4-year risk of physical disabilities, as demonstrated in a study with 3,153 
Chinese older adults (Auyeung et al. (2013). These findings highlight that apart from the absolute 
amount of fat mass, fat distribution and the relative proportion of fat to muscle mass also play a 
vital role. In fact, new models have emerged, suggesting that body composition assessments 
should take into account the health impact of both adipose tissue and lean mass within an 
individual. One such paradigm is the metabolic-load and metabolic-capacity model proposed by 
Siervo et al. (2015), which proposes that health risks should be estimated based on the relative 
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contribution of the two key components, fat mass (total and truncal) and lean mass, to 
physiological functions. 
 
Considering that overweight/obese adults will usually receive advice, such as embarking on a 
weight loss diet and increasing physical activity levels (NICE 2014) based on their BMI, it is 
plausible to assume that if BMI lies within the normal range they are not likely to be encouraged 
to change lifestyle practices, especially since the majority of GPs are still unfamiliar with the PA 
and health guidelines, or they do not have the time to engage in relevant consultations (Chatterjee 
et al. 2017; Cottrell et al. 2017). Not only that, but to date specific guidelines exist for 
undernourished older adults, obese adults, older institutionalised adults, and those with recurrent 
falls (NICE 2014; GOV UK 2017; NICE 2017), but not for independent-living dwellers who 
perhaps fall between normal overweight BMI ranges, some of who may be sarcopenic and/or 
obese based on a high % BF. In the current study there were cases of adults with a high %BF, but 
within a normal BMI range, who stated that clinicians have never discussed with them about body 
composition during older age, nor provided them with specific guidelines for diet and exercise, 
that may help them sustain or increase their muscle mass while promoting fat losses. On the other 
hand, those individuals with an increased BMI who will be advised to start a weight loss regime, 
without taking into consideration the amount of lean mass, the ratio of fat to muscle or distribution 
of fat, may jeopardize their health. This type of advice may be detrimental for the physical and 
overall health status of older adults who may be suffering from undiagnosed muscle atrophy 
(Johnson-Stoklossa et al. 2017). From a public health perspective, if sarcopenia and sarcopenic 
obesity are not detected at an early stage (ideally early detection during a visit to the GP), then the 
resultant impact on health may not be identified until at a late stage when sarcopenic obesity is 
established, and/or hospitalization is required. Hospitalisation and low physical activity can reduce 
muscle mass by ≥1 kg following as little as five days of bed rest (Ferrando et al. 2010; Dirks et al. 
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2017), which is very probable given that the average length of stay in hospital is one week 
(Eurostat 2017). Apart from the direct effect of reduced activity/hospitalization on muscle atrophy, 
the issue may become even more complex considering that neither muscle mass nor its ability to 
uptake and utilize glucose are likely to return to pre-admission levels, resulting in impaired glucose 
tolerance (McGlory et al. 2017). Additionally, even if physical activity and dietary patterns return 
to normal, MPS rates are likely to remain lower compared with pre-hospitalisation (McGlory et 
al. 2017). That is, failing to detect sarcopenia and sarcopenic obesity early, may result in an 
exacerbated cycle of muscle loss, anabolic resistance and increased risk of comorbidities.     
 
In summary, it is essential that a universally adopted operational protocol is agreed for the 
classification of obesity, sarcopenia and sarcopenic obesity in older age. It is also suggested that 
the use of BMI should be complemented with an index of body composition and fat distribution, 
such as % BF, fat to lean ratio, or lean mass/muscle mass adjusted for BMI, using a practical tool, 
such as BIA, unless a more robust method such as MRI, DXA or CT is available. As already 
discussed, BIA can be a very practical and affordable alternative ideal for use at a community 
level. In addition to body composition, a simple test of strength (e.g. handgrip) or function 
(walking speed) could be implemented by clinicians and health professionals in clinical settings 
and research studies for diagnostic purposes, in order to provide a more reliable evaluation of the 
physical capacity of the individual as recommended by the EWGSOP.  
 
7.2 Recommendations for future research  
Firstly, in terms of the operational diagnosis of sarcopenia, obesity and sarcopenic obesity, the 
sole use of BMI as a classification tool may not be the most appropriate method since the 
aforementioned conditions can be manifested even with normal BMIs. A large-scale study should 
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be conducted using either DXA or BIA for the measurement of body composition of older adults, 
particularly across different areas of Scotland, in order to form a clear picture of the true 
prevalence rates of sarcopenia and sarcopenic obesity. Dietary intakes should also be assessed in 
order to draw more robust conclusions about the relationship between protein intakes and body 
composition/ function. A longitudinal study should be conducted to assess the validity of the 
different definitions/cut-offs to predict adverse health effects. Secondly, at a community level, 
since nurses, physicians and GPs are usually the first point of contact for older adults when it 
comes to health issues, they should be better informed regarding healthy aging strategies and 
introduce affordable and reliable tests, e.g. walk test or hand grip test alongside BIA, in order to 
direct older adults to the appropriate health professionals.  
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Chapter 8. Discussion: A complex exercise and high-protein 
intervention to augment body composition and function in older 
age. A randomised controlled trial.     
 
When this study was introduced, it was the first one to combine a nutritional intervention with 
exercise training for sarcopenic obese older adults. Further, the scope of this study was to be a 
community-based rather than laboratory based study. Moreover, there is currently a paradigm shift 
from single ingredients/foods/interventions to more holistic approaches for the treatment of 
sarcopenic obesity, which underlines the importance and novelty of the current protocol. For 
example, as discussed later in this chapter, there are emergent studies that utilise the synergistic 
effect of different concepts such as protein/amino acids ingestion with Vitamin D and/or calcium, 
alongside exercise training (whole body training with mixed exercise elements). When this study 
was first designed in 2013, it was one of the first internationally to merge some of these paradigms 
into one study, targeting sarcopenic obese older adults. Although since then more studies have 
been published in this area, there is still a substantial lack of interventions providing ≥ 1.2 g protein 
kg bw-1 in older adults (Traylor et al. 2018). In addition, this study is the only one to combine 
higher protein intakes with a calorie deficit, vitamin D supplementation and whole body mixed 
exercise training for sarcopenic obese older adults. More importantly, although the sample size 
was small, this was one of the first studies to show that a substantial amount of fat loss can be 
achieved with a concomitant preservation of muscle mass. In addition, this is one of the first 
studies to provide preliminary but targeted evidence on protein intakes of sarcopenic obese older 
community dwellers.   
 
This chapter discusses the findings of the second part of the thesis, the intervention programme. 
Only participants who had a low muscle mass index with a concomitant high %BF were eligible 
to take part in the intervention trial. Changes in body composition, function and blood markers, 
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along with their dietary intakes are discussed in the following sections. Further, this chapter 
discusses the applicability of the study protocol to community settings, the challenges faced, and 
recommendations for future studies.  
 
8.1 Effectiveness of a lifestyle intervention in augmenting body composition and 
function in older adults with increased body fat and low muscle mass  
The challenges faced with sarcopenic obesity are complex considering that the aim of intervention 
strategies is to attenuate muscle atrophy, while promoting fat loss and a concomitant augmentation 
of physical function. Relative protein intakes of  > 1.0 g kg bw-1 (and up to 3.0 g kg bw-1) have 
the potential to suppress muscle mass losses during energy restirion (ER) (Churchward-Venne et 
al. 2013; Kim et al. 2016b), but in older adults with low muscle and high fat mass the ideal 
condition would be to attenuate these losses completely. Therefore, the most effective approach 
for weight loss interventions in obese older adults is to accompany a dietary approach with an 
exercise programme (Batsis et al. 2017). However, based on the findings presented in Chapter 2 
when this trial was designed there was insufficient evidence of a successful intervention achieving 
favourable changes in body composition of sarcopenic obese older adults, by exercise, diet or a 
combined intervention. Therefore, what was achieved in the current study was, and still remains, 
novel and provides useful information that can inform future studies.   
 
In the present trial an ER diet supplemented by a high-protein drink (resulting in a total daily total 
of 1.2-1.5 g protein kg bw-1) led to losses of approximately 5 kg of fat mass, whereas muscle mass 
was maintained. Participants in the exercise-only group who followed their habitual diet 
experienced a slightly larger increase in muscle mass of ~ 0.5 kg  but the change in fat mass was 
negligible. These results agree with the findings of Batsis et al. (2017), who suggested that exercise 
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alone can improve physical function but is not likely to lead to significant fat losses. Although 
these findings need to be confirmed in a bigger cohort, the addition of a protein supplement during 
ER appears promising in terms of body composition augmentation. However, a clear increase in 
muscle mass in the protein group was not observed, which could indicate that either a) increasing 
protein intake may attenuate muscle loss but cannot increase muscle mass more than exercise 
alone b) protein intake may need to reach > 1.5 g protein kg bw-1 in order to induce hypertrophy, 
especially in the presence of energy restriction. 
 
Although positive changes in body composition were noted in the current trial with the use of a 
protein supplement, the effectiveness of protein supplementation in enhancing muscle mass 
alongside resistance exercise (RE) is controversial (Morton and Phillips 2018).  Two recent meta-
analyses (Thomas et al. 2016; Morton et al. 2018) supported that the addition of extra protein to a 
RE regimen may not offer additional benefits in terms of muscle adaptations (size and strength) 
compared to RE alone, in healthy, frail or sarcopenic older adults. However, the findings of 
another meta-analysis in older adults (Liao et al. 2017a) were in favour of the synergistic effects 
of protein supplementation with resistance exercise, while others stand somewhere in between. 
For example, Finger et al. (2015) reported that protein supplementation with exercise may increase 
fat free mass but not muscle mass or strength. There are various factors that may account for these 
discrepant results. First and foremost, the cohorts in the reviewed studies were not homogenous, 
and as it has been discussed throughout this thesis, the nutritional needs and physiological 
adaptations can be different in healthy vs obese older adults. Moreover, it is currently unknown 
whether the anabolic response to protein feeding and exercise is different in older adults who 
suffer from both sarcopenia and obesity compared to obesity-alone, which therefore, warrants 
further research. For example, in older sarcopenic obese and non-sarcopenic obese women 
following exactly the same exercise protocol, only the non-sarcopenic obese group experienced 
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improvements in body composition (reduced %BF, fat mass and waist circumference) but not the 
sarcopenic obese group (Silva et al. 2018).  
 
Therefore, the lack of significant change or the discrepancies between studies may also be 
accounted for by the anabolic resistance phenomenon which can be manifested particularly in 
obese adults due to a diminished post-prandial MPS in response to protein-dense foods. This was 
first hypothesised and confirmed by Beals et al. (2016), however, participants in that study were 
young adults. Recently, Murton et al. (2015) and Smeuninx et al. (2017) confirmed this finding in 
older individuals. In the study by Smeuninx and colleagues, apart from old age, leg fat mass was 
found to be significantly negatively associated with myofibrillar protein synthesis in older adults. 
In addition, in lean older adults the myofibrillar MPS rates rose significantly higher during the 
post-prandial state (~38%) compared with baseline, whereas in obese older adults MPS did not 
change significantly (~9%) in either of the groups after ingestion of 15 g milk protein isolate, with 
both groups having similar muscle mass (Smeuninx et al. 2017). To date, no data exist for the 
potential differences in MPS rates between sarcopenic obese vs non-sarcopenic obese vs healthy 
older adults. Therefore, it should be determined whether or not sarcopenia alone or combined with 
obesity in older age can deteriorate MPS rates, which potentially explains the lack of significant 
changes in long-term studies with older adults.  
 
Secondly, protein supplementation pre- and/or post exercise training may not offer added benefits 
in terms of muscle hypertrophy if protein intake is already adequate. It has been shown that 
supplementation with 20 g protein in older men (76 ± 2 yr) cannot increase muscle fibre size more 
than exercise alone (~20% increase primarily observed in the type II fibres) (Verdijk et al. 2009). 
However, the lack of an additive effect might have been accounted for by the fact both groups had 
similar protein intakes, despite the extra supplemental protein in the intervention group. It has 
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been often documented in the literature that the addition of extra protein may displace other foods, 
either by direct replacement of habitual meals or indirectly via enhanced appetite control, e.g. 
increased feeling of satiation (Ferrando et al. 2010; Arentson-Lantz et al. 2015; Kerstetter et al. 
2015). As discussed in Chapter 2, section 2.4, this could have influenced the results in the study 
by Aleman-Mateo et al. (2012), since the addition of cheese to the habitual diet possibly induced 
faster satiation, and possibly full meals were not completed. Moreover, a high protein breakfast 
(~ 40 - 50 g protein), may affect appetite hormones (e.g. ghrelin) and impact subsequent meals, 
leading to reduced appetite and lower energy intake (Pal and Ellis 2010; Jacubowicz et al. 2017). 
While this would be advantageous for weight-loss purposes, it may add confounders in studies 
aiming to augment muscle mass in older age. Finally, the composition of the food matrix in the 
digesta per se may affect the rate of appearance of amino acids in circulation, e.g. carbohydrates 
may delay protein digestion and absorption with no impact on muscle accretion rates in healthy 
older adults (Gorissen et al. 2014). However, it is unknown whether co-ingestion of nutrients such 
as carbohydrates, dietary fibres and fat can potentially impact on MPS, positively or negatively, 
in older adults with reduced anabolic sensitivity.   
 
In the current study, the protein supplement was consumed at times where it theoretically would 
not directly affect other meals, i.e. immediately after the exercise class, or before bed. The purpose 
of providing a protein milk in the current study was not to add 50 g of extra protein on top of the 
habitual diet, but to help participants reach the targets for relative protein intakes (1.2 – 1.5 g kg 
bw-1), while restricting moderately their food intakes. Physical activity may affect appetite control 
and energy intakes, with a single exercise bout reported to increase the perceived pleasantness of 
high-carbohydrate and high-fat foods in women on restricted diets (Lluch et al. 1998; Beaulieu et 
al. 2016), which may potentially compromise the ER plan (and possibly even more so in older 
adults who, as discussed in Chapter 1 section 1.1.2, already have a higher preference for ‘sugary’ 
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foods). Therefore, the protein milk administered in this study was advantageous for multiple 
reasons;  potentially greater feelings of satiety that would help participants adhere to the weight 
loss plan while increasing relative protein intakes, as well as providing a flavoured milk-based 
protein-carbohydrate load to potentially a) satisfy the need for something sweet after exercise, b) 
restore glycogen (Biensø et al. 2015), c) rehydrate participants (Shirreffs et al. 2007), especially 
since dehydration is a widespread issue in older British adults, even in those with higher levels of 
independence (Wilson 2014), and d) repair and remodel muscle proteins (Phillips and van Loon 
2011).   
 
The amount of supplemented protein in studies with middle aged and older adults is only ~20 g, 
which based on the current knowledge is considered low and may also offer a possible explanation 
for the lack of added benefits in protein supplementation studies (Morton et al. 2018).  As 
previously discussed, an absolute or relative protein intake per meal should be ~35-40 g or ~0.4-
0.5 g kg bw-1, respectively, in order to overcome the anabolic resistance in older adults and 
significantly increase muscle protein synthesis rates (Moore et al. 2015; Witard et al. 2016b). In a 
trial with healthy adults aged 50-70 years, increasing relative protein content in breakfast and 
lunch from ~0.24 g kg bw-1 and 0.31 g kg bw-1, respectively to ≥ 0.4 g kg bw-1, resulted in 
significant increases in lean mass after 24 weeks (Norton et al. 2016). Further to the relative 
increase in each meal, the addition of extra protein increased the total relative intakes from 1.2 g 
kg bw-1 to 1.6 g kg bw-1. Therefore, when the addition of protein increases total and relative protein 
intakes, it has the potential to improve body composition. However, these findings were during 
energy balance, and not under conditions of ER.  
 
In the current study, a protein intake of a similar range was effective in maintaining muscle mass 
but not increasing it. Therefore, it could be hypothesised that during ER, protein intakes > 1.6g kg 
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bw-1 are needed to elicit muscle hypertrophy in older adults, especially since ER can lead to a 
higher utilization of amino acids for energy production and  make less available for tissue synthesis 
(Stokes et al. 2018). For example, during a 40% ER in younger adults, protein intakes of 1.6-2.4 
g kg bw-1 sustained MPS to rates comparable with those under energy balance (Pasiakos et al. 
2013). However, even if anabolic sensitivity is sustained, the absence of exercise is a limiting 
factor, which can eventually lead to muscle losses after three weeks of ER when protein intakes 
are reported to be 0.8 g kg bw-1, 1.6 g kg bw-1, or even as high as 2.4 g kg bw-1 (Pasiakos et al. 
2013). Thus, it is not surprising that an ER diet providing 1.2 g kg bw-1 did not manage to attenuate 
muscle loss in the absence of exercise in postmenopausal women (Smith et al. 2018). Even higher 
relative intakes, ~1.7 g kg bw-1 failed to maintain muscle mass in older overweight adults during 
a 25% ER diet (1.8 ± 2.2 kg lean body mass was lost over 12 weeks) (Backx et al. 2016). On the 
other hand, the addition of resistance exercise to an ER diet providing 1.3 g kg bw-1 protein was 
able to elevate myofibrillar MPS by ~26% in overweight and obese older adults, and maintain 
appendicular muscle mass [change of 0.0 ±0.7 kg] within a period of two weeks (Murphy et al. 
2015; Murphy et al. 2018). In fact, the elevation in MPS was independent of the feeding pattern, 
that is, MPS was similar between balanced feeding (four meals containing 25% of the daily protein 
needs) vs a skewed pattern (72% of daily protein supplied in dinner). Nevertheless, these findings 
should be interpreted with caution since results from acute/short term studies may not always agree 
with long-term studies and/or in groups with different characteristics. For example, in a six-week 
study by Boullanne et al. (2013) involving 66 older, malnourished (or at risk of malnutrition) 
rehabilitation patients (BMI≤ 22 kg m-2), a skewed distribution (~70% of the protein consumed in 
the midday meal), resulted in significantly higher skeletal muscle mass index (+0.2 kg m-2 vs -0.1 
kg m-2 in the balanced group), even though the total relative intake in both groups was the same 
(1.3 g kg bw-1). These discrepancies may be as a result of the ‘skewed-pattern’ diet providing at 
least one meal with > 30-40 g protein (vs ≤ 20 g in all meals in the balanced diet), whereas in the 
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study by Murphy et al. (2018) all meals in the balanced diet contained ≥ 30 g protein accompanied 
by resistance exercise, which most likely enhanced the anabolic response in both groups. These 
findings are in agreement with the current study, highlighting that as long as there is one meal 
with enough protein to optimally stimulate MPS in the presence of exercise training, then muscle 
mass can be maintained during ER-induced weight loss, independent of the feeding pattern.  
 
In younger adults who followed an ER diet only, protein intakes of ~ 2.4 g kg bw-1 accompanied 
by resistance exercise training can acutely elevate MPS to a degree that can eventually not only 
maintain lean mass but also increase lean mass while reducing fat mass across four weeks 
(Longland et al. 2016; Hector et al. 2018). Energy restriction can reduce MPS, and a lower MPS 
is believed to be the culprit of reduced muscle mass during ER. Therefore, providing ample protein 
is crucial, though the effectiveness of such high protein ranges has yet to be demonstrated in older 
adults. On the other hand, it is pivotal to acknowledge that perhaps no practical upper limit for 
protein intake that can maximise net protein balance exists (Deutz and Wolfe 2013). However, it 
can also be speculated that providing a very high amount of protein to the extent that it can 
suppress muscle breakdown and interfere with muscle remodelling (i.e. autophagy) would not be 
advantageous (Stokes et al. 2018). As previously discussed, impaired autophagy (diminished 
ability to restructure protein tissue) is associated with reduced muscle quality and quantity, and 
consequently, with frailty and sarcopenia (López-Otín et al. 2013). However, whether dietary 
manipulations can lead to impaired autophagy in older adults, and if so to what extent, is unknown.  
 
Since the completion of the systematic review, several new studies have been published with 
sarcopenic obese adults participating in exercise (Vasconcelos et al. 2016; Chen et al. 2017; Cunha 
et al. 2017; Huang et al. 2017; Liao et al. 2017b; Silva et al. 2018), nutritional (Muscariello et al. 
2016; Sammarco et al. 2017;), or combined interventions (Kim et al. 2016a), however, the ranges 
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of relative protein intakes provided were not higher than the ones employed by the current study. 
Muscariello et al. (2016) and Sammarco et al. (2017) are the only recent studies that employed a 
weight loss diet in sarcopenic obese adults. Similar to the current protocol, they combined ER with 
protein intakes of 1.2 g kg bw-1 (Muscariello et al. 2016) and 1.2 – 1.4 g kg bw-1 (Sammarco et al. 
2017). In the study by Sammarco and colleagues the energy deficit was 500-600 kcal, over four 
months. However, protein intakes of the control group were not reported, there was no exercise 
protocol, and the population cohort was not homogenous (n=19 women, age 52 ± 8 yr; age range: 
41-71 yr). Nevertheless, fat loss was similar to that reported in the present study (~5 kg; from 
51.3± 10.9 kg to 46.3± 12.3 kg) and proportionally more than the one reported by Muscariello et 
al. (2016) (~2.4 kg from 34.2± 4.3 to 31.8± 1.2 kg; n=108), which had a shorter period (three 
months) and possibly a smaller energy deficit. The diet provided 20-25 kcal kg-1 desirable 
bodyweight but it was not elaborated how desirable bodyweight was calculated. In relative 
agreement with the current results, skeletal muscle index increased in the study by Muscariello et 
al. (2016) in participants who performed 30 min of physical activities for at least five days week-
1 (no structured classes or other equipment/protocols were provided). Muscle mass index increased 
significantly in the high protein group (from 6.9± 0.1 kg m-2 to 7.1± 04 kg m-2), whereas declined 
significantly in the normal protein group (0.8 g kg bw-1) from (7.1± 0.2 kg m-2 to 6.9± 0.1 kg m-2), 
which is comparable to the change noted in the current study in EXD group (section 6.4). In the 
study by Sammarco et al. (2017), although participants followed their habitual lifestyle (no 
information on physical activities provided) an increase in fat free mass was noted (from 47.6 ± 
2.5 kg to 48.7± 2.1 kg), however, changes in muscle mass or muscle index were not provided, and 
therefore, increases in fat free mass may have been as a result of increases in muscle as well as 
connective tissue (Bosy-Westphal and Müller 2015).  
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The approximate loss of ~5 kg in fat mass observed in the current study and in the study by 
Sammarco et al. (2017) over a 4-month period was proportionally higher compared to the loss of 
~2.4 kg over three months reported by Muscariello et al. (2016). This difference may be accounted 
for by the energy deficit, which in the current study and that of Sammarco et al. (2017) was 500 
kcal, compared to an approximate estimate of ~300-500 kcal deficit employed by Muscariello and 
colleagues. It would have been interesting to compare compliance rates to dietary plans between 
studies, however, compliance was only reported in the current study. Moreover, the exercise 
protocol in the current study, albeit not of a high intensity, ensured that all participants engaged 
with mixed exercise training, which could potentially increase total energy expenditure and 
therefore, promote more fat loss. Additionally, median protein intake in the current study was 1.4 
g kg bw-1, which is higher than the 1.2 g kg bw-1 adopted by Muscariello et al. (2016), and was 
not reported by Sammarco et al. (2017), although authors aimed for similar protein intakes. Protein 
intakes may account for differences not only in muscle but also fat mass, since older adults 
undertaking an energy deficit diet are likely to lose more fat mass and retain more lean mass during 
the active weight loss period when consuming higher amounts of protein (Kim et al. 2016b). 
Sammarco et al. (2017) also noted an increase in fat free mass with a concomitant reduction in fat 
mass, which was surprising given the ER regimen and the absence of exercise training. However, 
this could be attributed to the fact that participants were younger, and perhaps more receptive to 
the anabolic stimuli of protein feeding and/or increased their physical activity levels (which were 
not measured).  
 
In order to interpret the findings of the current study and compare them with similar weight loss 
studies, the fundamental element to consider is energy deficit. Although as a generic rule, 3,500 
kcal deficit is required to produce 0.45 kg (1 lb) of fat loss (originally introduced by Wishnofsky 
1952), the magnitude of this deficit-associated weight loss is likely to decline markedly over time 
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(Heymsfield et al. 2012). Metabolic adaptations resulting from loss of energetically active tissue 
such as muscle, and the reduced caloric expenditure associated with weight-bearing movements, 
are principally responsible for this non-linear decrease in weight (Heymsfield et al. 2012). 
Moreover, other parameters, such as initial body weight and body composition may further 
confound weight loss, with obese individuals perhaps requiring a greater deficit than their 
eutrophic counterparts for any given amount of weight lost. Therefore, it was proposed that 
intentional weight loss does not come at a fixed value of 3,500 kcal lb-1  (or 3,500 kcal per 0.45 
kg) but is a dynamic process that can fluctuate for several weeks, and more importantly can also 
differ between men and women (Heymsfield et al. 2012). This theory agrees with Muller et al. 
(2016) who suggested that there are inter-individual differences in weight loss paradigms due to 
several factors, such as energy intake, diet composition, baseline fat mass and muscle mass, 
activity levels, the metabolic state of the individual and hormonal responses to dietary changes. 
Moreover, although gene expression profiles related to weight loss are activated linearly with the 
magnitude of ER, it has been recently suggested that there are pathways that do not follow that 
rule and may ‘switch on’ at certain thresholds, thus, may be activated at 40% ER, but not at 20% 
or 30% (Derous et al. 2017). Therefore, the effect of ER on genetic transcription can be a 
confounder. Although the current study has estimated the expected losses over a certain period of 
time based on the 3,500 kcal lb-1 rule (in the present study 0.45 kg or 1 lb week-1), realistically 
speaking the resultant weight loss is likely to be lower, considering also that adherence to diet 
cannot be 100%. Nevertheless, the important finding of all three studies in sarcopenic obese adults 
was that an increased protein intake (1.2-1.5 g kg bw-1) alongside a moderate energy deficit can 
result in a rate of fat loss ~0.8 - 1.2 kg month-1 while preserving muscle tissue.  
 
It can be hypothesised that the changes in body composition noted in the intervention arm of the 
current study, and primarily the loss of body fat, were accounted for by the dietary aspect of the 
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protocol, i.e. the energy deficit and increased protein intakes, and not because of the addition of 
vitamin D. This hypothesis is in agreement with a trial that included postmenopausal obese (but 
not sarcopenic obese) adults (n=24), consuming 1.2 – 1.5 g protein kg bw-1 alongside a daily deficit 
of ~ 400 kcal (Gordon et al. 2008). The intervention resulted in fat mass losses of 6.3± 3.0 kg fat 
mass after six months (≈ 1.05 kg of fat loss per month). Although this figure is proportionally 
slightly lower than the current one, the small discrepancy may be accounted for by the increased 
deficit employed in the current study combined with the exercise regimen. In a study by Gordon 
et al. (2008), all participants were supplemented with 25 μg vitamin D daily to ensure adequate 
serum 25 (OH) D concentrations. Although a mean loss of 17% in lean mass was reported, changes 
in muscle mass were not measured, which would have provided a direct comparison between the 
two studies in order to examine the effect of the exercise and nutritional regimen on muscle mass. 
Although the studies are not conclusive, it seems that the addition of vitamin D to a weight loss 
high-protein diet does not further augment body composition, which also agrees with the findings 
of a meta-analysis of trials in older adults undergoing an exercise training routine with 
supplemental Vitamin D (Antoniak and Greig 2017).   
 
Apart from dietary modifications, exercise is a key factor for potentially favourable physiological 
adaptations. In this study a multi-component moderate-intensity exercise regimen was employed, 
with aerobic, balance, resistance, and flexibility elements. The exercise-only group of the current 
study experienced small numerical improvements in body composition, and although not known 
if statistically significant, an important outcome was the attenuation of muscle loss. Changes of 
~1 kg in muscle mass in four to six months exercise interventions with older adults can be 
expected, and regardless of statistical significance they can be of clinical importance considering 
that without exercise the annual expected loss is ~0.2 kg in muscle mass (Peterson et al. 2011) 
which may be possibly greater in sarcopenic obesity. Although similar protocols have been found 
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effective for reducing the risk of falls and physical disability in older adults (Baker et al. 2007), 
there are only a few exercise studies targeting specifically at sarcopenic obese adults in the 
literature. Chen et al. (2017) assessed the effect of different types of exercise training on body 
composition and strength in 60 Japanese sarcopenic obese participants, aged 65 – 75 years. The 
study consisted of a resistance-only, aerobic-only, combined group (resistance and aerobic), and 
a control group exercise twice weekly for 12 weeks. The resistance group performed 8-12 
repetitions for three sets at 60%-70% 1RM. The aerobic group performed 5-10 min of stretching 
followed by aerobic exercises such as dance steps, leg and arm swings, combination steps (e.g. 
diamond steps, mumbo steps etc.) followed by 10 min of relaxing exercises. The combined group, 
alternated between an aerobic and a resistance session, whereas the control group followed their 
habitual lifestyle. Skeletal muscle mass increased similarly (approximately +0.2 kg) in all exercise 
groups whereas it decreased on average by 0.7 kg in the control group. At the end of the trial, 
marginal increases in muscle mass led to significantly greater SMM for all three exercise groups 
compared with the control group. The changes in the exercise groups are in agreement with the 
changes observed in the current study, not only in the exercise-only group but also in the exercise 
and diet group. Therefore, a change as low as +0.1 kg in muscle mass during caloric restriction 
should not be undervalued since it is on par with changes in studies without energy deficit, and 
additionally, it is unequivocally better than losses in muscle mass.  
 
It appears that changes of ± 1 kg of muscle and fat mass are expected in studies with sarcopenic 
obese older adults after 12 weeks of resistance exercise training (Cunha et al. 2017; Huang et al. 
2017; Liao et al. 2017b). For example, Huang et al. (2017) and Cunha et al. (2017) used a 
progressive resistance training programme for sarcopenic obese older adults with elastic bands 
(three weekly sessions, three sets x 10 reps at a moderate-high intensity of ~13 RPE Borg) which 
were similar to the current study. The changes noted were in the range of -1.0 kg to 0.3 kg for 
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muscle mass and -0.6 kg to -0.7 kg for fat mass. In contrast with these findings, Vasconcelos et al. 
(2016) and Silva et al. (2018) found no changes in the body composition of sarcopenic obese adults 
after a 10-week and 16-week RE trial, respectively. The study by Vasconcelos et al. (2016) 
employed a similar protocol to that of Balachandran et al. (2014) (discussed in detail in Chapter 
2), with the concentric part of the exercises performed as fast as possible, with both studies 
reporting no effect on body composition. Apart from the velocity of performed movements, the 
difference between these two studies and those that observed improvements in body composition 
was that the exercise sessions were twice a week and not three times. As discussed previously, 
frequency and volume are important factors, which has also been recently demonstrated by Cunha 
et al. (2017), who showed that an increased number of sets (three sets vs one set per exercise) 
performed three times weekly by sarcopenic obese older adults can significantly improve their 
muscle mass by ~1 kg , while reducing % body fat by ~2%. Despite the lack of body composition 
changes in the sarcopenic obese group (Silva et al. 2018), the important finding was that the 
healthy control group who followed the same exact exercise programme as the sarcopenic obese 
group, noted a significant improvement in body fat, waist circumference and waist to hip ratio. 
The sarcopenic obese phenotype was identified based on low FFMI and a BMI ≥ 27 kg m-2 which 
underlines again that impaired physiological adaptations in older age may come at BMIs lower 
than 30 kg m-2.  
 
 
The only other study to date examining the combined effects of a nutritional intervention with 
exercise training on body composition and function in sarcopenic obesity reported non-significant 
changes in fat mass (~ -0.7 kg) and muscle mass (~ +0.2 kg) (Kim et al. 2016a). The nutritional 
plan involved the daily administration of a leucine-rich supplement (1.2 g leucine complemented 
with all EAAs for a total quantity of 3 g), a vitamin D3 supplement (20 μg day-1) and tea rich in 
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catechins (540 mg) for three months, without energy restriction. The exercise programme was 
similar to the current study, however took place only twice a week. No significant time x group 
interactions were noted (four groups: nutrition-only, exercise only, exercise + nutrition, health 
education) in absolute fat mass, muscle mass or grip strength, therefore it could be suggested that 
Vitamin D supplementation (even alongside a small dose of leucine and EAAs) cannot amplify 
the effects of exercise training.  Therefore, it could be proposed that exercise alone can attenuate 
muscle loss in the absence of energy restriction, potentially alongside some small loses of fat mass 
in sarcopenic obese older adults, even in the absence of protein/vitamin D supplementation.    
 
Regarding strength and function, grip strength was numerically improved in the current study, 
possibly because upper body was engaged (although in low intensity exercises) in every session, 
adding to the total exercise volume and frequency of muscle engaged. As Schoenfeld and 
colleagues have demonstrated in recent meta-analyses, there is a graded dose-response 
relationship between number of sets and muscle growth, and additionally, major muscle groups 
should be engaged at least twice a week for muscle hypertrophy purposes (Schoenfeld et al. 2016; 
Schoenfeld et al. 2017). This agrees with Borde et al. (2015), who proposed that training frequency 
is pivotal (≥ twice weekly), as is volume (2-3 sets, ~10 repetitions per exercise) and time under 
tension (~6 s per repetition) for both muscle strength and morphology (e.g. size of type II fibres) 
to improve. However time under tension in the current study was only ~2 s in the first 14 weeks 
and 3 s (1 s for the concentric and 2 s for the eccentric) in the last two, which may explain to some 
degree the lack of substantial improvements in muscle mass.  
 
Therefore, based on the latter findings, the lack of changes in handgrip strength in the resistance 
and aerobic exercise group by Chen et al. (2017) may be accounted for by the low volume and 
frequency of exercise training for the upper body (only once a week), whereas lower body muscles 
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were engaged twice a week (both during resistance-only and aerobic-only).  As an outcome, knee 
and back extensor muscle strength were reported to be significantly higher in the resistance-only 
and in the combined-exercise group when compared to the control group after 12 weeks of exercise 
training. In the grip-strength test the resistance-only group scored significantly higher compared 
with the other groups, and was the only group with improved strength (+2.1 kg) over time. It is 
important to note that hand-grip was increased by 3.5 kg by week-8 in the resistance-only group 
but the improvement at week-12 was finally 2.1 kg. This improvement is in accordance with the 
changes observed in the current study (~ 2.0 kg) and Kwon et al. (2015b). However, as Nitschke 
et al. (1999) have shown, day-to-day variations in hand grip may fluctuate by as much as ~6 kg. 
Therefore, it is suggested that in order to confirm strong improvements in hand grip, the changes 
must exceed this threshold of +6 kg.  
 
The previous finding also agrees with a study by Kim et al. (2014), who proposed a minimal 
clinically significant difference of ~6.5 kg or a change of 20% in hand grip strength. However, 
this should be interpreted with caution as the study was conducted in young, middle aged, and 
older women during rehabilitation from a distal radius fracture. Scientists have used the concepts 
of meaningful (or clinically significant) change to evaluate the effectiveness of treatments and 
whether a change noted is clinically important for the health status of the individual, regardless of 
statistical differences. Such values are the ‘minimal clinically important differences’ (MCID) and 
‘minimal detectable changes’ (MDCs). However even the MDCs and MCIDs depends on the 
population characteristics, the standard deviation, intra-class correlation coefficient (ICC), 
standard error of the mean (SEM) or the validity of the independent test that has been used as an 
‘anchor’ (Chui et al. 2012). For example, in middle aged and older patients with hand osteoarthritis 
the MCID for hand grip may be 0.8 kg and 1.1 kg for the affected and the unaffected body side, 
respectively. In the only other study with a weight loss regimen and higher protein intakes, hand 
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grip did not change significantly (neither statistically nor clinically), indicating that perhaps 
exercise training is the main driving factor of changes in strength, regardless of protein intake 
(Muscariello et al. 2016).  
 
In terms of physical function, in the current study both groups noted improvements in gait speed, 
but EXD experienced a more pronounced improvement by 0.4 m s-1. In the study by Kim et al. 
(2016a) no significant changes were identified in grip strength (-0.2 kg in the exercise-only group 
to +0.5 kg in nutrition and exercise group) either between or within groups or over time. However, 
a significant time x group interaction was noted for walking speed which increased by ~0.2 m s-1 
in the exercise only group and by ~0.1 m s-1 in the other groups. These improvements are in 
accordance with those noted in the current study, and in the absence of significant increases in 
muscle mass, they may be accounted for mainly by neuromuscular adaptations, which usually tend 
to occur over the first 10 weeks of exercise training (Steib et al. 2010). Nevertheless, even an 
improvement of +0.05 m s-1 can indicate a small meaningful change in gait speed in older 
community-dwellers, with a change of +0.1 m s-1 indicating a substantial change for community-
dwellers as well as individuals with comorbidities such as Parkinson’s disease, stroke, Alzheimer's 
disease, and patients with hip fractures and osteoarthritis (Perera et al. 2006; Chui et al. 2012). 
Moreover, an increase of 0.1 m s-1 can be predictive of better survival in older adults, indicating a 
substantial improvement especially in the exercise-only group of the current study. Further, this 
shows that changes in function may be closely related to handgrip strength, however, substantial 
changes in strength are not a prerequisite for improvements in function.  
 
Indeed, although absolute changes in strength are important, studies have also suggested that 
maximal strength gains are not essential for functional improvements (Orr et al. 2006; Steib et al. 
2010). In fact, power training (i.e. force generation at high velocities) can effectively improve 
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muscle power and functionality in older adults (Steib et al. 2010). Two tests reflecting changes in 
functional improvement and especially leg power in the current study were the timed up and go 
(TUG) test and repeated chair stands; in which functional improvements were noted in both groups 
(with EX experiencing greater numerical improvement; section 6.5), which surpassed the cut-off 
of 1.7 s for a minimal difference of clinical importance (Jones et al. 2013).  
 
The findings of the current study highlight the importance of exercise training, even at moderate 
intensities, and regardless of dietary changes and weight loss. A recent systematic review by Byrne 
et al. (2016) has detailed the importance of muscle power and functionality in older age and how 
these outcomes can improve across a range of different exercise intensities, in the absence of 
dietary modifications. In fact, increased power and physical function can occur even at low-
moderate intensities, that is, 20% - 40% 1RM (Orr et al. 2006; Reid et al. 2015). Orr et al. (2006) 
demonstrated that older men and women exercising twice a week for 8-12 weeks at intensities 
20% 1RM at a fast concentric/slow eccentric fashion (a similar pattern was employed towards the 
end of the current trial), can experience significant improvements in balance. Similarly, Reid et 
al. (2015) demonstrated that exercising at 40% 1RM can significantly increase SPPB results by 
~1.3 points, which was not statistically different to the increase noted in their high intensity group 
(70% 1RM). This demonstrates that exercising at low-moderate intensities can improve physical 
function. Although in the current study SPPB scores were considerably high at baseline, numerical 
improvements were still seen that can be of clinical importance (section 6.5). Namely, changes of 
+0.5 and +1.0 in SPPB may indicate small but meaningful changes, and substantial changes 
respectively (Perera et al. 2006). Even an attenuation of the decline in SPPB (and its individual 
domains) may be important since score decreases of ≥ 1 points may increase subsequent five year 
mortality rates (Perera et al. 2005).  
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The above findings are in accordance with a meta-analysis by Steib et al. (2010) highlighting that 
significant improvements in functional tasks such as the ones performed in the present study e.g. 
timed up-and-go (TUG) test, repeated chair rise and gait speed, can be anticipated after a resistance 
exercise programme, with the magnitude of adaptations independent of exercise intensity. This 
phenomenon may be accounted for by several reasons. For example, sedentary and especially 
older adults with low to moderate strength may respond well to exercise training even at low 
training stimuli, which may be explained by the enhanced neuromuscular coordination, as 
mentioned previously (Steib et al. 2010). Moreover, a certain strength threshold exists, above 
which changes in strength do not necessarily translate into proportional changes in function (i.e. a 
20% increase in strength does not indicate a 20% increase in gait speed). This has been long 
established by Buchner et al. (1996), who suggested that strength training in older adults with low 
to moderate strength can have a substantial effect on physical performance, however, after a 
certain point any further gains in strength may benefit the physiological reserves but not function 
per se.  
 
Dynamic balance as assessed by 1-arm functional reach, presented numerical improvements with 
a noticeably greater absolute increase in the EX group (~8 cm) (section 6.5). It is established that 
simple progressive resistance exercise programmes utilizing elastic bands can improve functional 
reach by ~4 cm (McMurdo and Johnstone 1995), and this improvement is independent of lower-
limb strength gains (Chandler et al.1998). Ramsbottom et al. (2004) have reported significant 
improvements in functional reach, in an exercise programme comparable to the current one. 
Healthy older adults took part in two exercise classes weekly for 24 weeks. Single-arm reach test 
significantly increased from 23 cm to 34 cm in the exercise group, which was similar to the 
increase noted in the current study. Based on an analysis of four studies with older adults 
(community-dwellers, care-home residents, with Parkinson’s disease, or after hip fracture) a 
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meaningful change in 1-arm reach test has been reported to range from 4-11 cm (Steffen and Seney 
2008), which indicates that the exercise-only group in the current study experienced a clinically 
significant improvement. It is surprising, however, the fact that the EXD group did not note a 
similar change. It could be speculated that the EXD group had already scored well at baseline, and 
due to the nature of the test itself, there is only a certain amount of change that is physiologically/ 
biomechanically feasible. Perhaps individual differences, such as height and limb length may also 
limit the amount of improvement that can be achieved in this test.  
 
The results noted in the current study for the TUG test were comparable at baseline with those of 
Ramsbottom et al. (2004), with groups reporting times of ~7 s, to complete a full course. In the 
present study however, the improvement was noticeable with a decrease of ~2 s in both groups. 
Ramsbottom and colleagues showed that a decrease in time to complete TUG by ~1 s can indicate 
a statistically significant improvement, which is also close to the MDC value (1.1 – 1.4 s) (Wright 
et al. 2011; Alghadir et al. 2015). Although the decrease in fat mass experienced by the 
intervention group in the current study should theoretically have provided these subjects with an 
extra advantage compared to the control group, the improvements in TUG test were numerically 
similar in both groups, suggesting that exercise training may improve function independent of a 
diet-induced weight loss.  
 
Although the statistical significance should be corroborated statistically, it is suggested that the 
exercise training alone accounts for most of the functional improvements noted in the present 
study. For these numerical –and some clinically substantial- improvements, apart from the 
resistance generated by bodyweight exercises and the resistance bands, there were additional 
techniques that were employed and could account for the increased power and subsequent 
functional improvements. For example, during balance and aerobic training, exercises requiring 
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change of direction or swift step sequences were employed. Weight bearing exercises, such as 
chair stands (or squats with elastic bands) and press-ups against the wall, were performed at higher 
velocities, once participants started to feel more confident and able to move faster. Moreover, the 
band exercises during the last two weeks of the training were performed at maximum voluntary 
velocity. As discussed earlier, muscle retains its plasticity and ability to adapt to external stimuli 
even in old age. Therefore, exercising at low intensities has the potential to augment physical 
function, while offering the extra advantage of a lower perceived effort (Reid et al. 2015), which 
is pivotal in older age (Byrne et al. 2016). Perhaps tests requiring participants to move their body 
over a longer distance, e.g. the 400 m walk test and time-trials or repeated chair stands for 60 s, 
would have shown greater improvements in physical function in the EXD group since a large 
amount of fat mass was lost, and this should theoretically improve tasks that require body mass to 
be moved over space or for prolonged periods of time.  
 
In relation to quality of life, although a statistical significance was not confirmed in the present 
study, it is a positive outcome that numerical improvements were noted in most domains, and 
especially the ones regarding general health and perceived health in comparison with the previous 
year. The fact that the baseline scores for many of the HRQoL were already high indicates that the 
results might have suffered from the ceiling effect. That is, independent-living community 
dwellers who have the physical, mental and emotional capacity to take part in research studies, 
including exercise classes and dietary changes, are likely to be above average in terms of HRQoL 
compared with their counterparts and therefore, substantial subsequent changes in HRQoL 
domains are unlikely (de Vreede et al. 2007; Kwon et al. 2015b). Indeed, data from the Scottish 
Health Survey have indicated that the majority of adults ≥ 65 years in Scotland (41.2%) have 
scored in the lowest quintile for physical function (lowest quintile: < 42 points; n=435), whereas 
only 7.3% (n=76) scored in the highest quintile (> 56 points) (Ul-Haq et al. 2014). The higher 
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scores in HRQoL noted in the current study may therefore, reflect positive attitudes towards 
changes that may improve health (Ul-Haq et al. 2014), a theory that parallels with the willingness 
of participants to commit to the current four month research trial. None of the domains that scored 
≤ 70 at baseline decreased at the end of the trial, indicating that the numerical decreases were seen 
only in those domains with very high scores at baseline (≥ 80). This has also been observed in 
another study with sarcopenic obese participants, who after 10 weeks of exercise training did not 
report any significant improvements either over time or compared to the control group (no 
exercise), possibly because QoL scores were already high at baseline (≥ 80) (Vasconcelos et al. 
2018)  An anecdotal observation of the current study was that before, during or after the exercise 
classes, participants would frequently express concerns about the health status of people closely 
related to them, such as family members and friends. Such concerns seemed to have a negative 
effect on their mood, psychological status, and overall motivation. Perhaps this may account for 
the numerical decrease in emotional well-being in EXD, however, given that the group size was 
small, relatively trivial changes had the potential to skew the overall results, thus is important to 
interpret these results with caution. 
 
It could be speculated that the use of elastic bands lacks the element of a quantifiable progression 
in numerical terms. For example, one may find it easier to follow the progress made on resistance 
machines with a fixed and measurable resistance. Although participants were satisfied when they 
could advance one colour in the elastic band progression scale, the increase in their strength was 
not something that could be easily gauged. This is in agreement with Damush and Damush (1999) 
who noted that despite a resistance exercise programme for older women who exercised with 
elastic bands, was very practical, inexpensive and produced significant improvements in strength 
and function, in terms of perceived changes in quality of life domains, it may actually offer little 
benefits. This has also been proposed by Kwon et al. (2015b) who assessed changes in function 
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and QoL in 89 older adults with low muscle mass and strength after three months of training with 
elastic bands with/without participation in nutrition education classes. Although a mean change of 
+2.3 kg in handgrip strength was deemed significant in the exercise-only group, there were no 
subsequent changes observed in HRQoL domains; whereas the group that undertook exercise and 
cooking classes experienced a significant improvement in QoL domains, such as role limitations 
due to physical and emotional health, and bodily pain. Therefore, it is possible that despite the 
physical improvements from the exercise programme, the social interaction aspect was possibly 
the key parameter in improving perceived quality of life, with participants spending a few hours 
each week participating in shopping, cooking and eating together, something that enhanced the 
communication and relationship-building aspect of the programme. Moreover, Kwon et al. 
(2015b) suggested that bodily pain is likely to progress with ageing and it may not change or 
improve within a short period of time in older adults. Even in studies of ≥ 12 months duration, 
progression of pain has been reported (Sato et al. 2009).  
 
From analysing the Scottish Health Survey data, the physical function domain seems to be one of 
the most important predictors of overall mortality and coronary heart disease events (Ul-Haq et al. 
2014). In the present study, even though the physical function domain scored high at baseline, it 
still improved by 5-10 points in both study groups. Even such numerically small changes may be 
important since a decrease of 5-10 points in physical domain is associated with higher risk of 
mortality in older adults (Tsai et al. 2007; Otero-Rodriguez et al. 2010). The analysis of HRQoL 
in Scottish adults also showed that the physical function domain can predict mortality independent 
of adiposity, when the latter is defined as high BMI. This finding agrees with the overall concept 
of the current research, proposing that it is the relative contribution of muscle mass/function and 
adiposity that should be utilised instead of BMI, since for any given category of BMI the body 
composition phenotypes of individuals can differ considerably.   
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8.2 Dietary intake 
The current study is one of the first to present dietary patterns in older adults with low muscle 
mass and high body fat. The analysis of dietary intakes showed that participants followed a diet 
with a nutritional composition similar to the national average, with two exceptions. Energy intake 
was higher in the current cohort of women vs the national average, whereas relative energy 
contribution from protein was lower (section 6.2). It can be suggested that the current cohort were 
consuming more energy for proportionally less protein compared to the population average. The 
protein intake relative to bodyweight was 0.9 g kg bw-1 day -1, and since there are no NDNS data 
on this, a direct comparison cannot be made. In addition, a skewed pattern of protein intakes with 
low amounts of protein consumed at breakfast (~10 g) and a proportional rise in protein at 
subsequent meals (~20 g and ~30 g in lunch and dinner, respectively) was noted (section 6.2). It 
is important to note that these data refer to habitual intakes at baseline, before the introduction of 
any supplements or dietary modifications.  
 
These findings also highlight the fact that although several studies and specialist committees on 
healthy ageing have advocated the importance of increasing protein intake from 0.8 g · kg bw-1 · 
day-1 to 1.2 – 1.5 g · kg bw-1 · day-1 (Wolfe 2012; Deutz et al. 2014) it is questionable whether 
such practices have been adopted by all population groups, and in particular by those in most need.  
It is also pivotal to consider the fact that, even with protein intakes adhering to the current 
recommendations (~0.8 g kg bw-1 day-1), older adults can be in negative nitrogen balance during 
periods of physical inactivity (Ferrando et al. 2010), and increased protein intakes alone cannot 
attenuate the inactivity-induced loss of muscle mass (Ferrando et al 2010; Dirks et al. 2017). 
Therefore, focusing only on absolute intakes of protein without taking into consideration other 
262 
 
important parameters such as physical activity, and total energy intakes may not allow for a 
complete appreciation of the magnitude of this relationship. 
 
Perhaps the only recent UK dataset that can be compared with the current study is that by Cardon-
Thomas et al. (2017). In an observational study with 38 ambulatory and free-living community 
dwellers (n=27 women; n=11 men, aged ≥ 70 years, 68± 12 kg), mean energy intake was 1815± 
363 kcal, however, 30% of participants were men, which probably influenced mean energy intake. 
Mean protein intake was 1.14± 0.25 g kg bw-1, and protein contributed to energy intake by 17± 
3.4 % (Cardon-Thomas et al. 2017). It is noteworthy that 92% and 76% of the cohort consumed 
more than 0.8 g kg bw-1 day -1 and 1.0 g kg bw-1 day -1, respectively in the aforementioned study. 
These figures are higher compared with those reported in the current study. Given that body 
composition was not measured by Cardon-Thomas et al. (2017), whereas in the present study all 
participants had low muscle and high fat mass, it could be suggested that the low protein intakes 
reported in the current study may account to some extent for the low muscle mass and high % BF 
of participants. In the study by Cardon-Thomas et al. (2017) the daily protein distribution was 
skewed, with breakfast, lunch and dinner providing 18%, 39% and 44% of the daily protein intake, 
a pattern that is consistent with the findings of the current study. Therefore, it can be hypothesised 
that it is not the skewed pattern that affects body composition, instead it may be the total relative 
protein intakes. Indeed, as Houston et al. (2017) have proposed, those consuming < 1.0 g kg bw-1 
day -1 (and particularly those consuming ≤ 0.7 g kg bw-1 day -1) may be at increased risk of 
sarcopenia compared to those consuming ≥ 1.0 g kg bw-1 day -1. Therefore it could be proposed 
that in the normal distribution curve of protein intakes for the overall older population, the 
sarcopenic obese subgroup may lie at the lower end.  
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The previous hypothesis may also explain the higher (numerically) absolute relative intakes 
reported in healthy older subgroups (Cardon-Thomas et al. 2017) or the general 65+ UK 
population (Millward 2012) compared with the intakes from the present study, which however, 
noted a similar or even higher energy intake. Nevertheless, since there is a lack of comparative 
studies that investigate muscle mass/function with different protein intakes, in older (and 
especially sarcopenic obese) Scottish adults, unequivocal conclusions cannot be drawn. Without 
larger and long-term studies it is also not clear whether low protein intakes are an independent risk 
factor for sarcopenic obesity, or that low protein intakes are the outcome of a combination of 
inactive lifestyles, anorexia of ageing, cognitive or psyco-social factors, inflammation,  and other 
factors that may also lead to sarcopenia and obesity (Millward 2012). The latter agrees with 
Cardon-Thomas et al. (2017) who noted that protein intake was significantly and positively 
correlated with step count but inversely correlated with age and sedentary time; therefore, it can 
be hypothesised that those who were younger and more physically active reported higher relative 
protein intakes. Another important parameter is socioeconomic status which can influence protein 
intakes and therefore, should be considered in observational studies (Beasley et al. 2010). 
However, such information was not collected in the current study, which reflects a limitation.  
 
One of the largest European studies that has provided valuable information regarding dietary 
intakes and distribution of protein consumption is that by Tieland et al. (2012b), who assessed 
habitual intakes of 707 community-dwellers, 194 frail, and 286 institutionalised Dutch older adults 
(BMIs ~ 23 - 27 kg m-2). The institutionalized group consumed significantly less protein compared 
to the frail group and the free-living community dwellers (~0.8 g kg bw-1 vs ~1.0 g kg bw-1 vs ~1.1 
g kg bw-1, respectively). Their findings are consistent with the current study and those by Cardon-
Thomas et al. (2017), noting skewed protein distributions across the day; intakes gradually 
increased from breakfast (8 g in frail, 10 g in institutionalized and 12 g in community dwellers) to 
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lunch (18 g in frail, 25 g in institutionalized and 29 g in community-dwellers) and dinner (15g in 
institutionalized, 29 in frail and 30 g in community-dwellers). Therefore, this skewed pattern 
possibly characterizes the majority of the older populations in Europe (healthy independent living, 
frail, institutionalised etc.) and not just those in the UK who are sarcopenic obese, thus it would 
not be prudent to assume that the skewed distribution per se is the driving factor for frailty or 
sarcopenic obesity.  
 
In another large European study (n=900 adults, ≥ 60 years from the Nordic countries), it was 
shown that only ~25% of the entire cohort reached targets > 1.2 g kg bw-1 day-1, and this was 
primarily due to a large cohort of participants taking part in cooking classes (Jyvakorpi et al. 2015). 
Therefore, it can be suggested that knowledge of healthy eating can be important. Moreover, 
although mean daily protein intake of the overall population was approximately 1.0 g kg bw-1, 
around one third of the whole population cohort did not achieve the 0.8 g kg bw-1 intake. Regarding 
energy intake, the findings are in agreement with the present study, with daily mean caloric intake 
ranging between 1,300 and 1,700 kcal in older adults with similar BMIs (24-27 kg m-2). However, 
a sub-group analysis of the energy intakes and body composition of those who consumed < 0.8 g 
protein kg bw-1 intake, would have provided a better insight and a direct comparison with the 
current study.   
 
The only study with relatively comparable data to the current one is that of Muscariello et al. 
(2016). In a total of 130 obese Italian women (> 65 years old; BMI≥ 30 kg m-2), 104 of which had 
low muscle mass, mean daily energy intake was ~1,800 kcal with 15%, 55% and 30% contribution 
from protein (68 g), fat (248 g) and carbohydrates (60 g), respectively (Muscariello et al. 2016). 
Similar relative intakes were reported in the present study, especially with respect to protein 
(section 6.2). Total daily energy intake was higher compared with the present study, but this may 
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be explained by the smaller body size of the current participants (with a BMI of approximately 27 
kg m-2). Muscariello et al. (2016) commented that the protein content corresponded to 0.7±0.2 g 
protein per kg of desired bodyweight per day, however, it was not fully explained how such 
‘desired’ body weight was calculated. Given that desired bodyweight must be lower than their 
actual weight (since BMI >30 kg m-2), then the actual relative protein intakes must have been 
lower than 0.7±0.2 g kg bw-1. Therefore, there is relative agreement between studies highlighting 
that relative protein intakes may be low even when there is a surplus of energy in sarcopenic obese 
older cohorts.  
 
Although there are some preliminary findings for low protein intakes proportionally to energy 
intake in sarcopenic obesity, it is suggested that direct comparisons should be approached with 
caution, since there are considerable variations in protein intakes across study cohorts. Therefore, 
direct causation cannot be established.  
 
8.3 Blood markers 
This section discusses changes in the following blood markers 25(OH)D, IGF-1, ALP and hsCRP. 
Although the sample size was small in the current study, some numerical changes were noticed, 
which may be of clinical importance. Creatinine and TSH concentrations were both within the 
normal range both at baseline and at post-intervention for both groups, with no large fluctuations 
noted. Urea increased slightly above the reference range in one participant from the diet and 
exercise group, however, this small change was anticipated especially in the diet group who 
received supplementary protein (Frank et al. 2009).  
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In the current study, 25 μg vitamin D3 was administered to both groups EOD (~ 10 μg day-1) to 
ensure adequate vitamin D intakes and to avoid potential confounders associated with low serum 
25 (OH)D, such as poor physical performance in older adults (Wicherts et al. 2007; Kim et al. 
2011; Verlaan et al. 2017). There is a strong and inverse relationship between sarcopenia and 
serum 25(OH)D in older adults, with the association remaining significant even after adjusting for 
factors such as BMI, age, sex, smoking and physical activity (Kim et al. 2011), however, it should 
be highlighted that association does not imply causality. In the current study the change in both 
groups was similar after four months of supplementation. In EX it increased by 15 (-1, 31) nmol 
L-1 and in EXD by 19 (9, 27) nmol L-1 (section 6.9). All participants were supplemented, with the 
exception of one individual, who had to discontinue with vitamin D supplementation, and 
eventually experienced a noticeable drop in serum concentrations. Another participant 
experienced a decline in 25(OH)D, however they reported to have consumed vitamin D as per 
instructions. Although, the decline could be accounted for by seasonal variations (baseline 
measurement was taken in October and the final measurement in January) this was not observed 
in any other participants of the same group. Therefore, it could be due an individual response to 
vitamin D or more likely due to poor adherence to the protocol. 
 
In a 12-month RCT, Grimnes et al. (2017) administered to 275 postmenopausal women with 
osteopenia/ osteoporosis doses of Vitamin D of ~ 20 μg day-1 vs 163 μg day-1 for one year. Serum 
25(OH)D in the high dose group increased by 99.4±31.9 nmol L-1 (from 64.7± 21.4 nmol L-1 at 
baseline). The increase in the normal-dose group was 17.7± 16.9 nmol L-1 (from 64.1± 20.0 nmol 
L-1 at baseline) and was numerically comparable to the increase observed in the present study, 
despite a lower dose supplemented in the current protocol. Perhaps baseline concentrations play a 
role in the responsiveness to Vitamin D supplementation, since 20 μg Vitamin D3 day-1 for three 
and six months was recently reported to increase serum 25(OH)D by approximately 32 – 36 nmol 
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L-1, in pre-frail and frail participants > 65 years with baseline concentrations of ~ 36 nmol L-1 
(Vaes et al. 2018). Based on the current findings and others (Grimnes et al. 2017; Vaes et al. 2018), 
it can be suggested that daily supplementation with 10-20 μg (or 25 μg EOD) Vitamin D3 is 
adequate to increase serum concentrations by ~ 15-30 nmol L-1, depending on baseline levels.   
 
More importantly, findings by Grimnes et al. (2017) highlight the lack of significant changes in 
handgrip and knee extension strength, balance and quality of life between or within the two groups 
over time. This is in agreement with Vaes et al. (2018) who also reported no significant 
improvements in knee extension/hand grip strength, TUG test, SPPB scores, gait speed, and five 
repeated chair stands in the absence of exercise training. However, these finding do not parallel 
those from a meta-analysis by Muir and Montero-Ontasso et al. (2011), who concluded that daily 
doses of 20-25 μg can produce favourable changes in strength and balance in older adults, even in 
the absence of exercise. A recent meta-analysis has shown that daily administration of vitamin D2 
or D3 in doses 10-25 μg may not improve strength but may offer small but statistically significant 
improvements in the TUG test by 0.75 s (Dewansingh et al. 2018). Such discrepancies between 
studies may be due to genetic polymorphisms that can predispose certain individuals to better or 
worse outcomes depending on the individual’s genotype and vitamin D dosing regimen (Grimnes 
et al. 2017). In addition, another meta-analysis has suggested that vitamin D may be effective in 
improving strength and function only in older adults with baseline levels < 30 nmol L-1 (Beaudart 
et al. 2014). This is consistent with Stockton et al. (2011), who noted that improvements in strength 
are not expected in those with baseline concentrations > 25 nmol L-1, however significant 
improvements may be seen in those with < 25 nmol L-1.  This could provide a plausible explanation 
for the lack of benefits following vitamin D supplementation in the studies by Grimnes et al. 
(2017) and Vaes et al. (2018), and suggest that the changes noted in the current study were due to 
the exercise protocol and not the vitamin D supplementation, since all baseline serum 
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concentrations were > 30 nmol L-1. Even those participants who experienced a decrease in serum 
25(OH)D, noted numerical improvements in physical function at the end of the study.    
 
Apart from changes in strength and functional performance, vitamin D has been implicated in  
health conditions commonly seen in older adults. In a recent study examining the relationship 
between vitamin D status and heart disease, it was found that a low serum 25 (OH)D concentration 
was associated with a 12-fold increase in risk of heart failure (odds ratio [95%CI]: 12.19 (4.23–
35.16) (Porto et al. 2017). What is also noteworthy from this study, which was conducted in adults 
≥ 60 years, is the fact that the threshold for low serum Vitamin D was set at 75 nmol L-1 and not 
50 nmol L-1 which is the current threshold for adequate blood 25(OH)D concentration in the UK.  
If the threshold was to increase to 75 nmol L-1, only two participants in the current study would 
have met that target at baseline. Accordingly, after the supplementation period four participants 
did not attain a concentration of 75 nmol L-1.   
 
Another important biomarker is IGF-1, a mediator of growth hormones that is associated with 
physical and cognitive function in older adults (Doi et al. 2016). In the present study a median 
percent change of approximately 10 % was noted in EXD, whereas the EX group (control) 
experienced negligible changes. Overall variations in serum IGF-1 were detected at baseline with 
values ranging between 54 ng mL-1 and 101 ng mL-1, which perhaps may be accounted for to a 
certain degree by baseline differences in body composition, dietary factors and physical activity 
levels between participants (Heaney et al. 1999; Arnarson et al. 2015; Bjersing et al. 2017). 
Although no participants had serum IGF-1 values outside the normal range at baseline, five 
participants exhibited concentrations < 82 ng mL-1, which may reflect an increased risk for 
disability as suggested by Doi et al. (2016). In the study with older healthy adults IGF-1 was found 
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to be an independent predictor of physical and mental impairment, even after adjusting for factors 
such as physical activity and cognitive status. Doi and colleagues also noted that those in the 
lowest quartiles for IGF-1 (Q1: ≤ 82 ng mL-1 and Q2: 83-100 ng mL-1) had a significantly higher 
risk for disability compared to the highest quartile (Q4: ≥ 120 ng mL-1) after approximately 2.5 
years of follow up.  
 
Supplementation with 15 g of EAAs alone can significantly increase IGF-1 in healthy older 
women (Dillon et al. 2009). Considering that the content of intact protein is ~40-45% EAA, 15 g 
EAA would correspond to ~35 g protein (Ferrando et al. 2010). In the current study a bolus dose 
of 50 g milk protein was administered. Increased consumption of dairy products, particularly milk, 
has been shown to produce similar results in circulating IGF-1 concentrations in older adults 
(Heaney et al. 1999). Increased milk consumption (~ 16 g of additional dairy protein · day-1) can 
significantly raise serum IGF-1 by 10 % (Heaney et al. 1999). Similar increases have also been 
noted after the introduction of 45 g whey protein to habitual diets of older Caucasian adults (overall 
protein intake increased by 17 g day -1), which resulted in significantly higher serum IGF-1 (from 
10.74± 0.41 nM to 11.37± 0.53 nM) (Kerstetter et al. 2015). 
 
Although increases in IGF-1 concentrations were expected due to increased dairy protein intake, 
it has also been shown that a hypocaloric diet can negatively affect IGF-1 concentrations in both 
the short and long-term (Musey et al. 1993; Fontana et al. 2008). However, according to Musey et 
al. (1993), a high protein diet can in fact increase IGF-1 during two weeks of severe caloric 
restriction in obese adults (68% contribution of protein to total energy intake with a ~75% energy 
reduction), whilst also maintaining nitrogen balance. This effect was observed in the high-protein 
diet but not in the high-fat or high-carbohydrate diet, both of which led to decreased IGF-1 
concentrations and negative nitrogen balance. The authors proposed that serum IGF-1 is closely 
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related to protein intake, nitrogen balance and muscle mass. It has been shown that even after 
chronic energy deficits (1-6 years), a diet providing a small caloric restriction of ~300 kcal day-1 
does not negatively impact serum IGF-1 as long as protein intake is adequate (~17% - 24% of 
TEI) (Fontana et al. 2008). To examine the relationship between protein intakes relative to body 
weight and IGF-1, Fontana and colleagues measured changes in serum IGF-1 between adults 
consuming ~0.8 g kg bw-1 day-1 (10% of TEI) vs ~1.7 g kg bw-1 day-1 (24% TEI). Although energy 
was restricted by ~200 kcal more in the high-protein compared to the moderate-protein group, 
serum IGF-1 was significantly higher in the high-protein group after six years, suggesting that 
protein intake may be a more important predictor of changes in IGF-1 than ER. Although the 
aforementioned studies were conducted in young and middle-aged participants, it is plausible to 
hypothesise that despite the energy deficit in the current study, the increased protein intake in EXD 
accounted for the more noticeable change in IGF-1. Nevertheless, energy and dietary protein 
intake aside, exercise training is another variable that could have potentially affected circulating 
IGF-1.    
 
A study has suggested that IGF-1 concentrations may in fact decrease in overweight and obese 
older adults undergoing an exercise routine, despite improvements in lean mass and physical 
function (Arnarson et al. 2015). After a 12-week resistance exercise trial with older adults, 
Arnarson and colleagues reported that IGF-1 decreased significantly by ~ 6 ng mL-1 (from 112.1 
± 35.6 to 106.1 ± 35.2 ng mL-1). In addition, although at baseline the amount of lean mass was 
positively associated with serum IGF-1, this changed to an inverse association at the end of the 
study, with those experiencing the biggest increase in IGF-1 not gaining as much lean mass as 
those who actually experienced a decrease in serum IGF-1. However, this paradoxical finding 
should be interpreted with caution, since there were large inter-participant variations. Namely, in 
59% of the participants serum IGF-1 decreased, whereas in 39% of them IGF-1 increased, with an 
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overall net decrease of ~5%. Some of this variation may be explained by the adiposity of 
participants, since the leaner participants tend to experience a decrease in IGF-1, whereas those 
with higher fat mass, do not experience significant changes after 15-weeks of resistance training 
(Bjersing et al. 2017). The reduction in IGF-1 with exercise training has also been reported 
elsewhere in the literature (Schmitz et al. 2002; Nindl et al. 2004). The authors of these studies 
have speculated that it may occur at the initial stages of active muscle tissue synthesis, whereas it 
may plateau around week 15, or even increase in the long-term (>15 weeks) (Schmitz et al. 2002). 
Nindl et al. (2004) hypothesised that although total IGF-1 may decline after 12 weeks of resistance 
exercise, free IGF-1 concentrations may remain stable.  
 
To the researcher’s knowledge, Chen et al. (2017) is the only study to include IGF-1 data in 
sarcopenic obese older adults. The study showed that the type of exercise training can have a 
significant effect on IGF-1 concentrations, with both resistance exercise and mixed resistance-
aerobic training resulting in significantly higher concentrations than the control group (no 
exercise). Moreover, the mixed-exercise group experienced significantly greater serum IGF-1 
compared to the aerobic-only and control group, whereas the resistance-only group experienced a 
significantly higher IGF-1 compared to control only. However, in the current study the exercise 
protocol was similar in both groups, therefore it is not likely to have confounded the results. 
Moreover, the absolute concentrations reported in the study by Chen et al. (2017), with values 
ranging from ~ 3-5 ng mL-1, are substantially lower than what the current study and other studies 
have reported (Schmitz et al. 2002; Nindl et al. 2004; Fontana et al. 2008; Dillon et al. 2009; 
Arnarson et al. 2015). Therefore, the findings of that study need to be interpreted with caution.    
 
In the absence of large changes in IGF-1 in the control group (EX) in the present study, it can be 
hypothesised that the increase in IGF-1 in EXD is likely to be accounted for by increased protein 
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intakes, as suggested by Dillon et al. (2009) and Fontana et al (2008) who supported that protein 
intake is a key factor in IGF-1 modulation. This finding is also in accordance with Kerstetter et al. 
(2015) who noted that daily incorporation of 45 g whey protein in the diet for 18 months can 
increase IGF-1 significantly more than an isocaloric carbohydrate-rich supplement. Even smaller 
manipulations in dairy protein intake (e.g. additional 16-20 g dairy protein daily) can significantly 
increase IGF-1 concentrations (Heaney et al. 1999). The lack of numerical changes in the control 
group in the current study may be accounted for by reasons discussed earlier (Schmitz et al. 2002), 
or more likely by the lack of high intensities employed in the current programme. This notion has 
also been corroborated by Izquierdo et al. (2006), who suggested that exercise intensities of 60 to 
70% 1RM may not have the potential to induce significant changes in serum IGF-1 unless all sets 
are performed to volitional failure, or alternatively, if the exercise volume is very high (Izquierdo 
et al. 2006).  
 
To better understand the relationship between circulating IGF-1 and changes in body composition, 
it would have been interesting to have performed a third test mid-point between baseline and 
follow-up. Moreover, although total serum IGF-1 concentrations can provide meaningful 
explanations, it has also been suggested that measuring free IGF-1, and specific IGF complexes 
(e.g. IGF binding proteins such as IGFBP-3 and IGFBP-5) can perhaps offer more insightful 
information in terms of musculoskeletal growth and metabolic/physiological adaptations 
(Izquierdo et al. 2006; Yakar et al. 2009). Moreover, assessment of GH responses could potentially 
provide a better interpretation, especially considering that changes in body composition and body 
fat, can affect serum IGF-1 concentrations by modulating the secretion of GH (Savastano et al. 
2014).  
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Due to the small sample size, statistically significant changes could not be established for serum 
ALP within the current study, albeit small numerical alterations were noted in both groups. 
Alkaline phosphatase is routinely used in clinical tests as an indicator of hepatic function and bone 
metabolism as well as intestinal and pancreatic function. Although, total ALP contains a mixture 
of the isoenzymes from all these organs, the serum total ALP concentration is primarily a marker 
of bone health and secondly a marker of liver health, since these are the tissues from which most 
of the isoforms originate (Mukaiyama et al. 2015). A high serum ALP is associated with an 
increased risk of low bone density (Hwang et al. 2017). Adults aged ≥ 80 years exhibit higher 
serum ALP compared to adults ≤ 60 years, with increases in ALP indicating increased bone 
turnover and osteopenia (Mukaiyama et al. 2015). In the current study, the small within-group 
alterations in ALP may indicate that bone metabolism was probably not affected by the dietary 
regimen. However, as mentioned, the sample size was too small to draw clear conclusions. 
 
Heaney et al. (1999) assessed the effect of protein supplementation on ALP in older adults. The 
authors reported that the addition of three servings of milk to habitual diet (accounting for a change 
in protein intake by approximately +15-20 g daily) decreased ALP concentrations by 9%, which 
was a significant change over time. However, unequivocal conclusions cannot be reached since 
ALP concentrations declined similarly in the control group, with no significant differences 
between groups, indicating that protein intake was not solely responsible for the decrease in ALP.  
 
As Filipowicz et al. (2013) have stated, total serum ALP is directly associated with C-reactive 
protein, inflammation and higher mortality risk. It was also suggested that in the absence of bone 
or liver disease, the relationship between total ALP with CRP-related inflammation is mediated 
by fractions of isoenzymes other than bone or hepatic. Although the sample size of the current 
cohort was too small for conclusions to be drawn, a small numerical decline in both ALP and 
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hsCRP was seen in the exercise and diet group (EXD), whereas the respective markers in the 
control group either remained unchanged or increased marginally. 
 
High-sensitivity CRP is a blood protein that increases with inflammation and is linked to higher 
risks of sarcopenia, arteriosclerosis and CVD development (Hida et al. 2017), with a strong 
association with CRP (Helal et al. 2012). Moreover, hsCRP is associated with obesity (defined as 
high %BF) and sarcopenic obesity (defined as high %BF and low SMI) (Yang et al. 2015). Despite 
the small sample size, this is the first study to examine the effect of a lifestyle intervention on hs-
CRP in Scottish older sarcopenic-obese community dwellers. The changes in hsCRP in EX were 
negligible, whereas EXD experienced a median (% median) change of -0.8 mg L-1 (-30%) (Chapter 
6, section 6.9). Although it has been shown that there is an inverse relationship between grip 
strength, physical function and hsCRP (Granic et al. 2017; Hida et al. 2017), associations do not 
always indicate causality. For example, a change in strength over time does not necessarily imply 
changes in hsCRP (Granic et al. 2017). The findings of the current study suggest that the driving 
factor for changes in hsCRP was fat/weight loss and not changes in physical function.  
 
In a trial with adults ≥ 50 years, Nicklas et al. (2015) reported significant changes in bodyweight 
(-6.5 kg) and similar median (% median) declines to the current study in hsCRP [-0.4 mg L-1 (-
28%), p<0.05], after a weight-loss regimen. On the other hand, in another study with sarcopenic 
obese adults, it was noted that exercise alone did not significantly reduce CRP even in the presence 
of significant improvements in physical function (Huang et al. 2017), which is in agreement with 
the current findings and those of Kim et al. (2016a). Kim and colleagues reported improvements 
in physical function of sarcopenic obese older adults following exercise training, but in the absence 
of significant body fat losses there was no statistical change in hsCRP.  
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Another parameter that should be taken into account is abdominal obesity. Van de Bool et al. 
(2015) have shown higher hs-CRP concentrations in sarcopenic adults with abdominal obesity 
compared to sarcopenic counterparts with no abdominal obesity. Although it has not been 
statistically confirmed in the present study, the diet and exercise group experienced a greater 
reduction in sagittal abdominal depth, which could perhaps explain to some extent the decline in 
hsCRP. Thus, reductions in anthropometric markers of central obesity may have a favourable 
effect on inflammation. This hypothesis would be in agreement with the findings of van de Bool 
et al (2015) and Schrager et al. (2006), who proposed that obesity (particularly central obesity) 
can directly mediate an inflammatory response.  
 
Therefore, it can be proposed that a multi-angled approach for the management of sarcopenic 
obesity is necessary; that is, attenuating inflammation through decreases in body fat, as well as 
improving physical function through exercise training. A decrease in hsCRP in the current cohort 
would theoretically indicate a lower risk for CVD, this however, should be confirmed in large 
cohorts following standardised operational protocols once definitions of sarcopenia and 
sarcopenic obesity have been established (Wang et al. 2017). 
 
8.4 Health-risks associated with higher protein intakes and energy deficit 
In the current study, no evidence of impaired kidney function was observed. Serum creatinine 
concentrations were within normal levels at baseline and after 16 weeks of a high protein diet 
providing ~1.4 g protein kg bw-1 day-1. This is in agreement with Mikusova et al. (2016), who 
reported no significant changes in renal function in older sarcopenic adults after six months of 
protein intakes of ~1.5 g kg bw-1 day-1.  
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In terms of bone health, no substantial changes were noted in ALP, which combined with the 
increased IGF-1 concentrations in EXD suggests that the current protocol is not likely to have 
negatively affected bone health. Kerstetter et al. (2015) assessed the effect of daily administration 
of 45 g whey protein on both bone health and kidney function in older Caucasian adults. After a 
period of 18 months, there was no difference in bone density between the group receiving protein 
vs their counterparts receiving an isocaloric carbohydrate-rich supplement, despite a significant 
change in absolute protein intake by ~ +17 g and in relative protein intake from ~ 1.1 g kg bw-1 to 
1.3 g kg bw-1. Bone mineral density at the sites of interest (e.g. lumbar spine, femoral neck and 
total hip density) did not change either between or within groups. Moreover, the high protein group 
exhibited a significant increase in lean mass and serum IGF-1 at the end of the 18 months. As 
expected, a significantly higher concentration of urinary urea was noted in the protein group, 
however, renal function was normal and not different from baseline.  These findings are in 
agreement with systematic reviews and meta-analyses reporting no detrimental effects in response 
to protein intakes higher than 0.8 g kg bw-1 (Darling et al. 2009; Shams-White et al. 2017; Wallace 
and Frankenfeld 2017). In fact, protein intake over the current recommendations of 0.8 g kg bw-1 
may offer small but significant benefits by increasing bone mass density, and therefore, potentially 
reduce the risk of bone fractures (Darling et al. 2009; Wallace and Frankenfeld 2017). However, 
these were not measured in the current study.   
 
Regarding weight loss-induced impact on bone mass, a recent meta-analysis showed that bone 
health is inversely associated with relative fat mass (Dolan et al. 2017). Moreover, muscle mass 
and muscle density are positively associated with bone health and balance in obese older adults 
(Scott et al. 2018). Since muscle mass was maintained and fat mass losses were noted it could be  
speculated that the current protocol did not have a detrimental effect on bone health, however 
DXA assessments would need to confirm that. As Heaney et al. (1999) have noted even a ~1 – 2% 
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decrease in ALP over 12 weeks can indicate a significant improvement in bone metabolism. 
Although a numerical decrease of a similar range was noted in the EXD group, this hypothesis 
cannot be corroborated in a small sample size. For a more valid quantification of bone turnover 
the bone specific ALP (BSAP) isoenzyme should be tested, as BSAP is not affected by the diet or 
circadian variations (Seamans et al. 2011; Roudsari et al. 2012). However, a drawback of BSAP 
is that it is quite expensive to quantify and is therefore, not used frequently as a diagnostic marker 
(Mukaiyama et al. 2015).  
 
Chapter 1 has presented the acute effect of whey protein ingestion on impaired glucose uptake and 
insulin resistance as reported by Smith et al. (2015). Recently, Smith et al. (2016) conducted a 
long term study which found that a high protein diet during a period of energy deficit may lead to 
insulin resistance by impairing the ability of muscle to utilise glucose, and therefore, may cancel 
out the weight loss-induced metabolic benefits. However, there were some conflicting findings 
that need to be corroborated in future studies. For example, there were no differences between the 
low- and high-protein groups in fasted glucose, insulin levels, intrahepatic triglyceride content, 
intra-abdominal adipose mass or free fatty acid concentrations (Smith et al. 2016). Such 
differences would indicate metabolic impairments and insulin resistance (Alipour et al. 2007). In 
fact, the high-protein group experienced 45% lower losses of lean mass, which was a positive 
effect of the high protein regimen (Smith et al 2016). Although the present study used milk protein 
and not whey, a test to assess the effects of exercise and high protein intake on glucose metabolism 
could have been performed e.g. a glucose tolerance test. However, assessment of glycaemic 
control would require participants to present to study sessions in a fasted state, and would 
therefore, confound strength and functional tests, not to mention be an extra burden for 
participants. To the best of the researcher’s knowledge, no findings have been disseminated to 
imply a negative metabolic response to milk protein. Even in type II middle-aged and older 
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diabetic patients, the acute protein-induced insulinemia can favourably modulate post-prandial 
glycemia (Manders et al. 2014), and improve fasting and post-prandial glycemia, glycated 
haemoglobin and waist circumference in the long-term (Jakubowicz et al. 2017).  
 
8.5 Strengths, limitations and challenges of the intervention study  
The small sample size was the most profound limitation of the intervention trial. Although some 
changes (e.g. fat mass) were numerically noticeable (as well as clinically relevant), it is possible 
that they would reveal significant differences between/within groups had the sample size been 
large enough. Therefore, robust conclusions could not be drawn. Thus, the interpretation as to 
whether it was the dietary or the exercise regimen that accounted for changes reported was not 
based on the presence of statistical significances, but based on comparisons with other studies 
using similar methodologies and assessing similar outcomes in older and/or sarcopenic obese 
participants.   
 
Although the costs associated with the study were low, the budget and resources that the researcher 
had at his disposal was minimal for a clinical trial of this magnitude. The protein supplements 
were the main asset of this study and had to be purchased from a supplement company. As a result, 
the available budget was spent in its entirety for the protein supplements alone. The available 
budget would allow for a maximum of ~10 participants to complete a full 20-week protocol or 
~13 participants for a 16-week protocol. Equally important was the fact that the final prevalence 
of sarcopenic obesity in this cohort (12%) meant that in order to recruit > 50 participants (as per 
initial target), a minimum of 416 older adults were required to be screened, which turned out to be 
an unrealistic goal given the lack of available participant database.  
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The lack of an established pool of potential participants for studies was therefore a limitation, 
which impacted heavily on time and resources used at the beginning and throughout the course of 
the study. This issue became even more challenging considering that within QMU research usually 
involves young healthy cohorts. In light of this, the researcher established a small volunteer 
database, thus creating better prospects for future recruitment purposes. However, apart from 
recruitment, the main researcher of the study had to execute all practical applications of this study, 
including screening, dietary assessments, diet plans, data collection throughout the study 
(including the blood tests), and delivery of the exercise classes. On top of that, the researcher 
liaised with the supplement company, purchased the supplements and arranged for their delivery 
and distribution to participants. 
 
Habitual physical activity data could have been collected throughout the current study to assess 
potential changes in habitual physical activity levels, including sedentary time. Moreover, heart 
rate monitors or accelerometers could have been worn during exercise classes to estimate the 
energy expenditure during exercise, which would allow for a better understanding of how the 
exercise classes contributed to daily energy expenditure. Furthermore, there was a lack of specific 
data regarding regional body composition changes due to limitations of the BIA device, which did 
not allow for better quantification and interpretation of body composition changes, in particular 
visceral fat mass and appendicular lean mass. Moreover, regional analysis of muscle mass, would 
have allowed for a more dimensional assessment of muscle quality, e.g. hand grip strength per 
unit of arm lean mass (Liao et al. 2017b).    
 
Studies with older adults involving dietary and/or exercise interventions are likely to report drop-
out rates > 20%, as observed in a systematic review by Shams-White et al. (2017). In fact in studies 
with sarcopenic or sarcopenic obese older adults following an exercise or nutritional intervention, 
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drop-out rates of >30% have been documented (Wouters- Wesseling et al. 2003; Chen et al. 2017), 
which are in line with the drop-out rates reported in the current study. With regard to compliance 
with dietary protocols, Shams-White et al. (2017) have demonstrated that in most studies involving 
protein supplementation compliance is <80%. Therefore, the compliance rate of 80% for the 
overall diet and 92% for the protein drink in the current study was overall very good. This 
underlines the practical benefit and sustainability of providing a flavoured ready-to-drink protein 
supplement.   
 
Although the study was delivered in its entirety by one person (the primary researcher) this ensured 
consistency in day-to-day tasks, adherence to protocols, direct communication with the 
participants and the ability to resolve issues swiftly. Moreover, the relatively small number of 
participants per exercise class ensured that participants received individual feedback and were 
paid close attention to, which may not be feasible in large multi-centred studies where many 
trainers/researchers are involved and may thus, lack consistency. This also applies to the 
techniques used for anthropometric measurements, functional tests as well as the design of 
nutritional plans and implementation strategies.    
 
In the current study there was no conflict of interest as supplements were purchased without 
sponsorship from a company. The exercise classes were performed in classrooms resembling those 
in community centres, without the provision of any specialised exercise equipment. The only items 
available were chairs and elastic bands. The latter can be purchased at a low cost, and do not 
require any storage space or physical exertion to be moved from location to location. In addition, 
the supplements used are widely available to the general public, at a reasonable cost. Thus, the 
whole protocol can be easily adopted at a low cost, which is vital for the sustainability and 
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practicality of community-based interventions. Moreover, this study provides data which can 
inform cost-analysis components of larger trials.    
 
Although the importance of a healthy lifestyle has been recognized globally, it has been 
documented that approximately half of older adults are not likely to meet the targets for physical 
activity (PA) in developed countries (Hallal et al. 2012), including Scotland as discussed in 
Chapter 1. The reasons for this behavior may lie in personal beliefs and environmental factors, 
such as peer interaction and encouragement from others (Franco et al. 2017). For example, during 
the recruitment phase of the intervention trial, when the primary researcher was attending events 
for older adults, a common response from older adults who had an apparent physical impairment 
(e.g. slow gait speed, use of walking aids, muscle weakness) was that ‘I am doing a lot better than 
people of my age who use wheelchairs/ electric scooters, or are bed bound, therefore, I am doing 
well’.  It has been documented that older adults often believe that the consequences of ageing are 
inevitable, and just by living outside of institutionalisation should be considered as something 
positive for an older person (Bardach et al. 2016). In fact, older adults who accept age-related loss 
of muscle, function and strength that may be accompanied by conditions such as obesity, 
dyslipidemia and hypertension, tend to normalize their condition and therefore accept it, without 
feeling the need for improvement (Bardach et al. 2016). 
 
In general, people would often make enquiries to this research project after their GP had indicated 
that certain parameters should be improved (e.g. their lipid profile, or blood glucose 
concentration), thus they had specific reasons for participating. Furthermore, people who visited 
QMU labs for the screening tests, and were provided with specific body composition values (e.g. 
%BF or SMM) felt motivated to start exercising, because they felt they could quantify their 
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problem and had a reference point which would help them monitor their progress. As Bardach et 
al. (2016) has suggested, although the training of health professionals can be improved by putting 
emphasis on healthy ageing (than merely treating the age-related conditions with medication), 
their interaction with older adults can offer more than the obvious treatment. That is, by conducting 
health assessments (e.g. weight, waist circumference, blood tests) they can provide the older adults 
with a specific plan of what should be addressed in order to reduce health risks.  
 
Some potential participants in the current study were worried about exercise intensities before 
commencing the programme. For the same reason, at the end of the study some  individuals were 
timid about attending the exercise classes that were set up at QMU sports centre for those who 
wanted to keep exercising. That is, although they had a positive experience from the research 
programme they were concerned whether they would be able to keep up with the ‘new pace’. One 
participant, who dropped out of the study, mentioned that she was not encouraged by her family 
members to continue with the trial, after taking ill by a seasonal flu. Her family advised her that 
an exercise/nutritional programme was not suitable for an older person, and would hinder 
recovery. Another participant who dropped-out of the study, reported at QMU facilities after a 
holiday break with a sore neck, and was hesitant to continue in fear of aggravating her trapped-
nerve. The inability to keep up with training paces can lead to a sense of incompetence and low 
self-esteem and is one of the key barriers to exercise, not only due to the inability of some to keep 
up with the higher physical demands, but also due to perceived pain and distress, fear of falling 
and joint damage (Simmonds et al. 2015). Further, advice often received by peers/family/clinicians 
to avoid physical activities and ‘take things easy’ has been documented in the literature as the 
main barriers to exercise in older cohorts (Franco et al. 2017).  
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Further, encouraging older adults to follow a weight-loss diet and to consume a high-protein food 
can also be challenging, as previously documented by Appleton et al. (2016) and Bardach et al. 
(2016). Apart from reductions in chemosensory abilities (i.e. changes in palatability and taste with 
age), main barriers include practical issues. For example, the effort required to prepare food, 
convenience of consumption and affordability, as well as reduced spoilage and food wasting. 
Although older adults tend to initially reject the idea of fortified foods, they will regularly consume 
foods they have tasted and found acceptable, or have been commersialised for use only by older 
adults due to proposed health benefits that are related to older age (van der Zanden 2015).  
Similarly, older adults appear to be negatively affected by previous unsuccessful experiences 
(Bardach et al. 2016). For instance, after failed attempts to lose weight (which may have occurred 
more than once), individuals may subsequently feel that losing weight via dietary means is not 
something achievable and should not be pursued further. Moreover, mixed messages regarding 
diet can lead to confusion in older adults surrounding food choices, as well as decrease interest in 
healthy eating (Best and Appleton 2013).  
 
Finally, the location of the exercise classes was also a barrier to adherence to the trial, since the 
classes were not based at close proximity to Edinburgh’s city centre. Although the location could 
serve well the local communities, it was perhaps not ideal for those living in Edinburgh. This 
further limited the potential participant pool to only those who could walk to the premises, or use 
public transport/ private means. One of the individuals who decided to participate, despite residing 
at the opposite side of Edinburgh, recorded low attendance rates. As reported, the individual was 
keen to participate although she had difficulties reaching QMU premises. Commuting time was 
approximately two hours and required the use of more than one means of public transport. 
Moreover, the same participant was also caring for her spouse.  Indeed, competing priorities (e.g. 
caring for a family member, spending time with family, and social commitment), long distances 
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and multiple means of transport have also been documented by Franco et al. (2017) as key barriers 
for older adults to participate in physical activities.  
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8.6 Recommendations for future research  
Regarding nutrition interventions, apart from single ingredients/foods, recent research paradigms 
are rightfully shifting towards more multi-angled approaches, embracing the properties of various 
foods and/or supplements in order to help older adults augment their body composition and 
functional capacity. A recent study by Bell et al. (2017), has highlighted the importance of 
combining different nutritional supplements that can work in synergy to favour muscle growth 
and physical function in older adults even in the absence of exercise. Namely, whey protein (30 
g), creatine (2.5 g), vitamin D (500IU or 12.5 μg), calcium (400 mg), and poly-unsaturated n-3 
fatty acids (1.5 g) were consumed in a dietary supplement twice a day for six weeks by healthy 
adults aged over 60 years and with a mean BMI and % body fat of 28 kg m-2 and 33%, respectively. 
As creatine can enhance muscle strength and function in older adults (Devries and Phillips 2014) 
it is a supplement that could potentially complement a high-protein regimen in studies with 
sarcopenic obese individuals. Despite the positive initial results (increased lean mass by ~ 0.7 kg 
mass) (Bell et al. 2017), the practicality, sustainability and adherence to multi-supplement 
protocols should be evaluated in the long term.  
 
In another multi-component study, daily consumption of 10 g whey protein with 10 μg vitamin 
D3 and at least 2.0 g DHA + EPA resulted in significantly higher lean mass (~1.9 kg), improved 
lipid profiles and lowered fatigue in 45 adults with COPD (mean age ~69 years) over a period of 
12 weeks (Calder et al. 2017). Fish oils and n-3 polyunsaturated fatty acids (PUFAs) are regarded 
as potentially useful ingredients for the sensitisation of ageing muscle to anabolic stimuli such as 
protein feeding. For example, the ingestion of fish oils for eight weeks has revealed significant 
augmentation of anabolic responses to hyperaminoacidaemia and hyperinsulinaemia after acute 
protein feeding, in both young/middle aged (Smith et al. 20111a) and older adults (Smith et al. 
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2011b). The daily dose used in these studies was 4 g (~1.9 g DHA and 1.5 g EPA), which resulted 
in significant increases in mTOR and p70S6 kinase phosphorylation levels, as well as higher acute 
muscle synthetic responses after eight weeks of supplementation. 
 
Although these findings are promising, the main limitation is that most studies have been 
conducted in the short-term, with only a few protocols longer than 12 months in duration (Byrne 
et al. 2016; Kim et al. 2016b). In addition, as shown in the current study, it is not realistic to expect 
perfect attendance rates to exercise classes mainly due to illness, or other commitments. 
Considering also that significant muscle losses are likely even during very short periods of 
inactivity/immobilisation, examining the effects of lifestyle changes for a few weeks or even 
months under ‘ideal’ conditions may not be the most pragmatic paradigm for the assessment of 
lifestyle programme effectiveness and sustainability. Therefore, long-term studies are required 
that will utilise protocols under more realistic conditions. A way to potentially overcome the issues 
associated with short-term inactivity (e.g. muscle atrophy or loss of strength) would be the use of 
electromyostimulation (EMS) devices. These devices, if used prior to protein feeding, can 
significantly increase muscle protein synthesis rates in older adults by ~18% (Dirks et al. 2017). 
In the long-term they can increase muscle mass and strength, while promoting fat loss in sedentary 
or osteopenic older adults (Kemmler and Stengel 2013; Stengel et al. 2015), and also in sarcopenic 
obese adults who cannot participate in exercise training [SMI/BMI: +0.02 (95%CI: 0.01, 0.03); 
%BF -2% (-1.40, -2.68); grip strength: +1.9 (1.0, 2.8kg)] (Kemmler et al. 2017b; Kemmler et al. 
2017c). Therefore, it should be elucidated whether a combination of resistance exercise with the 
use of EMS on ‘rest days’ or days of low activity/inability to exercise can enhance the effect of 
protein feeding, which may result in more pronounced effects than resistance exercise and diet 
alone.  
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In relation to above, in a hypothetical 12-month programme the initial month(s) could be used to 
familiarise participants with exercise protocol and employ a more conservative approach in terms 
of dietary changes. The period would focus mainly on exercise technique, balance, proprioception 
and flexibility. The second phase would focus more on strength, endurance and aerobic exercises, 
introducing a slight caloric deficit (~200-300 kcal) ensuring an adequate carbohydrate intake. The 
third phase would introduce a moderate caloric deficit (~500 kcal) alongside a high protein intake 
(~1.5 g kg bw-1) and hypertrophy training with increased exercise volume, and time-under-tension. 
The next phase would focus on power and agility, maintaining high protein intakes. The final stage 
would involve exercising at higher training intensities, while the caloric intake would increase to 
meet the higher energy demand. Vitamin D3 could be supplemented throughout the year at low 
daily doses (10 μg daily or 25 μg EOD), in addition to omega-3 fatty acids, which could be 
introduced during the periods of more pronounced energy deficits. Emphasis should also be placed 
on adequate consumption of fruit, vegetables and whole-grain products in order to improve fibre 
intake to meet daily fibre recommendations of 30 g day-1 (SACN 2015). Increasing fibre intake 
may promote diversity in the microbiome and reduce inflammation (Kumar et al. 2016). During 
periods of inactivity due to illness, hospitalisation or other reasons, an EMS device could be 
utilised to attenuate muscle atrophy and maintain muscle strength.   
 
Apart from supplementation, it is important to conduct studies that aim to increase protein intakes 
by using easy to store and prepare high-protein foods. Therefore, foods that are usually preferred 
by this age group, e.g. high-protein soups as proposed by Donahue et al. (2014), can make the 
whole process more realistic, palatable and sustainable, with participants more likely to adhere to 
protocols. For example, egg-based dishes or lean beef could be used more regularly, or in higher 
quantities, to increase dietary protein (Phillips 2012; van den Heuvel 2017). A portion of 180 g 
lean beef can provide ~42 g protein which can raise MPS rates significantly higher than a 60 g or 
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120 g portion (Phillips 2012). However, care should be given to follow dietary guidelines 
regarding increased consumption of red/ processed meat. Alternatively, smaller portions of 
chicken or beef with mashed potatoes and vegetables could be enriched with protein by replacing 
butter with high protein milk (Ziylan 2016). However, such modifications require a certain degree 
of cooking skills and knowledge of food exchanges (e.g. low protein high energy-density for high-
protein low energy-density foods). Such skills and knowledge could be communicated via 
community-based cooking classes that would place emphasis on healthier lifestyle choices 
through peer-interactions.    
 
Finally, a better understanding of what the sarcopenic obese adults eat and why they opt for such 
choices can offer substantial benefits in designing future interventions. Apart from dietary content 
per se, appetite is an important parameter in controlling portion sizes, which can affect energy and 
macronutrient intake, an area that has been overlooked in sarcopenic obesity. As Hopkins and 
Blundell (2017) have noted, mechanisms regulating appetite are not yet fully understood even in 
healthy adults. They suggest that body tissues (especially lean mass) may affect appetite, with fat 
mass playing a role but to a lesser degree. Therefore, it could be hypothesised that the appetite 
control mechanisms of sarcopenic obese older adults may be dysregulated in comparison with 
their eutrophic counterparts, and should be evaluated in future trials. In an attempt to measure 
satiety ratings in healthy older community-dwellers, Ziylan et al. (2016) found mixed results in 
response to different portion sizes and protein contents. Based on the theory by Hopkins and 
Blundell (2017), it could be proposed that body composition may have affected the results. 
Therefore, it would be worthwhile investigating healthy, sarcopenic, obese, and sarcopenic obese 
older adults in future to determine whether appetite control mechanisms are dysregulated in 
sarcopenic obesity. This could inform future nutritional interventions.    
 
289 
 
Conclusion 
 
In conclusion, the present study is the first study to demonstrate that older Scottish independent-
living populations may suffer from increased rates of adiposity and low muscle mass, even with 
normal BMIs. Body mass index misidentified more than half of the cases of obesity and therefore, 
the true prevalence of obesity in Scottish older adults may be even higher than what is currently 
proposed. Classification of obesity based on BMI may also affect the phenotypic characteristics 
of older groups (e.g. muscle mass and strength) which can limit the pool of participants for 
sarcopenic obesity studies, and may add ‘noise’ to observational and intervention trials. Central 
adiposity may affect muscle strength and quality, even for non bodyweight-bearing physical tasks. 
The rates of sarcopenia may be higher in Scotland compared to England and other European 
countries, which combined with the increased obesity rates may predispose Scottish older adults 
to more health limitations. Moreover, if older adults can be sarcopenic and obese (based on low 
muscle mass/function and high percent body fat), even at normal BMIs, it raises questions 
regarding the quality of care that they will receive by healthcare professionals.  
 
A simple dietary intervention employing a moderate caloric deficit and increased protein intake 
via a ready-to-drink protein milk supplement can lead to favourable body composition changes in 
older adults with low muscle and high adiposity. Protein intakes of ~ 1.4 g kg bw-1 appeared to be 
sufficient in attenuating the loss of muscle mass during an energy deficit diet. In addition to 
increased protein intakes, a mixed exercise programme three days weekly with an emphasis on 
resistance, aerobic and balance exercises (without the use of sophisticated equipment but only 
bodyweight exercises and elastic bands) is likely to improve muscle strength and physical 
function. However, a dietary regimen is necessary to lower fat mass to a degree that is clinically 
meaningful, which may also attenuate adiposity-related inflammation.  
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The addition of a milk-based protein supplement does not negatively affect negatively kidney 
function or bone health, and was well tolerated by an older adult cohort. A low dose vitamin D 
supplementation protocol in line with the current guidelines can improve serum 25-
hydroxyvitamin D in older adults. However, its effectiveness in improving body composition and 
function in older adults with low muscle and high fat mass is still inconclusive. Despite this, it 
was shown to help older adults achieve serum concentrations > 50 nM. The combination of these 
paradigms could be incorporated into longer-duration studies with more participants, and perhaps 
include more diverse groups e.g. frail, institutionalised or older adults with physical disabilities, 
who have an unfavourable ratio of fat to muscle mass and poor muscle strength/function.   
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Appendix 1 Key summary ACSM recommendations for exercise 
in older adults (adapted by ACSM 2014). 
 
For Aerobic Exercise:  
• Frequency  
≥ 3 days / week for vigorous intensity or ≥ 5 days/week for moderate intensity activities. 
• Intensity 
On a physical exertion scale of 0-10, a score 5-6 would indicate moderate intensity whereas 7-
8 vigorous intensity. 
• Duration?  
Moderate activities should be performed in bouts of at least 10 minutes each for a total of 30-
60 minutes a day or 150-300 minutes a week. Vigorous activities can be performed for a total 
of 20-30 minutes a day for a total of 75-100 minutes a week.  
• What types of exercise? 
Walking, brisk walking, dancing and jogging.  Stationary cycling and aquatic exercise are ideal 
for those who cannot perform weight-bearing exercises. 
 
 
Muscle Strengthening/ Endurance Exercise: 
• How often?  
≥ 2 days / week 
• Intensity? 
Light intensity for beginners and moderate to vigorous intensity for the more experienced. On 
a scale 0-10, light intensity is < 5, moderate 5-6 and vigorous 7-8.  
• How many? 
8-10 different exercises, ≥ 1 set per exercise, 10-15 repetitions for each set.  
• Types of Exercise?  
Weight-bearing exercises, use of resistance bands, light dumbbells, stair climbing and other 
exercises engaging the major muscle groups such as legs, back, chest and arms.  
 
Flexibility: 
• How often? 
≥ 2 days / week 
• Intensity? 
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Stretch until you feel the tightness on the muscle or slight discomfort  
• For how long? 
Stretch and hold for 30-60 secs  
• Type: 
Slow movements that either maintain or increase the flexibility of joints for the major muscle 
groups. Static stretches (i.e. hold and stretch with no rapid movements involved) are preferred. 
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Appendix 2 Search Strategy 
 
Effectiveness of nutritional and exercise interventions in the management of sarcopenic 
obesity in older people: a systematic review (SEARCH STRATEGY)  
MEDLINE (PubMed) 
S1. (MH "Aged") OR aged OR (MH "Adult") OR adult OR (MH "Aging") OR aging OR (MH 
"Geriatrics") OR geriatric# OR (Over N1 (65 OR 60)) OR old* OR ag#ing OR senior# OR elder*   
S2. ( (MH "Sarcopenia") OR sarcopeni* OR sarcopenic obesity OR (MH "Muscle Weakness") 
OR (musc* N2 (weakness OR atroph* OR loss* OR low)) OR (MH "Muscular Atrophy") OR 
(MH "Frail Elderly") OR (MH "Atrophy") OR frail* OR lean)   
S3. (MH "Obesity") OR obes* OR (MH "Overweight") OR overweight OR (MH "Adipose 
Tissue") OR (MH "Adiposity") OR (high N1 (fat OR adipos* OR BMI OR Body Mass Index))   
S4. (MH "Exercise+") OR "exercise*" OR (MH "Exercise Therapy") OR (MH "Resistance 
Training") OR (MH "Walking") OR (MH "Running") OR ("Physical" N1 ("activit*" OR 
"training")) OR ("Exercis*" N2 ("endurance" OR "aerobic" OR "resistance" OR "balance" OR 
"combin*" OR "mixed" OR "multi#modal" OR "eccentric" OR "concentric" OR "isometric" OR 
"plyometric" OR "program*" OR "regime") OR "protocol") OR (MH "Physical Exertion") 
S5. (musc* N2 (mass OR gain OR strength OR size OR cross sectional area OR CSA OR thick* 
OR power OR growth OR enlarge* OR area OR volume OR hypertrophy OR recovery OR 
recovery) OR (speed OR gait OR grip OR (MH "Hypertrophy") OR hypertrophy OR (MH 
"Muscle, Skeletal") OR (MH "Muscle Strength") OR lean mass OR fat free mass OR life N2 
quality OR function* OR balance OR flexib* OR dynamic OR fitness OR capacity OR Activities 
N1 daily living OR ADL#)   
S6. (MH "Diet+") OR (MH "Energy Intake") OR (MH "Diet, Protein-Restricted") OR (MH "Diet, 
Reducing") OR (MH "Diet, Fat-Restricted") OR (MH "Diet, Carbohydrate-Restricted") OR (MH 
"Diet Therapy") OR (MH "Weight Reduction Programs") OR (MH "Weight Loss") OR (protein* 
N2 (high OR diet* OR intake OR whey OR milk OR supplement*)) OR (MH "Dietary 
Supplements") OR (MH "Dietary Proteins") OR supplement* OR Nutrition* OR (MH "Energy 
Metabolism") OR (Energy N2 (deficit OR reduced OR intake)) OR hypo#caloric OR (MH "Amino 
Acids") OR (MH "Amino Acids, Branched-Chain") OR (MH "Amino Acids, Peptides, and 
Proteins") OR (MH "Leucine") OR leucine OR HICA OR Hydroxy?isocaproic acid OR amino 
acids OR BCAA OR HMB OR methyl N1 butyrate OR creatine 
S7. S4 OR S5 OR S6   
S8. S1 AND S2 AND S3 AND S7 
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S9. AB ((MH "Intervention Studies") OR intervention OR Randomi?ed N2 (Control* OR clinical 
OR crossover OR Trial) OR RCT OR Clinical trial) OR TI ((MH "Intervention Studies") OR 
intervention OR Randomi?ed N2 (Control* OR clinical OR crossover OR Trial) OR RCT OR 
Clinical trial)   
S10. S8 AND S9   Limiters  - English Language; Human 
Results 600 (22/05/16) 
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Appendix 3 Overall strengths and rationale of the protocol  
 
Aspect Strength/ Rationale 
 
Bodyweight 
exercises 
initially 
-Everyone starts at the same baseline 
-Allows participants with no prior experience to familiarise themselves 
with the techniques  
-Minimise the risk of injuries   
 
Mixed Exericse 
Programme 
-Allows for improvements in several aspects of fitness that are important in 
older age e.g. strength, power, flexibility, aerobic capacity,coordination 
and balance  
 
 
 
 
Use of elastic 
bands 
-High Practicality (portable and affordable) 
-No need for specialized equipment (only an adequately spaced room with 
chairs)   
-Can augment muscle mass and strength/function 
-Safer than free weights 
-Minimise the ‘sticky points’ 
-Can facilitate different intensities and velocities for the concentric and 
eccentric parts of exercise  
-Can accommodate the needs for a group of adults with diverse skills and 
capacity to exercise  
-Ability to monitor progression 
 
 
 
 
 
Protein drinks  
-Help to increase protein intakes even during energy restriction 
-Protein content similar to what has been found in the literature to 
stimulate muscle protein synthesis after resistance exercise in older adults 
-Do not require cooking skills/knowledge 
-No extra financial burden for the participants 
-Long shelf life 
-Commercially available 
-Practical and convenient 
-Palatable/ different flavours 
-May promote satiety, thus better adherence to the energy deficit diet 
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-Can be used post-workout for rehydration, or in the evening as a pre-bed 
meal.  
Vitamin D 
supplementation 
-Helps minimise confounders related to vitamin D deficiencies 
-Adheres to UK guidelines.  
Overall -Can be replicated at a community level with minimum resources 
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Appendix 4.1 Single arm Functional Reach  
 
 
Figure IV-I Body position for the 1-arm functional reach test and measured distance.   
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Appendix 4.2 Diet Diary  
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Appendix 4.3 Formulas for the estimation of Resting Energy 
Expenditure 
(Henry 2005) 
 
 
Table IV-I Oxford predictive equations for basal metabolic rate in older adults (adopted by Henry 2005) 
Sex Age (yr) Kcal · day-1 
Men 60 – 70 13.0 bw + 567 
 70+ 13.0 bw + 481 
Women  60 – 70 13.0 bw + 572 
 70+  13.0 bw + 577  
Bw, bodyweight in kg 
 
 
 Example:  
 Female, age 73, Weight 76.0, PAL: 1.4 
 
BMR: 10.0*W+577= 10.0*76.0 +577= 1337 kcal 
Daily energy requirement: 1337 *1.4 = 1872 kcal  
Revised Energy Intake: 1872 - 500 = 1372 kcal  
 
 Daily Macronutrient Requirements  
 
Protein: 1.2 - 1.5 x 76.0= 91 - 114 g protein  365 - 456kcal (27 - 33% of total energy 
intake) 
Fat: 0.3 x 1372= 412/9 kcal= 46 g fat (30% of total energy intake) 
Carbohydrates: 504 – 595 kcal /3.75 kcal = 135 – 158 g  carbohydrate (37 - 43 % of 
total energy intake) 
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Appendix 4.4 Sample daily diet nutritional analysis 
 
Table IV-II  A sample of a hypocaloric high protein diet for a participant in the intervention group (based on 
Nutritics database)  
Meal and Food amount Energ
y 
(kcal) 
CHO 
(g) 
PRO 
(g) 
FAT 
(g) 
Breakfast 
     
Breakfast cereal, wheat biscuits 1 biscuit 66.0 14.5 2.1 0.4 
Milk, skimmed 1 mug (250ml)  85.0 12.0 8.8 0.8 
Peaches, raw, flesh and skin 1 medium (~110g) 36.3 8.4 1.1 0.1 
Morning Snack 
     
Apples, raw, flesh and skin 1 small (~100g) 53.0 12.1 1.1 1.6 
Oatcakes 1 biscuit 42.0 6.2 0.6 0.5 
Coffee, black (no sugar) 1 mug 5.2 1.0 0.1 0.1 
Lunch 
     
Bread, whole meal  1 medium (~35g) 80.0 15.5 3.5 0.9 
Vegetables (mixed salad e.g. peas, 
carrots, green beans and tomatos) 
1 cup (~160g) 68.0 10.8 5.4 0.8 
Olive Oil 1 tsp (~5g) 37.8 
 
trace 4.2 
Cheese, Cheddar 1 slice (~30g) 125.0 0.0 7.6 10.5 
Chicken, roasted size equal to a 
matchbox (~30g) 
53.0 
 
8.2 2.3 
Plums, raw, flesh and skin 2 medium (~110g) 21.6 5.3 0.4 0.1 
Afternoon Snack 
     
Oatcakes 1 biscuit 42.0 6.2 1.1 1.6 
Tea, black  1 mug 
  
0.3 
 
Dinner  
     
Bread, whole meal 1 medium slice 
(37g) 
80.0 15.5 3.5 0.9 
Vegetables (mixed salad) 1 cup (~163 g) 68.0 10.8 5.4 0.8 
Olive Oil 1 tsp  37.8 
 
trace 4.2 
Cheese, Cheddar 1 medium slice 
(~30g) 
125.0 0.0 7.6 10.5 
Chicken, roasted size equal to a 
matchbox (~30 g)  
53.0 
 
8.2 2.3 
Study Drink  
     
Promilk 50  1 bottle 320.0 26.7 51.0 1.0       
Total  
 
1398.
7 
145.1 113.3 43.6 
Total (% of daily energy) 
  
~40% ~30% ~30% 
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Appendix 4.5 Promilk 50- Full amino acid profile 
 
Table IV-III Amino Acid profile of Promilk50 
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Appendix 4.6 Example Log sheet Participant ### (Week 1 starting 
25/01/16) 
 Week 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Day  25 
Jan 
      14 
Mar 
       09 
May 
  
1 
Mon 
Diet                   
 VitD                   
 ProMilk                   
2 
Tues 
Diet                   
 VitD                   
 ProMilk                   
3 
Wed 
Diet                   
 VitD                   
 ProMilk                   
4 
Thur 
Diet                   
 VitD                   
 ProMilk                   
5 Fri Diet                   
 VitD                   
 ProMilk                   
6 
Sat 
Diet                   
 VitD                   
 ProMilk                   
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7 
Sun 
Diet                   
 VitD                   
 ProMilk                   
 
 
Notes:  
 Make sure you take 3 VITAMIN D TABLETS per WEEK. Put an X in the 
relevant box on the log sheet if you miss one. It does not have to be on 
consecutive days. If it is easier to remember you can take it on the exercise days 
(e.g. Monday-Wednesday-Friday).  
 
 Make sure you drink one Promilk50 everyday after the exercise class or in the 
evening before bed (on the non-exercise days). Put an X in the relevant box on the 
log sheet if you miss one. Put a check mark (✓) when you take one. Put an 
asterisk on the days that you have substantial changes in your diet plan (e.g. you 
dine out or you go on holidays etc.) and try to provide further information on the 
following pages (e.g. *Week 2, days 5-7: Weekend trip, I could only eat what was 
available at the hotel, and did not stick to the diet plan).  
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Appendix 4.7 Dietary advice given to participants 
 
General guidelines  
 Avoid fried (especially deep fried but also pan-fried*) foods such as fried rice/noodles or 
fried/battered meat – instead you can bake, boil, steam or microwave.  
 Try to make your own meals instead of buying processed ready-made foods.  
 In general prefer lean skinless meat, such as poultry and fish, or eggs/cheese/legumes 
(beans) for meat-free meals. If having port you can remove the visible fat. If you buy canned 
fish prefer the one in water.  
 If you eat out prefer stir-fried meals and eat a salad as a starter, or greens/rice instead of fried 
chips. 
 Avoid ready-made salad dressings based on cream/mayonnaise, or creamy-soups, instead 
you can use olive oil/olives (as per diet plan), vinegar, lemon juice for flavor. You can also 
improve the flavor by using spices, herbs, fresh ginger, zest of lemon/orange, garlic and 
onions (you can use as much as you like of these ingredients), in your meals, salads, soups, 
stews etc.  
 Try to limit red meat to once a week and avoid processed meat (e.g. sausages, burgers, 
bacon, salami etc.).  
 Try to stick to the plan and consume at least five portions of fruits and vegetables a day. 
Prefer fresh whole fruits over canned or dry. Apart from fresh fruit, aim to eat more non-
starchy vegetables: spinach, broccoli, lettuce, green beans, tomatoes, carrots, courgettes, 
cucumber, mushrooms etc.  
 Prefer whole-grain foods like brown rice, wholegreain bread/cereal (e.g. bran flakes) and 
oatcakes over white (white bread/pasta etc) or sugary foods such as cakes, sweets, cookies, 
croissants, chocolate, donuts, etc.  
 Drink lots of water and fluids throughout the day. You have no restrictions on tea as long as 
it has no added sugar (if sweetness is necessary you can use low-calorie sweeteners, or have 
your tea with a piece of fruit as per individual plan). Avoid soft drinks and sugary/fruit 
juices. Read the ingredients, if it mentions sugar, glucose, fructose, any kind of syrup, or 
concentrated fruit juice you should better avoid it.  
 
Programme specific guidelines 
 
 Make sure you take any notes of deviations from your individual diet plan on the log sheet, 
and raise any concerns that you may have regarding the diet or any other aspect of the 
programme with the person responsible for the programme.  
 Remember to take your Vitamin D tablets. Tick (X) the relevant box on the log sheets if you 
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miss a tablet (there are no strict rules on the timing of this, but for your own convenience 
you can take it on Monday, Wednesday, Friday).  
 Make sure you take one (1) Promilk every day. On the exercise days, you are advised to take 
it right after the exercise and on non-exercise days before bed (e.g. one hour before bed).  
 Shake well the Promilks before consumption.  
 Store the Promilks in a cool and dry place under 25oC. When you open it, you can consume 
it within 30 mins or store in the fridge for later consumption.   
 
* You can pan-fry if you use a minimum amount of oil (as per plan) or water. 
 
Keep coming to the exercise class. The diet and exercise work hand in hand, therefore it is 
important that you try your best to follow both. 
 
Example guidelines for participants a) with a varied schedule b) who wanted to add some 
alcohol to the diet, c) found it difficult to adhere to portion sizes, d) could not consume 
Promilk50 in one sitting.    
 
 It is very important to consume the quantities as stated in your diet plan. If necessary you 
may change the timings of the meals (except for the Promilk50, see above) but make sure 
you have some source of protein (e.g. meat, dairy, legumes) in your main meals as per diet 
plan.  
 You can add as much leafy greens to your lunch and dinner as you like to increase the 
volume of the meal.  
 If you feel that the lunch and/or dinner are still not enough you can also increase the portion 
size of the salad/vegetables but do not add more than recommended oil or salad dressing. 
Try to start with the salad/vegetables before the main meal. Have snacks as stated in your 
individual diet plan between the main meals, and ensure you drink plenty of water/tea (or 
other beverages as per individual plan throughout the day).  
 You can have a total of three 330 mL bottles of beer OR two 330 mL beer + one small 
glass of wine per week. Make sure you drink plenty of water regularly before and after 
the alcoholic beverage. You can also swap the alcoholic beverage for sparkling water.  
 
Adapted from:  
 
FINK, L., [no date]. Feeling satisfied may be your ticket to successful weight management. 
[online].Canada: Weight watchers [viewed 15 May 2014]. Available from: 
http://www.weightwatchers.ca/util/art/index_art.aspx?tabnum=1&art_id=34441 
 
HARVARD HEALTH PUBLISHING., [2014]. How to spot - and avoid - added sugar [online]. 
[viewed 09 November 2014] Available from: https://www.health.harvard.edu/staying-
healthy/how-to-spot-and-avoid-added-sugar 
 
JOSSE, A.R., 2011. Body Composition and Bone Health During Hypoenergetic Diet- and 
Exercise-induced Weight Loss Are Enhanced by Diets Higher in Dairy Foods and Dietary 
Protein. PhD thesis ed. McMaster University. 
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NHS., [no date]. Live well [online]. [viewed 05 April 2014]. Available from: 
https://www.nhs.uk/live-well/ 
 
ROBINSON, L., SEGAL, J. and SEGAL, R., 2013. Healthy Eating. Simple Ways to Plan, 
Enjoy, and Stick to a Healthy Diet [online]. US: HELPGUIDEORG International and Harvard 
Health Publishing. [viewed 09 February 2014]. Available from: 
https://www.helpguide.org/articles/healthy-eating/healthy-eating.htm 
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Appendix 4.8 Exercises  
 
Table IV-IV Exercise programme 
←Regression Exercise Progression → 
 Warm Up (10 min)  
Walk next to the wall for 
support 
Walk Around the room Brisk Walking  
 Upper Body twist- Seated Upper body twist- Standing 
 Seated arm raises (lateral and 
front) 
 
 Seated Heel Raises  
 Seated Toe raises  
 Seated Leg march Standing by the wall single-leg 
raise 
 Neck Rotation  
 Leg (Hip) Extension  
 Shoulder lateral rotation 
(external rotation) 
 
Tap toes laterally (Standing hip 
abduction/adduction) 
Leg swing- lateral   
 Standing Leg curl (knee flexion)  
 Wall press Stand slightly further away from 
the wall or single-arm wall press 
 Standing knee raise Knee to opposite elbow 
 Mini squat with arms front raise   With trunk rotation (‘wood 
chop’) 
 Balance (5-10 min)   
 Sideways walking  
 
Grapevine walk - Fast Sideways 
walking with lower centre of 
gravity 
Heel to toe parallel walk Heel to toe walk heel to toe walk with neck 
rotation  
 Walking with toe raises  
 Combination footwork, with 
markers on the floor (as 
presented by Dawes and Roosen 
2012) 
 
 Main body - Resistance (30-35 
min)  
 
 Core  
 Trunk rotation- with straight 
arms 
With EBs  
 Seated back extension  
Abdominal flexion seated 
Side bend (lateral flexion/ 
extension) 
With EBs 
With EBs 
 
With EBs 
 Legs  
 Knee Extension  With EBs 
Mini Squats (knee flexion) with 
hands supported on the chair 
Chair Stand  Squat in front of the chair 
(without sitting) Squat w. EBs 
 Lateral leg abduction With EBs 
 Leg (Hip) extension  With EBs 
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Calf Raises Seated  Calf Raises Seated With hands 
on knees  
Calf Raises with EBs 
 Calf Raises Standing by the wall 
both legs 
Standing single leg 
 Chest  
 Chest press  With EBs 
 Chest Flies With EBs 
 Back   
 Seated Row With EB 
 Inverse Flies With EB    
 Lat Pull down With EB 
 Arms  
 Shoulder Press With EB 
 Shoulder raises, lateral With EB 
 Bicep Curls With EB 
 Tricep Extension With EB 
 Cool down- Stretching (10 
mins) 
 
Stretching for: Neck, Shoulder, Triceps, Biceps, Chest, Back, Abs, Quadriceps, Hamstring, Calf 
   
   
 
 
Adapted from: 
BAECHLE, T.R. and WESTCOTT, 2010. Fitness professional’s guide to Strength Training Older Adults. 
2nd ed. Leeds: Human Kinetics. 
DAWES, J. and ROOSEN, M., 2012. Developing Agility and Quickness. Leeds: Human Kinetics.  
KNOPF, K.G., 2013. Resistance band workbook. Illustrated Step-by-Step Guide to Stretching, 
Strengthening and Rehabilitative Techniques, Berkeley: Ulysses Press 
NHS., 2014. Exercises for older people [online]. [viewed 03 June 2014]. Available from: 
http://www.nhs.uk/Tools/Pages/Exercises-for-older-people.aspx 
NATIONAL INSTITUTE OF AGEING., [no date]. [online]. [viewed 14 June 2014]. Available from: 
https://www.nia.nih.gov/health/exercise-physical-activity 
PATHS FOR ALL., 2014. Strength and Balance Programme [online]. [viewed 25 July 2014].Available 
from:  http://www.pathsforall.org.uk/pfa/health-professionals/strength-and-balance.html 
SEQUIN, R.A., EPPING, J.N., BUCHNER, D.M., BLOCH, R., 2002. Growing Stronger: Strength 
Training for Older Adults [online]. Massachusetts: Center for Disease Control [viewed 10 June 2014]. 
Available from: https://www.cdc.gov/physicalactivity/downloads/growing_stronger.pdf 
WILLIAMSON, P., 2011. Exercise for special populations (1st ed.) Wolters Kluwer/Lippincott Williams 
& Wilkins.  
388 
 
Appendix 4.9 Sample size calculation 
 
Sample size equation:  n = 2[(a + b)²σ²]    
           (μ1−μ2)² 
 
        
n = sample size in each group 
μ1 = population mean in treatment Group 1 
μ2 = population mean in treatment Group 2 
μ1 − μ2 = the difference the investigator wishes to detect 
σ² = population variance (SD) 
a = 1.96 (conventional multiplier for alpha = 0.05) 
b = 0.842 (conventional multiplier for power = 0.80) 
 
Figure IV-II. Calculation of sample size assuming alpha =0.05 and power =0.08 (Noordzij et al. 
2010). 
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Appendix 5 Outliers in cross-sectional data 
 
 
A B 
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Figure V. Boxplots for BMI (A), SMI (B), SMM (C), and Fat mass (D) for the screening test (Test 1) in men (n=29) and women 
(n=79) of the overall cohort. 
C D 
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Publication 1: Systematic Review  
 
THEODORAKOPOULOS, C., JONES, J., BANNERMAN, E. and GREIG, C., 2017. 
Effectiveness of nutritional and exercise interventions to improve body composition and muscle 
strength or function in sarcopenic obese older adults: A systematic review. Nutrition Research. 
May, vol. 43, pp. 3-15. 
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Publication 2: Poster presentation 
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Publication 3: Oral Poster Presentation 
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Publication 4: Oral Presentation 
Screening for sarcopenia and dynapenia in older Scottish community-dwellers; the 
impact of body composition on muscle strength and quality. 
 
Christos Theodorakopoulos1, Elaine Bannerman2, Carolyn A.Greig3, Jacklyn Jones1 
1Dietetics, Nutrition and Biological Sciences, Queen Margaret University, Edinburgh, 2School 
of Medicine, University of Dundee, Dundee, 3School of Sport, Exercise and Rehabilitation 
Sciences, University of Birmingham, Birmingham, UK 
 
Keywords: Dynapenia, Sarcopenia, Muscle Strength, Muscle Quality 
Background: Dynapenia (loss of muscle strength) and sarcopenia (the combined loss of 
muscle mass and strength/function) are both associated with physical disabilities in older 
adults[1][2]. Moreover, fat mass may impact the development/progression of these conditions 
as high adiposity has been associated with lower muscle quality and higher rates of lean 
mass losses[3]. 
Objectives: This study examined the relationship between body composition and muscle 
strength and quality in older Scottish community-dwellers screened for sarcopenia and 
dynapenia. 
Methods: The European Working Group on Sarcopenia in Older People (EWGSOP) criteria 
were used[2]: low strength (dynapenia) was defined as handgrip strength (HG) <20kg in 
women and <30kg in men and sarcopenia as skeletal muscle index <6.76 kg*m-2 in women 
and <10.76 kg*m-2 in men, combined with dynapenia. Dual frequency bioelectrical 
impedance analysis (BIA) was used to estimate fat mass (kg) lean mass (kg) and skeletal 
muscle mass (SMM; kg) and a handgrip dynamometer to measure HG. Muscle quality was 
defined as the ratio of HG per unit of lean mass. A Spearman’s test was used to assess 
associations between handgrip, muscle quality and body composition. 
Results: One hundred and eight people were screened (29m, 79f), median (IQR) age 70 
(67, 75) years and BMI 26.9 (24.1, 30.7) kg*m-2. Prevalence of dynapenia was 17.2% in men 
and 21.5% in women and sarcopenia 13.8% in men and 15.2% in women. Handgrip strength 
was significantly associated with both lean mass (n=105; rho=0.62, p<0.001) and SMM 
(rho=0.63, p<0.001), whereas a small but significant negative relationship was observed 
between handgrip strength and fat mass (rho=-0.25, p<0.01). Muscle quality was 
significantly and negatively associated with fat mass (n=105; rho=-0.51 p<0.001) (Figure 1). 
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